Gulf Chapter American Association of Clinical Endocrinologists

Gulf Chapter
American Association of
Clinical Endocrinologists
1st Annual Meeting
October 12, 2012
CHAPTER II: MEMBERSHIP

Section 1. Eligibility. All members in good
standing of the American Association of
Clinical Endocrinologists (AACE) licensed to
practice medicine in the Gulf countries (Saudi
Arabia, Bahrain, Kuwait, United Arab
Emirates, Oman and Qatar) shall be eligible
for membership in the Chapter.
CHAPTER III: MEETINGS

Section 1. Annual Meeting. The Chapter shall hold an
annual meeting, open to all members and invited
guests, at a time and place designated by the Chapter
Board of Directors. The purpose of meeting shall be to
elect Chapter Officers and Chapter Board of Directors
members, present education programs, and to transact
other business that may come before the Chapter.
Section 4. Quorum. At any meeting of the membership
of the Chapter, a majority of the members present and
voting at such meeting shall constitute a quorum for
the transaction of business.
CHAPTER IV: BOARD OF DIRECTORS

Section 2. Composition. The Chapter Board of
Directors shall consist of: the officers of the
Chapter, four members of the Chapter at large,
and one member appointed by the Chapter
President.
Section 3. Election and Term of Office. The

Chapter Board of Directors shall be elected by the
members of the Chapter present and voting at
each annual meeting of the Chapter, and shall
serve for three (3) years.
CHAPTER V: OFFICERS
Section 1. Officers. The officers of the Chapter
shall consist of the President, President Elect, the
Secretary/Treasurer and the Immediate Past
President.
Section 2. Election and Term of Office. The term
of office of shall be for one year and the Chapter
Officers shall be elected by the members of the
Chapter at an annual meeting.
Board of Director Nominees

1.
2.
3.
4.
5.
6.
7.
8.
Thamer Alessa, MD; Kuwait

Eman M Alfadhli, MD; KSA
Mohammed Hussein AlGhamdi, MBChb,FRCPC,FACP
FACE; KSA
Naji Jameel Aljohani, MD; KSA
Juma M Alkaabi, MD FACE; UAE
Aishah Ali Alkhzaimi, MD, KSA
Mohamed Abdullah Al-Lamki,
MBChB, MSc, FRCP; Oman
Nasreen Abdulkarim Al-Sayed,
MD FACP; Bahrain
9.
10.
11.
12.
13.
14.
15.
Salem Arifi Beshyah, MBBCh

MRCI MRCP (UK) FRCP PhD;
UAE
Nabil Kamal Elnaggar, MD;
KSA
Imad El-Din Ginawi El-Sadig,
MD; UAE
Amin Ahmad Jayyousi, MD;
Qatar
Satendra Kumar Multani, MD
FACE; UAE
Huda Ezzeddin Mustafa,
MD ECNU; UAE
Mahmoud Ali Zirie, MD FACE;
Qatar
Secretary/Treasurer Nominees
1. Wiam Ibrahim Hussein, MD FACE FACP;
Bahrain
2. Khalid Faiq Mohammed Salih, MD FACE; UAE
Vice President Nominees

1. Ali Saeed Alzahrani, MD FACE; KSA
2. Ali Barnard Khalil MD, FACE; UAE
President Nominees
1. Fatma AlMarashi, MD FACE; UAE
2. Kamal A S Al-Shoumer, BSC, MB, DIC, PhD,
FRC FACE; Kuwait
3. Mahmoud Mohamed A Fikri, MBBCh, PhD;
UAE
4. Ahmed A K Hassoun, MD FACE; UAE
Candidate
Information
Submissions
*The following materials were submitted to AACE by the
candidate and appear in alphabetical order by position. Click on
the name to be directed to the appropriate candidate materials.
Board of Director
Candidates
1. Thamer Alessa, MD; Kuwait
2. Eman M Alfadhli, MD; KSA
3. Mohammed Hussein Al-Ghamdi, MBChb,FRCPC,FACP FACE;
KSA
4. Naji Jameel Aljohani, MD; KSA
5. Juma M Alkaabi, MD FACE; UAE
6. Aishah Ali Alkhzaimi, MD, KSA
7. Mohamed Abdullah Al-Lamki, MBChB, MSc, FRCP; Oman
8. Nasreen Abdulkarim Al-Sayed, MD FACP; Bahrain
9. Salem Arifi Beshyah, MBBCh MRCI MRCP (UK) FRCP PhD;
UAE
10. Nabil Kamal Elnaggar, MD; KSA
11. Imad El-Din Ginawi El-Sadig, MD; UAE
12. Amin Ahmad Jayyousi, MD; Qatar
13. Satendra Kumar Multani, MD FACE; UAE
14. Huda Ezzeddin Mustafa, MD ECNU; UAE
15. Mahmoud Ali Zirie, MD FACE; Qatar
Personal Statement

Serving a role of a promoter of health and well being has always been my ambition,
beginning in medical school, going through the journey of medical residency and
fellowship in the United States and then taking the responsibility of a full time
physician in Kuwait taking care of patients and engaging in social and scientific
activities. I have learned the role of AACE and other similar scientific societies very
early in my medical career and through the mentoring from great physicians and
professors in the University of Miami, like Dr.Paul Jellinger, a past president of
AACE, who taught me during my fellowship the importance of medical knowledge
and how to share them to other colleagues.

To be a part of such a very well known medical society, AACE, and be serving in the
Gulf Chapter Board of Directors, is a promising goal and would love to fulfill it. I see
any medical society like a bridge between clinical knowledge and clinical practice
specially with using the well-known AACE excellent medical and scientific
reputation. I see the role of the Gulf Chapter to be establishing this bridge by several
ways:
1) Providing medical information for physicians
2) Conducting annual, or similar, scientific meetings to discuss medical
literature, medical updates and Gulf based research developments and
presentations
3) Sharing the medical, clinical and research experience from AACE Faculty
4) Proving mentoring opportunities in the Gulf region for research and medical
experience
5) Periodic newsletters describing latest Endocrine news, like medical, legal,
research and even social activities
6) Promoting Endocrine science to medical student and young physicians
through encouraging attending the AACE annual and the Chapter meetings
with a learning track specified to them plus the experience from AACEs own
Endocrine University
7) Involving the public in promoting health by establishing ways to reach media
outlets or by using social networking or through educational or social
institutions

I believe the AACE Gulf Chapter, will serve a big role in the local Endocrine medical
society and I would love to be a part of it.
Thamer M. Alessa, M.D.

Mail Address
P.O. Box 5975
Safat, 13060
Kuwait
Contact Information
Cell: (+965) 99877855
Email: thamermd@gmail.com
Twitter : @thameralessa
EDUCATION
July 2009June 2011
Fellowship in Endocrinology, Diabetes and Metabolism at the J. Maxwell

McKenzie Fellowship Program. University of Miami/Jackson Memorial Hospital
and the Miami VA Hospital Florida/USA
Nov 2005Nov 2008
Internal Medicine Residency Program at the University of Miami/Jackson

Memorial Hospital and the Miami VA Hospital Florida/USA
20002003
Kuwait University Faculty of Medicine

B.M., B.Ch. Bachelor of Medicine and Surgery degree.
19962000
Kuwait University Faculty of Medicine

B.Med.Sc., Bachelor of Medical Sciences degree.
EXPERIENCE
Aug 2011 Present
Endocrine Division - Mubarak Al-Kabeer Hospital State of Kuwait Senior

Registrar
Nov 2008July 2009
Internal Medicine - Mubarak Al-Kabeer Hospital State of Kuwait Assistant

Registrar
Aug 2004Nov 2005
Internal Medicine - Mubarak Al-Kabeer Hospital State of Kuwait Assistant

Registrar
Aug 2003Aug 2004
Mubarak Al-Kabeer Hospital State of Kuwait Internship
Jul 2001
Professional Exchange Clerkship, International Federation of Medical Students

Associations (IFMSA)
General Surgery elective for 4 weeks at Virchow-Klinikum Hospital, Berlin,
Germany.
RESEARCH & PUBLICATIONS

June 2011
Poster Presentation at the Endocrine Society 93rd Annual Meeting in Boston,

Massachusetts with a title High HDL-Cholesterol Is Common in Older Adults
with Type 1 Diabetes (T1DM)
Alessa T, Szeto A, Mendez A, Chacra W, Goldberg R.
Competed for the Presidential Poster Competition.
June 2010
Management of Diabetic Dyslipidemia: an update Review Article

Alessa T, Goldberg R. International Diabetes Monitor. 2010; 22(5):203-212.
Thamer M. Alessa, M.D.

June 2010
Poster Presentation at the Endocrine Society 92nd Annual Meeting in San Diego,
California with a title Pituitary Dysfunction in a Patient with RosaiDorfman
Disease.
Alessa T.
Aug 20062008
Inhaled Insulin Research Study University of Miami Miller School of Medicine

Diabetes Research Institute
Joint Dr.Hernandez-Cassis in a research project towards studying the use of inhaled
insulin in patients with Type 1 diabetes.
2002
7th Annual Health Sciences Poster Day, Health Science Center. Faculty of Medicine
- Kuwait University
Alsuwaidan MT, Alessa TM, Almutawa FA. Assessing Personality Profiles Among
Physicians of Different Specialties in Kuwait.
HONORS & AWARDS

July 2010June 2011
Chief Fellow, the J. Maxwell McKenzie Endocrinology, Diabetes and Metabolism

Fellowship Program. University of Miami/Jackson Memorial Hospital and the
Miami VA Hospital Florida/USA
2002
Kuwait Medical Students Association Outstanding Student Award

Honored by Dr. Muhammad Al-Jarallah, Minister of Health.
2001
HRH the Emir of Kuwaits Graduation Ceremony

Honored by His Royal Highness for graduating in high standing.
2000

Honored by the Dean of the Faculty of Medicine.
1997

Honored by Vice-rector of Kuwait University.
MEMBERSHIPS
2010Present
2009Present
2006Present
2003Present
Endocrine Society
American Thyroid Association
American Association of Clinical Endocrinologists.
Kuwait Medical Association.
CERTIFICATIONS
Educational Commission for Foreign Medical Graduates certification.

Medical Council of Canada Evaluating Examination.
American Board of Internal Medicine (ABIM) Certification Examination Aug 17th
2009.
The International Society for Clinical Densitometry (ISCD) Clinical Densitometry
Certification exam (CCD), June 2011.
My name is Eman Alfadhli, Assistant professor of Medicine, consultant

Endocrinologist and Vice Dean of Pharmacy Collage at Taibah University- Girls
section, Madinah, Saudi Arabia. I got a fellowship in Endocrinology and metabolism
from King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia in
2002. Then I worked as a Clinical Research fellow in islet transplantation program at
University of Alberta, Edmonton, Canada in 2004. In 2009, I served as a visiting
scientist and research scholar in Endocrinology and Metabolism at University of
California, Los Angeles, Harbour Medical Centre at United State of America.
I am honoured to be nominated for a position on the Board of Directors of the Gulf
Chapter of the American Association of Clinical Endocrinology. I believe strongly in
the goals of the Gulf Chapter: advocating for policies and actions that enhance the
science and practice of endocrinology; promoting the professional development of
endocrinologists through educational initiatives; and recognizing excellence in
endocrinology in the Gulf area.
AACE has been at the forefront of the profession in field of endocrinology. As a
Board member at the Gulf Chapter, I will work to make sure that AACE Gulf Chapter
be a leader in the Gulf region. I will work to maintain close collaboration with other
AACE chapters and other endocrinology organizations which is necessary for
successful policy formulation. AACE also serves an important function for the
continuing education and professional development of endocrinologists. This is
achieved in part by the stellar scientific value of the annual meeting program, the
other meetings, and courses that conducted by AACE. I would like to see Gulf
Chapter of AACE grow and expand in professional development. AACE is a
proactive in the continuing education of its membership. I believe the greatest asset
of AACE is its membership. In particular, I appreciate the variety of endocrinologists
from all areas, government, industry, and academia. I feel it is vital for AACE Gulf
Chapter to find ways to actively engage membership from different areas and I would
like to be a member of the Board Directors. Also I like to continue efforts to expand
membership with an emphasis on minorities, students, and early career
endocrinologists in all settings.
CURRICULUM VITAE
Dr. Eman Mohammed Alfadhli
Name
Eman Mohammed Al Fadhli, MD, MRCP, SBIM,

ABIM, JBIM
Place of birth
Al Madinah Al-Monawara, Saudi Arabia
Marital status
Married
Present position
:
Assistant professor of Medicine at Taibah
University, Madinah
Al-Monawara
Vice Dean of the Pharmacy Collage at Taibah
University- girls section
Contact information:
Mobile: 0555305170, Home: 04- 8443195

E Mail: alfadhli2005@yahoo.com.
Wasel 7373 Ash shuraybat,
Ibraheem Bin Abbad Street
Unit No 1
Almadinah 42316-5353
Saudi Arabia
Education
Medical School
King Saud University, 1994
Internship
King Saud University, 1994 - 1995
Residency
Riyadh Armed Forces Hospital

Sept 1995- Sept 1999
Fellowship
Senior Registrar, Endocrinology

Riyadh Armed Forces Hospital
Oct 1999 Sept 2000
Fellow in Endocrinology
King Faisal Specialist Hospital & Research Centre
Oct 2000 December 2003

Clinical Research fellow in islet transplantation
and Endocrinology
University of Alberta, Edmonton, Canada
Jan 2004 December 2004.
Visiting
scientist
and
Research
scholar
Endocrinology and metabolism
University of California, Los Angeles, United State
December 2008 November 2009
Past Positions
in
:* Locum as a consultant endocrinologist at different

hospitals in Saudi Arabia:
-King Fahad medical City, Riyadh on 2005 and 2007
-King Fahad Hospital, Al-Madinah Al-Monwarha on
2008
-Royal commission Hospital, Jubail 2008.
-Royal commission Hospital, Yanbu 2010.
-National Guard Hospital, Riyadh on 2010.
* Acting Vice Dean of Medical Collage at Taibah
University, Madinah Monwarha
Feb 2007- June 2007
* Consultant Endocrinologist
King Fahad Hospital, Al-Madinah Al-Monwarha
Feb 2005 until Nov 2005
Certifications
1. Membership of Royal College of Physicians (MRCP) of Internal Medicine, June
1999
2. Arab Board of Internal Medicine, February 2000
3. Jordanian Board of Internal Medicine, February 2000
4. Saudi Board of Internal Medicine, November 2000
3
5. Medical Council of Canada Evaluating Exam (MCCEE), February 2003
Presentations at Symposiums:
1- Recent Advances in Diabetes Management, at Islet transplantation

symposium with collaboration with City of Hope, King Faisal Specialist
Hospital & Research Center, Riyadh, Saudi Arabia, 2003.
2- Islet Cell Transplantation, at Endocrine update symposium, Riyadh, Saudi
Arabia, Military Hospital, March 30, 2005.
3- Islet Cell Transplantation, at Diabetes update symposium, Saudi Society of
Family & community Medicine, Al- Madinah, Saudi Arabia, May 11 2005.
4- Diabetes in pregnancy, at Saudi Society of Family & community Medicine,
Madinha, Saudi Arabia, March, 2006.
5- Islet Cell Transplantation, at Surgery Update Symposium, Madinha, Saudi
Arabia, April 3-5, 2006.
6- Advances in Diabetes Management, at First annual symposium of
diabetes, Taibah University, Madinha, Saudi Arabia, 15/1/2007.
7- Advances in Diabetes Management, at Taibha club for Diabetes &
Endocrinology, Madinha, Saudi Arabia, March 5, 2007.
8- Difficult case of Graves disease, at Taibha club for Diabetes &
Endocrinology, Madinha, Saudi Arabia, April 5, 2007.
9- Endocrine emergency, at Introduction to Emergency Nursing course at

King Fahad Hospital, Madinha, Saudi Arabia, 31/10/2007.
10- Adrenal incidentaloma, at Taibha club for Diabetes & Endocrinology,
Madinha, Saudi Arabia, November 12, 2007.
11- Diabetes in pregnancy, at Maternal and Child Health Care Course,
Madinha, Saudi Arabia, december, 2007.
12- Management of Diabetic Peripheral neuropathy, at Diabetic Foot miniSymposium, Taibah University, Madinha, Saudi Arabia, 2/3/2008.
13- Adrenal incidentaloma, at Update in Diabetes & Endocrinology
symposium, Madinha, Saudi Arabia, March 22, 2008.
14- Diabetes in pregnancy, at Update in Diabetes & Endocrinology
symposium, Madinha, Saudi Arabia, March 23, 2008.
15- Update in the management of Gestational Diabetes, at First International
Diabetes & Obesity Conference, Taif, Saudi Arabia, April 27-29, 2008.
16- Continuous glucose monitoring system, at First International Diabetes &
Obesity Conference, Taif, Saudi Arabia, April 27-29, 2008.
17- Diabetes and Pregnancy, at Diabetes Care Course, Madinha, Saudi Arabia,
May 21-22, 2008.
18- Insulin therapy, at Diabetes Care Course, Madinha, Saudi Arabia, May 2122, 2008.
19- Advances in Diabetes Management, at Jubail Hospital, Saudi Arabia,
15/8/2008.
20- Adrenal incidentaloma, at the Second Diabetes and Endocrinology
Conference, Jeddah, Saudi Arabia, August 26-27, 2008.
21- Diabetes in pregnancy, at the Second Diabetes and Endocrinology
Conference, Jeddah, Saudi Arabia, August 26-27, 2008.
22- Update in the management of Gestational Diabetes, at International

Diabetes Day, Madinha, Saudi Arabia, November 12, 2008.
23- Advances in Diabetes Management, at International Diabetes Day,
24- Initiation and Adjustment of insulin therapy for T2DM after failure of OHA,
at International Diabetes Day, Madinha, Saudi Arabia, November 12, 2008.
25- Update in the management of Gestational Diabetes, at Update in
Endocrine Disorders Symposium, Alula, Saudi Arabia, March 24-25, 2010.
26- Management of T2DM: Initiation and Adjustment, at Update in Endocrine
Disorders, Alula, Saudi Arabia, March 24-25, 2010.
27- Update in the management of Gestational Diabetes, at the Forth Jeddah
Update in Diabetes and Endocrinology Conference, Saudi Arabia, October
11-13, 2010.
28-Endocrine emergency, at Introduction to Emergency Nursing course at
29-Management of T2DM: Initiation and Adjustment, at Medical Therapy
Conference. Madinha, Saudi Arabia, February 24-25, 2010.
30-Management of T2DM: Initiation and Adjustment, at Diabetes
Management Course for Physicians, , King Fahad Medical City, Riyadh,
Saudi Arabia, March 12-16, 2011.
31- Islet Cell Transplantation, at Surgery Update Symposium, at Diabetes
32-Endocrine emergency, at First Aid course for Nurses at King Fahad
Hospital, Madinha, Saudi Arabia, 14/6/2011.
33-Management of T2DM: Initiation and Adjustment, at Recent Advances in
Medicine, Saudi Germani Hospital, Madinha, Saudi Arabia, September 2022, 2011.
6
34-Management of hyperglycemia in hospitals at Annual Regional Hajj

Symposium, King Fahad Hospital, Madinha, Saudi Arabia, October 4-5,
2011.
35-Hyperglycemic crises in Patients with Diabetes at First RCMC Emergency
Care Regional Symposium. Yanbu, Saudi Arabia, November 21-22, 2011.
36-Management of hyperglycemia in hospitals at Six Taif National Diabetic
Conference, Taif, Saudi Arabia, March 20-21, 2012.
37- Management of hyperglycemia in hospitals at First Update Internal
Medicine Conference, Madinha, Saudi Arabia, April 25-26, 2012.
Courses and Symposia

1- Royal Free Hospital course of Internal Medicine, London, 1998
2- BPR course of Internal Medicine, London, 1998
3- Medipass course of Internal Medicine, London, 1998
4- Adult Medicine course for MRCP II & Arab Board in Hammadi Hospital,
Riyadh both written and clinical courses, September 1998 and February
1999 respectively.
5- Adult Medicine course for MRCP II and Arab Board in Al Qassim, 1997 and
1999
6- Basic ECG course at Riyadh Military Hospital, 1994
7- Advanced ECG course and arrhythmia course, 1998
8- Basic course in general ultrasound, 1997
9- 6th Advanced Medicine Symposium, Riyadh Armed Forces Hospital, 1996
10- 7th Advanced Medicine Symposium, Riyadh Armed Forces Hospital, 1998
11- 5th Saudi Gastroenterology Association Meeting, AlKhobar, November
1997 (attended and participated in a case report about Primary
amyloidosis of the liver
12- 2nd Acute Medicine Symposium, Riyadh Armed Forces Hospital, 1995
13- 3rd Acute Medicine Symposium, Riyadh Armed Forces Hospital, 1997
14- 4th Acute Medicine Symposium, Riyadh Armed Forces Hospital, 1999
15- 10th Saudi Neurosciences Symposium, King Faisal Sepcialist Hospital &
Research Centre, Riyadh, 2000
16- International Symposium on Osteoporosis, Security Forces Hospital,

Riyadh, 2002
17- Diabetes Care 2002 working Together for Prevention and Control, King
Khalid Eye Specialist Hospital, Riyadh, 2002
18- Fundamental of conducting Research symposium, King Faisal Specialist
Hospital & Research Centre, Riyadh, 2002
19- 2nd Endocrine and Diabetes Update Symposium, King Khalid University
Hospital, Riyadh, 2002.
20-Personal Digital Assistants, May 29, 2004, University of Alberta, Edmonton,
Canada.
21-Endocrine Society annual meeting, June 16-19 2004, New Orleans, LA,
USA.
22-Ms Word (1) course, August 4, 2004, University of Alberta, Edmonton,
Canada.
23- Ms Word XP (2) course, September 20 4,2004, University of Alberta,
Edmonton, Canada.
24- Ms Excel (1) course, August 6, 2004, University of Alberta, Edmonton,
Canada.
25- Ms Excel (2) course, August 13, 2004, University of Alberta, Edmonton,
Canada.
26- Ms Power Point XP (1) course, September 22 4,2004, University of Alberta,
Edmonton, Canada.
27- The Canadian Diabetes Association (CDA)/Canadian Society of
Endocrinology and Metabolism (CSEM) Professional Conference and
Annual Meeting, October 27 - 30, 2004 Quebec City, Canada.
28-Endocrine update symposium, Riyadh, Saudi Arabia, Military Hospital,
March 30 2005.
9
29- Diabetes update symposium, Madinha, Saudi Arabia, Saudi Society of

Family & community Medicine, May 11 2005.
30-Update on diabetes symposium, Jeddah, Saudi Arabia, October 2006.
31-Surgery Update Symposium, Madinha, Saudi Arabia, April 2006.
32- First annual Madinah diabetes and metabolism conference, Madinha,
Saudi Arabia, June 2006.
33- Medical Education Workshop (1) Taibah University, Madinha, Saudi
Arabia, 17/6/2006
34- Medical Education Workshop (2) Taibah University, Madinha, Saudi
Arabia, 17/11/2006.
35- National symposium and workshop on liver disease, Madinha, Saudi
Arabia, 18-19/11/2006.
36- First annual symposium of diabetes, Taibah university, Madinha, Saudi
Arabia,15/1/2007.
37- Taibha club for Diabetes & Endocrinology, Madinha, Saudi Arabia, one
day in March, April, June & February, 2007.
38- Medical and surgical aspects of neuroendocrine disorders symposium,
King Faisal Specialist Hospital & Research Centre, Riyadh, 3-4/4/ 2007.
39- Infertility and reproductive endocrinology symposium, Madinha, Saudi
Arabia, 23/5/2007.
40- Evidence Based Medicine course, King Fahad Hospital, Madinha, Saudi
Arabia, 19- 22/5/2007.
41- Conference in Diabetes Economics Vital Investments, Riyadh, Saudi
Arabia, 3-5/11/2007.
10
42- Maternal and Child Health Care Course, Madinha, Saudi Arabia, December
29, 2007.
43- 7th Clinical Research Professionals Course, Riyadh, Saudi Arabia, King
Faisal Specialist Hospital & Research Centre, Riyadh, 19-30/1/ 2008
44- Diabetic Foot mini-Symposium, Taibah University, Madinha, Saudi Arabia,
2/3/2008.
45- Symposium in Growth Hormone, Jeddah, Saudi Arabia, February 21 2008.
46- Symposium in Disorders of Vitamin D Deficiency, at King Fahad Medical
City, Riyadh, Saudi Arabia, February 27 2008.
47-Update in Diabetes & Endocrinology symposium, Madinha, Saudi Arabia,
March 22-23, 2008.
48- First International Diabetes & Obesity Conference, Taif, Saudi Arabia, April
27-29, 2008.
49- Accreditation for Healthcare Institutions workshop, Central Board of
Accreditation for Healthcare Institutions, Jeddah, May, 4-7 2008.
50- Diabetes Care Course, Madinha, Saudi Arabia, May 21-22, 2008.
51-The Second Diabetes and Endocrinology Conference, Jeddah, Saudi
Arabia, August 26-27, 2008.
52- International Diabetes Day, Madinha, Saudi Arabia, November 12, 2008.
53- Advances and management of thyroid and parathyroid diseases
symposium, Cedar- Sinai Medical Center, Los Angeles, California, United
State, March 14-15, 2009.
54- Annual Rachmiel Levine Diabetes and Obesity Symposium, City Of Hope,
Los Angeles, United State, March 18-21, 2009.
55- The 31st Symposium on Thyroid 2009, University of Southern California,
Los Angeles, California, United State, May 9, 2009.
11
56- Introductory Hands-On Thyroid Ultrasound Workshop, Washington, DC,

United State, June 9, 2009.
57- Endocrine society meeting for 2009, Washington, DC, United State, June
10-13, 2009.
58- Update in Endocrine Disorders Symposium, Alula, Saudi Arabia, March 2425, 2010.
59-First Taibah University Clinical Toxicology Workshop, at Taibah University,
Madinha, Saudi Arabia, May 5-6/2010.
60- The Forth Update in Diabetes and Endocrinology Conference, Jeddah,
Saudi Arabia, October 11-13, 2010.
61- EndNote workshop, Madinah, Taibah University, November 29-30 2010.
62- Electronic Education Course 1, at Taibah University, Madinha, Saudi
Arabia, 6/12/2010.
63- Electronic Education Course 2, at Taibah University, Madinha, Saudi
Arabia, 7-8/12/2010.
64-Endocrine emergency, at Introduction to Emergency Nursing course at
65-Medical Malpractice Conference, Medical & Legislative perspective 2011,
at Taibah University, Madinha, Saudi Arabia, 4-6/1/2011.
66-Management of T2DM: Initiation and Adjustment, at Medical Therapy
Conference. Madinha, Saudi Arabia, February 24-25, 2010.
67-The Essential Academic Leader, Jazan University, Saudi Arabia, March 5-6,
2011.
68-Management of T2DM: Initiation and Adjustment, at Diabetes
12
69- Islet Cell Transplantation, at Surgery Update Symposium, at Diabetes

70- Clinical Endocrinology: 2011, Massachusetts General Hospital, Harvard
Medical school, Boston, USA, April 6-10, 201.
71- AACE Diagnostic Endocrine Neck Ultrasound and UGFNA Course, San
Diego, USA, April 11-12, 2011.
72- 20th Annual Meeting and Clinical Congress of the American Association
of Clinical Endocrinology: 2011, San Diego, USA, April 13-17, 2011.
73- Effective Communication workshop, at Taibah University, Madinha, Saudi
Arabia, 21-25/6/2011.
74-SPSS course, at Taibah University, Madinha, Saudi Arabia, 28-31/6/2011.
75-Workshop on How to become a successful trainer, at Taibah University,
Madinha, Saudi Arabia, 2-8/6/2011.
76-First Aid course for Nurses at King Fahad Hospital, Madinha, Saudi Arabia,
11-15/6/2011.
77- Recent Advances in Medicine, Saudi Germany Hospital, Madinha, Saudi
Arabia, September 20-22, 2011.
78-Annual Regional Hajj Symposium, King Fahad Hospital, Madinha, Saudi
Arabia, October 4-5, 2011.
79-. First RCMC Emergency Care Regional Symposium. Yanbu, Saudi Arabia,
November 21-22, 2011.
80-Third Saudi Pediatrics Endocrine Conference, Madinha, Saudi Arabia,
January 4-5, 2012.
81- Six Taif National Diabetic Conference, Taif, Saudi Arabia, March 20-21,
2012.
13
82- First Update Internal Medicine Conference, Madinha, Saudi Arabia, April
25-26, 2012.
Organization for Courses and Symposia:

1-Member of the Organizing Committee for Islet transplantation symposium with
collaboration with City of Hope, at King Faisal Specialist Hospital & Research
Center, Riyadh, Saudi Arabia, 2003.
2- Chairman of the Organizing Committee for Update in Diabetes &
Endocrinology symposium, Madinha, Saudi Arabia, March 22-23, 2008.
3- Chairman of the Organizing Committee for International Diabetes Day,
Awards:
-
Best resident of Internal Medicine, Riyadh Armed Forces Hospital, 1996
Award for obtaining annual Internal Medicine prize in Riyadh Armed Forces
Hospital for 2 years, 1997 & 1998
Riyadh Armed Forces Hospital Award for achievement, 2000
14
15
Riyadh Armed Forces Hospital Award for achievement, 2001
Member of:
-
Chief of Taibha club for Diabetes & Endocrinology, Madinha, Saudi Arabia.
Board member of Saudi Society for Endocrinology & Metabolism
Member of Endocrine Society.

Member of American Association of Clinical Endocrinology.
Member of the International Society for Clinical Densitometery (ISCD).
Member of Diabetes Care Course.
Member Taibah medical Doctors.
Member Central Board for Accreditation of Health Institutes (CBAHI).
Peer- reviewer for:

-
16
The Annals of Saudi Medicine Journal.
Papers:
1. Edmond A. Ryan, Breay W. Paty ,Peter A. Senior David Bigam, Eman Alfadhli,
Norman M. Kneteman, Jonathan Lakey and A.M. James Shapiro. Five year
follow-up after clinical islet transplantation, Diabetes, VOL. 54, JULY 2005.
2. Intesar Sultan, Eman Alfadhli, Lobnha Saber, and Nahid Abdulgani. Is type 2
diabetes mellitus a risk factor for vitamin D insufficiency, Journal of Taibah
University, Medical Science, 2007; 2 (1, 2): 30 - 41.
3. Hussein Raef, Eman Alfadhli, Alya Al Hajjaj, Siema Bakheet and Abdulrahman
Al-Nuaim. High rate of persistence/ recurrent disease among patient with
thyroid cancer: Factors affecting non-remession. Ann Saudi Med 28(4) JulyAugust 2008
4. Raef H, Malabu UH, Alfadhli E, Al-Hajjaj A, Al-Sobhi S, Rifai A, Al-Nuaim A.
Prognostic value of postoperative and post-ablative serum thyroglobulin
levels in patients with differentiated thyroid cancer. Niger J Med. 2008 OctDec;17(4):391-5.
5. Alfadhli E, Koh A, Albaker W, Bhargava R, Ackerman T, McDonald C, Ryan EA,
Shapiro AM, Senior PA. High prevalence of ovarian cysts in premenopausal
women receiving sirolimus and tacrolimus after clinical islet transplantation.
Transplant International, 2009 Jun; 22(6):622-5 .
6. Eman M Alfadhli. Secondary adrenal insufficiency
antiphospholipid syndrome. Intern Med. 2009;48(22):1963-6.
and
primary
7. Eman Alfadhli, Manal Ibrahim Hanafi, Intessar Sultan. Assessment of selfreported cardoimetabolic risk awareness among physicians. Bulletin of
Alexandria Faculty of Medicine. 2009 Nov.
8. Eman Alfadhli. Cholesterol deposition around small joints of the hands in
familial hypercholesterolemia mimicking Bouchard's and Heberden's nodes
of osteoarthritis". Intern Med. 2010;49(15):1675-6.
9. Eman Alfadhli, Andrew G. Gianoukakis. Management of severe thyrotoxicosis
when gastrointestinal tract is compromised. Thyroid. March 2011, 21(3): 215220.
17
10- Eman Alfadhli, Allergy to insulin glargine. J Med Cases 2011;2(1):4-6.
Abstracts:
10. E Alfadhli, M Ahmed, A Almahfouz, A Alarifi, H Raef, F Al Dayel and S Al
Sobhi. Vitamin D Deficiency (VDD) Associated with Primary
Hyperparathyroidism (PHPPT) Presenting With Giant Brown Tumors (BT)
Mimicking Primary Bone Malignancy (PBM). Presented at the Endocrine
Society 84th Annual Meeting, June 2002, San Francisco
11. E Alfadhli, M Ahmed, A Arifi, A Almahfouz, F AlDayal and S AlSobhi. (Poster)
Adrenalcortical Carcinoma (ACC): Long Term Remission. Presented at the
Endocrine Society 84th Annual Meeting, June 2002, San Francisco
12. H Raef, E Alfadhli, A Almahfouz. TB of the thyroid Gland Mimicking
Subacute thyroiditis. Presented at the Endocrine Society 84th Annual Meeting,
19-22 2002 June, San Francisco
13. E Alfadhli, M Ahmed, S Alsifri, A almahfouz, F AlDayel and S. Alsobhi.
Vagaries in the Presentation of Primary Hyperparathyroidism (PHPPT).
Presented at the Endocrine Society 84th Annual Meeting, June 2002, San
Francisco
14. E Alfadhli, A AlHajjaj, S Bakheet and H Raef. Succesful Ablation Rate of
Differentiated Thyroid Cancer at KFSH&RC Using I123 for Pretreatment Whole
Body Scan (WBS) and Factors Affecting Remission. Poster presentation at the
American Thyroid Association, Oct 2002.
15. Hussein Raef, Eman Alfadhli, Alya Al Hajjaj, Siema Bakheet and Abdulrahman
Al-Nuaim. Contributing Factors to the High Recurrence/Persistence Rate
among Patients with Differentiated Thyroid cancer in the Kingdom of Saudi
Arabia.
Presented at the Endocrine Societys 85th Annual Meeting,
Philadelphia, USA, 19-22 June 2003
16. Nora Kahtani, Abdullah Alarifi, Eman Alfadhli, Suzan Salam, Mohammed
Ahmed, and Saif al Sobhi. The Usefulness of T3/T4 ratio in Early Detection of
18
Subclinical Hypothyroidism. Presented at the 6th King Faisal Specialist

Hospital research annual day, 31 December 2003 - Riyadh. Also presented as
a poster at the Endocrine Society Annual Meeting, June 2004, New Orleans,
USA.
17. Abdulraof Almahfouz, Eman Alfadhli, Mohammed Ahmed, Hussein Raef and
Ali Alzahrani. Factors Predictive of Clinical Responses to Pioglitazone in
Uncontrolled Diabetic Patients. Presented at the 6th King Faisal Specialist
Hospital research annual day, 31 December 2003 - Riyadh.
18. Anthony Yin, Eman Alfadhli, Michelle Htun, Sandy Faulkner, Robert Dudley,
Laura Hull, Andrew Leung, Ronald Swerdloff and Christina Wang. Effect of
dietary fat on the pharmacokinetics of an oral formulation of testosterone
undecanoate (SEDDS) in hypogonadal men. Presented at the Endocrine
Society Annual Meeting, June 2010, San Diego, USA.
Referees:
- Entessar Sultan, MD. Professor of Medicine
Consultant Endocrinologist
Department of Medicine, Taibah University.
Jameat Road, Madinha.
Saudi Arabia. Po Box 344
- Ali S. Alzahrani, MD, FRCP, FACE, FACP.
Visiting Professor at Johns Hopkins University, Baltimore, USA
P.O. Box 3354, Riyadh 11211
Kingdom of Saudi Arabia
- Ronald S. Swerdloff, M.D. Professor of Medicine
David Geffen School of Medicine at UCLA
Chief Division of Endocrinology
Harbor-UCLA Medical Center
1000 W. Carson St. Box 446, Torrance, CA 90502
Phone: (310) 222-1867
Fax: (310) 533-0627
19
American Association of Clinical Endocrinologists

245 Riverside Avenue Suite 200 Jacksonville, Florida 32202 Phone: (904) 353-7878 Fax: (904) 353-8185 http://www.aace.com
Gulf Chapter of the American Association of Clinical Endocrinologists

(Bahrain, Kuwait, Omar, Qatar, Kingdom of Saudi Arabia, United Arab Emirates)
1st Annual Meeting

October 12, 2012
Attn: Gulf AACE Chapter Members,
In accordance with the American Association of Clinical Endocrinologists (AACE) International Chapter Bylaws Model,
the first annual meeting of the Gulf Chapter of AACE will be held on October 12, 2012 in conjunction with the Emirates
Endocrine Conference in Dubai. The purpose of this meeting is to adopt and ratify Chapter Bylaws and to elect the
Chapter Board of Directors who will be responsible for management of the property and affairs of the Chapter. This
meeting is open to all Gulf-AACE members and their invited guests.
If you have an interest in serving as a member of the Gulf Chapter of AACE Board of Directors, please complete and
return the form below by September 4th, 2012. A copy of your CV or a bio-sketch should be included with your
nomination, along with a statement of why you would like to serve on the Gulf Chapter Board of Directors; candidate
statements are limited to one page. Please send your response to jcockley@aace.com or by fax at 904/404-4173.
1
Name:
Address:
City:
ALKHOBAR 31952
Country:
Email:
Mohammed H AL-Ghamdi.FRCPC,FACE,FACP
P O Box 20610
Saudi Arabia 31952

drmghamdi@hotmail.com
2
Are you agreeable to having your email address shared with the new leadership of the Gulf Chapter of AACE for the
purposes of Chapter business? _x__ yes ___ no
3
Indicate the Board of Director position for which you would like to be nominated (description of duties on page 2)
___ President
___ Vice President
___ Secretary
___ Treasurer
_x__ Board of Director Member
___ CV or bio-sketch included
___ Candidate statement included


1st Annual Meeting

October 12, 2012
1
Name: NAJI Jameel Aljohani PO BOX 59045 Riyadh 11525
Address: King Fahad Medical City
City: Riyadh
Country: Saudi Arabia
Email: najij@hotmail.com
2
purposes of Chapter business? _*__ yes ___ no
3
___ President
___ Vice President
___ Secretary
___ Treasurer
_*__ Board of Director Member
Dr. Juma M Alkaabi

BSc, MBChB, DTM&H, FRCP, FACP,FACE
The Gulf Chapter of the American Association of Clinical Endocrinologist
SelfIam Associate Professor of Medicine at the Faculty of Medicine and Health Sciences, UAE
University and consultant Internist, Endocrinologist at the two teaching hospitals (Tawam and
Al-Ain). I provide comprehensive ambulatory setting and consultative service in General Internal
Medicine, Endocrinology, Diabetes and Metabolism where, I deliver a modern clinical service,
.
I obtained the basic medical science degree from the University of St. Andrews Scotland in 1990
and the Medical Degree from University of Manchester- England in 1993. Subsequently I trained
in Internal Medicine in the United Kingdom followed by Clinical Fellowship in Endocrinology
and Metabolism at the University of Alberta- Edmonton- Canada where I spent two years and a
half as clinical fellow at the department of Endocrinology and Metabolism and I was attached to
the islet cell transplant unit.
I have significant inputs into the clinical healthcare system of the UAE through my membership
of the Ministry of Health National Diabetes Committee. In the community, I made my speciality
of diabetes reachable and understandable by the general population to direct involvement with
national guidelines preparations and awareness campaigns. I have been active in contributing to
the CME, public health awareness in the community. In addition, I have been successful in
organising the Annual Diabetes Workshops in the Faculty of Medicine UAE University and
have been a member of the scientific committee for many local conferences, workshops and
scientific meetings.
Why I am applying for the Board of Directors membership of the Gulf Chapter of the
AACE?
This can be summarized in the following points;
1.
2.
3.
4.
I have been encouraged to apply.

To organize and facilitate high caliber scientific meetings in the Gulf States.
To encourage potential candidates to join the AACE and the Gulf Chapter of the AACE.
To facilitate regional collaboration in terms of dissemination and implementation of the
latest guidelines in clinical practice.
5. To encourage research; the Gulf Chapter of the AACE may play a major role in
encouraging more active clinical or basic science research in the region through the
networking among the endocrinologist in the region.
For more information, kindly find the enclosed CV.
Many thanks.
Juma M Alkaabi
DR. JUMA AL-KAABI CV SEPTEMBER, 2012
CURRICULUM VITAE
DR. JUMA MUSABAH MOHAMMED AL-KAABI

ASSISTANT PROFESSOR AND CONSULTANT, INTERNAL
MEDICINE/ENDOCRINOLOGY-DIABETES & METABOLIC DISEASES
Nationality
Professional address
U.A.E. National.
Faculty of Medicine and Health Sciences,
Department of Internal Medicine
UAE University,
PO Box 17666,
Al Ain,
United Arab Emirates.
Telephone:
Fax:
E-mail:
+971 3 7137472
+971 3 7672995
j.kaabi@uaeu.ac.ae
QUALIFICATIONS
BSc, MBChB, MRCP(UK), DTM&H, FRCP, FACP, FACE and a Canadian Clinical Fellowship in
Endocrinology and Metabolism.
CURRENT POSITION
Associate Professor of Medicine at the Faculty of Medicine and Health Sciences- UAE University,
Consultant, Internal Medicine/Endocrinology-Diabetes & Metabolic Diseases at Al Ain and Tawam
Hospitals.

GMC REGISTRATION NUMBER
4027081
HAAD LICENSE
GD 6505, Consultant Internal Medicine/Endocrinology-Diabetes & Metabolic Diseases.
FELLOWSHIP
The Royal College of Physicians of London and Edinburgh
The American College of Physicians
The American Association of Clinical Endocrinologists
LIST OF DEGREES
1985-1987
Scottish Highers
Clydebank College Glasgow - Scotland.
1987-1990
Bachelor of Medical Sciences
The University of St. Andrews- Scotland.
1990-1993
MBChB
The University of Manchester-England.
April 1999
Diploma of Tropical Medicine and Hygiene (DTM&H), The University of London.
July 1999
Membership of The Royal College of Physicians MRCP(UK)
October 2005
Clinical Fellowship Program in Endocrinology and Metabolism - University of Alberta,
Edmonton- Canada
March 2008

Fellowship of The Royal College of Physicians of Edinburgh
June 2008
Fellowship of the American College of Physicians
July 2008
Fellowship of the Royal College of Physicians of London
December 2008
Fellowship of the American College of Endocrinologists
MEMBERSHIP OR FELLOWSHIP OF PROFESSIONAL SOCIETIES
1.
The General Medical Council of the U.K.
2.
Royal College of Physicians of Edinburgh.
3.
College of Physicians and Surgeons Province of Alberta.
4.
The American College of Physicians (01274189) Membership.
5.
The Endocrine Society - Membership (221494).
6.
American Association of Clinical Endocrinologists (AACE).
7.
American Diabetes Association.
8.
The International Society for Clinical Densitometry.
9.
FMHS Diabetes and Cardiovascular Research Priority Group.
10.
The UAE National Diabetes Committee.
11.
Member of the Scientific Committee of the Shaikh Hamdan bin Rashid Al Maktoum Award
for Medical Sciences.
12.
Emirates Medical Association.
13.
The Emirates Endocrine Club.
RECOGNITION AND AWARDS
1987-1990
Eight merit certificates in different medical science courses were awarded during Bachelor of
Medical Sciences studies at the University of St. Andrews-Scotland.
2000-2001
Elected by the medical students of College of Medicine, SQUH, Oman to be awarded Clinical Tutor
of the Year.
2008-2009
Elected by students and faculty to receive the FMHS Distinguished Teaching Award .
17 Nov. 2011
May 2012
Elected by students and faculty to receive the FMHS Distinguished
ADVISORY COMMITTEES
2010 and up-to-date
Scientific Committee of the Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences
Oct. 2011
PhD Advisory Committee
Dec.2011
Fellowship Program at the UAE University.
Jan. 2012
FULL LIST OF PUBLICATIONS IN PEER REVIEWED JOURNALS
1. T. E. Adrian, S. Gariballa, K. A. Parekh, S. A. Thomas, H. Saadi, Al Kaabi JM, N.

Nagelkerke, B. Gedulin and A. A. Young. Rectal taurocholate increases L cell and insulin
secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers.
Diabetologia Clinical and Experimental Diabetes and Metabolism (accepted).
2. Al-Kaabi JM, Al Neyadi M, Al Darei F, Al Mazrooei M, Al Yazedi J, Abdulle A. Terrestrial
snakebites in the South East of the Arabian Peninsula: Patient Characteristics, Clinical
Presentation, and Management. PLoSone Journal. Open Access Article URL;
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0024637
3. Al-Kaabi JM, Bayan Al-Dabbagh, Hussein Saadi, Salah Gariballa, Javed Yasin. Effect of
coffee consumption on the Glycemic index of Khalas dates tested in healthy and diabetic
subjects. Published in ClinicalTrials.gov Identifier: NCT01422668.
4. Al-Kaabi JM, Wheatley AD, Barss P, Al Shamsi M, Lababidi A, Mushtaq A. Carbon
monoxide poisoning in the United Arab Emirates. International Journal of Occupational and
Environmental Health, Vol 17, No 3 (2011).
5. Al-Kaabi JM, Al-Dabbagh B, Ahmad S, Saadi H, Gariballa S, Al Ghazali M. Glycemic
Indices of Five Varieties of Dates in Healthy and Diabetic Subjects. Nutrition Journal, May
2011, 10:59. Open Access Article URL: http://www.nutrition.com/content/10/1/59.
6. Hussein Saadi, Al-Kaabi JM, Mahmoud Benbarka, Ali Khalili, Wael Mahmeed, Nicolas
Nagelkerke, Alessandro Salustri, Leila Abdelwarthe, Elsadig Kazam, Awad Al Essa, Javed
Yasin, and Bayan Al-Dabbagha. Prevalence of Undiagnosed Diabetes and Quality of Care in
Diabetic Patients Followed at Primary and Tertiary Clinics in Abu Dhabi, United Arab
Emirates (Accepted in May 2011 for publication in the Journal of Rev Diabet Stud.).
7.
Raffan E, Soos MA, Rocha N, Tuthill A, Thomsen AR, Hyden CS, Gregory JW, Hindmarsh
P, Dattani M, Cochran E, Al-Kaabi JM, Gorden P, Barroso I, Morling N, O'Rahilly S,

Semple RK. Founder effect in the Horn of Africa for an insulin receptor mutation that may
impair receptor recycling. Diabetologia. 2011 May; 54(5):1057-65.
8. Hussein Saadi, Nicolaas Nagelkerke, Al-Kaabi JM, Bachar Afandi, Fatima Al-Maskari,
Elsadig Kazam. Screening Strategy for Type 2 Diabetes in the United Arab Emirates. AsiaPacific Journal of Public Health; July 2010; 22(3)54-59.
9. Kamal S, Al-Kaabi JM, Ellis M, Gariballa S. Pulmonary nocardiosis masquerading as severe
community-acquired pneumonia. European Journal of Emergency Medicine Feb.2010
edition.
10. Al-Kaabi JM, Mushtaq A, Al-Maskari FN, Moussa NA, Gariballa S. Hypokalemic periodic
paralysis: a case series, review of the literature and update of management. Eur J Emerg
Med. 2010 Feb;17(1):45-7.
11. Al-Kaabi JM, Al-Maskari F, Saadi H, Afandi B, Parkar H, Nagelkerke N. Physical activity
and reported barriers to activity among type 2 diabetic patients in the United Arab Emirates.
Rev Diabet Stud. 2009 Winter;6(4):271-8.
12. Al-Kaabi JM, Thomas JT, Moussa NA. Transient Gestational Diabetes Insipidus: A case
report, review of the literature and update on the management. The Endocrinologist
18(6):270-272, Nov/Dec.2008.
13. Al-Kaabi JM, Al-Maskari F, Saadi H, Afandi B, Parkar H, Nagelkerke N. Assessment of
dietary practice among diabetic patients in the United Arab Emirates. Rev Diabet Stud. 2008
Summer;5(2):110-5.
14. Al-Kaabi JM, Lewanczuk RZ, Chik CL. Pericarditis with cardiac tamponade and addisonian
crisis as the presenting features of autoimmune polyglandular syndrome type II: a case
series. Endocr Pract. 2008 May-Jun;14(4):474-8.
15. Al-Kaabi JM, Ghazal-Aswad S, Sagle M. Babies as desired: Ethical arguments about gender
selection. Emirates Medical Journal (2007); 25(1): 1-5.
16. Saadi H, Carruthers SG, Nagelkerke N, Al-Maskari F, Afandi B, Reed R, Lukic M, Nicholls
MG, Kazam E, Algawi K, Al-Kaabi JM, Leduc C, Sabri S, El-Sadig M, Elkhumaidi S,
Agarwal M, Benedict S. Prevalence of diabetes mellitus and its complications in a

population-based sample in Al Ain, United Arab Emirates. Diabetes Res Clin Pract.78
(2007) 369-377.
17. Nayar RC, Al-Kaabi JM, Ghorpade K. Primary Nasal Tuberculosis: A Case Report. Ear Nose
Throat J. 2004 Mar;83(3):188-91.
18. Woodhouse NJ, El-Shafie OT, Mehar A, Johnston WJ and Al-Kaabi JM. Spironolactone
Responsive Familial Hypertension: A Potentially High Prevalence of Mineralocorticoid
disease in Oman. Saudi Med J 2003; Vol. 24 (2):229-231.
19. Varghese JC, Al-Kaabi JM, Dabbagh K, Al-Rawas O. Simple Aspiration -Versus Intercostal
Tube Drainage in the Management of Spontaneous Pneumothorax: Case Report and Review
of the Literature. Oman Medical Journal (19), Nov 2002:47-51.
20. Al-Kaabi JM, Samir S. Hussein, Charles S. Bukheit , Nicholas J. Woodhouse, Omiema T.
Elshafie, Haddia Be
Treatment. Saudi Med J 2002 Sept; 23 (9):1049-53.
21. El-shafie O, Al-Kaabi JM , Bererhi H, Woodhouse NJ. Severe Osteoporosis in Childhood
Anorexia Nervosa : Dramatic Remineralisation of Bone and Vertebral Body Remodeling
During Recovery. Oman Medical Journal, Feb.2002 ; 18 (3): 19-21.
22. Al-Kaabi JM, Euan Scrimegeour, Andre Louon, Bazdawi M. Al-Riyami. Tetanus: A Clinical
Review. Saudi Med J 2001; Vol.22 (7): 606- 609.
23. Scrimegeour E, Gallagher M, Al-Kaabi JM. Venomous Snake-Bite and Use of Polyvalent
Snake Antivenom in Oman. Oman Medical Journal, Vol.18 (1) August 2001: 20-26.
PUBLICATIONS IN A NON-PEER REVIEWED JOURNALS:

1. Saadi H, Afandi B, Al-Kaabi JM. Prevalence of Diabetes Mellitus and its Complications in A
Population
Based Sample in Al Ain, United Arab Emirates. Commentary in Health and
Diabetes; Jordan Arabic Magazine. July 2010.
ABSTRACTS, CONFERENCE PRESENTATIONS AND PROCEEDINGS
1. Al-Kaabi JM, Saadi H, Benbaraka M, Khalili A. Cardiovascular risk profile of diabetic

patients followed in primary and tertiary clinics in Abu Dhabi, United Arab Emirates.
Accepted for World Cardiology Congress (WCC) Annual Meeting, 19-21 April 2012; DubaiUAE.
2. Fakhra Al Darei, Juma Al Kaabi, Mariam Al Neyadi, Mariam Al Mazrooei, Jawaher Al
Yazedi, Abdishakur Abdulle. Terrestrial snakebites in the United Arab Emirates and Oman:
Patient characteristics, clinical presentation, and management.The Eighth International
Scientific Conference for Medical Students in the GCC Countries. Sultan Qaboos University
Muscat-Oman 28th Jan.-1st Feb.2012.
3. Al-Kaabi JM, Al-Dabbagh B, Saadi H, Gariballa S, Yasin J. Effect of coffee consumption on
the glycemic index of khalas dates tested in healthy and diabetic subjects. Presentation at the
Annual Endocrine Society Meeting, June 2011, Boston- USA.
4. Al-Kaabi JM, Al Neyadi M, Al Darei F, Al Mazrooei M, Al Yazedi J. Terrestrial snakebites
in South East Arabia: Presentation, Management and Complications. Biomedical Research
Day, 10th May, 2011, FMHS, UAE University.
indices of five types of dates in healthy and diabetic subjects. Oral presentation at the 16 th
Annual Diabetes and its complications workshop, FMHS, 16th April 2011.
Indices of five varieties of dates tested in healthy and diabetic subjects. The 2nd SEHA
Annual Research Conference, 12th- 13th Dec, 2010, Abu Dhabi- UAE.
7. Adrian T, Saadi H, Gariballa S, Al-Kaabi JM, Nagelkerke N. Can Diabetes and Obesity be
treated through the rectum? The 46th EASD Annual Meeting of the European Association for
the Study of Diabetes, Stockholm, Sweden, Sept., 20-24th, 2010.

8. Saadi H, Nagelkerke N, Al-Kaabi JM, Afandi B, Al-Maskari F, Kazam E. Screening strategy
for type 2 diabetes mellitus in the UAE. Diabetes: Journal of the American Diabetes
Association; June, 2010 Volume 59 Supplement 1; 2367-PO: A620.
9. Adrian T, Gariballa S, Parekh KA, Thomas SA, Saadi H, Al-Kaabi JM, Nagelkerke N,
Gedulin B, Young AA. The Bile Acid Brake: A Novel Target for Treating Diabetes and
Obesity. Diabetes: Journal of the American Diabetes Association; June, 2010 Volume 59
Supplement 1; 602-P: A164.
10. Al-Kaabi JM, Al-Maskari F, Saadi H, Afandi B. Prevalence of peripheral vascular disease
among diabetic patients attending the diabetes center at Tawam hospital-UAE. Diabetes:
Journal of the American Diabetes Association; June, 2010 Volume 59 Supplement 1; 2367PO: A620.
11. Al-Kaabi JM, Al-Maskari F, Saadi H, Afandi B. Prevalence of peripheral vascular disease
among type 2 diabetic in Al Ain Medical District. 15th Annual Workshop on Diabetes and its
complications, FMHS, UAE University, Al Ain, UAE. 13th March, 2010.
12. Adrian T, Saadi H, Gariballa S, Al-Kaabi JM, Nagelkerke N. Release of Rectal Hormones
for Weight Loss and Improvement of Type II Diabetes Mellitus. FMHS, March, 2010.
13. Saadi H, Nagelkerke N, Al-Kaabi JM, Afandi B, Al-Maskari F, Elsadig K. Screening
strategy for type 2 diabetes mellitus in the UAE. 15th Annual Workshop on Diabetes and its
complications, FMHS, UAE University, Al Ain, UAE. 13th March, 2010.
14. Al-Kaabi JM, Al Neyadi M, Al Darei F, Al Mazrooei M, Al Yazedi J. Terrestrial snakebites
in South East Arabia: Presentation, Management and Complications. The 7th Scientific
Conference for Medical Students in the GCC countries, King Abdulaziz University, Jeddah,
Saudi Arabia. February, 2010.
15. Saadi H, Nagelkerke N, Al-Kaabi JM, Afandi B, Al-Maskari F, Kazam E. Screening Strategy
for Type 2 Diabetes in the United Arab Emirates. Global Health Conference, Al Ain, UAE. 4
January, 2010.
16. Al-Kaabi JM, Al-Maskari F, Saadi H, Afandi B, H Parker. Assessment of Physical Activity
in Diabetic Patients in United Arab Emirates. The Annual Meeting of the Endocrine Society;
Washington DC, USA. 10-13 June, 2009.

17. Al-Kaabi JM, Al-Maskari F, Saadi H, Afandi B. Prevalence of peripheral diabetic
neuropathy and peripheral vascular disease among type 2 diabetic in Al-Ain district. 14th
Annual Workshop on Diabetes and its Complications, FMHS, UAE. 4th April, 2009.
18. Al-Maskari F, El-Sadig M, Al-Kaabi JM, Afandi B. Knowledge, attitude and practices of
diabetic patients in Al-Ain City, United Arab Emirates. The 90th Annual meeting of the
Endocrine Society, San Francisco, USA. 15-18 June, 2008.
19. Al-Kaabi JM, F Al-Maskari, H Saadi, B Afandi, H Parker. Assessment of physical activity
and dietary practices among diabetic patients. 13th Annual Workshop on Diabetes and its
Complications, FMHS, UAE University, Al Ain, UAE. 22 March, 2008.
20. Al-Kaabi JM, Lewanczuk RZ, Chik CL. Cardiac Tamponade and Addisonian crisis as the
presenting feature of Autoimmune Polyglandular Syndrome Type 2- A Case Series. The
Annual CDA Professional Conference, Edmonton, Canada. 20 October, 2005.
21. Al-Kaabi JM, F Al-Maskari, H Saadi, B Afandi, H Parker. Assessment of physical activity
and dietary practices among diabetic patients among diabetic patients. 13th Annual Workshop
on Diabetes and its Complications, FMHS, UAE University, Al Ain, UAE. 22 March, 2008.
22. Mclean M, Al-Kaabi JM.
board examinations: use of a MOCK examination. The 13th Ottawa International Medical
Education Conference on Clinical Competence. 5-8 March, 2008.
23. Al-Kaabi JM, Al-Maskari F, Saadi H, Afandi B, H Parker. Assessment of Physical Activity
and Dietary Practices among Diabetic Patients in Al-Ain District. The 1st International
Conference on Advanced Technologies & Treatments for Diabetes (ATTD), Prague, Czech
Republic, 27 February 1 March, 2008.
24. Al-Kaabi JM, Al-Maskari F, Saadi H. Assessment of Physical Activity and Dietary Practices
among Diabetic Patients in Al-Ain District, UAE. Proceedings from the 8th Annual Scientific
Research Conference, Al Ain, UAE. 23-25 April, 2007.
25. Saadi H, Carruthers G, Nagelkerke N, Al-Maskari F, Afandi B, Reed R, Lukic M, Nicholls G,
Kazam E, Algawi K, Al-Kaabi JM, Leduc C, Sabri S, El-Sadig M, Elkhumaidi S, Agarwal
M, Benedict S. National Survey of Diabetes and its Complications - A Pilot Study.
Proceedings from 8th Annual UAE University Research Conference, Al Ain, April, 2007.
10

26. Al-Maskari F, El-Sadig M, Al-Kaabi JM , Afandi B. Knowledge, Attitude and Practices of
Diabetic Patients in Al-Ain Medical District, UAE. Proceedings from 8th Annual University
Research Conference, Al Ain UAE. April, 2007.
Annual CDA Professional Conference, Edmonton, Canada. 20 October 2005.
Residents Poster Day, University of Alberta, Canada. 19 May 2005.
29. Al-BahraniA, Al-Kaabi JM. Dyslipidemia as predictor of abnormal glucose tolerance.
College of Medicine Poster Day, Sultan Qaboos University, Oman. 7th February 2000.
CONGRESSES, CONFERENCES, WORKSHOPS AND SEMINARS

7th Jan.2012
Invited speaker
Update on the Management of
, Al Ain
UAE.
24th Jan. 2012

Invited speaker at Cardiff University Postgraduate Diploma in Diabetes introductory lectures. The
- Dubai, UAE.
15th of Feb. 2012

Conduction of the certifying examination for the Diabetic Educator course at Rashid Hospital- Dubai.
I prepared 120 MCQ exam paper (2 sessions) covering the main topics of the course. Out of the 38
candidates enrolled in the course, 30 passed the exam and the department of medical education at the
FMHS- UAE University issued the certificates.
19th - 20th Feb. 2012
Conducting and organizing the MRCP-PACES Examination at Al Ain Hospital. On Mond. The 20th
of Feb. I was examiner for the whole day.
11
25th Feb.2012
Conducting and participating as an examiner in the one-day Mock-OSCE examination of the Internal
Medicine residents preparing for the Board examination. There were 28 residents from various
hospitals in the Emirates.
3rd March 2012
Invited chairman
ed by multidisciplinary team from
Tawam hospital looking after difficult pituitary cases requiring surgical intervention or radiation
therapy, Al Ain UAE.
7th March 2012

Invited presenter
edicine residents
as part of their academic half day activity. Al Muwaji ambulatory Health Care Service Al Ain.
16th-17th March 2012
Invited chairman
Center of Excellence in Ras Al Khaima- UAE.
18th -21st April 2012
Presenting research poster at the annual meeting of World Congress of Cardiology in Dubai. The
abstract of the poster was accepted for publication incirculation Journal.
3rd-5th May 2012
Invited moderator for case based workshop with interactive sessions with the audience of the 2nd
EUC (Emirates Societies United to Compact Diseases) conference, Dubai- UAE.
12th May 2012
Organizer, Chairman of the scientific Committee and speaker at the 17th annual diabetes/endocrine
disorders conference at the FMHS.
12th May 2012
Speaker Update on the Management of Hypo-V
Diabetes Mellitus and Endocrine Disorders, FMHS- Al Ain- UAE.
20th - 29th May 2012
12
th
annual conference on

Participant in the Ultrasound and FNA thyroid hand-on Course and attending the annual meeting of
the American Association of the Clinical endocrinologists; Philadelphia USA.
24th June to the 5th July 2012
Examiner in the FIE OSCE Examination and Coordinator of the Clinical FIE Examination.
11th July 2012
Scientific Interview at Abu Dhabi TV
dealing with diabetes during the fasting of the holy month of Ramadan (30 min.)
13th July 2012
Organizer, Chairman of the scientific Committee and speaker at the symposium
Al Ain- UAE (4 CME activity).
Diabetes
13th July 2012

Speaker Review of the Guidelines-
Al Ain- UAE.
4th Jan.2011
Scientific Interview at Sama Dubai TV with Prof. Ibrahim Galadari (30 min.)
21st Febraury 2011
Invited Examiner for the MRCP (UK) PACES Examinations, Al Ain hospital -UAE.
22 -24 March 2011
Attendance of the International Osteoporosis Foundation Conference Meeting. Valencia- Spain.
16th April 2011
Organizer, Chairman and Speaker at the 16th Annual Diabetes Workshop at the FMHS.
26th May 2011
at 1st Al Buraimi International Endocrine
Conference, Buraimi- Sultanate of Oman.
4-8th June 2011
Attendance and poster presentation in the 93rd Annual Meeting of the Endocrine Society, BostonUSA.
12th -16th September
Attendance of the Annual Meeting of the European Association for the Study of Diabetes (EASD);
Lisbon- Portugal.
13

7th-8th Oct.2011
- UAE.
19th-22nd Oct.2011
Attendance of the annual meeting of the International Osteoporosis Foundation (IOF) Dubai- UAE.
29th Oct.2011
Member of the scientific committee in reviewing and updating the National Diabetes Practice
Guidelines- UAE.
17th Nov.2011
3rd December 2011

Organizer and chair of the scientific committee of the IDF Congress Satellite Symposium at the
FMHS, Al Ain- UAE.
Dec 4-8, 2011
Invited Chairman of a scientific session (Diabetes Education) at the World Diabetes Congress-IDF
Meeting in Dubai-UAE.
21-22 January 2010
Participant in the Insulin Pump Therapy and Continuous Glucose Monitoring Workshop. Beirut,
Lebanon.
17th February 2010
Chairperson
Ain, UAE.
13th March 2010

Organizer and a speaker in the 15th
14th March 2010
Attendance and a Chairman of a Scientific Session in the 1st Abu Dhabi Diabetes Congress, Abu
Dhabi, UAE.
17th April 2010
Chairman of the Scientific Meeting
Ain, UAE.
April, 2010
Invited Speaker at Al-Noor Hospital-
14
28-30 April 2010

th
Pan Arab
, Syria.
3-7 May 2010

Attendance of the
Amman, Jordan.
June, 2010
Examiner for the OSCE course for the Internal Medicine Residents held at the FMHS.
25th -29th June 2010
Attendance and presentation at the Annual Scientific meeting of the American Diabetes Association,
Orlando- Florida, USA.
20th -24th Sept. 2010
Scientific Presentation and Attendance of the European Association for the Study of Diabetes,
Stockholm-Sweden.
28th Sept. to 2nd Oct. 2010
Participant in the Board Review Course and the Endocrine Clinical Update by the Endocrine Society.
Los Angeles USA.
25th - 27th Nov. 2010
Speaker
abetes: The principles and the P
Diabetes and Endocrinology 2010 Conference, Abu Dhabi- UAE.
12-13th Dec. 2010
Poster presenter
S
onference, Abu Dhabi- UAE.
th
14th -16 Dec. 2010
Member of the Scientific Committees and chairperson of the 6th Dubai International Conference for
Medical Sciences and the Emirates Endocrine Congress 2010. Dubai- UAE. Chairman of in the
Scientific Sessions.
18th Dec.2010
Speaker
anagement of O
UAE.
20th & 21st Dec.2010
Official Delegate and Participant in the 2nd Workshop on Leadership in Health Research 2010,
establishing Research Priorities in the UAE. Ministry of Health, Dubai- UAE.
15


1st Annual Meeting

October 12, 2012
Name: Dr. Aishah Ali Mohamed Ahmed Alkhzaimi

Address:Jareer street, P.O.Box 28322,
City: Riyadh
Country: Saudi Arabia
Email: aishahekhzaimy@hotmail.com
purposes of Chapter business? yes
___ President
___ Vice President
___ Secretary
___ Treasurer
___ Board of Director Member
CV or bio-sketch included

1st Annual Meeting

October 12, 2012
Dear Sir,
AACE is well-known world wide of their excellent activities that attract the endocrinologists all
over the world to attend and participate in. I have attended the meetings of AACE and they were
very impressive along with their thyroid workshops.
With every AACE meeting, there is always an appreciation of the role of other chapters of
ACCE in different countries and their contributions in AACE are well recognized. I felt that we
need to have a role too to participate and support AACE by having our Gulf Chapter of AACE.
At the moment, Im a board member in Saudi society of endocrinology and metabolism since
March 2010 and I have been organizing many educational activities including latest international
conference by Saudi society that is going to be held in November 2012.
I have organized an endocrine course over 6 weeks for all the family physicians in the kingdom
of Saudi Arabia in September 2011 and February 2012 beside , another endocrine teaching
course for all the clinical fellows in September 2012. I have been attending all the board
meetings of the Saudi society of endocrinology that is held monthly.
I feel I have the energy, the motivation, the commitment to participate actively to serve the Gulf
Chapter. For that reason, I would like to nominate myself as a board member in the Chapter.
Sincerely,
Dr.Aishah Alkhzaimi, MBBS, FRCPC
Assistant professor of medicine
Endocrinology Consultant
King Saud University
King Khalid University Hospital
Tel: +966542763640
CURRICULUM VITAE
PERSONAL DATA
Name: Aishah Ali Mohd Ahmed Ekhzaimy
Date of birth: 15th January 1975Sex: Female
Nationality: United Arab Emirates
Address in UAE: P.O. Box 50340

Dubai
United Arab Emirates
Tel: 011 971 50 4897071/0542763640/0553433393 ( Riyadh)
Email:aishahekhzaimy@hotmail.com/aishah.ekhzaimy@gmail.com
ACADEMIC QUALIFICATIONS
Year
School
2009
MCC I and
2007
American Board of
Endocinology and Metabolism
2006
II
Royal College of Physicians and

Surgeons of Canada
Place
Canada
Achievements
Full MCC lisence
American board of
Endocrinology and Metabolism
Mcgill University,
Canada
FRCPC, Subspecialty in
FRCPC, Internal Medicine
2005
Royal College of Physician and

Surgeon of Canada
QueensUniversity,
Canada
2005
American Board of Internal

medicine
2000
MCCE Exam
Muscat,Oman
MCCE
2000
Faculty Of Medicine, United

Arab Emirates University
University
United Arab
Emirates
M.B.B.S
(Bachelor Of Medicine &
Bachelor Of Surgery)
American Board of Internal

Medicine
1992
Fujairah Secondary School
UAE
High School Certificate
PROFESSIONAL EXPERIENCE
January 2010- current:
Assistant professor, Internal medicine and Endocrinology consultant at King Saud
University, KKUH, Riyadh, Saudi Arabia
October 2009 January 2010:
3 months of Locum as an endocrinology consultant at KFMC in Riyadh, SA
June 2009- September 2009:
Internal medicine and endocrinology consultant at Humber River Regional Hospital,
Toronto, Ontario, canada
August 2008- March 2009
Working as a consultant endocrinology/internal medicine at Fujairah Hospital, Ministry
of Health
January 2008-June 2008
Worked with Dr. S. Ezzat in clinical Endocrine oncology at University of Toronto
February 2007-June 2008
Third year clinical training in thyroid cancer and endocrine oncology at Western Ontario
University
January 2005- January 2007
Residency training program as a clinical fellow in Endocrinology and metabolism at
Mcgill University
January 2002- December 2004
Residency training program in internal medicine at Queens university, Ontario
November 2001- December 2001
Pre-assessment period of 2 months( PEAP) at Queens University, Ontario
October 2000- October 2001
12 months of working experiences as a resident in internal medicine department in AlAin Hospital in UAE taking the 1st call responsibility to cover Emergency medicine unit,
outpatient clinics and coronary care unit.
September 1999- September 2000

Internship year: mandatory rotations in different subspecialty to complete clinical skills
requirement for MBBS including internal medicine and subspecialty rotations for 6
months, general surgery and surgical subspecialty rotations for 6 months in the university
hospitals of UAE ( Al-Ain and Tawam hospitals).
June 1998
Summer elective in general internal medicine and infectious disease in Cleveland
hospital, Ohaio, USA for 2 months
During these periods I gained considerable experience in the management of emergency
cases and critically ill patients. I have been involved in the management of large number
of diabetic patients and patients with different endocrinological and metabolic problems.
I have performed lots of clinical skill procedures : arterial and venous canulation, central
lines, endotracheal intubation, swan ganz catheterization ,chest tube insertion,
thoracocentesis , paracentesis,bone marrow aspiration and biopsy. I have done many
thyroid FNA s during my training and my practice with and without US guidance.
ADDITIONAL TRAINING AND SKILLS

May 2008
Achieved the award of the president of AACE for the third place in
prevention 5 k marathon in florida
Power of
September 2007
Teaching Medical students at University of Western Ontario
July 2006
A chief resident in endocrinology department at Mcgill Univesity
June 2006
Participated in improving residents teaching skills workshop at Mcgill University
May 2006
Summer course in clinical epidemiology at Mcgill University
February 2006
Teaching medical students at Mcgill University basic physiology of endocrinology
July 2004
Endocrinology elective for 4 weeks in Kingston General Hospital at Queens University

with Dr. Houlden
September 2003
Endorinology elective for 4 weeks at University of Toronto with Dr. R. Silver
June 2000 and October 2002
BCLS and ACLS courses at Tawam hospital in UAE and Queens university in Canada
Extensive involvement in teaching medical students and residents during the 5 years of
residency training in Canada
ACADEMIC ACHIEVEMENTS AND PRESENTATIONS

1. Always the first in all the classes during elementary, primary and secondary
school
2. Sheikh Hamad bin Saif Award Students Geniuses
3. Award for Mathematics Olympic Gulf in the secondary school
4. A project in diabetes mellitus complications, management plan, follow up and
compliance rate among diabetic patients. The study was conducted in peripheral
health clinics in Al-Ain city in 1998
5. A project in breast cancer screening among females from 35 years and above in
UAE in 1993
6. Presented at the serial clinical grand rounds at Queens university Intensive
Glucose management in the ICU in October 2004
7. Research at Mcgill university starting May2006 in Gestational Diabetes looking at
the Percentage of return for post partum OGTT screening among gestational
DM women and the ways to improve the return
8. Presented a case of a novel mutation in the calcium-sensing receptor gene in a
hypocalcemic patient with SLE at CSEM meeting in Toronto in October 2006 and
in the combined round at Mcgill University
9. Sheikh Rashid awards in United Arab Emirates for the American and Canadian
boards in Internal Medicine and Endocrinology in May 2008
PROFESSIONAL ORGANISATIONS
Associate member of American college of physician

Member of Endocrine society
Member of American Association of Clinical Endocrinology
Associate member of American Thyroid Association
Fellow of Royal college of physician of Canada
Member of UAE Endcorine society
Board member of Saudi Society of Endocrinology and Metabolism
COURSED AND MEETING ATTENDED

Attended many conferences in UAE during the internship
Attended annual American college of physician meeting of internal medicine in April
2004 in New Orleans
Attended cardiology and EKG course at Queens university in 2004
Attended the endocrine society CEU in Toronto in October 2005
Attended Harvard course of clinical endocrinology in Boston in April 2006
Attended the 88th annual endocrine society meeting in Boston in June 2006
Attended CDA and CSEM meeting in Toronto in October 2006
Attended the 89th annual endocrine society meeting in Toronto in June 2007
Attended AACE meeting in florida in May 2008.
Attended Canadian Endocrine update in Hamilton and Osteoporosis clinical course in
May 2008
Attended the 91st annual endocrine society meeing in June 2009
Attended the 92nd annual endocrine society meeting in june 2010
Attended the 93rd annual endocrine society meeting in june 2011
Attended the AACE annual meeting in San Diego in May 2011
Organized Endocrine course for Family physician in Riyadh, SA in September 2011
and February 2012Organized Endocrine course for Clinical Fellows in Saudi Arabia in September 2012
Member of scientific committee of the 1st international conference of Saudi Society of
Endocrinology and metabolism in November 2012
REFERENCES
1. Dr. P. Doran
Program director of Endocrinology program at Mcgill University
687 Pine Avenue West Montreal, Quebec H3A 1A1
Tel: 1514 934 1934
Fax: 1514 982 0825
2. Dr. Simon Wing
Director, Division of Endocrinology and Metabolism, McGill University
687 Pine Avenue West Montreal, Quebec H3A 1A1

Tel: 1514 934 1934
Fax: 1514 982 0825
3. Dr. Mark Trifiro
Acting director of Endocrinology department at JGH
Associate professor of internal medicine
3755 Cote. Ste . Catherine street
Montreal, Quebec, H3T 1E2
Tel: 1514 3408260 X 5269
4. Dr. R. Morton
Professor, Department of medicine
Division of nephrology, Queens university

Medical director, Peritoneal dialysis program, Kingston general hospital
5. Dr. S. Ezzat
Department of endocrinology and metabolism, Mt. Sinai hospital
Endocrine oncology, Princess Margret Hospital, Toronto
Tel: 416 586 8505 email: sezzat@mtsinai.on.ca


1st Annual Meeting

October 12, 2012
1
Name:
Dr Mohamed Abdullah Al-Lamki
Address:
City:
P O BOX 399
MUSCAT
Country:
Email:
SULTANATE OF OMAN
m allamki@gmail.com
2
purposes of Chapter business? ___ yes ___ no
3
___ President
___ Vice President
___ Secretary
___ Treasurer
I propose by Candidancy as board member to facilitate and oversee the establishment /activities of the AACE Gulf Chapter.
Personel details:
Full name:
Mohamed Abdullah Al-Lamki
Title:
Doctor,Senior Consultant Endocrinologist &

Clinical Director Department of
Medicine,Royal Hospital,Oman.
MBchB.Msc ,FRCP(UK)
Biography text:
The biography should not exceed a maximum length of 150 words.

Please insert biography text here:Clincal Director in Department of Medicine at the
Royal Hospital,Muscat ,Oman. Training in Egypt and Glasgow,thereby returned to
Oman and headed the department of endocrinology ,mostly laying the foundation
for a multidisciplinary care, modules and pathway for electronic oriented clinical
standards of care. For the last 5years was involved and designed the National
Diabetes,Endocrine and Metabolic Center.I am now the Clinical Director in Medicine
and chairman to commission the National Center.Additional post, committee member
for the National Diabetes program in Oman,founding member of Gulf group for the
study of diabetes, and current vice-president of Diabetes Asia Study Group, and Ex
President of Oman Diabetes Association.
Educational: Trained in Ein-Shams,Egypt: MBchB,Glasgow Uk for masters in
Endocrinology and MRCP,Became a Fellow and presently Examiner for the Paces
Royal College -UK
Professional Experience; internal Medicine and Endocrinology,both covering diabetes
and general endocrinology-Utilization of pattern management in diabetes,and using
Glp-1 very early,prior to its release in the MENA region.
Academic and Professional achievements :the introduction of clinical moduleselectronic.The use Glp-1 and initiation of education for nurses, intregreted care system
using soft-ware and pattern management for diabetes care.
Profession Interest:Chronic disease Management system ,integrated in Clinical
practice.Neuroendocrine tumors,Diabetes and Hepatitis.


1st Annual Meeting

October 12, 2012
1
Name:
NASREEN AL-SAYED, BMedSci,MD, FACP.
Address: ARABIAN GULF UNIVERSITY, COLLEGE OF MEDICINE & MEDICAL SCIENCES- ALJAWHARA
MEDICAL CENTER.
City:
Country:
Email:
P.O. BOX 26671, MANAMA

BAHRAIN
n_alsayed@hotmail.com OR nasreen.alsayed@yahoo.com
2
3
___ President
___ Vice President
___ Secretary
___ Treasurer
NASREEN AL-SAYED, BMedSci., MD, FACP.

I feel very honoured to have the opportunity to nominate myself for the Board of Director Member
position. I've been a member with AACE since 2009 and am very much excited for us to have AACE
chapter in the Gulf region. I feel this is a real opportunity to become more involved in AACE at the gulf
level. I am very much motivated to achieve the impossible and here is a chance for me to really help.
The Gulf AACE chapter will have a tremendous scientific impact on the Endocrinology field in the region
and Middle East. Knowing how prevalent diabetes and other common endocrinological disorders are in
the region, The Gulf AACE chapter will, no question, have a great influence in promoting scientific
awareness and guidance among Endocrinologists in the region.
I am currently working as a full time faculty staff at The Arabian Gulf University, College of Medicine
and Medical sciences and practicing as Endocrinologist and Lipidologist at the University Clinics at
Princess Aljawhara Medical Center which will eventually transform to King Abdulla Medical city in the
very near future in Bahrain.
I did Internal Medicine residency training at Sinai-Grace Hospital, Wayne State University, Detroit,
Michigan (USA) and Endocrinology fellowship at Cleveland Clinic Foundation (USA). In addition, I
recently had a Board Certification in Clinical Lipidology.
I have been very active in the field at professional as well as at community level. I am currently working
on several research papers pertaining to diabetes, lipids and endocrinological disorders through my post
with the University. In addition, I am chairing the scientific and event committee for the upcoming First
Regional Diabetes Symposium in Bahrain. I am active member in several Endocrine/Diabetes
organizations and societies such as American Diabetes Association, The Endocrine Society, National lipid
association and Fellow of American College of Physicians. At community level, I have attributed to
several community based lectures and awarenesss, several TV and radio interviews locally and
regionally and community health projects the latest being The Diabetic Project for School Children and
The Metabolic Syndrome Network Project with Bahrain Ministry of Health. I am one of the very few
Endocrinologists in the region and Middle East to hold board certification in clinical Lipidology and to
treat resistant cases of hypoparathyroidism with parathyroid hormone. I have good working relationships
with authorities in Bahrain Ministry of Health as well as the Endocrinologists in Bahrain and the gulf
region.
Because of all the benefits I have gotten from AACE, I feel it is only right that I do what I can to give
back to this organization. Running for Board of Director Member is the best way I can think of to say
Thank you to AACE.
Looking forward to your support,
Nasreen AL-Sayed, BMedSci., MD, FACP.
CURRICULUM VITAE
Dr. Nasreen AbdulKarim AlSayed M.D. FACP
Date of Birth :
October 11, 1970
Place of Birth:
Manama, Bahrain
Nationality
Bahraini
Mobile
Residence :
Email
:
+973- 33989330
+973-77173939
nasreen.alsayed@yahoo.com
Marital status:
Married with three children
Qualifications:
Secondary General Certificate of Education,

Ministry of Education, Bahrain, June, 1988
Ranked 6th over Bahrain with a score of 95%
Bachelor Degree of Basic Medical Sciences.
Arabian Gulf University, College of Medicine.
M.D. with Distinction (ranked second) from the Arabian Gulf
University College of Medicine.
Manama, Bahrain September 1988 to May 1995.
Golden Medal for the most prominent student.
American Board Certification in Internal Medicine
Board Certified, August, 2000. Re-certified 01/2011.
Endocrinology , Metabolism and Diabetes Fellowship Training,
Cleveland Clinic Foundation 2010-2011.
American Board Certification in Clinical Lipidology, 2011.

Elected as Fellow of American College of Physicians 07/2010.
.
Certification of training in Thyroid ultrasound and FNA.
Certified in Insulin Pump Therapy.
ECFMG Certificate, September 1996
Valid indefinitely.
Bahrain Medical License Examination Certificate.
Work Experience:
July 1995 June 1996
Internship in Salmaniya Medical

Center, Bahrain
July 1996 August 1996
Emergency rotation in Salmaniya

Medical Center, Bahrain
Sept. 1996 Dec. 1996
Radiology rotation in Salmaniya

Medical Center, Bahrain.
Jan 1997 May 1997
Internal Medicine resident in

Salmaniya
Medical
Center,
Bahrain.
Internal Medicine Resident in
Sinai-Grace Hospital, Wayne State
University,
Detroit
Medical
Center, U.S.A.
July 1997 June 2000
Jan 2001 August 2002
Internal Medicine Consultant at

American
Mission
Hospital,
Manama, Bahrain
Sept 2002 February 2004

Bahrain
Specialist
Hospital,
Manama, Bahrain.
March 2004- Dec 2008

Joslin Diabetes Center Affiliate
Manama, Bahrain.
July 2010- June 2011
Advanced fellowship training in

Endocrinology & Metabolism
Cleveland Clinic Foundation
Private Clinic in Alkindi Hospital
November 2011-August
2012
February 2012-current
Senior lecturer, Arabian Gulf

University. Will be promoted to
Assistant Professor by February
2013.
September 2012
Private Practice Princess

Aljawhara Medical Center,
affiliated with Arabian Gulf
University.
Research &
Conferences:
1. Nasreen Al-Sayed, Mona Areqat, Wassim Almawi,
"Association of comorbid Depression, Anxiety, Stress
Disorders in Bahraini type 2 diabetes patients.", a clinical
Research, Bahrain, Journal of Endocrinological Investigation, 2008 Nov; 31(11):1020-4.
.
2. Wassim Almawi, Nareen AL-Sayed, Mona Areqat,
Association of selective HLA class II susceptibility
Conferring and protective haplotypes with type 2
Diabetes in patients from Bahrain & Lebanon.
Published: Clinical & Vaccine Immunology, Nov-2006
P-1296-1298, Vol.13. No.11.
3. Nasreen AL-Sayed, Robert Zimmerman, ACE Inhibitors
better than ARBs In Reducing Albuminuria in Type 2
Diabetics, Cleveland Clinic Foundation, Abstract presented
in Endocrine Society meeting 2011, in process for
publication in Endocrine practice.
4
Experience (7 years) in treating a Bahraini patient with a

resistant case of idiopathic hypoparathyroidism with
synthetic PTH, Collaboration with NIH, USA.
Al Sayed N, Farroq A, Hepatic Encephalopathy in a

Patient with Non-Alcoholic Steatohepatitis-(NASH).
Poster presentation at American College of Physicians
(ACP) meeting, Traver city, Michigan September 1999.
Al Sayed N, Al-Room K, The Prevalance of Bronchial

Asthma among children living in Industrial area in
Bahrain Research in Arabian Gulf University, in March
1993.
Currently, enrolled in several ongoing research projects

in Diabetes, Lipidology and Endocrinology funded by
Arabian Gulf University.
Attended several workshops and conferences in Bahrain

and U.S.A. covering different displays including general
health care and medical education. A list of some of the
conferences:
1
2
Medical Education Conference and its Future

Prospectus, March 1995.
Hypertension
Management
Conference,
November, 1999 Ann Arbor, Michigan.
Treating Type 2 Diabetes in Culturally Diverse

Populations, (Conference)
August 2000 - Dearborn, Michigan.
4 New Directions in Myocardial Revascularization
Conference, September, 1999, Troy, Michigan.
6 Arab Health Diabetes Congress, Dubai, UAE.
Accredited by American Academy Of Continuing
Medical Education.2004.
7 The first International GGSD Conference, Arab
Health 2005, Dubai, UAE.
8 41th Annual Meeting of The European Association
for The Study of Diabetes, Sept. 2005
Athens, Greece.
9 Arab Health Diabetes Congress, Dubai, UAE
Accredited by American Academy of Continuing
Medical Education. 2006.
10 Invited as guest speaker at "Hypoparathyroidism
Conference" to share my experience in treating a
Case of Hypoparathyroidism with PTH.
April, 2006, June 2007, June 2008, USA.
11 Endocrinology Board Review, Cleveland Clinic
Foundation,October 2010.
12 Diabetes Day Symposium, Cleveland Clinic
Foundation, 2010,
13 Thyroid Ultrasound and FNA course, Cleveland
Foundation, September, 2010
14 The 20th Annual AACE congress,
April, 2011 San Diego.
15 AACE Thyroid Ultrasound and FNA course,
April, 2011, San Diego.
16 The Endocrine Society Annual meeting, Boston
2011.
17 The 21st Annual AACE congress, May 2012,
Philadelphia.
Extra Curricular
Activities &
Memberships:
1.
2.
3.
4.
5.
Member of National Lipid Association.

Member of Bahrain Medical Society.
Member of American Diabetes Association.
Member of American College of Physicians.
Member of American Association of
Endocrinologists.
6. Member of the Endocrine Society.
Clinical
7. Member of Hospital Improvement Committee in

American Mission Hospital. (2001-2002)
8. Member in Radiology Committee in American Mission
Hospital. (2001-2002)
9. Member in Medical Record Committee in American
Mission Hospital. (2001-2002)
10. Member of HTH World wide (International Travel
Health Organization).
11. Member in Infection Control Committee in Bahrain
Specialist Hospital. (September 2002-February 2004).
12. Member in Medical Record Committee in Bahrain
Specialist Hospital. (September 2002-February 2004).
13.Scientific and Education Program Coordinator,
Joslin Diabetes Center Affiliate. Bahrain. (2004-2008)
14. Chairperson of the "Education Advisory Committee",
Joslin Diabetes Center Affiliate. Bahrain.(2004-2008).
15. Chair of Event Committee and CO-Chair of the program
committee of the upcoming First Regional Diabetes
Symposium that will be held in Bahrain, January 2013.
16.Several TV interviews locally and regionally pertaining
mainly to Diabetes and endocrinologic disorders
17. Several community based lectures and presentations
On Endocrinology & Diabetes.
Languages:
Arabic (Fluent written and spoken)
English (Fluent written and spoken)


1st Annual Meeting

October 12, 2012
Name:
Salem Arifi Beshyah
Address:
Center for Diabetes and Endocrinology, Sheikh Khalifa Medical City, Karamah Street
City:
Abu Dhabi
Country:
Email:
Beshyah@yahoo.com
purposes of Chapter business? Yes
___ President
___ Vice President
___ Secretary
___ Treasurer
X
Board of Director Member
Yes CV or bio-sketch included
Yes Candidate statement included
SHORT BIOSCETCH AND STATEMENT
Dr. Salem A BESHYAH, MBBCh DIC PhD FRCP

Consultant Endocrinologist, Endocrinology Division, Department of Medicine,
Sheikh Khalifa Medical City, Abu Dhabi, UAE.
E-mail: Beshyah@yahoo.com Tel: 00971505662723 Skype: Beshyah2010
Overview:
Salem Beshyah qualified from the Medical School of Tripoli in 1981. He started his
clinical training in Tripoli till 1985 when he moved to the UK. He obtained his MRCP
(UK) and MRCPI during his introductory year in Scotland under the auspices of the
Royal College of Physicians and Surgeons of Glasgow. He then trained as a clinical
registrar in Leicester and Bedford (1987-1989). He did four-year clinical research
fellowship in working on the clinical and metabolic consequences of hypopituitarism
and growth hormone deficiency which was the subject of his PhD thesis. After further
clinical training, he was appointed consultant physician in diabetes and
endocrinology in Harlow, Essex UK for 10 years; Very keen on education and was
the Royal College of Physicians Tutor for the last 3 years in Harlow. In 2006, he
moved to his current post and has been very active in organizing CME local, national
and regional activities.
Why I am nominating myself for Board member of Gulf Chapter Interests:
Wide clinical interests:
I am a clinican with wide range range of interests who has been in practice for a
good while of 16 years as a consultant endocrinologist. I have clinical interests
covering thyroid disease, practical management of diabetes, diabetic foot and
cardiovascular disorders in diabetes. My academic Interests: Cultural aspects of
diabetes care, continuous medical education, translational Research.
Contributions:
Contributed as volunteer to many activities. Regular visitor to the relevant clinical
units in Libya (Tripoli, Zawia, Sebha and Benghazi) to support, teach and examine.
Founding member and Honorary Treasurer and Web master of the Libyan
Association for Diabetes and Endocrinology; Contributed to the organization and
conduct of the 4th ,5th ,6th ,7th and 8th National Congress for Diabetes and
Endocrinology as a true non governmental activity.
Personal skills:
Skilled organizer of academic activities (see www.endodiablibya.org &
www.excellenceincme.org), sponsorship negotiator, researcher and author (over 50
publications; 38 of which are medline), speaker (Arabic and English) and editor (3
years standing as the associate editor of Ibnosina Journal of Medicine and
Biomedical Sciences see www.ijmbs.org).
If elected, I will work with the president and other members of the board to see the
Gulf Chapter as an effective trans-national body of experts that help the profession
and patients in the fields care, education and research.

CURRICULUM VITAE

Doctor Salem Arifi BESHYAH
MBBCh DIC PhD FRCP
CONTACT DETAILS:
Home:
Villa 3,
Street 1 (joining 25 and 23),
Sector 23, Al Moshref,
Zone 1,
Abu Dhabi, UAE
Work:
Diabetes and Endocrine Division,

Institute of Medicine,
Sheikh Khalifa Medical City,
Abu Dhabi, UAE
Tel +971 50 5662723
Fax +971 2 6103420
E-mail:
beshyah@yahoo.com
CURRICULUM VITAE
I. PERSONAL DETAILS:
Name:
Gender
Date of birth:
Marital status:
Salem Arifi BESHYAH

Male
18.6.1956
Married, Three children (23, 21, 11)
II. EDUCATION:
1971-1974
1974-1981
1989-1993
Suk El-Giuma Secondary School, Tripoli, Libya.

Faculty of Medicine, Tripoli University, Tripoli, Libya.
St Marys Hospital Medical School, Imperial College of Scence,
Technology and Medicine, University of London, UK
III. QUALIFICATIONS:
M.B., B.Ch. (1981)
M.R.C.P.I. (1987)
M.R.C.P. (U.K.) (1987)
D.I.C. (1994)
Ph.D. (1994)
F.R.C.P. (2000)
Faculty of Medicine, Tripoli University, Tripoli, Libya.

Royal College of Physicians of Ireland, Dublin, Ireland.
Royal Colleges of Physicians (UK).
Imperial College of Science, Technology and Medicine London.
St Marys Hospital Medical School, University of London,
London, UK
Royal College of Physicians of London
IV. DETAILS OF REGISTRATION:

Limited Registration:
Full registration
Specialist Register:
UK Licence to Practice
UAE Licence to Practice
UAE= GD9721
1st February 1986

No 3399932, 23rd March 1989 to date.
General Internal Medicine, 1st October 1996 and
Diabetes and Endocrinology, 1st October 1996
in any grade in above specialities= 3299933
as a consultant endocrinologist, SKMC, Abu Dhabi,
V. HOUNORS AND DISTINCTIONS:

Secondary School:
Grade: Excellent (the 9th at a nationwide exam)
Medical School:
Grade: Very Good (Second Class Honours); The second

top graduate on the final year.
VI. SENIOR POSTS:

Current 17.9.2006 Date
Senior Consultant Endocrinologist, Division of Endocrinology, Department of
Medicine, Sheikh Khalifa Medical City, Abu Dhabi, UAE
I have joined 2 other senior endocrinologists. The services are focused at delivering
high quality outpatients endocrine and diabetes services and high quality endocrine
and diabetic consultations for inpatients under other specialities. I have 6 OPD clinics
per week (3 endocrine and 3 diabetic) and 1:3 on second on-call for the specialty.
In addition, I took on the role of coordinating the CME and Educational Activities for
the centre, I have coordinated several CME programmes of 1-5 CM credits each. I
was invited to lecture at several of Abu Dhabi medical institutions (Al Noor Hospital,
ADNOC, Al-Ahlia and HAAD). I Key Note Lecturer for the 11th Al-Ain Diabetes Work
Shop, Al-Ain, UAE) and was a member of the Medicine Update 2007 organizing
committee and the Quality Improvement Committee, coordinated the MM activity
and the Consultants Journal Club for the Department of Medicine. I have
coordinated (jointly with Dr Asma Deeb) the excellence in Diabetes and
Endocrinology and with Dr Assem Gharsaa The Excellence in Acute Medicine.
Head, Division of Endocrinology: Dr. Mahmoud Benbarka, MD FACE
1.5.1996 8.9.2006
Consultant Physician in General Medicine, Diabetes and Endocrinology, Princess
Alexandra Hospital, Harlow, Essex, UK.
Clinical Audit Lead (1.1.1997 - 31.12.1999)
Unit Training Director/Royal College Tutor (1.1.2003 - 31.8.2006)
I initially started this job as a locum for 4 months (May to August, 1996) during
which I was appointed to the substantive post on the 26.July 1996.
This is a full-time NHS post. The fixed sessions include 2 ward rounds and 4 OPD
clinics together with acute medical on call rota of 1:6 for the first 4 years, now
1:12. One of the OPD clinics is a medical/endocrine and the other three are
diabetic clinics (on three different sites to meet the geographical needs of the
district).
The medical/diabetic firm consists of four junior doctors (a Diabetes Specialist
Registrar on North Thames Rotation, Staff Grade Doctor, a medical SHO on our 24
month rotation and a pre-registration House Physician), three Diabetes Specialist
Nurses and a part time Diabetes Link Midwife, and two Clinical Assisstant
sessions in Diabetes Care.
The diabetic care is delivered via the conventional diabetic clinics and by the three
nurses following patients up in the community. A new Diabetes Education Centre
is used for educational sessions, walk-in services and to see out of clinic
consultations for urgent and high risk patients. All OPD diabetic clinic sessions are
supported by dietary advise and chiropody services.
There is a close cooperation with the local medical opthalmology unit (Miss
Dierdre Flaye), and the vascular surgeon (Mr Refson). I have Combined Thyroid
Clinic (1st Friday of the month) with the local thyroid surgeon (Miss Jenkins) and a
Diabetic Ante-natal Clinic (Jointly with Mr Hartwell). I have established a close
working relationship with Professor John P. Monson (Saint Bartholomews
Hospital) for tertiary endocrine referrals and the Renal physicians in the
surrounding hospitals for joint management of diabetic renal disease.
During this appointment I had been the Clinical Audit Lead and I ran an effective
well attended programme. For three years. (1.1.1997-31.12.1999).
I was the Unit Training Director/Royal College Tutor. I run an active educational
programme catering for the needs of the SHOs preparing for the MRCP and other
juniors. 1.1.2003-31.8.2006.
I am very keen on continuing education. I regularly lecture and lead workshops for
GP and Practice Nurses in the locality and the region in addition to my commitments
to teaching of medical students and Junior Doctors in Hospital
VII. TRAINING POSTS AND EXPERIENCE (in reverse chronological order):

19.2.96 - 30.4.1996
Senior Registrar (Locum):
In general medicine and diabetes/endocrinology at the Central Middlesex Hospital,
London. This locum post included ward work, OPD clinics, acute medical on take
(1:8) and teaching of medical students (from St Marys Hospital Medical School). The
OPD cover included 1 diabetic, 1 endocrine and 1 general medical/new diabetic
clinics.
Consultants:
Dr. S. McHardy-Young, MD FRCP

Dr. A. Grenfell, MD FRCP
1.10.95 - 18.2.96
Short Locums in General Internal Medicine & Diabetes/Endocrinology:
During this period I have took up short term appointments in general and geriatric
medicine including a locum consultant physician in general medicine and
diabetes/endocrinology working with Dr. Richard Paisey at Torbay Hospital, Torquy
(5 weeks) and a locum registrar/senior registrar in medicine at the West Middlesex,
Mayday, Chase Farm, Royal Free, Edgware General and Wexham Park hospitals.
29.5.95 to 13.9.95
Senior Registrar (Loum)
In general medicine and diabetes/endocrinology at Guy's Hospital, London. This
locum post included the cover for ward rounds, OPD clinics and acute medical on
take (1:6). The OPD cover included 2 diabetic, 1 endocrine and 1 general medical
clinics. I also support the metabolic ward staff in the care of walk-in diabetic
patients and supervision of patients undergoing dynamic endocrine investigations.
Consultants:
Dr. Robert Knight, FRCP

Dr. Jacke K. Powrie, MD FRCP
Dr. Brendan Hicks, MD FRCP
1.1.95 - 28.5.95
Senior Registrar (Temporary)
In general internal medicine and diabetes/endocrinology at St. Mary's Hospital,
London. The range of clinical duties cover ward rounds, OPD clinics and acute
medical on take (1:5). The weekly OPD cover included 2 diabetic, 1 endocrine and 1
lipid clinics in addition to an alternate weekly attendance at the reproductive
medicine clinic and doing a once monthly joint diabetic-renal clinic.
Consultants:
Professor Desmond G. Johnston, PhD FRCPath FRCP

Dr. Robert S. Elkeles, MD FRCP
Dr. Stephen Robinson, MA MD FRCP
Professor Stephen Franks, MD FRCP
1.8.94 - 30.9.94
Consultant Physician in GIM/Diabetes & Endocrinology (Locum)
In acute general medicine and diabetes/endocrinology at Hillingdon Hospital,
Uxbridge, Middlesex. The duties include ward rounds, OPD clinics and acute medical
on call rota of 1:5.
1.4.94 - 31.7.94
Medical Registrar/Senior Registrar (locums)
In acute general medicine at several hospitals in and around London (Central
Middlesex, West Middlesex, Wittington Hospitals in London and Medway Hospital,
Kent). The duties included ward rounds, OPD clinics and resident acute medical on
take including cover for the accident and emergency department and coronary care
unit.
1.1.94 - 31.3.94
PhD Writing up Period
Unit of Metabolic Medicine at St. Mary's Hospital Medical School, London.
Thesis Title: Clinical and Metabolic Studies on Hypopituitarism and Growth
Hormone Treatment in Adults Submitted to St Marys Hospital Medical School,
Imperial College of Science, Technology and Medicine, University of London, London.
13.9.89 - 31.12.93
Clinical Research Fellow/Honorary Registrar
Unit of Metabolic Medicine at St. Mary's Hospital Medical School, London.
During this research fellowship, I have conducted clinical and metabolic studies on
the consequences of conventionally-treated hypopituitarism in adults (body
composition, bone mass and metabolism, quality of life and cardiovascular risk). I
was also responsible on the planning and running of a trial of GH replacement
therapy in hypopituitary adults to assess the effects on well-being, body
composition, physical performance, bone mass and metabolism, lipid metabolism
and carbohydrate tolerance. The work resulted in numerous presentations at
national and international meetings and several publications in quality journals.
In addition to the research work, I was doing regular endocrine, diabetes and lipid
clinics at St. Mary's, St Charles and Northwick Park hospitals. Research fellows are
also involved in the academic and clinical activities of the unit of metabolic medicine
including teaching of medical students and supervision of the B.Sc. (Clinical Science)
students during their research project module.
During this period, I kept my skills in acute general medicine by covering absent
colleagues at the registrar/SR level on regular basis. I have also done a full time
locum senior registrar at Northwick Park Hospital, Harrow in acute general medicine
and diabetes/endocrinology between 1.10.1992 and 31.12.1992. The acute on take
rota was 1:5. (Consultant: Dr Charles. Edmonds).
Consultant:
Professor Desmond G. Johnston, PhD FRCPath FRCP
1.2.89-12.9.89
Medical Registrar
General medicine, Bedford General Hospital, Bedford.
I was working for two consultant physicians with interest in diabetes and
gastroenterology. The on take rota was 1:3. The duties include one general medical
and two diabetic clinics and one GI endoscopy session per week. In addition to the
normal medical ward work, the registrar looks after patients in the coronary care
and intensive care units.
Consultants:
Dr. A.A. Buchanan, BSc FRCP

Dr. J.H.B. Saunders, MD FRCP
23.3.87 - 16.1.89
Medical Registrar:
General medicine, Leicester General Hospital, Leicester.
Working for a consultant physician with interest in diabetes and endocrinology (19
months). I used to assist and supervise the SHOs and HOs on the ward and on
coronary care unit (when on call). Regular OPD work includes a general medical
clinic, a diabetic clinic and a diabetic foot clinic per week. There are 3 other less
frequent diabetic clinics conducted in the community around Leicester. The team
takes part in care of diabetic patients during pregnancy both as in and out-patients.
For the remaining 3 months of this post I worked for two consultant physicians with
special interest in gastroenterology. Duties include 3 OPD clinics a week and one
endoscopy session. The on call rota throughout the post was 1:4.
Consultants:
Dr. A. C.(Felix) Burden MD FRCP

Dr. C.P.T. Alexander, FRCP
Dr. A.C.B. Wicks, MD FRCP
1.12.86 - 20.3.87
Medical Registrar:
General medicine, Hairmyres Hospital, East Kilbride, Scotland
This was an acute medical post with on take rota of 1:6. In addition to ward work, I
was doing 2-3 general medical OPD clinics weekly.
Consultants:
Dr D. Datta, FRCP
Dr Chris J. Clark, MD FRCP
1.3.86 - 30.11.86
Senior House Officer:
General medicine, Victoria Infirmary , Glasgow, Scotland.
I was involved in the day-today care of acute patients with unselected medical
problems and doing twice a week general medical, cardiology and diabetes OPD
Clinics.
Consultants:
Prof. Norman. MacKay, FRCP, Dr David Ballantyne, MD FRCP

Dr Duncan MacIntyre, MD FRCP, Dr Colin M. Kesson, MD FRCP
1.11.85 - 26.2.86
Clinical Attachment:
General medicine, St Laurence's Hospital, Dublin, Ireland.
During this period I was attending ward rounds, OPD clinics and the clinical meetings
in the hospital.
Consultant:
Dr James Finuacane, BSc MD FRCPI
1.11.83 - 30.9.85
Medical S.H.O./Registrar:
In general medicine, Tripoli central hospital. During this post I have acquired more
experience in acute medicine and endocrinology. I also had some experience in
gastroenterology, including upper GI endoscopy and flexible sigmoidoscopy. I was
doing general medical, endocrine and gastroenterology OPD clinics. I also had the
opportunity of bedside teaching of medical students.
Consultants:
Prof. Ibrahim H. Sherif, FRCPEd

Dr. Mohamed Abu Baker Ahmed, FRCPEd
1.5.83 - 31.10.83
Medical Senior House Officer:
Intensive Care Unit, Tripoli Central Hospital. During this period I gained clinical
experience in all aspects of intensive care medicine including resuscitation, cardiac
pacing and care of patients on assisted ventilation.
Consultant:
Dr. Mohamed AbuBaker Ahmed, FRCPEd
1.3.82 - 30.4.83
Senior House Officer:
In general medicine, Tripoli Central Hospital, Tripoli Libya. I have been involved in the
day to day care of patients with acute medical problems, and in a unit with particular
interest in general endocrinology. I had extensive practice in all bedside clinical
procedures I was doing a general medical and an endocrine clinic weekly.
Consultant:
Prof. Ibrahim H. Sherif, FRCPEd.
1.3.81 - 28.2.82
Junior House Officer:
Internship rotation in medicine and surgery, in the main teaching hospitals in Tripoli,
Libya.
Consultants:
Prof. Ibrahim H. Sherif, FRCPEd.

Prof. A. Atluri, FRCS
PUBLICATIONS:
Full Paper:
A. Original Publications:
Sherif IH, Vanderley C, Beshyah S & Bosairi S. Sella size and contents in Sheehan's
syndrome. Clinical Endocrinology 1989; 30: 613-618.
Jones R, Beshyah SA, Curryer G & Burden AC. Modification to the "Leicester
Scotchcast Boot". Practical Diabetes 1989; 6: 118 -119.
Beshyah SA, Anyaoku V, Niththyananthan R, Sharp P & Johnston D G. The effect of
subcutaneous injection site on absorption of human growth hormone: Abdomen
versus thigh. Clinical Endocrinology 1991; 35: 409-412
Shahi M, Beshyah SA, Hackett D, Sharp P, Johnston DG & Foale R. Myocardial
dysfunction in treated hypopituitary adults: a possible explanation for increased
vascular mortality. British Heart Journal 1992: 67: 92-96
Beshyah SA, Jowett NI, Burden AC. Metabolic control during Ramadan fasting.
Practical Diabetes 1992; 9: 54-55
Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN and Johnston DG.
Detection of premature atherosclerosis by high-resolution ultrasonography in
symptom-free hypopituitary adults. Lancet 1992; 340: 1188- 1192
Beshyah SA, Markussis V, Harbourne T, Nicolaides AN and Johnston DG. Normal
haemostatic mechanisms despite increased vascular mortality in hypopituitary
adults. Hormone and Metabolic Research 1993; 25: 449-450.
Beshyah SA, Sharp P, Gelding SV, Halliday D & Johnston DG. Whole- body leucine
turnover in adults on conventional treatment for hypopituitarism. Acta
Endocrinologica 1993; 129: 158-164.
Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A & Johnston DG. Effect of growth
hormone replacement therapy on calcium and bone metabolism in hypopituitary
adults. Clinical Endocrinology 1994; 40: 383-392.
Beshyah SA, Shahi M, Skinner E, Sharp P, Foale R and Johnston DG. Cardiovascular
effects of growth hormone replacement therapy in hypopituitary adults. European
Journal of Endocrinology 1994; 130: 451-458.
Rutherford OM, Beshyah SA & Johnston DG. Quadriceps strength before and during
growth hormone treatment in hypopituitary adults: relationship to changes in lean
body mass and IGF-I. Endocrinology and Metabolism 1994; 1: 41-47.
Lynch S, Merson S, Beshyah SA, Sharp P, Skinner E, Priest RG & Johnston DG.
Psychiatric morbidity in adults with hypopituitarism. Journal of The Royal Society of
Medicine 1994; 87:445-447.

Beshyah SA, Anyaoku V, Newton P and Johnston DG. Metabolic abnormalities in
growth hormone deficient adults: I. Serum insulin like growth factor-I. Endocrinology
and Metabolism 1994; 1: 167-172.
Beshyah SA, Henderson A, Niththyananthan R, Sharp P, Richmond W and Johnston
DG. Metabolic abnormalities in growth hormone deficient adults: II. Carbohydrate
tolerance and lipid metabolism. Endocrinology and Metabolism 1994; 1: 173-180.
Rutherford OM, Beshyah SA, Schott J, Watkins Y & Johnston DG. Contractile
properties of the quadriceps muscle in growth hormone deficient hypopituitary
adults. Clinical Science 1995; 88: 67-71.
Beshyah SA, Freemantle C, Shahi, M, Anyaoku, V, Merson S, Lynch S, Skinner E,
Sharp P, Foale R and Johnston DG. Replacement treatment with biosynthetic human
growth hormone in growth hormone deficient hypopituitary adults. Clinical
Endocrinology 1995; 42: 73-84.
Al-Shoumer KAS, Beshyah SA, Niththynanathan R & Johnston DG. The effects of
glucocorticoid replacement regimen on glucose tolerance and intermediary
metabolism in hypopituitary adults. Clinical Endocrinology 1995; 42: 85-90.
Beshyah SA, Shahi M, Foale R and Johnston D G. Cardiovascular effects of prolonged
growth hormone replacement in adults. Journal of Internal Medicine 1995; :237:3542.
Beshyah SA, Freemantle C, Thomas E, Rutherford OM, Page B & Johnston DG.
Abnormal body composition and reduced bone mass in growth hormone deficient
hypopituitary adults. Clinical Endocrinology 1995; 42: 178-189.
Beshyah SA, Henderson A, Niththyananthan R, Skinner, E., Anyaoku, V., Richmond,
W, Sharp P and Johnston DG. The effects of short and long term growth hormone
replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate
tolerance. Journal of Clinical Endocrinology and Metabolism 1995; 80: 356-363.
Beshyah SA, Kyd P, Thomas E, Fairney A and Johnston DG. The effect of long-term
growth hormone replacement therapy on bone metabolism and bone mineral
density in hypopituitary adults. Clinical Endocrinology 1995; 42: 249-254.
Beshyah SA, Freemantle C, Thomas E, Page B, Murphy M & Johnston DG.
Comparison of body composition measurements derived from total body potassium,
bio-impedance analysis and dual energy X-ray absorptiometry in hypopituitary
adults before and during growth hormone replacement. American Journal of Clinical
Nutrition 1995; 61: 1186-1194.
Beshyah SA, Rutherford OM, Thomas E, Murphy M & Johnston DG. Assessment of
regional body composition by dual energy X-ray absorptiometry in hypopituitary

adults before and during growth hormone treatment.
Endocrinology and
Metabolism 1995; 2: 147-155.
Beshyah SA, Henderson A, Baynes C, Copping D, Richmond W and Johnston DG.
Post-heparin plasma lipase activity in hypopituitary adults. Hormone Research 1995,
44:69-74.
Beshyah SA, Gelding SV, Andres C, Johnston DG and Gray IP. Beta cell function in
hypopituitary adults before and during growth hormone treatment. Clinical Science
1995; 89: 321-328.
Al-Shoumer KAS, Page B, Thomas E, Beshyah SA & Johnston DG. Effects of four
years treatment with biosynthetic human growth hormone (GH) on body
composition in GH-deficient hypopituitary adults. European Journal of Endocrinology
1996; 135: 559-567
Markussis V, Beshyah SA, Fisher C, Parker K, Nicolaides AN & Johnston DG.
Abnormal carotid wall arterial wall dynamics in symptom-free hypopituitary adults.
European Journal of Endocrinology 1997; 136: 157-164.
Al-Shoumer KAS, Gray R, Anyaoku V, Huges C, Beshyah S, Richmond W & Johnston
DG. Effects of four years treatment with biosynthetic human growth hormone (GH)
on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient
adults. Clinical Endocrinology 1998; 48: 795-802
Chrisoulidou A, Kousta E, Beshyah SA, Robinson S and DG Johnston. How much and
by what mechanisms does growth hormone replacement improve the quality of life
in GH-deficient adults ? In: S M Shalet (ed.): Growth hormone in Adults. Bailliere's
Clinical Endocrinology and Metabolism 1998; 12 (2): 261-279.
Chrisoulidou A, Beshyah SA, Rutherford R, Spinks TJ, Mayet J, Kyd, P, Anyaoku V,
Haida A, Ariff B, Murphy M, Thomas E, Robinson S, Foale R & Johnston DG, Effects of
seven years growth hormone (GH) replacement therapy in hypopituitary adults.
Journal of Clinical Endocrinology and Metabolism 2000: 85: 3762 - 3769.
Bosseri S & Beshyah SA. Characteristics of diabetic patients with end-stage renal
failure on chronic haemodialysis in Tripoli, Libya. Diabetes International 2001; 11: 1921.
Beshyah SA. Tomaso Casoni (1880-1933): a forgotten pioneer remembered. Libyan
Journal of Medicine. 2008;3(4):197-9
Beshyah S. Libyan journal of medicine: achievements and challenges. Libyan J Med.
2008 Dec 1;3(4):204-5
Beshyah SA. Goran Rothman: The Swedish physician, botanist, author and North
African explorer. Libyan Journal of Medicine. 2009 Mar 1;4(1):48-50

Beshyah SA, Benbarka MM, Khalil AB. The Practices and Outcomes of Diabetic
Patients during Ramadan Fast: A Survey in a Specialist Clinic. Ibnosina Journal of
Medicine and Biomedical Sciences. 2009; 1(1): 16-19
Beshyah SA. Diabetic patients and Ramadan fasting: What advice do they get and
from whom?. Qatar Medical Journal 2009;18:77-8.
Benbarka MM, Khalil AB, Beshyah SA, Marjei S, Awad SA. Insulin pump therapy in
Moslem patients with type 1 diabetes during Ramadan fasting: an observational
report. Diabetes Technol Ther. 2010;12(4):287-90.
Khalil AB, Beshyah SA, Benbarka MM, DaBell J, Bernsen R. The effect of sitagliptin
therapy in suboptimally controlled metformin-treated type 2 diabetes patients: A
Middle Eastern experience. International Journal of Diabetes and Metabolism 2010;
18:55-58
Bisheya AF, El-Mijbri SAB, Beshyah SA, Sherif IH. Community pharamacists
knowledge, attitudes and practices in diabetes care in Tripoli, Libya. Ibnosina Journal
of Medicine and Biomedical Sciences 2011;3: 89-95.
Beshyah SA, Khalil AB, Benbarka MM and Mustafa HE. Hospitalization Patterns of
Diabetic Patients to a Tertiary Hospital in AbuDhabi, United Arab Emirates. Ibnosina J
Med BS 2011;3:113-23
Beshyah SA, Saadi HF, Sherif IH. Continuing medical education in the developing
world: timely need for better structure and regulation as a quality issue. Ibnosina
Journal of Medicine and Biomedical Sciences 2012; 4 (1):1-8
Beshyah SA, Khalil AB, Roberts Jr. DL, Noshi M. Subacute Thyroiditis Complicated by
Extra-Thyroidal Abscess: A Very Rare Presentation of Tuberculous Thyroiditis.
Ibnosina Journal of Medicine and Biomedical Science. 2012; 4(4):127-133.
Zaidi, M. A., Griffiths, R., Beshyah, S. A. & Zaidi, M. A. Blood and body fluid exposure
related knowledge, attitude ad practices of hospital based healthcare providers in
UAE. Safety and Health at Work. 2012;
Khalil AB, Beshyah SA, Awad SA. Benbarka MM, Haddad M, Al Hassan D, Kahwatih M,
Nagelkerke N. Ramadan Fasting in Diabetes Patients on Insulin Pump Therapy
Augmented by Continuous Glucose Monitoring: An Observational Real-Life Study
Diabetes Technol Ther. 2012;14(9):(in press)
Beshyah SA, Al Mehri W and Khalil AB. Osteoporosis and Its Management: An
Exploratory Study of the Knowledge, Attitudes and Practices of Physicians Working in
the United Arab Emirates. Submitted to: Archives of Osteoporsis
Mustafa HE, Bernsen RM, Beshyah SA. Glycaemic management of type 2 diabetic
patients attending a tertiary care centre in United Arab Emirates. Submitted to:
Journal of Diabetology.
B. Review Articles
Beshyah SA and Sherif IH. Ramadan fasting and diabetes mellitus. Practical Diabetes
Digest 1989; 1: 31-32
Sharp P, Beshyah SA and Johnston DG. Growth hormone disorders and diabetes. In:
Alberti KGGM & Johnston DG (eds.): Secondray Diabetes.
Bailliere's Clinical
Endocrinology and Metabolism 1992; 6: 819-828
Johnston DG, Beshyah SA, Markussis V, Shahi M, Sharp P, Foale R and Skinner E.
Metabolic changes and vascular risk factors in hypopituitarism. Hormone Research
1992; 38(S1): 68-72.
Al-Shoumer KAS, Beshyah SA and Johnston DG. Growth hormone and malignancy.
Endocrine-Related Cancer 1994 1: 19-26.
Beshyah S. Islamic views on medical ethics. [Translation to Arabic]. Bulletin of the
Islamic Call Society (Tripoli, Libya). 1998; 15:827-832
. ( )
1998 827-832 15 .
Beshyah SA and Johnston DG. Cardiovascular disease and risk factors in adults with
hypopituitarism. Clinical Endocrinology. 1999; 50:1-15
Johnston DG, Al-Shoumer KAS, Chrisoulidou A, Kousta E, Beshyah S. and Robinson S.
Long term effects of growth hormone therapy on intermediary metabolism and
insulin sensitivity in Journal of Endocrine Investigations 1999; 22: 37 - 40.
Beshyah SA, Benbarka MM and Sherif IH. Practical management of diabetes during
Ramadan fast. Libyan Journal of Medicine. 2007; 2
Beshyah SA and Sherif IH. Care for People with Diabetes during the Moslem
Pilgrimage (Haj): An Overview . Libyan Journal of Medicine. 2007; AOP: 071211
Zaidi MA, Beshyah SA and Griffith R. Needle Stick Injuries: An Overview of The Size of
The Problem, Prevention And Management. Ibnosina Journal of Medicine and
Biomedical Sciences 2010;2(2):53-61.
Beshyah SA. Non-Communicable Diseases And Diabetes Care Guidelines:
Epidemiology And Call For Collective Action. February, 6th 2010, Dat Elmad
Conference Hall Complex, Tripoli, Libya Ibnosina Journal of Medicine and Biomedical
Sciences. 2010;2: 142-148.
Beshyah SA. Fasting During The Month of Ramadan for People with Diabetes:
Medicine and Fiqh United at Last Ibnosina Journal of Medicine and Biomedical
Sciences. 2009; 1(2): 58-60
Beshyah SA, Fathalla W, Saleh A, Al-Kaddour A, Noshi M, Al Hatheethi H, Al-Saadawi
N, Elsiesi H, Amir N, Almarzouqi M, Khalil A, Benbarka M, Ahmed U, Mustafa HE, AlMahmeed W. Ramadan Fasting and The Medical Patient: An Overview for Clinicians.
Ibnosina Journal of Medicine and Biomedical Sciences 2010; 2(5): 240-257.
Book Chapters:
Beshyah SA, Shahi M, Mayet J, Foale R and Johnston DG. Growth hormone and the
cardiovascular system. In: M. Ranke and J.S. Christiansen (eds). The Complexity of
Endocrine Systems. J &J-Verlag , Mannaheim, 1996: pp 131-155.
Johnston DG, Al-Soumer KAS, Beshyah SA, Chrisoulidou A, Kousta E & Anyaoku.
Interactions of cortisol and growth hormone replacement: Intermediary metabolism.
In: SWJ Lamberts (Ed.) The Diagnosis and Treatment of Pituitary Insufficiency.
BioScientifica Ltd. Bristol. 1997: pp 63-77.
Sherif IH & Beshyah SA. Diabetes and Ramadan. In: G.V.Gill, J-C Mbanya & G. Alberti
(Eds.) Diabetes in Africa. FSG Communications Ltd. Cambridge. 1997, pp 269-273.
Johnston DG, Al-Shoumer KAS, Beshyah SA, Chrisoulidou A, Kousta E & Anyaoku.
Growth hormone replacement in young adults: if and when to continue. In: R
Stanhope (ed) Adolescent Endocrinology BioScientifica Ltd. Bristol. 1998; pp
Beshyah SA. Is cardiovascular mortality increased in hypopituitary adults ?. In:
J.P.Monson (ed) Challenges in Growth Hormone Therapy. Blackwell Science. pp 93105; 1999
Beshyah SA, Lakhdar A and Gill GV. Acute diabetic emergencie in the Arab World.
In: A A Lakhdar & GV Gill (editors): Diabetes in The Arab World. FSG Communications
Ltd. Cambridge. 2005, pp: 199-210.
Beshyah SA and Sherif I. Diabetes during Ramadan and Haj. In: A A Lakhdar & GV Gill
(editors): Diabetes in The Arab World. FSG Communications Ltd. Cambridge. 2005,
pp: 225-240.
Beshyah SA and Blouza-Chabchoub S. Diabetes and Pregnancy. In: A A Lakhdar & GV
Gill (editors): Diabetes in The Arab World. FSG Communications Ltd. Cambridge.
2005, pp 249-267.
II. Other Contributions:

Abstracts of Presentations:
Beshyah SA & Burden AC. Haemoglobin, haematocrit and foot ulceration. Diabetic
Medicine 1988; 5 (Suppl): 30
Burden A C, Jones R, Beshyah S A & Curryer G. Modification of the "Scotchcast Boot".
Diabetic Medicine 1988; 5 (suppl): 30
Beshyah S A, Jowett N I & Burden A C. Effects of Ramadan fasting on metabolic
control in diabetes. Diabetic Medicine 1988; 5 (suppl.): 32-33.
Jowett N I, Ray-Chaudri K, Beshyah S & Burden A C. Standard diabetic care and
serum cholesterol. Diabetic Medicine 1989; 6 (suppl 2): 27A
Lynch S, Beshyah SA, Merson S, Sharp P, Priest RG & Johnston DG. Psychological
features of growth hormone deficiency in adults. Journal of Endocrinology 1990; 127
(Suppl): 60
Copping D, Beshyah SA, Baynes C, Henderson A, Richmond W, Sharp P & Johnston
DG. Plasma lipids, body fat distribution and plasma lipase activity in growth
hormone deficient adults. Journal of Endocrinology 1990; 127 (Suppl): 61
Beshyah SA, Sharp PS, Anyaoku V, Fishman D & Johnston DG. Absorption of
subcutaneously injected human growth hormone. Journal of Endocrinology 1990;
127 (Suppl): 59
Beshyah SA, Freemantle C, Parnell J, Johnston DG & Sharp P. Body composition in
hypopituitarism: bioelectrical impedance versus total body potassium. Journal of
Endocrinology 1991; 129 (Suppl): 232
Shahi M, Beshyah S, Hackett D, Sharp P, Foale R & Johnston D G. The effect of
growth hormone deficiency on cardiac structure and function in hypopituitarism.
Journal of Endocrinology 1991; 129 (Suppl): 179
Shahi M, Beshyah S, Hackett D, Sharp P, Johnston D G & Foale R. Cardiac structure
and function in growth hormone deficiency. British Heart Journal 1991; 66(1): 58
Shahi M, Beshyah S, Hackett D, Sharp P, Johnston D G & Foale R. The effects of
growth hormone deficiency on cardiac structure and function. European Heart
Journal 1991; 12 (8-Abstracts Supplement): P389
Beshyah SA, Thomas E, Sharp P and Johnston DG. Bone mineral status in
hypopituitary adults. Journal of Endocrinology 1991; 131 (Suppl): 95
Markussis V, Beshyah S A, Fisher C, Renton S, Nicolaides AN and Johnston D
G.Increased carotid intima-media thickness in hypopituitary adults. Journal of
Newton PJ, Beshyah SA, Anyaoku V, Sharp P and Johnston DG. Time course of
metabolic response to subcutaneously injected human growth hormone. Journal of

Beshyah SA, Anyaoku V, Skinner E, Niththyananthan R, Sharp P and Johnston DG.
Increased diabetes and glucose intolerance in adults treated for hypopituitarism.
Journal of Endocrinology 1992; 132 (Suppl): 240
Markussis V, Beshyah SA, Harbourne T, O'Brien D, Chrysanthou B, Nicolaides AN and
Johnston DG. Increased vascular mortality in hypopituitary adults is not contributed
to by abnormal clotting mechanisms. Journal of Endocrinology 1992; 132 (Suppl):
241
Beshyah SA, Kyd PA, Sharp P, Johnston DG & Fairney A. Biochemical markers of bone
formation in hypopituitary adults. Bone and Mineral 1992; (Suppl 1) 222
Beshyah SA, Gelding SV, Robinson S, Murphy C, Sharp P, Halliday D & Johnston DG.
Leucine turnover in hypopituitary adults. Clinical Science 1992; 83: 4P-5P.
Shahi M, Beshyah S, Sharp P, Johnston D G & Foale R. Beneficial effects of growth
hormone replacement therapy on myocardial function. British Heart Journal 1992;
68(1): 129
Beshyah S A, Markussis V, Fisher C, Nicolaides AN and Johnston D G. Vascular disease
in hypopituitary adults . Cardiovascular Disease Prevention: UK 1992 held on 28-31
July 1992, London. Conference Programme and Abstracts Book (Poster number 23,
page 45).
Beshyah S A, Henderson A, Niththyanathan R, Skinner E, Baynes C, Richmond W and
Johnston DG. The atherogenic risk factors in hypopituitary adults. Cardiovascular
Disease Prevention: UK 1992 held on 28-31 July 1992, London . Conference
Programme and Abstracts Book ( Poster 24, Page 45).
Beshyah S A, Henderson A, Anyaoku V, Baynes C, Richmond W, Sharp P and Johnston
DG. Metabolic risk factors for vascular disease adult hypopituitarism. Ninth
International Congress of Endocrinology, 1992: Abstract P.11.03.053), Nice, France.
Markussis V, Beshyah S A, Fisher C, Nicolaides AN and Johnston D G. Abnormal
carotid compliance and distensibility in hypopituitarism. Ninth International
Congress of Endocrinology, 1992: Abstract N= P.08.01.045), Nice, France.
Beshyah SA, Sharp P, Anyaoku V, Henderson A, Niththyananthan R, Skinner E,
Freemantle C, Parnell CJ, Richmond W & Johnston DG. Effects of growth hormone
replacement on body composition, lipid metabolism and carbohydrate tolerance in
40 hypopituitary adults. Journal of Endocrinology 1992; 135 (Suppl): P114
Beshyah SA, Sharp P, Kyd P, Thomas E, Fairney A & Johnston DG. The effect of
biosynthetic human growth hormone (replacement) therapy on calcium and bone
metabolism in hypopituitary adults. Journal of Endocrinology 1992; 135 (Suppl): P119

Beshyah SA, Sharp P, Halliday D & Johnston DG. The effects of growth hormone
therapy on leucine metabolism in hypopituitary adults. Clinical Science 1993; 84: 43p
Beshyah SA, Anyaoku V, Newton P, Sharp P & Johnston DG. Clinical and
anthropometric correlations of serum insulin-like growth factor 1 in growth hormone
deficient adults. Journal of Endocrinology 1993; 137 (Suppl): P138
Beshyah SA, Gray IP, Niththyananthan R, Andres C & Johnston DG. The effect of
growth hormone therapy on fasting insulin and proinsulin levels in hypopituitary
adults. Journal of Endocrinology 1993; 137 (Suppl): P139
Beshyah SA, Shahi M, Anyaoku V, Skinner E, Sharp P, Foale R & Johnston DG. Clinical
and physiological effects of biosynthetic human growth hormone replacement
therapy in hypopituitary adults. Clinical Science 1993; 85 (Suppl.29):1P.
Al-Shoumer KAS, Beshyah SA, Niththynanathan R & Johnston DG. Glucocorticoid
replacement regimen and glucose tolerance in hypopituitary adults. Journal of
Endocrinology 1993; 139 (Suppl.): P126
Beshyah SA, Rutherford OM, Thomas E, Murphy M & Johnston D.G. Regional body
fat distribution in hypopituitary adults before and after growth hormone treatment:
A study by dual energy X-ray absorptiometry. Journal of Endocrinology 1993;
139(Suppl.): P127
Beshyah SA, Henderson A, Niththyananthan R, Anyaoku V & Johnston DG. Does
glucocorticoid replacement therapy contribute to the increased vascular risk in
growth hormone deficient hypopituitary adults? Journal of Endocrinology 1993; 139
(Suppl.):P128
Rutherford OM, Beshyah SA, Watkins Y, Schott J & Johnston DG. Contractile
properties of the quadriceps muscle in growth hormone deficient hypopituitary
adults. Journal of Endocrinology 1993; 139 (Suppl.):P129
Rutherford OM, Beshyah SA & Johnston DG. Quadriceps strength in adult growth
hormone deficiency before and during growth hormone treatment. Journal of
Physiology 1993:473: 213P.
Beshyah SA, Freemantle C, Page B, Thomas E, Murphy M & Johnston DG. Changes in
body composition during growth hormone therapy in adults: Comparison of total
body potassium, bio-impedance and dual energy X-ray absorptiometry. Clinical
Science 1994; 83 (suppl 30): P22
Al-Shoumer KAS, Beshyah SA, Niththynanathan R & Johnston DG. Day to day
variation in
glucose tolerance and intermediary metabolites caused by
glucocorticoid replacement therapy in hypopituitary adults. Clinical Science 1994; 83
(Suppl 30):P22
Beshyah SA, Freemantle C, Shahi M, Foale R and Johnston D.G. Effects of long term
growth hormone replacement in hypopituitary adults on body composition, exercise
tolerance and muscle strength. Journal of Endocrinology 1994; 140 (Suppl.) :P166.
Beshyah SA, Henderson, A, Richmond, W and Johnston, D.G. The effect of long term
growth hormone replacement in hypopituitary adults on plasma lipids, lipoproteins
and apoproteins. Journal of Endocrinology 1994; 140 (Suppl.) :P165.
Al-Shoumer KAS, Andres C, Beshyah SA, Gray, IP and Johnston DG. Day to day
variation in pancreatic beta cell products caused by glucocorticoid replacement
therapy in hypopituitary adults. Journal of Endocrinology 1994; 140 (Suppl.) :P164.
Beshyah SA, Niththyananthan R, Skinner E, Sharp P and Johnston DG. The effect of
long term growth hormone replacement on carbohydrate tolerance in hypopituitary
adults. Endocrinology and Metabolism 1994;1 (Suppl. B): 32
Beshyah SA, Skinner E, Aghil FM and Johnston DG. Resting energy expenditure in
growth hormone deficient adults. Journal of Endocrinology 1994; 143 (Suppl.): P75.
Beshyah SA, Kyd P, Fairney A and Johnston DG. The effects of long term growth
hormone replacement therapy on calcium and bone metabolism in hypopituitary
adults. Bone 1994; 15: 729-730.
Beshyah SA, Skinner E, Aghil FM and Johnston DG. The effect of growth hormone
replacement on resting energy expenditure in growth hormone deficient adults.
Journal of Endocrinology 1995;144: P293.
Beshyah SA, Shahi M, Mayet J, Skinner E, Foale R and Johnston DG. Heart size and
function in hypopituitary adults: Comparison with normal controls and clinical and
metabolic correlations. Journal of Endocrinology 1995; 147: OC46.
Al-Shoumer KAS, Hughes C, Richmond W, Beshyah SA and Johnston DG. Beneficial
changes in plasma lipids, lipoproteins in hypopituitary adults after 4 years of growth
hormone replacement therapy. Journal of Endocrinology 1995; 147: OC47.
Chrisouidou A, Anyaoku V, Beshyah SA, Al-Shoumer KAS, Robinson S and Johnston
DG. Effects of GH treatment for 7 years versus no treatment on anthropometry and
vascular risk factors in adult hypopituitarism. Journal of Endocrinology 1998;
150(Suppl.): P151
Chrisoulidou A, Kyd P, Beshyah SA, Rutherford O, Fairney A and Johnston DG. Effects
of 7 years of growth hormone (GH) treatment on bone metabolism in adult
hypopituitarism. Endocrinology. Proceedings of the 81st Meeting of the Endocrine
Society, San Diego, 12-15 June 1999. p394,
Chrisoulidou A, Ariff B, Mayet J, Beshyah SA, Shahi M, Foale R and Johnston DG.
Effects of 7 years of growth hormone (GH) treatment on heart function and structure
in adult hypopituitarism. Proceedings of the 81st Meeting of the Endocrine Society,
San Diego, 12-15 June 1999: P2-528 pp 392.
Bosseri, S, Beshyah SA, Ismail MMA, Lazreg I, Shafeh T & Sherif IH. Clinical and
biochemical characteristics of 270 Sheehans syndrome patients. Journal of
Endocrinology. 2000; 164(Suppl):P202
Ismail MMA, Alaswad M, Ejamail A, Abdelaziz H, Shawesh K, Dorar N, Beshyah S &
Sherif I. Metabolic control of type 2 diabetes using Repaglinide during the fasting
month of Ramadan; IDF Programme Book; Abstract P332, November 2000.
Khawaja T, Alaswad M, Kekkli M, Beshyah SA & Sherif IH. Reduced bone mass in
Sheehans syndrome. Endocrine Abstracts 2001; 1: P11
Abouglila K, Magbari M, Sayer JW & Beshyah SA. Management of hyperglycaemia
during acute myocardial infarction: an audit of DIGAMI-based practice Diabetic
Medicine 2001;
Beshyah SA, Bay NA and Sherif IH. Awareness of Libyan women of the menopause.
Third Pan Arab Congress on Endocrinology and Diabetes. Damacus October 25th-28th
2001. Proceedings Book.
Beshyah SA, Bisheya AF, El-Mijbri S. and Sherif IH. Role of community pharmacists
in diabetes care.Third Pan Arab Congress on Endocrinology and Diabetes. Damacus
October 25th-28th 2001.
Beshyah SA and Sherif IH. A Short Diabetes Knowledge Test in Arabic. Third Pan
Arab Congress on Endocrinology and Diabetes. Damacus October 25th-28th 2001.
Beshyah SA, Aylwin S, Abouglila K & Monson JP. 'Brittle Addison's disease' but not
'Brittle diabetes' in a young woman with Addison's disease and type 1 diabetes
mellitus. I. Endocrine Abstracts 2002, 3: P19
Khoo B, Field B, Rosenfelder B, Lowe DG, Beshyah SA & Monson JP. Cushing's
syndrome due to apparently autonomous adrenal hyperplasia in a patient with
multiple endocrine neoplasia type I. Endocrine Abstracts 2002, 3: P122
Beshyah SA, Bay NA & Sherif IH. Awareness of Libyan women of the menopause and
their attitudes to hormone replacement therapy. Endocrine Abstracts 2002, 3: P214
Ravikumar C, Mukhtar SF & Beshyah SA. Transient thyrotoxicosis following total
laryngectomy. Endocrine Abstracts 2002; 4: P8
Mukhtar SF and Beshyah SA. Unusualy long 'honeymoon' in a 45 year old man with
type 2 diabetes mellitus. Diabetic Medicine 2004; 21(suppl.):P214.
Beshyah SA, Al-Fallouji H & Neave F. Complete right vocal cord paralysis: a very rare
complication of radioiodine therapy for hyperthyroidism. Endocrine Abstracts 2004,
7: P301
Beshyah SA. (invited speaker) Epidemiology, clinical management and outcome of
diabetic pregnancies in the Arab world: An overview. Int J Diabetes & Metabolism (2005)
13: 30-59
Beshyah SA. (invited speaker) Evaluation and management of clinically-inapperent

adrenal masses (incidentaloma) Programme Book. 6 th Pan Arab Congress of
Endocrinology and Diabetes. March 2-4, 2005 Alexandria, Egypt
Beshyah SA. Optimal use of the old and newer oral antidiabetic drugs. Abstract Book
of The Fourth Libyan Diabetes and Endocrinology Conference 2006:WS1.2 (invited)
Koduah D, Stoner E, Phillips R and Beshyah SA. Lesson of the week: delayed diagnosis
of secondary hypoadrenalism due to isolated ACTH deficiency in an adult because of
lack of hyperpigmentation and electrolyte disturbances. Abstract Book of The Fourth
Libyan Diabetes and Endocrinology Conference 2006:P04
Sagar AS, Sherif IH and Beshyah SA. The practical diabetes knowledge of the final
year medical students in Tripoli, Libya. Abstract Book of The Fourth Libyan Diabetes
and Endocrinology Conference 2006:P09
Beshyah SA and Sherif IH. Medical complications of obesity in adults. Libyan Journal
of Medicine. 2007; 2 (supplement 2): S2.1 (invited)
Beshyah SA and Benbarka MM. Hospitalization pattern of people with diabetes .
Libyan Journal of Medicine. 2007; 2 (supplement 2): P8.
Beshyah SA. Effective insulin therapy. Libyan Journal of Medicine. 2008; 3
(supplement 1): S1.4 (invited).
Beshyah SA. Practices and outcomes of diabetic patients during Ramadan fast in Abu
Dhabi, United Arab Emirates. Libyan Journal of Medicine. 2008; 3 (supplement 1):
OC1
Beshyah SA Who advises diabetic patients during Ramadan ? Libyan Journal of
Medicine. 2008; 3 (supplement 1): P14.
Letters, Proceedings, Book reviews:

Beshyah SA. Thyroid emergencies (letter). Hospital Update 1987;13: 585
Beshyah SA. Coding human insulin (letter). Practical Diabetes 1987; 4: 245.
Beshyah SA, Thomas E, Skinner E, Sharp P & Johnston DG. Total body and spine bone
mineral density in women with hypopituitarism (Proceedings). In: Ring EFJ, ed.
Current Research in Osteoporosis and Bone Mineral Measurement II:1992. London:
The British Institute of Radiology,1992: pp 17-18
Beshyah SA, Thomas E, Freemantle C, Parnell CJ and Johnston DG. The place of dual
energy X-ray absorptiometry in measurement of lean body mass and percent body
fat in hypopituitary adults (Proceedings). In: Ring EFJ, (ed). Current Research in
Osteoporosis and Bone Mineral Measurement II:1992. London: The British Institute
of Radiology, 1992: pp 62-63
Sharp P, Beshyah SA and Johnston DG. Cardiovascular risk factors in growth
hormone deficiency: effects of growth hormone replacement Endocrinology and
Metabolism 1995; 2 (Suppl A): 13-14.
Lynch S, Beshyah S & Merson S. Psychiatric aspects of hypopituitarism (letter).
Journal of The Royal Society of Medicine 1995; 88:603-604 [PubMed Indexed]
Beshyah SA, Schiff R & Al-Jehani FS. National crash call number is needed (letter). Br.
Med. J. 1996; 313; 429. [PubMed Indexed]
Al-Shoumer KAS, Kousta E, Beshyah S and Johnston DG. GH deficiency - Does it cause
atherosclerosis? The 3rd Internationational hGH symposium on GH deficiency in
Adults. Vienna , 6 September 1996.
Beshyah SA. Taking growth hormone away from paediatrics (Book review). Lancet,
1997; 349:366-367.
Beshyah S (Editor) Supplement The Fifth Libyan Diabetes and Endocrinology
Conference, 1-3 May 2007, Teachers Union Hall, Tripoli, Libya. Libyan Journal of
Medicine. 2007, 2
Salhin AA, Hajjaji IM, Deeb AA and Beshyah SA. Meeting Report: The Fifth Libyan
Diabetes and Endocrinology Conference, 1-3 May 2007, Teachers Union Hall, Tripoli,
Libya. Libyan Journal of Medicine. 2007, 2
Al Hajjery, OM, Majdi G and Beshyah SA. Meeting Report: Sheikh Khalifa Medical City
Medicine Update 2007, Hilton Hotel, Abu Dhabi, UAE. 24-26th April 2006. Libyan
Journal of Medicine. 2007 (volume 2)
Beshyah S and Salhin AA. (Guest Supplement Editors). Supplemnt The Sixth Libyan
Diabetes and Endocrinology Conference, 28-38 April 2008, Skydome, Tripoli, Libya.
Libyan Journal of Medicine. 2008 (volume 3)
Beshyah SA. Libyan Journal of Medicine: Achievements and challenges. (Letter)
Libyan Journal of Medicine. Libyan J Med. 2008 Dec 1;3(4):204-5.
Salhin A, Besheya TA, Beshyah SA. Conference Report: The Seventh Libyan Diabetes
and Endocrinology Conference (LDEC2009), April 7-9, 2009 Tripoli, Libya. Ibnosina
Journal of Medicine and Biomedical Sciences Vol 1, No 3 (2009)
Elamami A, Gad S, Beshyah SA. The fourth annual conference of the Arab Association
for the Study of Diabetes and Metabolism (AASD); 1820 November, 2009, Cairo
Sheraton Hotel, Cairo Egypt. Ibnosina Journal of Medicine and Biomedical Sciences
Vol 2, No 2 (2010)
Salhin A, Beshyah S. Abstracts of the 7th Libyan Diabetes and Endocrinology
Conference. Ibnosina Journal of Medicine and Biomedical Sciences 2009; 1(1): 25-43
Salhin AA, Eltabal SA, Habeb AM, Beshyah SA. Abstracts of the Eighth Libyan
Diabetes and Endocrinology Conference. Ibnosina Journal of Medicine and
Biomedical Sciences. 2010; 2(5): 212-236
Beshyah SA, Deeb A. Excellence in Diabetes and Endocrinology 2010. Ibnosina
Journal of Medicine and Biomedical Sciences 2010; 2(6): 294-306
Beshyah SA. Book Review: Textbook of Diabetes. Ibnosina Journal of Medcine and
Biomedical Sciences 2011,3(4):133-134
Patients Educational Leaflets/Booklets:
Beshyah SA. The Basic Information on Diabetes: A simplified guide for Arab diabetic
patients in Britain (Patients Information Booklet; Arabic). Arab Health Care
Foundation, London. 1996

Issam M Hajjaji & Salem A Beshyah. Guide to Diabetes in Libya (in Arabic): 2002

Media Interviews:
Interview with National Libyan Radio: Health and safety during Ramadan fasting.
1985. Broadcast divided on several episodes during the month of Ramadan 1985.

Interview with Radio Spectrum International- Arabic Services 1996: On General
Health Issues with live Q&A.

Interview with MBC Satellite TV 1997: On General Health Issues with live Q&A.
Interview on the Daily Paper Al-Sharq Al-Awsat (Arabic) on Ramadan Fasting and
Diabetes 2002.
Interview with Ghazala Magazine (Arabic): Diabetes in Libya. January 2005:

Interview with OEA Daily Paper (Tripoli, Libya) on the Diabetes in Libya, The Sixth
Libyan Diabetes and Endocrinology Conference. Oea 2008; Year 2, Number 219 Page
3. (date 5th May 2008).
Interview with Al-Bayan News Paper (Abu habi, UAE) on 16 December 2007

WORK IN PROGRESS:
1. Book: Basic Information on Thyroid Disease (Arabic); Stage 80% Complete
2. Book: Basic Information on Diabetes (Arabic) Stage 60% completion.
3. Paper: Central Hospital Abu Dhabi (1966-2008): Over 40 years of Services to
the Community. A short historical account of the journey of Central hospital.
Stage: data collection and early drafting.
4. Type 2 Diabetes: a chapter in a multi-author book Oea Medical Review
5. Causes and management of Osteoporosis: a survey of the knowledge,
attitudes and practices of physicians in the United Arab Emirates - Survey
completed; data analysed, first draft of manuscript produced.
6. Causes and management of obesity: a survey of the attitudes and practices of
physicians in the United Arab Emirates Survey completed; data being
analysed.
IX. OTHER ACADEMIC ACTIVITIES:
1. Membership of learned societies:
Member, British Diabetic Association,
Member, British Society for Endocrinology
Member, Growth Hormone Research Society
Member, British Medical Association.
Member, Arab Medical Association (UK & Ireland)
Member, ABCD: Association of British Clinical Diabetologists.
Fellow; Royal Colleges of Physicians of London
Member, Libyan Doctors Society.
Founder Member, Pan Arab Congress of Endocrinology and Diabetes
Founder Member, Libyan Association for Diabetes and Endocrinology
Full Member, Emirates Endocrine Club 2006-2008
2. I have acted as a referee for the following journals:

European Journal of Endocrinology.
Clinical Endocrinology.
Jamahyria Medical Journal (Member, International Advisory Board)
Libyan Journal of Medicine
Qatar Medical Journal
Ibnosina Journal of Medicine and Biomedical Sciences.
Chair of the Programme Organizing Committee for The Fourth, Fifth, Sixth and
Seventh Libyan Diabetes and Endocrinology Conferences.
Member, The UAE National Diabetes Committees Guidelines Advisory Group 20072008 and Reviession group 2011.
Founder Honorary Treasurer, The Libyan Association for Diabetes and Endocrinology,
Tripoli, Libya 2008-todate (two terms).
Member, The National Libyan Diabetes Care Guidelines Task Force 2008-2010.
Web master of The Libyan Association for Diabetes and Endocrinology Official Web
Site www.endodiablibya.org
Coordinator: LADE Summer School 2007-2010, a series or lectures and minisymposia organized by the Libyan Association for Diabetes and Endocrinology in
Tripoli. www.endodiablibya.org/news.html
Associate Editor, Ibnosina Journal of Medicine and Biomedical Sciences. 2010-to
date. (one term is 2 years).
SUPPORTING DOCUMENTS:


1st Annual Meeting

October 12, 2012
Name:
NABIL KAMAL ELNAGGAR
Address:
HAI ALJAMEA HOSPITAL
City:
JEDDAH 21433
Country:
KSA
Email:
NELNAGGAR@YAHOO.COM
P.O BOX .10153
___ President
___ Vice President
___ Secretary
___ Treasurer
CANDIDATE STATEMENT
I have the honor to apply for being one of the director group of the AACE chapter in the
GULF area since Im a member of the international committee of the AACE, Ive been
working in the field of diabetes exclusively for the last 30 years in the Kingdom of Saudi
Arabia, Ive been involved in almost all the activities taking place in the middle east, Ive
organized a lot of international conferences and symposia in the region, we carried on a
lot of professional education programs for both physicians and educators along with
training courses for diabetes nurses. Ive instituted the oldest and most reputed society
for diabetologists (Jeddah Diabetes Club) and another one (Jeddah Hypertension &
Atherosclerosis Club) which are very active in promoting updates in diabetes fields.
I have the vision that I can serve and promote AACE Gulf chapter efficiently; supported
by my long experience, extensive relations, popularity and enthusiasm, besides being a
member of the international committee of the AACE.
I have also the goal of developing professional growth in this area through providing
AACE guidance and improving quality of services for both the health care providers and
the patients.
I aim also to initiate and enhance the collaboration of the working and active societies,
associations clubs and authorities in the Gulf to work hand in hand with the AACE
chapter for improving the care of diabetics.
Again, it will be my honor and privilege to share in the Gulf chapter as a member of the
directory board.
Dr. Nabil Elnaggar.
DR. NABIL EL NAGGAR

DR. NABIL EL NAGGAR, MBBCh, MSc, FICA, FESC
D i a b e t o l o g i s t & H e a d o f D i a b e t e s C e n t e r, H a i A l j a m e a H o s p i t a l .
Chairman of Jeddah Diabetes Club.
Chairmen of Jeddah Hypertension and Atherosclerosis Club.
H e a d o f C M E C o m m i t t e e o f H ai A l J a m e a H o s p i t al , J e d d ah , S A .
EDUCATION & EXPERIENCE
Graduated 1977, College of Medicine, Alexandria University, Rotating Houseofficer in Alexandria University
Hospitals 1978-1979, Registrar of Internal Medicine, Department of Diabetes and Metabolism 1979-1982, MSc
degree in Internal Medicine 1982, Fellowship of the Scientific Council of the International College of
Angiology 1985, Certified Professional Diabetes Instructor (Virginia University), Trained in many centers in
Europe and USA (Josllin) in the field of Diabetology including insulin pump therapy, diabetic foot care,
Professional Physician Training and Patient Diabetes Educator training, Advanced training on Vascular
Medicine and Atherosclerosis.
MEMERSHIPS:
Fellow of the American College of Angiology (FICA)
M e m b e r o f A m e ri c a n D i a b e t e s A s s o c i a t e d ( A D A )
M e m b e r o f ( A A C E ) A m e r i c a n A s s o c i a t i o n o f C l i n i c a l E n d o c ri n o l o g i s t s
Life Member of the International Diabetes Federation (IDF)
Member of the European Associated of Study of Diabetes (EASD)
Fellow of the ESC (European Society of Cardiology),Member of the preventive and rehabilitation committee
Member of ESH (European Society of Hypertension)
M e m b e r o f E g y pt i a n G r o u p o f D i a b e t e s ( E G S D )
Member of British Diabetes Association (BDA)
Member of American Gastroenterology Association (AGA)
Qualified Diabetes Professional Instructor (Virginia University)
Member of EAEDA (Egyptian Association for Endocrinology , Diabetes and Atherosclerosis).
The Egyptian Physician Syndricate
SCIENTIFIC ACTIVITIES:
Head of scientific Clubs (JDC, JHAC), Editor in chief of different local Publications & Newsletters issued monthly,
Organizer of many training courses programs and CME programs in the field of diabetes, sharing in awareness
Programs through radio broadcasts, newspaper articles, and World Medical Health Days Celebrative activities,
Organizer and President of many International Conferences held in Jeddah (JDC International Diabetes
Symposium, Jeddah International Diabetes Taskforce Program, Saudi-Dutch symposia, Annual JDC-SGH
International Symposia, JDC Collaborative Diabetes Workgroupetc). Interested in Diabetes Research, study of
aspects related to the Metabolic syndrome and dyslipidemia, obesity, and cardiovascular risk factors.
F r e q u e n t S p e a k e r i n l o c al , N a t i o n al an d I n t e r n at i o n al S y m p o s i a.
PUBLICATIONS:
EDITOR OF JDC newsletter (monthly)
EDITOR OF JHAC newsletter (The Vessel) published monthly
EDITOR OF Mens Health newsletter (Bimonthly)
1.
2.
Saied Khader , Waleed AbdelFattah , Abdulqawi Almansari , Nabil K. Elnaggar.Safety and efficacy of
switching to biphasic insulin aspart 30/70 (BIAsp 30) under the routine diabetic care in patients with
type 2 diabetes: The IMPROVE observational study in the Gulf region. International Journal of Diabetes
Mellitus 2 (2010) 110113.
Philip Home , Nabil El Naggar , Mohammed Khamseh , Guillermo Gonzalez-Galvez,
Chunduo Shen , Praful Chakkarwar , Wenying Yangf. An observational non-interventional
study of people with diabetes beginning or changed to insulin analogue therapy in non-Western
countries: The A1chieve study. Diabetes Research and Clinical Practice,2011, 94: 352-363
3.
Philip Home, Siddharth N Shah, Guillermo Gonzaliz-Galves, Nabil K Elnaggar,

Praful N Chakkarwar, Leon E Litwak. Starting Insulin Detemir in Older Versus Younger
Adults with Type 2 Diabetes Mellitus: Results from the A1chieve Study.
Presented at the American Diabetes Association, 812 June 2012, Philadelphia, PA, USA.
4.
Bassam Ben Abbas, MD, Waleed Abdel Fattah, MD, Nabil el-Nagar, MD, Magdy Abdel Fattah Abdouand, MD,
Abdulqawi Almansari, MD, Diaa Mansour Ewais, MD.Insulin detemir: Safety and efficacy of treatment with insulin
detemir in a population of people with diabetes (type 1 or type 2) in Saudi Arabia and the Gulf countries: An open
label non-interventional study on people in routine clinical diabetes treatment (The Predictive Study. The Review
of Diabetic Studies Hermansen, Lund, Clemmensen, et al.Vol. 4 No. 2 2007
5.
Nabil El Naggar, Jihad Haddad, Rachid Malek, Zanariah Hussein, JianWen Chen, Wenying YangImproved
glycaemic control in people with T2D switched from a glargine-based prandial insulin regimen to a basal-bolus
regimen with insulin detemir and insulin aspart: A1chieve data. Submitted To be presented in the EASD annual
Meeting 2012, Berlin, Germany. Control/Tracking Number: A-12-548-EASD.Tracking Number: A-12-548-EASD.
6.
El Naggar N, Soewondo P, Khamseh ME, Chen J, Haddad J. Efficacy and safety of biphasic insulin aspart 30 in
patients on prior biphasic human insulin: Data from A1chieve; a 24-week, international, prospective, multi-centre,
open-labelled, non-interventional study. Under Publication.
7.
Nabil El Naggar, Jihad Haddad, Rachid Malek, Zanariah Hussein, JianWen Chen, Wenying Yang
Improved glycaemic control in people with T2D switched from a glargine-based prandial insulin regimen to a
basal-bolus regimen with insulin detemir and insulin aspart: A1chieve data. Under Publication.
8.
El-Naggar N, Khudada K, Mariswamy N, El-Sayed H, Abdel Fattah W. Safety of Insulin Analogues in People with
Type 2 Diabetes in the Gulf region: a Subgroup Analysis from the A1chieve Study. Presented in the 3rd World
Conference of the Diabetes Asia Study Group (DASG) 2012.
CURRICULUM VITAE
PERSONAL DETAILS:
Name:
Dr. Imad El-Din Ginawi El-Sadig
Sex:
Male
Date of Birth:
19-January-1955
Place of Birth:
Khartoum, Sudan
Nationality:
Sudanese
Marital Status:
Married
Three children (15, 13 & 11)
Address:
Uptodate Medicare Centre, Al Dhiyafah Street, Dubai Islamic Bank

Building, Flat 116, Satwa
P.O. Box 117476
Dubai
U.A.E.
Contact Information: Home:

009714-2236272
Business: 009714-3986608
Fax:
009714-3984417
E-mail: imadelsadig@hotmail.com
Mobile: 0097150-6258252
0097150-7700402
EDUCATION:
Congress High Secondary School, Omdurman, Sudan
Faculty of Medicine, University of Khartoum, Sudan
1969-73
1973-79
QUALIFICATIONS:
MB, BSc
MRCP-UK
April 1979
March 1996
MEMBERSHIP OF LEARNED SOCIETIES:
Collegiate Member of the Royal College of Physicians of Edinburgh

Collegiate Member of the Royal College of Physicians of London
Member of the British Endocrine Societies.
Member of The American Association Of Clinical Endocrinologists
Member of The American Diabetes Association
CLINICAL INTEREST:
REGISTRATION:
General Medicine,
Diabetes & Endocrinology
Full Registration GMC-UK

DOH License, Dubai as:
Medical Specialist& Endocrinologist
PRESENT APPOINTMENT:
Medical Specialist & Endocrinologist,
UpToDate Medicare Centre, Dubai
Medical Specialist & Endocrinologist
Ultra Care Medical Group, Dubai
19/01/2005 Till present

01.12.1999 till 30/12/2004
PREVIOUS APPOINTMENTS:
Staff Grade Physician
Diabetes & Endocrinology
Sunderland Royal Hospital-UK
05.08.1999-31.10.1999
Specialist Registrar (LAS)

Diabetes & General Medicine
Llandough Hospital,University Hospital of Wales,Cardiff
01.07.1999-31.07.1999
Medical Registrar
General Medicine & Endocrinology
University Department of Medicine, Glasgow Royal Infirmary
06.08.1997-30.06.1999
Senior House Officer

Geriatric & General Medicine
Roodlands and Eastern General Hospital
East-Lothian NHS Trust, Edinburgh
05.02.1997-05.08.1997
Medical Resident (Senior House Physician)

General Medicine
Zayed Military Hospital, Abu Dhabi, United Arab Emirates
17.09.1995-30.12.1996
General Practitioner (Medical Officer)

General Medicine
Al-Falah Military Hospital, Sharjah, U.A.E.
24.04.1986-16.09.1995
Medical Officer
General Medicine
Soba University Hospital, Khartoum, Sudan
07.08.1985-24.11.1985
General Practitioner
Accident & Emergency Medicine
Al-Salam Hospital, Sadah, North, Yemen
19.02.1982-18.12.1984
Medical Officer (Senior House Officer)

General Medicine
Omdurman University Hospital, Khartoum, Sudan
01.07.1980-18.12.1981
Rotating Internship (Junior House Officer)

Omdurman University Hospital, Omdurman, Sudan
01.07.1979-30.06.1980
Short Term Locum Posts:

Locum Specialist Registrar in Diabetes and Endocrinology
Oldham Hospital, Manchester, UK
Locum Medical Registrar, Cardiology & General Medicine
Greenish District General Hospital, London
Locum Medical Registrar, Respiratory & General Medicine
Greenish District General Hospital, London
03.07.2001-27.07.2001
23.05.1999-28.05.1999
29.07.1998-03.08.1998
POST-GRADUATE TRAININGS:
January 1985
Attended the five-month Course in Internal Medicine at the

Edinburgh Postgraduate Board, Pfizer Foundation.
October 1990
One month Clinical Attachment with Dr. M.P. Skander,

Consultant Geriatrician, Good Hope Hospital, Sutton,
Coldfield, Birmingham, in Geriatric and General Medicine.
August 1990
One month Clinical Attachment with Dr. S.D. Gupta,

Consultant Geriatrician, Sunderland District General
Hospital, in Geriatric & General Medicine.
October 1994
One month Clinical Attachment with Professor L.K.

Borysiewicz, University Hospital of Wales, in Infectious
Diseases & General Medicine.
CONFERENCES & COURSES:

IDF Dec 2011
2Ist World Diabetes Congress
EASD Sept 2011
ADA July 2011
Endo July 2011
10-13 March 2011
Lisboa Purtugal
Sandeigo USA
Boston US
CV RISK Management
Asia Pacific regional meeting, Istanbul,Turkey
46th Annual Meeting of EASD
Stockholm, Sweden
20-24 September 2010
23-26 April, 2010
Exploring gold standards for lipid management in

CHD, diabetes & stroke of the vascular biology
group,Hangzhou, China.
27-28 February ,2010
GOLD(Global Outreach for learning in Diabetes)

The middle East and Asia Pacific Meeting
Maximizing the benefits of individualized treatment in type 2
Diabetes. Dubai ,UAE
IDF 2009
18-22 October ,2009
20th World Diabetes Congress

Montreal ,Canada
30-31 October 2008
First Middle East Stand Alone

Limassol, Cyprus
A new Dawn in Cardio & Vascular Protection

Barcelona, Spain
7-11 September 2008
44th Annual Meeting of the European Association for

the Study of Diabetes
Rome, Italy
29 August-03 September 2008
European Society of Cardiology Congress

Munich, Germany
22-25 May 2008
The Thyroid & Reproductive Symposium

Riga
2008
Merck Serono Diabetes Symposium

Grand Hyatt, Dubai
25-28 November 2007
10th Congress of the European Society for Sexual

Medicine
Lisbon, Portugal
19-20 October 2007
Optimizing Diabetes Care Symposium

Limassol, Cyprus
26-27 October 2007
3rd International Summit on Cardio Metabolic Risk

Associated with Intra-abdominal Adiposity
Prague, Czech Republic
43rd Annual meeting of The European Association for

the Study of Diabetes
Amsterdam, The Netherlands
04-08 March 2007
Meeting of the British Endocrine Society

Birmingham, UK
03-04 February 2007
The Journey of Risk Progression & Reduction

Istanbul, Turkey
08 September 2006
First Annual Update on Diabetes and Endocrinology

Ras-Alkhaima, U.A.E.
16-18 June 2006
Roses Assembly Meeting

Cairo, Egypt
07-10 June 2006
The 6th PAN-ARAB Congress of Gastroenterology

Beirut, Lebanon
05-07 April 2006
Present Trial Summit Meeting

Bangkok, Thailand
28-31 March 2006
The 10th Pan Arab Conference on Diabetes

Cairo, Egypt
19-20 January 2006
Setting a New Standard in Cholesterol Management

Dubai, U.A.E.
European Congress of Endocrinology

Goteborg, Sweden
19-20 June 2005
First Advisory Board Meeting (Crestor)

Dubai, U.A.E.
24-26 March 2005
Cairo, Egypt (MSD meeting)
14-17 December 2004
Impart Summit Meeting: Novomix R 30 & Beyond

Lisbon, Portugal
03-04 December 2004
Reducing the Burden of Cardiovascular and Metabolic

Diseases: From Bench to Bedside
Dubai, U.A.E.
25-26 November 2004
New Clinical Insights in Cardiovascular Protection

Muscat, Oman
28 August- 01 September 2004
European Congress of Cardiology

Munich, Germany
24-26 March 2004
Arcoxia Regional Opinion Leaders Meeting

Beirut, Lebanon
22-24 March 2004
The British Endocrine Societies Meeting

Briston, UK
13-20 February 2004
Optimizing Lipid Management: Reducing Cardiovascular

Risk, Beirut, Lebanon
13-14 January 2004
Advancing Nutrition in Diabetes Speakers Summit

Bangkok, Thailand
03-13 October 2003
The Cardiovascular Continuum: The Promise of

Protection
Marrakech, Morocco
The Oxford Advanced Endocrinology Seminar,

St. Annes College, Oxford, UK
24-26 July 2003
Obesity Clinical Practice Update, presented and

Moderated by Prof Philip James (UK), and Prof Nick Finer
(UK), Cairo, Egypt
06-09 June 2003
The Pfizer Cardiovascular Workshop

Mont Carlo, France
26-29 January 2003
Arab Health Congress

Dubai, U.A.E.
12-16 March 2000
The 19th joint Meeting of the British Endocrine Societies

in Birmingham, UK.
August 1997-June 1999
Specialist Registrar Training Programme in Diabetes &

Endocrinology organized by west of Scotland Board for
Specialist Registrars postgraduate training, as a day release
teaching on monthly basis.
12-15 April 1999
The 18th joint meeting of the British Endocrine

Societies, at Bournemouth.
09-11 April 1999
Advanced University Programme on Osteoporosis at

Robinson College, Cambridge.
19 May 1998
CME medical education project in Diabetes and

Endocrinology by Scotland & North East England
Section.
Nine wells Hospital, Dundee.
September 1997
Osteoporosis Symposium, one day workshop organized

by the Royal College of Physicians of Glasgow
05-06 December 1997
The Caledonian Society for Endocrinology winter

meeting, Edinburgh.
UK EXPERIENCE:
My post in Sunderland Royal University Hospital, as Staff Grade Physician with Professor
R.L. Kennedy (Professor of Diabetes & Endocrinology) and Dr. A.J. Chapman (Consultant
Endocrinologist) in a busy Diabetes Centre and Endocrinology practice gave me good insight
in the management and care of diabetic patients. I am involved twice weekly in Diabetes New
Patient Clinic and once weekly in Diabetes Review Clinic, Diabetes Foot Clinic, Antenatal
Diabetes Clinic (joint clinic with obstetrician), Thyroid Clinic and Endocrinology Clinic. I do
Diabetics In-Patients ward round once weekly.
My post as a Medical Registrar at the University Department of Medicine, Glasgow Royal
Infirmary-General Medicine and Endocrinology, gave me good chance to practice medicine
in a very busy 920-beds teaching hospital, where I have worked with Professor J.H. Mckillop
(Professor of Medicine), Dr. J.A. Thomson (Reader in Medicine and Consultant
Endocrinologist), Dr. H.W. Gray (Consultant Physician with interest in Nuclear Medicine)
Professor G.D.O.Lowe (Professor of Vascular Medicine, Professor M. Lean (Professor of
Human Nutrition) and Dr. F. Drybrugh (Consultant Biochemist). As the specialty interests of the
Department included General Medicine, Endocrinology, Mineral Metabolism, Nuclear Medicine,
Stroke Unit, and Thrombosis/Hemophilia, I have gained tremendous experience in these
disciplines excluding nuclear medicine.
My responsibility included in-patients Care as far as their investigations, management and day
to day follow up are concerned. I also had full commitment in the Out-Patients Clinics,
including General Medicine Clinic, Thyroid Clinic, General Endocrine Clinic and Mineral
Metabolism Clinic. The Acute Medical Receiving Rota was 1 in 4, in which I was first on-call
covered by SPR and Consultant from home, responsibility here was reviewing all patients with
acute medical emergencies following referral from the community, A & E Department and the
rest of the hospital Non-Medical Departments, arranging their appropriate investigations,
performing emergency procedures and putting into action a clear management plan. I shared
Acute Receiving Duties in the CCU, once or twice every month. I did regular Independent
Ward Rounds at least twice weekly. I used to cover the wards over the week-ends once or
twice per month from home (on call).
Excellent Experience gained in dealing with all medical and cardiac emergencies, stroke
management and in general medicine. Good experience gained in management and
investigations of Thyroid Disease, Adrenal Disorders, Gonadal Dysfunction, Parathyroid
Disease, and Metabolic Bone Disease.
During my post at Roodlands and Eastern General Hospital in Edinburgh, I spent six weeks
each in Medical Unit, Geriatric Assessment and Rehabilitation Wards, Acute Admission wards at
Eastern General Hospital and the long term Residential Wards, Acute Admission wards at
Eastern General Hospital and the long term Residential Wards plus Day Hospital at Edenhall and
Eastfortune Hospitals. In the medical unit, I worked with Dr. R. J. Kellt (Consultant Physician).
I was in charge of a General Medical Ward with direct admission of medical emergencies from
the community for management and further investigations. I worked with Dr. G.B. Rhind
(Consultant Physician) looking after in-patients in the Acute Assessment and Rehabilitation
wards, long term residential wards and day hospitals. During this post, I enjoyed working as part
of a multi disciplinary team including physiotherapists, OT & social workers. Excellent
Experience gained in Geriatric Medicine.
PREVIOUS WORK EXPERIENCE:

In my internship year, in one of the three large teaching hospitals in Khartoum, I spent three
months each in Obstetrics and Gynecology, General Surgery, General Medicine, and Pediatric
Medicine. The following year, I worked wholly in the Department of Medicine at the same
hospital, in a very busy general medical unit, where I learned to perform all basic procedures
under supervision, and also started learning fibreotic upper gastrointestinal endoscopy. My post
in north Yemen was spent largely in the Accident and Emergency Department, but also helped in
primary care clinics. I have enjoyed working in Al-Salam Hospital with American and British
Consultants, and junior staff of different nationalities.
On my return to Sudan, I joined the Department of Internal Medicine at a second large teaching
hospital in Khartoum, consolidating my basic training in general medicine. Because further
postgraduate studies require more resources than I could afford in Sudan, I decided that I should
take advantage of an offer of a better paid post with the UAE Armed Forces, starting in Sharjah.
There, initially I had to work in all departments, but after two years I managed to get myself
attached full-time to the medical department, where I worked with Dr. M.A. El-Bur, whose
particular interest was Cardiology in addition to General Medicine, and Dr. M. Abdullkarim,
who was a chest physician, with both of whom, I covered all aspects of Acute Medical Care. In
particular, I was looking after patients in ICU, and I learned to perform some specialized NonInvasive Cardiac investigations, such as Exercise Tolerance test and Echocardiography. I passed
the MRCP Part 1 in February 1993.
In 1995, I had the opportunity to follow Dr. El-Bur to the main Military Hospital in Abu Dhabi,
in UAE, where there were a full range of consultants in Department of Medicine, better
Laboratory and X-Ray facilities and Cardiac Catheterization Laboratory. In addition to General
Medicine with Professor N McD Davidson, I rotated every four months through Cardiology,
Gastroenterology, Diabetes & Endocrinology, Respiratory Medicine, and Infectious
Diseases. There were no house physicians here, so I was first on-call (rota varied between 1:4
and 1:7), with Specialist or Consultant second on-call from home. Duties involved the
management of all medical emergencies with ICU cover (which also receives acute cardiac
emergencies), in-patient care and various specialties out-patients clinics.
I passed the MRCP Part 11 in March 1996.
In 1997, my ambition forced me to come to UK to have some experience in western medicine
and to raise my knowledge in general medicine to the highest level.
CLINICAL SKILLS:
I am competent in routine procedures, including central venous cannulation, Pleural aspiration
and drainage (fluid/air), acetic fluid drainage and lumbar puncture. I am familiar with Treadmill
Exercise Testing, Echocardiography, and Cardiopulmonary Resuscitation. I have recently
updated my ALS PROVIDER Certificate which will expire on 14/09/2000. I can perform
endotracheal intubation, and have limited experience in controlling ventilators. I am familiar
with the various Endocrinological & Mineral metabolism investigations, patients management
and long term follow up. CME is an ongoing personal goal. I have never had any difficulty
learning new techniques, and I am keen to learn all other tasks that develop in the future, which I
should think present no problems.
TEACHING EXPERIENCE:
Based in a teaching hospital (Glasgow University Medical Dept.), I gained an extensive teaching
experience.
I was involved in teaching of both undergraduate and postgraduate MRCP candidates clinical
teaching sessions. Once weekly, I used to teach the final medical students bedside clinical
methods, and another one hour session on practical procedures. I also taught the Dental medical
students bedside medical history taking. Teaching also occurred in the out-patients clinics.
I took an active part in the very successful teaching programme in GRI for candidates sitting part
11 of MRCP, involving preparation for the long and short cases and viva. Since passing the
MRCP, I have been given increasing responsibilities in teaching others and arranging teaching
programmes. I have enjoyed teaching juniors, particularly after passing the MRCP, and I am
keen to continue to do so.
Once weekly, a unit clinical meeting was held for either Case presentation, unit Research results,
Audit or X-ray meeting. I had regular presentation in these meetings.
AUDIT EXPERIENCE:
I am involved in our once weekly mineral metabolism audit in which we discuss selected
patients who imposed either diagnostic or management dilemma.
An audit for endocrinology cases is held every two months, which I also attend.
RESEARCH EXPERIENCE:
Ongoing research:Vrtue study: Combaring Vildagliptin and Metformin with Sulphonyl

ureas and Metformin during Ramadan
Edge study International study comparing the the efficacy and tolerability of
Vildagliptine and other oral hypoglycaemic tablets in combination therapy Study will
close 31/03/2011
I have been involved in Impart research study
I have been involved in Prove it research study
I have been involved in Achieve 1 & Achieve 2 research study as well
I have been involved in research at Glasgow Royal Infirmary about:
Unnecessary parathyroidectomy in Familial Hypocalciuric Hypocalcaemia at the
west of Scotland.
How useful is nuclear medicine scanning in the investigation of primary
hyperparathyroidism.
I have great desire to do more research in future.
PUBLICATIONS:
An abstract: Cushings syndrome caused by CRH secretion from a carcinoid tumour?
Has been accepted for a poster presentation & published in Proceedings of the ACB
(Association of Clinical Biochemists) National Meeting, Focus 99, Manchester UK, 17-21
May 1999.
An abstract: Unnecesarry parathyroidectomy in Familial Hypocalciuric Hypercalcaemia.
A poster and publication of this research study has been presented at the Scottish Society for
Experimental Medicine meeting in Aberdeen on the 7th of May 1999.
An abstract: How useful is nuclear medicine scanning in primary hyperparathyroidism.
Accepted for poster presentation & publication at the Scottish Society for Experimental
Medicine on 7th of May 1999.
Management of thyrotoxicosis in pregnancy: Electronic response to an Editorial in BMJ

02-Jan-1999: Vol. 318 5-6, issue 7175 (www.bmj.com)
CAREER INTENTIONS:
My first aim must be to convey my experience in General medicine, Diabetes and Clinical
Endocrinology gained in UK best Hospitals in this part of the world, as I have already upgraded
my level to match that of my peers working in Western Health Care and western teaching
hospitals. I intend to join a teaching hospital if possible to provide the expertise I gained in UK
in teaching Internal Medicine to the medical undergraduate & postgraduate students. Research
in Diabetes and Endocrinology is also on of my goals under the right setting. Working both in
my chosen Subspecialty, General Medicine & having the joy of Teaching and Research will only
be the driving force for my future career intentions.
MEMBERSHIP OF LEARNED SOCIETIES:
Collegiate Member of the Royal College of Physicians of Edinburgh

Collegiate Member of the Royal College of Physicians of London
Member of the British Endocrine Societies.
Member of the American Association of Clinical Endocrinologists
Member of the American Diabetes Association
RECREATIONAL ACTIVITIES:
Computers
Reading
Exercise: Walking, jogging
REFEREE:
Provided on demand:
Provisional
Old:
Recent:
-United Arab Emirates

-North Yemen
-Sudan
-UK


1st Annual Meeting

October 12, 2012
1
Name:
Dr. Amin Jayyousi
Address
P.O BOX 39098
City:
Doha
Country:
Email:
Qatar
ajayyousi@hmc.org.qa , aminjayyuosi@hotmail.com
2
3
___ President
___ Vice President
___ Secretary
___ Treasurer
WEILL CORNELL MEDICAL COLLEGE, CORNELL UNIVERSITY

CURRICULUM VITAE
Date of preparation:
A.
12th. MARCH 2012
GENERAL INFORMATION
Required Information:
Name:
Office address:
Office telephone:
Office fax:
Home address:
Home telephone:
Cell phone:
Beeper:
Email:
Citizenship:
If not a U.S. Citizen, do you have,
for the U.S.A., an
Immigrant visa or
Non-immigrant Visa
AMIN A.JAYYUOSI
QATAR- DOHA P.O. BOX 3050
+974-4439-2308
+974-4439-2745
QATAR-DOHA P.O. BOX 39098
+974-4411-3678
+974-5553-0236
211-0284
ajayyousi@hmc.org.qa
QATARI
Yes, I have
Optional Information:
Birth date:
Birth place:
Marital status:
Spouses name:
Childrens name and ages:
Race/Ethnicity:
B.
March 13th, 1953

JORDAN
SINGLE
---------------------------ARAB
EDUCATIONAL BACKGROUND
Degree
M.B.B.S
MASTER PROGRAM
INTERNAL MEDICNE
Institution Name and

Location
JORDAN
UNIVERSITY
JORDAN
OF JORDAN
UNIVERSITY
JORDAN
Dates
attended
Year
Awarded
1971-1978
1978
1979-1982
1982
C.
PROFESSIONAL POSITIONS AND EMPLOYMENT
1.
Post-doctoral training (include residency/fellowships)

Title
Institution name and location
ROTATING INTERN
JORDAN
Dates held
UNIVERSITY 1978-1979
RESIDENT 1 IN
INTERNAL MEDICINE
RESIDENT 2 IN
INTERNAL MEDICINE
CHIEF RESIDENT IN
INTERNAL MEDICINE
2.
1980-1981
1981-1982
Dates held
Hospital positions (e.g., attending physician)

Title
Dates held
SPECIALIST INTERNAL
MEDICINE
HAMAD HOSPITAL/DOHAQATAR
1982-1984
1992-1996
SPECIALIST
ENDOCRINE &
DIABETES
CONSUALTANT C
CONSUALTANT B
CONSUALTANT A
4.
1979-1980
Academic positions (teaching and research)

Title
3.
HOSPITAL
JORDAN UNIVERSITY
HOSPITAL
JORDAN UNIVERSITY
HOSPITAL
JORDAN UNIVERSITY
HOSPITAL
1984-1992
1996-2000
2000PRESENT
Other Employment
Title
D.
LICENSURE, BOARD CERTIFICATION, MALPRACTICE
1.
Licensure
a. State
JORDAN MEDICAL
LICENSE
QATAR MEDICAL
LICENSE
Number
Dates held
Date of issue
Date of last
registration
1978
TILL NOW
1982
TILL NOW
b. If no license:
1. Do you have a temporary certificate?
2. Have you passed the examination for
foreign medical school graduates?
c. DEA number (Optional):
2.
Board Certification
Full Name of Board
JORDAN BOARD OF
INTERNAL MEDICINE
3.
Board Certificate
1982
Date of Certification
1982
Malpractice insurance
Do you have Malpractice Insurance?
Name of Provider:
NO, I DONT
Premiums paid by:

E.
PROFESSIONAL MEMBERSHIPS (medical and scientific societies)
Member/officer
Name of Organization
JORDANIAN MEDICAL SYNDICATE

JORDANIAN MEDICAL SOCIETY OF INTERNAL
MEDICEN
GULF LIPID CLUB BOARD MEMBER
GGSD (GULF GROUP FOR STUDY OF DIABETES )
BOARD MEMBER
QATAR DIABETES ASSOCIATION FOUNDING
MEMEBR
AACE (AMERICAN ASSOCIATION OF CLINCAL
ENDOCRINOLOGY)
QATAR MEDICAL SOCIETY
Active Member American Endocrine Society
F.
Dates held
1978- PRESENT
1984- PRESENT
1989
2010
1996
2000
2007
2012
HONORS AND AWARDS
Name of award
Date awarded
KING HUSSEIN OF JORDAN Award

Qatar Diabetes Association Award
HMC Award for 25 years service
KING ABDALLAH BIN ABD ALAZIZ Award
STARS OF EXCELLENCE HAMAD HOSPITAL
1982
2007
2008
2010
2011
3
Award
DALM VII Diabetes, Obesity the Metabolic
syndrome
Doha-Qatar , March 14th -16th ,2011
Diabetes Awareness Campaign Award
G.
2011
2012
INSTITUTIONAL/HOSPITAL AFFILIATION
1. Primary Hospital Affiliation:
HAMAD MEDICAL COORPORATION

HOSPITALS
2. Other Hospital Affiliations:

3. Other Institutional Affiliations:
H.
EMPLOYMENT STATUS
Name of Current Employer(s):

Employment Status:
I.
HAMAD MEDICAL COORPORATION

SENIOR CONSULTANT
ENDOCRINOLOGY & DIABETES
CURRENT AND PAST INSTITUTIONAL RESPONSIBILITIES AND

PERCENT EFFORT
1. Teaching (e.g., specific teaching functions, courses taught, dates)

Course, role, institution, etc.
Lecturer, Qatar University students Medical laboratory course
Lecturer, Qatar Nurses High school
Preceptor, Medicine Patient and Society I. Weill Cornell Medical
College in Qatar
SPEAKER IN DIABETES LECTURES FOR PRIMARY HEALTH
CARE PHYSICIANS AND PHYSICIANS IN PRIVATE SECTOR.
Dates
1988-1992
1989-1994
2004-present
GIVING LECTURES IN DIABETES/ ENDOCRINE WEEKLY

ACTIVITY
SINCE 1982
DEPARTMENT OF MEDICINE GRAND ROUND LECTURES

AND CASE PRESENTATION
YEARLY
LECTURING RESIDENT MEDICINE AND PRIMARY HEALTH

CARE PHYSICIAN ROTATING IN DIABETES/ ENDOCRINE
DIVISION
SINCE 1982
TEACHING RESIDENT DURING WARD ROUND
SINCE 1982
TEACHING RESIDENT IN OUTPATIENT CLINIC
SINCE 1982
SINCE 1982
2. Clinical care (duties, dates)

Duties
Date
Consultant , Running seven Clinics per week,

Endocrine & Diabetes
1984-present
Four morning clinics (7:00 AM 11:00 AM)

Three evening clinics ( 5:30 PM- 9:00 PM)
Consultant, Ward Rounds for Medical Students,

Residence and fellows ; Inpatient surgical & medical,
Women Hospital, Cancer Centre, Geriatric Hospital,
Psychiatry Hospital, Cardiac Centre.
1984-present
Consultant , On Call Duty, covering consultations at night

1984-present
for Hamad Medical Corporation Hospitals ( A&E and Inpatients)
3. Administrative duties, including committees, dates

Duties
Dates
Advisor, His Excellency SH.Hamad Bin Suhaim Althani

X-Minister of public health In Qatar
Committee Member for selection Endocrine & Diabetes
fellows.
Committee Member for gestational diabetes guidelines
Committee Member of women hospital out patient
department
Acting Head Endocrine & Diabetes section
Committee Member Diabetes unit project
Advisory Board Member for Eli-Lilly company
Advisory Board Member for Bristol Mayer Squib
Company
1990-1992
2010-present
2011
2011
2000-present
2011-Present
2011
2011
4. Research
Description
Dates (if
Applicable)
My main interest is multi-disciplinary focusing on diabetes

prevention in Qatar as well as diabetes problem from aetiology,
Presentation , Complications and Management in Qatar
Research with Weill Cornell Medical college Qatar:

High prevalence of the APOE Arg 145 cys
Dyslipidemia At-risk polymorphism in African
Derived populations
Identification of Novel risk locus for type 2 diabetes
in Qataris linked to selected skin pigmentation genes
Exome Sequencing of only seven Qataris identifies
deleterious alleles relevant to Qatars national health
profile
Principal Investigator(PI): Efficacy & Durability of
GLP-1 / Thiazolidinedione versus Basal-Bolus insulin
therapy in poorly controlled type 2 DM patients
NPRP No. : 5-273-3-079
Co-Investigator : Qatar Diabetes Prevention Study
submitted for funding QNRF
Co-Investigator: The impact of structured medication

therapy management on the clinical & Humanistic outcomes
of diabetes: A randomized controlled trial in Qatar.
NPRP No. : 5- 206- 3- 060
Co-Investigator : CORRELEATE STUDY With CedarsSinai Hospital & Cardiac Centre in Qatar
Supervisor : Comparison between different types of statins
used to treat dyslipidemia in diabetic patients in Qatar with
focus on efficacy and safety profile on hepatic and renal
functions, Funding : HGH Medical research centre approved
27500 QR
Current Percent Effort (%)
Teaching
Clinical Care
Administration
Research
TOTAL: 100%
J.
35%
35%
10%
20%
Does the activity involve WCMC

students/researchers? (Yes/No)
Yes
Yes
NO
Yes
RESEARCH SUPPORT
Current Research Support:
1.
Source
Amount
HGH Medical research centre
27500QR
Name of Principal Investigator:
Lulwa Barakat
Duration of support
(dates)
1 year
Individual's role in project,

40%
including percent (%) effort:
Title or Subject (Optional): Comparison between different types of statins
used to treat dyslipedmia in diabetic patients in Qatar with focus on efficacy
and safety profile on hepatic and renal functions.
K.
EXTRAMURAL PROFESSIONAL RESPONSIBILITIES
Responsibility
Speaker: GGSD Gulf Group for Study of Diabetes,

Doha- Qatar
Organizer & Moderator: First International Diabetes
Dates
December 26th
2009
October 19th -20
course with Harvard Medical School , MODULES I & II

course with Harvard Medical School , MODULES III & IV
Speaker: 3rd International Gulf Group for the study of
diabetes, Jeddah- Saudi Arabia
course with Harvard Medical School , MODULE V
Speaker: WORLD DIABETES DAY, Prediction &
prevention of diabetes type 2.
Speaker: DIABETES AND PREGNANCY IN QATAR
Speaker & Moderator: XVII International DALM
symposium on diabetes, obesity and the metabolic
syndrome
Speaker & Moderator & Member of Organizing
Committee: First International AACE Gulf Conference
on diabetes obesity and other endocrine diseases
Moderator: Diabetes educator symposium
IDF World diabetes congress Dubai
The 3rd Congress of the Jordanian society of
endocrinology, diabetes and metabolism JSED
1st Qatar National chronic disease surveillance strategy
workshop
Qatar Health conference, Primary health track
Lilly Diabetes forum, Beirut Lebanon
45thAnnual meeting of EASD European Association for
the Study of Diabetes Vienna- Austria
the Study of Diabetes Stockholm-Sweden
2nd DASG International conference Secondary
prevention of Diabetes Doha-Qatar
Therapeutic choices in patients with diabetes:
Implications for glycemic control, treatment adherence
and quality of life Eli Lilly Company, Barcelona- Spain
Workshop on insulin pump therapy and REAL TIME
CGM, Doha- Qatar
Diabetic foot symposium, Doha-Qatar
Board Member : 1st Gulf Lipid Club conference,
Muscat- Oman
International conference Childhood diabetes & obesity,
Doha- Qatar
2nd World Congress CODHY Controversy to Consensus
in Diabetes, Obesity and Hypertension BarcelonaSpain
17th Annual meeting and Clinical Congress AACE,
Orlando- Florida
2009
January 16th 2010
February 9th 11th 2010

March 6th 2010
November 2011
January 2011
March 14th -16th
2011
January 14th
16th 2011
November 17th
2011
December 4th
8th 2011
May 3rd -7th
2010
November 16th
17th 2009
December 15th
2010
May 28th -29th
2010
September 30th2nd October 2009
September 20th
-24th 2010
March 26th -27th
2010
September 29th
2009
January 20th
2007
November 19th
2005
1989
October 10th 12th 2008
October 30th
November 2nd
2008
May 14th 2008
Changing the course to glucose control Dubai-UAE

The Second Congress of JSED- AACE, Amman Jordan
AlAmal Hospital First Cancer Conference, Doha-Qatar
the Study of Diabetes, Lisbon- Portugal
Diabetes Expert forum Eli Lilly Company, BarcelonaSpain
Fasting and Diabetes symposium by NovoNordisk, DohaQatar
ACGME competencies, assessment Tools, Supervision
and feedback technique workshops, Doha Qatar
Moderator: The First Qatar Thalasemia Forum on Growth
and Endocrine Complications of Thalasemia and the first
meeting of the international Group for studying
Endocrine complications of Thalasemia, Doha Qatar
Medical Education Conference HMC & Weill Cornell
Medical College, Qatar
Workshop Gestational Diabetes HMC & Brighman
women hospital
Bydureon Advisory Board Meeting, Dubai- UAE
Advance in diabetes Master Class Meeting, Dubai- UAE
Moderator: Open Medical Institute Satellite
Symposium Diabetes Management-Doha/Qatar
Expert Meeting: ORIGIN Study Focused meetingAbou Dhabi/UAE
Awarded: The fourth Annual Forum: Qatar National
Research Fund Doha/Qatar
21st American Association of Clinical Endocrinologists
Philadelphia/USA
L.
November 9th
&10th 2007
May 16th-19th
2007
February 5th -7th
2009
September 2011
May 20th-21st
2011
Jun 11th 2011
October 6th 2011
October 2nd -3rd
2011
January 20th 22nd 2012
January 29th
2012
February 25th,
2011
April 30th 2011
May 5-6, 2012
May 10th, 2012
May 15, 2012
May 23-27,
2012
BIBLIOGRAPHY
1. Articles in professional peer-reviewed journals

1. Jayyousi A, Wisam Ghadban, Mahmoud Zirie, Daoud Al-Khateeb,
Hassan Mobayedh, Ahmed El-Aloosy. Radioiodine treatment of
hyperthyroidism, success rate & influence of thyrostatic medication. Saudi
Medical Journal. 2003; April : 24(4) :347-51.
2. Jayyousi A, M.Zirie, Ibrahim Mohd .Denovo mutation in multiple
Endocrine Neoplasia 2B: Family study & Review of Literature. The
Endocrinologist. 2001; 11: 237-243
3. Jayyousi A. Antithyroid drugs: a review, HAMAD Pharmacy Bulletin &
drug information. 1985; Vol. 2, No. 6, 1-3.
4. Jayyousi A. NABIL ISSEH. Dyslipidemia in Qatari patients with noninsulin dependent diabetes, international diabetes digest. 1996. Vol.7, No.
1.
5. Jayyousi A., A.Toukan etal Trithiozine in treatment of duodenal
ulcer.Jordan Medical Journal 1984; Vol.18, No.1.
2. Presentations (Optional. Other than invited lectures. List 10-20 best or

most recent only)
Lectures delivered on the following subjects Didactic/ CME
1. CONNs disease.
2. Insulinoma.
3. Graves disease.
4. DKA.
5. Polycystic ovary disease.
6. Hypoglycemia.
7. Does intensive glucose control reduce CV disease risk
8. Thyroid disease and pregnancy.
9. Gestational of diabetes
10. Thyroiditis.
11. Addisons disease.
12. Pheochromocytoma.
13. Prevention of diabetes.
14. Prolactinomas.
15. Thyroid Nodules.
16. Diabetes therapy update for pharmacists in private sector.
17. Diabetes overview for primary health care physicians.
18. Diabetes awareness campaign for Indian community.
19. Patient education about diabetes awareness & endocrine disease through
media ( Radio station, Aljazeera Satellite and News papers both Arabic and
English).
20. Booklets for patients education about diabetes and exercise, Fasting
Ramadan, Hajj, Sick days.
Date:
07/06/2012
Signature:
Amin A. Jayyuosi


1st Annual Meeting

October 12, 2012
1
Name: DR SATENDRA KUMAR MULTANI
Address: AL ZAHRAWI HOSPITAL,OMAN STREET,AL NAKHEEL
City: RAS AL KHAIMAH, PO BOX 5442
Country: UNITED ARAB EMIRATES
Email: satendramultani@gmail.com
2
purposes of Chapter business? _YES__ yes ___ no
3
___ President
___ Vice President
___ Secretary
___ Treasurer
CURRICULUM VITAE
Dr Satendra Kumar Multani
MBBS, MD (Med), DNB (Med), MNAMS,
DM (Endocrinology),FACE, MRCP-SCE(Endocrinology)
Endocrinologist / Diabetologist
Al Zahrawi Hospital ,PO Box- 5442, Al Nakheel
Ras Al Khaimah, UAE.
Adjunct Faculty, Internal Medicine, RAK MHSU,
Ras Al Khaimah, UAE.
Contact No: - + 971 50 3732514
Fax No.: +971 7 2288588
DOB- 26th April 1975
Off. - + 971 7 2288544
Email- satendramultani@yahoo.co.in
satendramultani@gmail.com
CARRIER OBJECTIVES:
To obtain a respectable position in the field of

Endocrinology through optimal delivery of updated and evidence based knowledge to the
suffering human beings & by getting involved in clinical research with special reference to
diabetes, thyroid disorders & metabolic bone disorders.
PERSONAL STRENGTH AND SKILLS:

I am a highly motivated, Innovative, Proactive, Ambitious, Committed, Goal oriented, &
Balanced person with strong work ethics. I am endowed with excellent communication,
leadership, organizational and interpersonal skills.
EDUCATIONAL QUALIFICATION
QUALIFICATION
PERIOD
FROM
TO .
M.B.B.S.
(INTERNSHIP)
September
1992 to
March 1998.
MD
(General/Intern
al Medicine)
May 1998 to
April 2001
ACADEMIC
INSTITUTE
COUNTRY
YEAR
AWARDED
SSMC, APSU,
Rewa, Madhya
Pradesh
India
April, 1998
GMC, BU, Bhopal,

Madhya Pradesh
India
June, 2001
DNB
(General/Intern
al Medicine)
May 1998 to
April 2001
DM(Endocrinology)
August 2001
to July 2004
National Board of
Examinations, New
Delhi
Seth GSMC, KEMH,
Mumbai
India
September,
2003.
India
August, 2004
ADDITIONAL QUALIFICATION / TRAINING DETAILS:
MRCP(UK)-SCE(Endocrinology) Specialty Certificate Examination In

Endocrinology conducted by Royal College of Physicians UK- June 2012.
Fellow of American College of Endocrinology (FACE) - Awarded by American
College of Endocrinology at Boston, April 2010.
Visiting Fellow in Endocrinology, Diabetes & Metabolic Bone Clinic at
University of Basel, Switzerland, August 2009.
Visiting Fellow in Endocrinology and Diabetes at Diabetes Endocrinology
Centre of Western New York, July /August 2008.
First international Diabetes Course in the UAE (5 Modules- 2009-2011)
organized by AACE- Came first in UAE in course evaluation.
IOF Osteoporosis Diagnosis Course with Densitometry Certification (Passed
the exam with highest marks), Dubai, UAE, in March 2008.
17th IOF Advanced Training Course on Osteoporosis at Lyon, France, January
2008.
Research in Diabetology (Research in Diabetes Epidemiology and
Biostatistcs) Course held by Steno Diabetes center, Denmark at Aurangabad
, India in Feb 2005.
Advance training in Hormone assays (RIA /IRMA) at Bhabha Atomic Research
Centre (BARC), Mumbai, India in October 2004.
IELTS - Band score - 7.5, Speaking-8, Writing- 7, Listening -7, Reading-8.
MNAMS - Member of National Academy of Medical Science, New Delhi.
CURRENT POSITION
Specialist A Endocrinologist & Diabetologist
Al Zahrawi Hospital, Ras Al Khaimah, UAE.
Period From June 2005 to till date (7 years).
Currently I am working as an Endocrinologist & Diabetologist in this private hospital at Ras
Al Khaimah, UAE. I am independently responsible for managing most of the problems
related to diabetes, thyroid, hypertension, lipid disorders and adult endocrinology. I have
started the Endocrine & Diabetes department in this hospital and it is supported by state of
art laboratory.
My achievements during this tenure are as follows:
A. I have been actively involved in Diabetes education for diabetic patients and I
have conducted various diabetes education programmes at hospital and
community level.
B. I have been regularly organizing educational programmes on Obesity Prevention
and Management for general public including my patients.
C. To update the physicians of this Emirate on Diabetes and other Endocrine related
disorders, I started the CME programmes in collaboration with AKMG, Ministry of
Health and Medical Universities. We had organized the First Annual Update on
Endocrinology and Diabetes in September 2006 in RAK. The last meeting
organized by me was on 5th March 2010 3rd Endocrine & Diabetes Update.
D. Guest speaker & chairman for various diabetes & Endocrine related CME
activities at Ras Al Khaimah, Dubai, Ajman, and Fujairah.
E. Besides these, I am constantly updating my knowledge & expertise by attending
national/ international CME programmes and conferences.
Adjunct Faculty in Internal Medicine, RAK MHSU, Ras Al Khaimah, UAE.

Since last 4 years, I am attached to one and only medical university in Ras Al Khaimah
emirate of (RAKMHSU) as an Adjunct faculty in department of Internal medicine. I am
actively involved in teaching related to diabetes & endocrinology, conducting research with
faculty from different departments and organizing CME activities for students, faculty as
well as for clinicians in this region.
Visiting Fellow in Endocrinology , Diabetes & metabolic bone clinic at

University of Basel , Switzerland , August 2009.
I went as a visiting fellow to this centre and worked with Dr. Marius Kraenzlin and his
team . Dr. Kraenzlin is a consultant of Calcium- and Bone Metabolism in the Division of
Endocrinology, Diabetology and Clinical Nutrition at the University Hospital Basel and he
is the professor of endocrinology and the faculty of medicine at the University of Basel. He
is a committee member of various scientific societies and past president and actual
secretary of the Swiss Society for Osteoporosis and secretary of the Swiss Society of
Endocrinology and in Diabetology. He is involved in clinical research studies of metabolic
bone disease with a particular interest in biochemical markers. M. Kraenzlin is author of
more than 150 scientific articles. He is the IOF representative for Clinical Densitometry
Course conducted all over the world time to time. He is also a regular reviewer for
several scientific journals. His centre is one of the largest centres in Switzerland dealing
with metabolic bone disorders. I felt fortunate to be there and my learning about metabolic
disorders was tremendous. I came across the commonest to rare metabolic disorders. The
most important aspect of my learning was rational use of various bone markers & newer
molecules in management of osteoporosis. Overall it was great experience which has
added a lot to my learning curve in endocrinology.
Visiting Fellow- Endocrinology And Diabetes At Diabetes

Endocrinology Centre Of Western New York, Buffalo (USA).
Period - July /August 2008.
3
I went to this centre to work with Dr. Paresh Dandona who is the founder and director of
the department. This centre is part of a comprehensive clinical care and education
programme sponsored by Kaleida Health , the regions largest health care system and
State University of New York at Buffalo School of Medicine and Biomedical
Sciences . This centre is the regional leader in the advancement of research and
treatment for diabetes and its complication. The centre is renowned for its work on role of
oxidative stress in diabetes and effect of various antidiabetic therapies on it. The
researchers for the centre have demonstrated the unique properties of Insulin in terms of
anti-inflammatory, anti atherogenic, antifibrinoloytic actions. They have also demonstrated
the prevalence of hypogonadism in type 2 diabetes patients and its clinical importance.
It was great opportunity for me to work at this centre and the
experience that I gained as a visiting fellow was unforgettable and outstanding in terms of
learning the American standards of care for diabetes patients, the importance of
aggressive management of diabetes and its related complications, understanding &
implementing the rigorous research protocols etc.
PREVIOUS POSITIONS HELD

A. Lecturer (Consultant) in Endocrinology and Diabetes.
Seth G. S. Medical College, KEM Hospital, Mumbai, INDIA 400012.
Period- 16th November 2004 to 24th May 2005.
I have worked as a lecturer in Endocrinology and Diabetes in this Municipal Corporation

Hospital. This was a consultant post and I was a part of team of consultants in decision
and policy making of department besides handling the patients independently.
During this period, I received the A R SETH best paper award for my research
during superspecialty training.
B. Senior Specialist Registrar (Endocrinology And Diabetes)

Seth GS Medical College, KEM Hospital, Mumbai, INDIA 400012.
Period- 2nd August 2004 to 15th November 2004
I have worked as a post DM senior registrar in Endocrinology and Diabetes in this largest
Municipal Corporation Hospital in Mumbai. This was equivalent to consultant post and I
was a part of team of consultants in decision and policy making of department. During
this period I have undergone advanced laboratory training (RIA/IRMA

COURSE) at BARC, Mumbai.
Details Of Specialist Registrar
Endocrinology And Diabetes
(Fellow-Ship)
Training
(Dm)
In
Duration Three years (From 1st August 2001 to 31st July 2004)
Supervised by - Professor and Head Dr. Nalini S. Shah
Professor and Former Head Dr. Padma S. Menon
King Edward Memorial Hospital is a largest teaching and tertiary care hospital of
approximately 1800 beds established in 1926 and located in Mumbai, India. The
Endocrinology department is nationally renowned, particularly for clinical and research
activities relating to diabetes mellitus and other endocrine disorders. This department
4
handles the adult as well as Pediatric endocrine cases as one of the professors is
trained in pediatric endocrinology at UK.
Both the endocrinology consultants supervised me throughout my training at KEM
Hospital. This was evidence-based comprehensive training and it covered all the aspects
of adult and pediatric endocrinology. During this period, I gained adequate expertise in
diagnosis and management of diabetes mellitus, thyroid disorders, neuro-endocrinology,
growth and puberty disorders, intersex disorders, adrenal disorders, metabolic bone
diseases etc. During this period, I was actively involved in research, teaching & other
academic activities. I had regularly presented interesting cases, seminars & journals in
interdepartmental, intradepartmental & intercollegiate meetings. It was a comprehensive 3
years training covering all the aspects of adult and pediatric endocrinology.
CONFERENCES/ COURSES/ WORKSHOPS:

2011
IDF,Dubai,4th 8th Dec 2011.
IOF Regionals, Dubai.1st Middle East & Africa Osteoporosis Meeting,19th22nd October 2011,Dubai,UAE.
2nd International Diabetic Foot Conference,24th-25th Sept 2011, Dubai, UAE.
13th European Congress of Endocrinology, 30th April- 4th May 2011,
Rotterdam, Netherland.
20th Annual Congress of American College of Clinical Endocrinologists
(AACE), April 2011, San Diego, USA.
Update on Medical & Surgical Practice- Participated as Speaker &
Delivered a talk on Osteoporosis, Jan 2011, RAK.
Cardiology Update, Feb 2011, RAK.
2010
Emirates Endocrine Congress, December 2010,Dubai.
The International Diabetes Summit, October 2010, Dubai.
70TH Scientific Sessions ADA 25th 29th June 2010, Orlando, Florida USA.
IOF World Congress on Osteoporosis & 10TH European Congress on
Clinical & Economical Aspects of Osteoporosis & Osteoarthritis, May
2010, Florence, Italy.
19th Annual Congress of American College of Clinical Endocrinologists
(AACE), April 2010, Boston, USA.
Gulf 6th Growth Update Meeting, April 2010, Dubai, UAE.
GOLD (Global Outreach for Learning in Diabetes) meeting, Feb 2010
Dubai, UAE.

2009
AFES ASEAN Federation of Endocrine Societies, Nov 2009, Bangkok,
Thailand.
Emirates Diabetes Congress 2009, November 2009, Dubai, UAE.
Introductory Hands On Thyroid Ultrasound Workshop at Endo Society
meeting 8th June 2009, Washington DC.
91ST ENDO Society Meeting 9 13th June 2009 Washington DC.
69TH Scientific Sessions ADA 5th 9th June 2009, New Orleans, USA.
7th Gulf Heart Association Conference, 9-11th April, Dubai, UAE.
GOLD (Global Outreach for Learning in Diabetes) meeting, 21-22nd March
2009, Istanbul, Turkey.
Mayo Clinic Endocrine update 2009 (in Collaboration with Al Noor
Hospital) 18-20th March, Abu Dhabi, UAE.
5
TEACHING EXPERIENCE
I have been actively involved in teaching throughout my post graduation, specialist
registrar training and after that till date. Currently I am holding the teaching post at RAK
Medical & Sciences University since last 3 yrs. My total teaching experience after post
graduation is around 8 years.
RESEARCH EXPERIENCE
I have been actively involved in research activity after registration for post
graduation to till date. It was a part of my training during MD and DM and I have done
following prospective studies during my training :
A. During post graduation- Vitamin C (Ascorbic acid) estimation in serum and
gastric juice in patients infected with Helicobacter pylori.
B. During Endocrinology Fellowship Training - Study of Bone Mineral Density and
effect of Various Environmental factors on it, in resident doctors working at
Teaching Hospital.
C. During Current Employment: Currently I am involved in research activities in
collaboration with RAK Medical & Health Sciences University and have presented
papers in various International Conferences.
PAPERS AND PUBLICATIONS
SK Multani, M Jain, FK Hassan. Poster presentations on Pre-Diabetes &

Cardiovascular Risk Factors in Multiethnic Hypertensive Population of
United Arab Emirates (UAE) at 20th Annual Congress of American College of
Clinical Endocrinologist, April 2011, San Diego,USA.
SK Multani, M Jain. Poster Presentation on Prevalence of Non-Alcoholic
Fatty Liver Disease (NAFLD) in Multiethnic Diabetic population of UAE & Its
Correlation with Cardiovascular Risk Factors at 20th Annual Congress of
American College of Clinical Endocrinologits , April 2011,San Diego,USA.
Multani SK et al. Survey and evaluation of various epidemiological factors in a
multiethnic Diabetic Population in Ras Al-Khaimah, UAE. Indian Journal of
Pharmacy Practice Volume 4 Issue 1 Jan-Mar, 2011,18-25.
Multani SK, Sarathi V, Shivane V, Bandgar TR, Menon PS, Shah NS. Study of
bone mineral density and effect of various environmental factors on it, in resident
doctors working at a teaching hospital. J Postgrad Med Jan2010 Vol 56 Issue 1.
SK Multani, M Jain (Abstract Published) .Prevalence of Obesity & Central

obesity in multiethnic Type 2 Diabetic population of UAE & their association
with other co morbidities. 70TH Scientific Sessions ADA 25th 29th June 2010.
Orlando, Florida USA.
SK Multani, M Jain, FK Hassan. Poster presentations on Hypovitaminosis D in
Multiethnic Population of United Arab Emirates (UAE) at World Congress on
Osteoporosis, May 2010, Florence, Italy.
SK Multani, M Jain. Poster Presentation on Clinico-epidemiological
Characteristics & Glycemic Control in Arab /Nonarab Diabetic Population
in UAE at 19th Annual Congress of American College of Clinical

Endocrinologits , April 2010,Boston,USA.
SK Multani, NS Shah, PS Menon, M Jain. Poster Presentation- Vitamin D Status
in Resident Doctors Working at a Tertiary Hospital in Mumbai, India. ENDO
Society Annual Meeting 2009, Washington DC,USA.
SK Multani, Meenakshi Jain. (Published)- Clinico Biochemical Profile of Type 2
Diabetes Patients among the Multiethnic Population in United Arab Emirates
(Abstract). 69TH Scientific Sessions ADA 2009,New Orleans ,USA.,
Jain RK, Asthana BS, Multani SK, Rajdev S. Prospective Study of Pre & Post
Treatment Levels Of Vitamin C In Serum And Gastric Juice In Dyspeptic Patients
Infected With Helicobacter Pylori (Abstract). Jr. of Gastroenterology and
Hepatology 2001; 16(suppl).
Kalgikar A M, Khandelwal AG, Chandratreya S, Multani SK, Shah NS, Menon PS.
Metformin In Polycystic Ovary Syndrome (Abstract). ESICON (Endocrine Society
of India Annual Conference) 2002, Kolkata (India).
John M, Bandgar T, Multani SK, Mappa P, Shah NS, Menon PS. Does
Postoperative Cortisol Levels Predict Long Term Cure In Cushings Disease
(Abstract). ESICON 2003, Bangalore (India).
Mappa P, Bandgar T, John M, Multani SK, Shah NS, Menon PS. Respose To
Radioactive Iodine In Patients With Graves disease (Abstract). ESICON 2004,
Guwahati (India).
Multani SK. Study Of Bone Mineral Density And Effect Of Various Environmental
Factors On It, In Resident Doctors Working At Teaching Hospital (Abstract).
ESICON 2004, Guwahati (India). I have got the A R Seth award of year 2004 for
this paper presentation.
Bandgar T, Mappa P, John M, Multani SK, Shah NS, Menon PS. ComparisonvOf
Block Replacement Therapy And Carbimazole Treatment In The Management Of
Graves Toxicosis (Abstract). ESICON 2004, Guwahati (India).
Multani SK , Shah N. S. Diagnosis and management of Precocious Puberty.
Impressions- Quarterly Journal of MBIAP (Mumbai branch of Indian Academy of
Pediatrics) Sept 2004; 4(3): 6-9.
PROFESSIONAL ORGANIZATIONS : I am the member of following

Professional organizations:
Life member of International Diabetes Federation (IDF)
American Diabetes Association (ADA).
European Association for the Study of Diabetes (EASD).
American Association of Clinical Endocrinologists (AACE).
Emirates Osteoporosis Society (EOS).
Life member of Endocrine Society of India (ESI).
Life member of Association of physicians of India (API).
Life member of RSSDI, India.
Life member of Indian Thyroid Society (ITS).
Life member of Indian Society of Bone Mineral and Research (ISBMR) and IOF.
Pediatric Endocrine Society, India.
LICENSURES
MOH, UAE (Specialist A License Endocrinology)

DOH- Evaluation- Specialist A
Endocrinology, License not issued but
evaluation is valid till June 2012.
7
MMC (Maharashtra Medical Council),India.

MCI (Medical Council of India)
MP Medical Council
AWARDS AND HONOURS:
Honored by MOH for contribution in Private sector in Treatment of Diabetes.
Honors in Anatomy, Pharmacology and Pathology during MBBS.
Distinction in Internal Medicine during MBBS.
A R Seth award for Year 2004 for best paper presentation at annual Conference
of Endocrine Society of India.
Nominated for A.V. Gandhi Award For Excellence In Endocrinology in India, 2004.
CLINICAL INTERESTS: Besides diabetes following are my areas of special

interest:
Metabolic bone disorders - Vitamin D deficiency and osteoporosis.
Pubertal disorders in Children.
Pregnancy and Diabetes.
Metabolic syndrome and prediabetes.
Thyroid disorders in Pregnancy.
Growth hormone deficiency childhood and adult.
REFERENCES
1. Dr. Paresh Dandona,
MD,Dphil,FRCP,FACP.FACE,FACC
Founder & Director
Diabetes- Endocrinology Centre of
Western New York
Kaleida Health
3 Gates Circle, Buffalo, NY (USA)
14209
Off- 1716 8874069
Fax- 1716 887 4773
Email- PDandona@KaleidaHealth.Org
3. Dr. Ajay Chaudhuri
MD, MRCP(UK)
Assistant Director
Diabetes- Endocrinology Centre of
Western New York
Kaleida Health
3 Gates Circle, Buffalo, NY (USA)
14209
Off- 1716 8874069
Fax- 1716 887 4773
2. Dr. Marius Kraenzlin , MD.

Professor, Department of Endocrinology
& Diabetes.
Missionsstrasse 24
CH-4055 Basel
Tel. +41 61 264 97 97
Fax +41 61 264 97 96
Email: marius.kraenzlin@unibas.ch
4 . Dr. Nalini Shah,

MD,DM (Endocrinology)
Prof and Head, Department of
Endocrinology
OPD No. 103, Old building, First floor
Seth G S Medical College and K E M
Hospital,
Parel, Mumbai, 400012, INDIA.
Telephone no: Mobile - (0) 9820223288,
Office - +91 22 24168714
8


1st Annual Meeting

October 12, 2012
1
Name: Huda Ezzeddin Mustafa
Address:
City:
Abu Dhabi
Country:
Email:
P.O. Box 45620

hezzeddin@hotmail.com
2
3
___ President
___ Vice President
___ Secretary
___ Treasurer
____ Board of Director Member
____ CV or bio-sketch included
____ Candidate statement included
Candidate Statement
27th. Aug. 2012
Dear Sir/Madam,
I would like to congratulate all Endocrinologists in the Gulf region for this
great opportunity to have a Chapter Board of Directors in this part of the
world.
By nominating myself to be a member of this prestigious scientific Board, it
gives me a chance to help other colleagues in the field of Diabetes &
Endocrinology to get linked to latest scientific developments, national and
International meetings, research opportunities, and further career
development.
This goes in line with the countrys general mission in encouraging
scientific advances, and to have representatives from the local medical
circle in international scientific bodies like the American Association of
Clinical Endocrinologists, particularly women physicians from the Gulf
region who proved their success in leadership positions.
I believe with my modest expertise, good communication skills, and my
devotion and dedication, I would serve positively on the Gulf Chapter Board
of Directors.
Kind regards,
Huda Ezzeddin Mustafa MSc, MRCP, ECNU

ACEE membership: 10619
CURRICULUM VITAE
Dr. Huda Ezzeddin Ibrahim Mustafa
MSc. MRCP (Endocrine & Diabetes), ECNU
Personal Details
Date Of Birth
31 May, 1970
Address
Nationality
E-mail
Marrital status
Married
Telephone
(Work)
(mobile)
P.O.Box: 45620
Abu-Dhabi, U.A.E.
hezzeddin@hotmail.com
hmustafa@skmc.ae
++ 9712 8191307
++ 97150 6156923
Qualifications
Postgraduate:
Endocrine Certification in Neck Ultrasound. 2011

American College of Clinical Endocrinology
Royal College of Physicians Certification in Endocrinology & Diabetes 2010

United Kingdom
MSc Health Sciences (Diabetes), 2009.

Warwick Medical School.
The University of Warwick. Coventry. UK.
Membership of the Royal College of Physicians of London. MRCP (UK), 2001.
Diploma In Clinical Endocrinology (1996)

Hammersmith hospital, Imperial College, formerly Royal
Postgraduate Medical School. London, UK.
Diploma in Health Emergencies In Large Populations (1994)

University of Geneva, faculty of Medicine.
In collaborationwith the International Committee of the Red Cross (ICRC), and
World Health Organization (WHO).
Primary University Degree: MBBS 1992. College of Medicine and Medical

Sciences. King Faisal University, Saudi Arabia.
Internship: July 92 July 93. King Fahad University Hospital. Al-Khobar, SA.
Undergraduate:
Posts & Clinical Experience

September, 2010 Date
Consultant in Endocrinology and Diabetes. Centre for Diabetes & Endocrinology. Sheikh Khalifa
Medical City in partnership with Cleveland Clinic. Abu Dhabi, United Arab Emirates.
September, 2007 August, 2010
Specialist in Endocrinology & Diabetes. Centre for Diabetes & Endocrinology. Sheikh Khalifa
Medical City in partnership with Cleveland Clinic. Abu Dhabi, United Arab Emirates.
April, 2003 August, 2007

Specialist Physician and Endocrinologist in the Department of Internal Medicine. Mafraq Hospital.
Abu-Dhabi, United Arab Emirates.
October, 2004 Date (Honorary Post)
Lecturer post in Gulf Medical College of Ajman/ Mafraq Hospital
January, 2003 August, 2007 (Honorary Post)
Chief Coordinator of Internship Program in Mafraq Hospital, Abu Dhabi.
August, 2002 August, 2007 (Honorary Post)
Quality Improvement representative for the department of Internal Medicine & Cardiology in Mafraq
Hospital in accreditation for the Joint Commission Standards of Health Care.
September, 1995 September, 1996
Honorary Clinical Assistant in the Department of Endocrinology and Metabolism. Hammersmith
Hospital. London, UK. ( GMC No. 96/0182 ).
October, 1996 April, 2003

(Senior Resident Physician)
October, 1993 August, 1995 (Junior Resident Physician)
Resident Physician in the department of Internal Medicine of Mafraq Hospital, Abu-Dhabi.
July, 1992 July, 1993

Internship Training programme. King Faisal University teaching Hospitals. Eastern province. Al
Khobar. Saudi Arabia
Specialised skills
3-5 January, 2012

Good Clinical Practice in Medical researchMinistry of Health. Dubai. UAE
20 . August, 2011
Endocrine Certification in Neck Ultrasound (ECNU)
American College of Endocrinology, US
27 . June, 2008
Good Clinic Practice training. NovoNordisk.
30 . April, 2008
Certified Pump Trainer. Medtronic Minimed Paradigm Real Time System.
21-24 January, 2008

Insulin Pump Therapy, theory and practice
MSc Diabetes module. Warwick Medical School. Coventry. UK
19 23 March, 2007
Understanding Research and Critical Appraisal in Health Care
Warwick Medical School. Coventry. UK
th
th
th
Memberships
Member of the Royal College of Physicians of London. UK.

Member of the Society for Endocrinology, UK.
Member of the American Diabetic Association, USA.
Member of the American Association of Clinical Endocrinologists, USA.
Member of the Diabetes Education Study Group (DESG), Europe.
Member of the Diabetes Education Study Group of Abu-Dhabi
Papers and Presentations
H.M.Attia, H. Ezzeddin, T. Khader. A Localized Morphoea/Idiopathic polymyositis overlap.

Clinical Rheumatology 1999;15 No 3: 307-309.
H. Mustafa, A.P. Goldstone, S. Bloom. Long Term Follow-up of pancreatic Vipomas. The 16 .
Joint Meeting of British Endocrine Societies. April, 1997. Harrogate, UK (Poster).
H. Ezzeddin, M Sharaan, T Hashem. The Outcome of Implimenting the diabetes therapeutic

patient education programme in primary health care setup in Abu-Dhabi. International Journal
of Diabetes and Metabolism 2006;14(S1):39.
H. Mustafa, R. Amin, R. Ahmad, K. Al Jaberi. The effect of Diabetes Education on glycaemic

th
control during the month of Ramadan in a tertiary hospital. The 12
Annual International
Diabetes Complications Workshop in Al Ain. Faculty of Medicine & Medical Sciences. UAE
University. Al-Ain, Abu Dhabi, UAE. ( March, 2007)
H. Mustafa. Coffee Consumption & Diabetes. The 13 . Annual International Diabetes

Complications Workshop in Al Ain. Faculty of Medicine & Medical Sciences. UAE University. AlAin, Abu Dhabi, UAE. (March, 2008)
H. Mustafa. International Diabetes Management Practices Study (IDMPS. Wave 3). A

worldwide disease registry. American Diabetes Association meeting. Paris, France (April,
2008)
H. Mustafa, S. Llahana, R. Bernsen. Glycaemic control in people with DM2 in A tertiary Centre
of the UAE: an audit of A1c in relation to different anti-diabetes management strategies. The
th
14 . Annual International Diabetes Complications Workshop in Al Ain. Faculty of Medicine &
Medical Sciences. UAE University. Al-Ain, Abu Dhabi, UAE. (April, 2009)
H. Mustafa, S. Beshyah. Lesson of the week: Not just another Hairy Woman. The seventh
th
th
Libyan Diabetes & Endocrinology Conference (CDEC 2009), 7 9 April 2009. Tripoli, Libya
(Poster 11).
H. Mustafa. Polycystic Ovarian Syndrome: an overview. EXCELLENCE in Diabetes and

Endocrinology International Conference. Abu Dhabi, UAE (October 2010)
H. Mustafa. Polycystic Ovarian Syndrome in Adolescence. International Conference of

Pubertal Disorders. Kuwait (March 2011)
Beshyah SA, Khalil AB, Benbarka MM and Mustafa HE. Hospitalization Patterns of Diabetic
Patients to a Tertiary Hospital in AbuDhabi, United Arab Emirates. Ibnosina J Med BS
2011,3(4):113-123
H. Mustafa Hirsutism in the Arab World. Pan Arab Congress of Endocrinology & Diabetes.
Beirut, Lebanon (October 2011)
th
th
Clinical Audits
Insulin PumpTherapy Audit in a Tertiary Diabetes Center SKMC. Abu Dhabi, UAE (2011-2012)
Glycaemic control in people with diabetes in SKMC-Diabetes centre in relation to anti-diabetic

management strategies. Abu Dhabi, UAE. (2008)
Diabetes control in type 2 DM in Primary Health Care of Abu Dhabi (UAE). (2004)
Patient satisfaction following cardiac catheterisation procedures. (2004)
Bed occupancy rate before and after the introduction of outpatient cardiac catheterisation
service. Mafraq Hospital, Abu Dhabi. UAE (2001-2003)
Staff compliance with registration of pre and post cardiac catheterisation checklists. Mafraq
Hospital, Abu Dhabi, UAE (2003)


1st Annual Meeting

October 12, 2012
Name: Mahmoud ALI Zirie

Address:
City:
Hamad Medical Corporation,P O BOX 3050

Doha
Country:
Qatar
Email:
mahmoudzirie@usa.net
purposes of Chapter business? ___
yes
___ no
___ President
___ Vice President
___ Secretary
___ Treasurer
___
Board of Director Member
CURRICULUM VITAE
Name: Mahmoud
A. Zirie, MD
Date of preparation: July15th, 2012
A. GENERAL INFORMATION
Office Address:
Hamad Medical Corporation

Department of Medicine
P.O.Box: 3050
Office Telephone:
(974)44392488, 44392434
Office Fax:
(974) 44392745
Home Address:
P.O.Box: 39370, Doha- Qatar
Home Telephone:
(974) 44868436
Cell Phone:
(974) 55564898
Beeper:
2231198
Email:
mzirie@hmc.org.qa
mahmoudzirie@usa.net
Citizenship:
Jordan
B. DEGREES :Degree
Institution name, city and state
Dates attended
Year Awarded
MBBS
School Of medicine,
Jordan university
Amman- Jordan
1973-1980
1980
CERTIFICATION
Name of specialty
Board Certificate #
American Board of Endocrinology, Diabetes and Metabolism

American Board Internal Medicine
Arab Board - Internal Medicine
MRCP Part I
Jordan Board - Internal Medicine
Flex
TOEFL
ECFMG
Date of Certification
Nov. 1997
Aug. 1994
Mar. 1988
Oct. 1987
May 1986
June 1993
Nov. 1990
July
1990
C. BIBLIOGRAPHY
Peer Reviewed Articles
1. "Plantar Temperature Response toWalking in Diabetes with and without Acute
Charcot: The Charcot ActivityResponse Test (CART)," by Bijan Najafi, James
Wrobel, Gurtej Grewal, Robert Menzies, Talal Talal, Mahmoud Zirie and David G.
Armstrong . Accepted for publication in Journal of Aging Research.
2. High Prevalence of the ApoE Arg145Cys Dyslipidemia At-risk Polymorphism in
African- derived Population (submitted for publication) Maen D. Abou Ziki*1,2,
Yael Strulovici-Barel*1, Neil R. Hackett1, Juan L. Rodriguez-lores1, Jason G.
Mezey1,3, Jacqueline Salit1, Sharon Radisch1, Charleen Hollmann1, Lotfi
houchane2, Joel Malek2, Mahmoud A. Zirie4, Amin Jayyuosi4, Antonio M. Gotto,
Jr5, and Ronald Crystal1,5 (1Department of Genetic Medicine ,Weill Cornell
Medical College ,New York, New York,2Department of Genetic Medicine,Weill
Cornell Medical College Qatar 3Department of Biological Statistics and
Computational Biology ,Cornell University , Hamad Medical Corporation
,5Department of Medicine ,Weill Cornell Medical College New York, NY )
3. Quantitative Proteomic And Metabolomic Profiling By UPLC-MS/MS Confirms
Altered Pathways In Diabetes", in the HUPO2010 Sydney, AU.
Authors: *Prabhjit Kaur and *Nasser Rizk (*Equal Contri-bution), Sereen
Ibrahim, Prabhdeep Cheema, Kathryn Sheikh, Mahmood Zirie, Amrita KCheema
4. The utility of an electronic adherence assessment device in type 2 diabetes
mellitus: a pilot study of single medication
Nadir Kheir1, William Greer2, Adil Yousif3, Hajer Al-Geed1, Randa Al
Okkah1, Mahmoud Zirie4, Amy Sandridge5, Manal Zaidan6
1College of Pharmacy, 2Sidra Medical and Research Centre,
3Department of Statistics, College of Arts and Sciences, Qatar
University, 4Hamad General Hospital, Hamad Medical Corporation,
Doha, Qatar; 5Private Research Consultant, 6Al Amal Cancer Centre,
Hamad Medical Corporation, Doha, Qatar, Dove press Journal : Patient
Preference and Adherence July 2010, Volume 2010:4 Pages 247 - 254
5. Inflammatory Markers and intimal Media Thickness in Diabetics with Negative

Myocardial Perfucion Scan.Douraid K.Shaker,Ibrahim Mohammed, Mahmoud A.
Zirie,Dawod Al Khateeb,Abdul Salim Kiliyanni,Jasim Al Suwaidi. J Clin Med Res
Publish a head of print doi:10.4021/jocmr2009.05.1239
3
6. Success Rate of Radioiodine treatment of Hyperthyroidiism in Qatari Patients.

Sara M Darwish, Wisam K Gadban, Mahmoud A. Zirie, Daoud A. Al Khateeb
(Accepted for Publication in Qatar Medical Journal)
7. Is male fertility associated with type 2 diabetes mellitus? Bener A, Al-Ansari AA,
Zirie M, Al-Hamaq AO. Int Urol Nephrol. 2009 Apr 21. PMID: 19381857
8. Prevalence of Metabolic Syndrome According to Adult Treatment Panel III and
International Diabetes Federation Criteria: A Population-Based Study.
Bener A, Zirie M, Musallam M, Khader YS, Al-Hamaq AO. Metab Syndr Relat
Disord. 2009 Mar 25. [Epub ahead of print]
9. Prevalence of diagnosed and undiagnosed Diabetes Mellitus and its risk factors in
a Population bases study of Qatar; Abdulbari Bener, Mahmoud Zirie, Ibrahim M.
Janahi, Abdulla O.A.A. Al Hamaq, Manal Musallam, nick J. Wareham; Diabetes
Research Clinical Practice ;2009-4450 (8 pages)
10. The Prevalence of Erectile Dysfunction in Type 2 Diabetic and Non-Diabetic Men:
A Comparative study; Abdulbari Bener, Abdullah Al ansari, Mahmoud Zirie,
Abdulla O.A.A. Al Hamaq, Ibrahim M. Janahi, Hashim S. Mohammed. Curr Urol
2007;1:89-94
11. Lack of association between the Pro12Ala polymorphism of the PPAR-gamma 2

gene and type 2 diabetes mellitus in the Qatari consanguineous population. Badii
R,Bener A, Zirie M, Al-Rikabi A, Simsek M, Al-Hamaq AO, Ghoussaini M,
Froguel P, Wareham NJ. Acta Diabetol. 2008 Mar; 45(1):15-21.
12. Hypoadiponectinemia in obese and diabetic subjects in state of Qatar. Nasser
Rizk, Reham Awni, Mohamed Osman and Mahmoud Zirei, Int J Diabetes &
Metabolism (2008) 16:123-129]
13. Intelligent Diabetes Assistant: Using Machine Learning to Help Manage Diabetes
Duke D.L., Thorpe C., Mahmoud M, Zirie M. Camegie Mellon Univ. Qatar
Campus, Doha. Computer System and Applications, 2008 AICCSA 2008
IEEE/ACS International Conference. April 2008(913-914).
14. Metabolic Syndrome and its components among Qatari population. Musallam M ,
Bener A, Zirie Mal-Gaud Y, Al-Hamaq A, Othman M, Tewfiq I. Int. J. Food
Safety, Nutrition and Public Health, Vol. 1, No.1,2008 (88-102).
15. Lipids, Lipoprotein (a) profile and HbA1c among Arabian Type 2 diabetic patients.
Abdulbari Bener, Mahmoud Zirie , Mohammed H. Daghasg, Abdulla O.A.A Al
Hamaq, Ghazi Daradkeh, Ammar Rikabi. Biomedical Research 2007; 18 (2): 97102.
16. Prevalence and predictors of osteoporosis and the impact of life style factors on
bone mineral density; Abdulbari Bener, Mohammed Hammoudeh and Mahmoud
Zirie; APLAR J. of Rheeumatology 2007; 10: 227-233
17. Lipoprotein profile in Arabian type 2 diabetic patients. Relationship to coronary
artery
diseases. Daghash MH,Bener A,Zirie M,Dabdoob W,Al-Hamaq AO,AlArabi ZA. Int. J Cardiology. 2007 Sep 14; 121(1):91-2...
18. Erectile dysfuncion in men with and without type 2 diabetes mellitus. Bener A,Alansari A,Zirie M,Al-HamaqAO,Janahi I,Mohammed H S.Current Urology 2006
19. Which Comes First- Renal dysfunction or High Blood Pressure?: Elevated Blood
Pressure and Risk of End- Stage Renal Disease in subjects without Baseline
Kidney Disease.(Hsu CY, McCulloch CE,, Zirie M,. Van der Woude FJ) J Am
Soc Nephrol 16:2817-2820,2005
20. Carnosine as a protective factor in diabetic nephropathy: Association with a
leucine repeat of the carnosinase gene CNDP1. Bart Janssen .Mahmoud
ZirieFokko J.van der Woude. Diabetes 2005, 54:2320-2327.
21. Bone density measured by dual energy x-ray absorptiometry in Qatari women,
(Mohammed Hammoudeh, Mohammed Al-Khayarin,Mahmoud Zirie, Abdulbari
Bener), [maturitas.2005 Nov-Dec; 52(3-4)319-27.Epub 2005 Jul 1].
22. Is obesity a protective factor for osteporosis. ( Abdulbari BENER, Mohammed
HAMMOUDEH, Mahmoud ZIRIE, Richard HELLER). Aplar Journal of
Rheumatology 2005; 8: 32-38).
23. Genetics, Obesity and Environmental risk factors associated with type 2 diabetes.
(Abdulbari Bener, Mohamoud Zirie, Ammar Al-Rikabi.), [Croat Med J. 2005 Apr;
46(2):302-7 ].
24. Zinc states in type 2 DM. and its relation to glucose and lipids profile. ( Gazi
Daradkeh, Mahmoud Zirie, Amine Jayyousi, I. Mohammad, B. Al-Owainati, M.
Daghash , M. Othman), [ completed, to be submitted for publications].
25. First documented case of conns syndrome in Hamad Medical Corporation. ( Dr.
Sara Darwish, Mahmoud Zirie, Issam A. Al- Bozom ).Qatar medical journal
5
26. Complications of Diabetes Mellitus among Patients attending outpatient clinics in

Qatar. [Zirie M.A., Yousef M.F. Al Mashaly A] Qatar Medical Journal, Vol. 12.
No. 2, Dec. 2003
27. Radioiodine treatment of hyperthyroidism.
Success rate and influence of
thyrostatic medication. Wisam K. Ghadban, MD, MRCP(UK), Mahmoud A. Zirie,
MD, FACE, Daoud A. Al-Khateeb, MD, Amin A. Jayyousi, MD, Hassan M.
Mobayedh, MD, Ahmed A. El-Aloosy, PhD. Saudi (Med J 2003; Vol. 24 (4): 347351
28. De Novo Mutation in Multiple Endocrine Neoplasia 2B Family Study and
Review of Literature Mahmoud Zirie, MD, FACE, Ibrahim Mohammed, MD,
FACE, Amin Jayyousi, MD, Mohammed Al Harami, MD, FRCS. . The
Endocrinologist; Vol. 11 No. 3, 237 243, 2001.
29. Multiple Endocrine Neoplasia 2A: Report of a family with a study of three
generations in Qatar; Mahmoud Zirie, MD, FACE, Ibrahim Mohammed, MD,
FACE, Mohammed El-Emadi, MD, FRCS, Abdurazzak Haider, MD, FASCP.
Endocrine Practice; Vol. 7, No. 1, 19-27; 2001
30. Diabetes Retinopathy; Zirie M A: Diabetes Insight, Vol 1, No. 4,; 19-20, June
1998.
31. New Classification and Diagnostic Criteria for Diabetes, Optimal BP control in
diabetic; Zirie M A: Diabetes Insight, Vol. 1, No. 4; 21-22, June 1998.
32. Intensive Insulin Therapy; Zirie, M A.: Diabetes Insight; Vol. 1, No. 3, 11 16,
December 1997.
33. Carbamazepine (e BZ) Interfering with 24-hour urine-free cortisol; Zirie, M A.
Griffing G. The Endocrinologist; 7:116-118, 1997.
34. Diabetes Centers; Zirie, M A.. Diabetes Insight; Vol. 1, No. (1): 16-18, Nov. 1996.
35. Peripheral Vascular Disease and Diabetic Foot; Zirie, M A: - Nov. 1996. Special
symposium published by Qatar Diabetes Association.
Books, Book Chapters and Reviews
(
Mahmoud Zirie, MD, Ibrahim Janahi, MD. Your Guide to Diabetes, an

educational book directed to Diabetic patients. Published by Hamad
Medical Corporation, Doha-Qatar, Feb. 2004.
Mahmoud
Zirie,MD.
Ibrahim Janahi,MD
.Sara
Darwish,MD.
.photographed book for Diabetes, an educational book directed to Diabetic
patients. Published by Hamad Medical Corporation, Doha-Qatar, April
2008
6
D. PROFESSIONAL POSITIONS AND EMPLOYMENT
Post-doctoral training including residency/fellowship

Title
Dates
1. In USA
FELLOWSHIP:
Second Year Post-Doctoral

Fellow, Endocrinology, Diabetes
and Metabolism
University of Missouri
Columbia, MO 65212
July 1995 June 1996
First Year Post-Doctoral

Fellow, Endocrinology, Diabetes
and Metabolism
University of Missouri
Columbia, MO 65212
July 1994 June 1995
RESIDENCY:
PGY III Resident*

Internal Medicine
Michigan State University
Hurley Medical Center
Flint, MI 48503
July 1993 June 1994
PGY I Resident
Internal Medicine
Michigan State University
Hurley Medical Center
Flint, MI 48503
July 1992 June 1993
One year credit for previous experience.

7
2. Outside USA
Rotating Internship
Jordan University Hospital
Amman Jordan
July 1980 June 1981
Resident
Internal Medicine
Jordan University Hospital
Amman Jordan
July 1981 June 1982
Resident
Internal Medicine
Hamad General Hospital
Doha Qatar
July 1982 Dec. 1982
Arab Board for Internal Medicine

Residency Program
Hamad General Hospital
Doha Qatar
Jan. 1983 Dec. 1985
Senior Resident- Medicine

Doha Qatar
Jan. 1986 June 1986
Hospital positions (attending physician, if applicable)

Title
Dates
Consultant,
Hamad Medical Corporation (HMC)
Head\Endo.Diab .and Doha Qatar
metabolism
Consultant,
HMC
Endocrinology,
Doha Qatar
Diabetes
and
Metabolism
Senior Specialist
HMC
Endocrinology,
Doha Qatar
Diabetes
and
Metabolism
April 97- to date
Specialist
Endocrinology,
Diabetes
Metabolism

Doha Qatar
July 88 Feb.90

Doha Qatar
July 86 June 88
July 96-April 97
March 90 June
92
and
Specialist
Internal Medicine
Academic Position
Assistant Professor of Medicine -Weill Cornell Medical College in Qatar
E. Licensure
State
Number
Date of Issue
Date of last registration
Missouri - USA
106733
Aug.03.94
Valid
Jan.31.2013
DEA
Qatar
BZ 4223830
4597
10/11/2009
present
through
F. Professional Membership (medical and scientific societies)

Member/officer
Name of Organization
Fellow, American Association of Clinical Endocrinologists

Fellow, American College of Physician
Member, American Association of Clinical Endocrinologists
Member, American college of physicians
Associate, American college of physicians
Member of Jordan Medical Association
Registered Internist in Jordan
Member, Qatar Diabetes Association
Dates held
May
2000
present
Jan.
2000
present
April
1998-May
2000
April
1995Jan.2000
July
1992-April
1995
July 1980
present
May
1986
present
Aug.1996-present
G. Honors and Awards

Name of award
1. Hamd Medical Corporation Spirit of Service Award Glowing

Star 2010
2. Stars of Excellence (Employee awards and Recognition
Program)
From Hamd Medical Corporation
3. Diabetes Asia study Group (DASG)
4. Supreme Council of Health Public Health Department Qatar
5. Hamd Medical Corporation (Participation in Qatar Health
2009)
6. the Gulf Group for the Study of Diabetes
7. Qatar Diabetes Association (Participation in International
Conference Childhood Diabetes & Obesity)
8. Hamd Medical Corporation (Participation in1st Qatari
ophthalmology subspecialty symposium
Date awarded
May 23rd ,2010

May 23rd ,2010
March , 2010
March , 2010
Dec, 2009
Dec, 2009
Oct, 2008
May, 2008
10
9. Qatar Diabetes Association (Participation in Diabetes

Integrated Care symposium
10.
Hamad Medical Corporation (Participation in3rd Qatar
International Medical Congress
11.
Hamad Medical Corporation Maternal and Child health
section
12.
Computer literacy training, HMC
April 2007
Nov. 2005
Feb., 2002
April 06 - 10
,2002
13.
WHO work shop on training the trainers, HMC, Doha- Dec. 22 - 26,
Qatar
2000
14.
First
Qatar
International
Oncology
Conference Nov. 18 20,
Management of Breast, Colon, Thyroid and Lymphoma in the 1999
New Millennium, Doha Qatar.
15.
Qatar Diabetes Association.
Participation in the Dec. 12. 1999
leadership Assessment Workshop on childhood and Adolescent
Diabetes.
16.
Qatar Diabetes Association. Participation in the activities Nov. 13 - 18,
during Diabetes Week.
1999
17. The Environment Friend Center, Doha Qatar
March 22 -26,
1998
18.
Arab Board of Internal Medicine, Doha Qatar
Sep. 1998
19.
Qatar Diabetes Association. Diabetes and Human Rights, Nov. 14- 16, 1998
Doha Qatar.
20. Qatar Diabetes Association Volunteers day, Doha Qatar.
Dec. 05, 1998
21. Youth and Sports Association. Umsalal Youth Center, Doha - Nov. 18, 1998
Qatar.
22. Hamad Medical Corporation Public Relations; Diabetes Jan. 01, 1997
TV Program. Doha Qatar.
H. Institutional/Hospital Affiliation
Primary Hospital Affiliation:
Other Hospital Affiliations:
Other Institutional Affiliations:
Cornell Medical College Qatar Campus
11
I. Current and Past Institutional Responsibilities and Recent Effort

Teaching (list courses and your role)
Residents from different training programs (as listed below), rotate in Endo/Daib.
Division. We teach them theoretical and practical aspects of Endo, Diab. And
metabolism, this includes: Attend DM/Endo clinics to see how we manage patients, asking them to do
history and physical examinations then to discuss the case with the attending
physician.
Attend inpatients rounds, with bed side teaching.
Attend Endo/Diab. Educational Activities (Lectures, case presentations,
journal club). We ask them to participate actively by preparing and delivering
topics under supervision of the staff .
Arab Board for Internal Medicine
Physicians to run diabetes clinics in Primary Health centres
Residents from expatriate training program (ETP)
Residents from Family Medicine program.
Teaching for medical students during summer vacation.
Educational Activities:In the capacity of head of Endo/Diab. Division., I Prepare the schedule and
participate in the following activities:
1.
2.
3.
4.
Weekly Activity, Tuesday 7-8 am. Covered by endocrine staff.

Endocrine Surgical Conference, once /month.
State of the art lecture, once / year, to medicine department.
Endocrine case presentation, Monday, house staff conference, 2
times/ year.
Clinical Care:I am participating in clinical patient care since my graduation 1980.

I do 3 half day clinics per week, 3 mornings (7-11) am., each clinic serves 18-25
patients
- Sunday7-11 am. : General Endocrine clinic.
- Tuesday 8-11 am. : Thyroid clinic
- Thursday 7-11 am.: Diabetic clinic
The rest of the time is divided between inpatients rounds,
consultations, research, and administrative issues.
Administrative duties (including committees):12
Title
Head
of
Endocrinology, Diabetes
Division
Doha Qatar
and
Date
Metabolism April 1997- present
Chief of Dietetic & Nutrition Section
June 1997 Dec. 2000
Committees:
1. Hamad Medical Corporation-Doha Qatar
Promotion Committee- Medicine Dept.

Academic Health System- Community
engagement
Hyperbaric Medicine Service Clinical
Committee
Pharmacy Transformation Program Clinical
Practice Workgroup
Action on Diabetes -Steering Committee
Research Advisory Committee
2. Primary health care

Health Promotion committee
3. Qatar Diabetes association
Head of scientific committee
4. International Committees
AACE-Gulf Chapter
Efforts
Current percent effort
Teaching
Clinical Care
Administration
Research
Total
20%
50%
10%
20%
100%
J. Research Effort (present)

13
1. Body Worn Sensor Technology for improving diabetic care during activity of
Daily living. [Proposal No. : NPRP 08 -499-3-109 Funded by QNRF second
cycle]. Dr. Mahmoud A. Zirie, consultant Endocrinology\Diabetes ,Hamad
Medical Corporation Prof. David Armstrong ,University of Arizona-USA Dr.
Bijan Najafi, Rosalind Franklin University ,North Chicago-USA
2. System approach towards diabetes research using molecular profiling tools.
[Proposal No. : NPRP 08-740-3-148 Funded by QNRF second cycle].
Dr.Mahmoud A.Zirie,consultant Endocrinology\Diabetes ,Hamad Medical
Corporation Dr.Nasser Rizk Md, PhD who is a Professor of physiology and
endocrinology at the Qatar
University Dr. Amrita K. Cheema in the
department of Oncology in Georgetown University, Washington D.C. USA.
3. Collection of Blood for Gene Expression/Genomic Studies in Individuals
with Diabetes (Qatar) Ronald G. Crystal, MD Genetic Medicine (WCMC
NY and Qatar) and Medicine (WCMC NY Lotfi Chouchane, PhD Genetic
Medicine (WCMC Qatar) Mahmoud Zirie, MD Head of Endocrinology,
HMC Amin Jayyousi, MD Consultant Endocrinology, HMC Ibrahim
Mohammed, MD Consultant Endocrinology, HMC
4. Characterization of Metabolic Defects in Arab and Mexican American
Subjects at Increased Risk of Type 2 Diabetes Dr. Mahmoud Zirie-HMC Dr.
Muhammed Abdulghani-Texas University USA (NPRP 4-247-3-076 Funded
by QNRF)
5. Metabolic Syndrome in patients receiving antipsychotics in the Qatari and
Kuwaiti population Dr. Mahmoud Zirie, Dr. Hassan Al Amin WCMC-Qatar
(NPRP 4-267-3-085 Funded by QNRF)
6. Efficacy and Durability of GLP-1/Thiazolidinedione versus Basal-Bolus

Insulin Therapy in Poorly Controlled T2DM Patients (NPRP 5 - 273 - 3 079 funded by QNRF) Prof. Muhammad Abdul-Ghani(UTHSCSA), Prof.
Ralph DeFronzo( UTHSCSA), Dr. Mahmoud Zirie (Hamad Medical
Corporation), Dr. Amin Jayyousi(Hamad Medical Corporation)
7. Creation of a Metabolic Core Facility for Obesity, Diabetes and
Cardiovascular Research in HMC( NPRP 5 - 467 - 3 - 124 funded by
QNRF), Dr. Mahmoud Zirie (Hamad Medical Corporation),Prof.
Muhammad Abdul-Ghani( UTHSCSA) Prof. Ralph DeFronzo (UTHSCSA)
8. The Qatar Diabetes Prevention Study (QDPS): Effect of Metformin/

Pioglitazone/Exenatide on the Incidence of T2DM and Microvascular
14
Events In Qatari IGT individuals. NPRP X-029-3-011,(submitted to the

Exceptional program - QNRF), 5-years projects.
Lead PI- Mahmoud Zirie, MD, Hamad Medical Corporation, Doha, Qatar
Co-PI Abdul-Bari Bener- PhD, Hamad Medical Corporation, Doha
Qatar.
Co-PI Amin Jayyousi, MD, Hamad Medical Corporation, Doha, Qatar.
Co-PI Abdallah Al-Hammaq, PhD, Qatar Diabetes Association.
Co-PI Khaled Al Bader, MD, Primary Health Care Corporation, Doha,
Qatar.
Co-PI- Muhammad Abdul-Ghani, MD, PhD, Diabetes Division,
UTHSCSA, San Antonio, TX.
Co-PI Ralph DeFronzo, MD, Diabetes Division, UTHSCSA, San Antonio,
TX.
K. Abstract:
Zirie, M, Mohammed, I, El-Emadi M, Haider, A. Multiple Endocrine Neoplasia Type
2A: The role of genetic study. 24 28 Oct. 2000. Amman Jordan.
Zirie, M, Griffing G, University of Missouri-Columbia. Ret-Proto-Oncogen in
hereditary Medullary Thyroid Carcinoma. Hamad Medical Corporation, Doha
Qatar, April 6-8, 1996.
Zirie M, Griffing G, University of Missouri-Columbia. Carbamazepine interfering
with 24-hour urine free cortisol. American College of Physicians, Missouri Regional
Meeting, September 29 - October 1, 1995, Lake Ozark, Missouri.
Thanigari S, Zirie M, Horowitz S, Carmigniani S, Griffing G, University of MissouriColumbia. Thyrotoxic periodic paralysis with painless thyroiditis. American College
of Physicians, Missouri Regional Meeting, September 29 October 1, 1995, Lake
Ozark, MO.
Zirie M, Setter M. Michigan State University, Hurley Medical Center, Flint.
Theophylline toxicity and the use of hemodialysis. American College of Physicians,
40th annual Michigan Scientific Meeting, September 22 25, 1994, Grand Traverse
Village, Michigan.
Zirie M, Setter M, Michigan State University Center, Flint. Theophylline toxicity
and the use of hemodialysis. American College of Physicians, 16th Annual Associates
Meeting, May 6, 1994. Flint, Michigan.
L. Training Courses-Hamad Medical Corporation

15
Essential Disaster Administration & managements Support (EDAMS) Course

Immediate life Support (ILS) on 15th October ,
Hazardous Materials & waste Management
Infection Control
Fire Safety
Immediate life Support (ILS)
Hamad Medical Corporation - General Orientation Program 13th July ,2005
M. Conferences:
1. AACE 21st Annual Scientific & Clinical Congress, May 2327,2012.Philadelphia,PA-USA
2. 47th Annual Meeting of the. European Association for the Study of
Diabetes(EASD) 12 - 16 September 2011 Lisbon Portugal.
3. XVII International DALM symposium on Diabetes, Obesity, and the
Metabolic Syndrome, March 14-16,2011 Doha-Qatar
4. First International AACE Conference on Diabetes, Obesity and Other
Endocrine Diseases
The American Association of Clinical Endocrinologists (AACE), in
collaboration with Hamad Medical, Inc, in Qatar, the Qatar Diabetes
Association and the Qatar Foundation, is organizing the First
International AACE Conference on Diabetes, Obesity and Other
Endocrine Diseases to be held at the Sheraton Convention Center in
Doha, Qatar from January 14-16, 2011. (Dr. Mahmoud Zirie, speaker &
Chairman of organizing committee)
5. The 3rd Congress of the Jordanian Society of Endocrinology, Diabetes &
Metabolism (JSED) , The 2nd Joint JSED-AACE Congress & The 9th
Congress of the Pan Arab Society of Endocrinology & Diabetes (PASED).
On May 3-7 2010 Amman Jordan.
6. Secondary Prevention in Diabetes, 2nd Diabetes Asia study Group (DASG)
International Conference, on March 26-27, 2010. [Speaker]
7. The 3rd international Gulf Group for the Study of Diabetes Conference
Feb. 9-11, 2010 , kingdom of Saudi Arabia Jeddah
8. American Association of Clinical Endocrinologists 1st International
Diabetes course in Qatar Module V- March 6th , 2010 [Speaker]
16
9. American Association of Clinical Endocrinologists 1st International

Diabetes course in Qatar Modules III & IV - Jan 16th , 2010
10. Diabetes & Cardiovascular Risk organized by The Gulf Group for the
Study of Diabetes 26 December 2009, Doha- Qatar [Speaker]
11. Qatar Health 2009 13th -14th December 2009, Doha- Qatar [Speaker]
12. 11th European Congress of Endocrinology. Istanbul, Turkey, 25-29 April
2009.
13. Childhood Diabetes and Obesity, Doha-Qatar October 10-12,2008
[Speaker]
14. AACE 17th Annual Meeting & Clinical Congress The Art & Science of
Endocrinology: Focusing on Best Patient Outcomes May 14-18, 2008
Walt Disney World Dolphin Resort Orlando, FL
15. 1st Qatari Ophthalmology Subspecialty Symposium Doha-Qatar 9th -10th
May,2008.
16. Diabetes, Genetics, Enviromental Factors. Qatar University-DohaQatar.Dec.13th 2007
17. Fighting Osteoporosis on two fronts; Dubai. UAE, December 16,2005.
18. Diabetic Foot Symposium (put feet first . Prevent amputation) Doha,
Qatar, November 19,2005. (Organizer).
19. Diabetes Update 2005; Manama, Bahrain, September 29 30, 2005.
20. 6.European Society of Hypertension (15th European Meeting on
Hypertension).Milan Italy, June 17-21, 2005.
21. Reducing Cardiovascular risk pathways to prevention. Sharm El-SheikhEgypt, 14 17 April, 2005.
22. International Symposium on Male infertility. Doha Qatar, March 26,
2005 (Speaker).
23. The first international -Gulf Group for Study of Diabetes- Conference.
Dubai UEA, 13 -15 Feb. 2005.
24. The 3rd International scientific symposium Diabetes and Obesity.
Doha- Qatar, Feb. 5, 2005. (Organizer & Speaker).
17
25. Intensive Adult Workshop on Insulin Pump therapy and CGMS

Medtronic, April 15 16, 2004, Dubai, UAE.
26. Diabetes Foot Multi-disciplinary Team Symposium. Doha-Qatar, March
6, 2004.
27. Diabetes and the Kidney disease, an International Conference arranged
by Qatar Diabetes Association and Hamad medical Corporation, Doha
Qatar, 20 21 Feb. 2004 (Speaker)
28. Osteoporosis Awareness Symposium, Doha Qatar, Oct. 23, 2003. [
speaker ].
29. 11th European Congress on Obesity, 30th May 3rd June, 2001, Vienna,
Austria.
30. 5th Joint Symposium between Department of Medicine (HMC) and
Primary Health Care. Diabetes Mellitus. March 22, 2001, Doha Qatar
(Speaker).
31. The Gulf Group for the study of Diabetes. February 14 15, 2001, DohaQatar (Speaker).
32. 2nd Pan-Arab Endocrinology Conference. 24 28 Oct., 2000, Amman
Jordan (Speaker).
33. 2nd Joint Symposium between Medical Department (HMC) and Primary
Health Care. Osteoporosis, June 1, 2000. Doha Qatar.
34. American Association of Clinical Endocrinologists. Ninth Annual
Meeting and Clinical Congress, May 3-7, 2000. Atlanta-GA-USA.
35. The Third Conference of the Pan-Arab Hypertension Society. February 59, 2000, Abu Dhabi, UAE.
36. First International Conference on Erectile dysfunction and Infertility in
Qatar. February 26-28, 2000. Doha-Qatar, Member of organizing
committee.
37. 6th Doha Medical Symposium What is New? May 17, 2000.
38. Hypertension Management in the New Millennium. March 30, 2000,
Doha-Qatar Speaker.
39. Osteoporosis. June 1, 2000, Doha Qatar, Speaker.
18
40. First Qatar International Oncology Conference Management of Breast,

Colon, Thyroid and Lymphomas in the New Millennium. Nov. 18th
20th, 1999; Doha Qatar.
41. 35th Annual Meeting of the European Association for the study of
Diabetes. September 28 - October 2, 1999; Brussels Belgium.
42. Are all Glitazones the same? Addressing Insulin resistance as a
fundamental issue. A satellite symposium held on Tuesday 28th
September 1999, Brussels Belgium.
43. Repaglinide a prandial glucose regulator. Implication of UKPDS, Insulin
in Type 2 Diabetes. April 22, 1999; Hurgadah Egypt.
44. 4th Doha Medical symposium on Interesting cases in Hamad General
Hospital. April 15, 1999; Doha Qatar.
45. Individualization of the Antihypertensive therapy for the complicated
patient. Middle-East University program, March 18 19, 1999. Dubai
UAE.
46. 2nd Hamad Medical Corporation Nephrology symposium. March 13-14,
1999. Doha-Qatar.
47. 3rd Doha Medical Symposium on Diabetes Mellitus: Clinical
Manifestation and Recent Development. Hamad Medical Corporation,
Doha-Qatar, December 1st, 1998 organizing committee.
48. Clinical Endocrinology Update 98. Boston, Massachusetts, USA, Nov. 1
4, 1998.
49. 2nd Doha Medical Symposium: Gross and Microscopic diagnosis. Hamad
Medical Corporation, Doha Qatar June 25th, 1998 Speaker.
50. Gastro/Diabetes forum: diabetes in the Gulf. Clinical evaluation of type 2
diabetes mellitus, Insulin treatment for type 2 DM, and Humulog Lispro
Insulin. May 4 8, 1998, Istanbul Turkey.
51. Valsartan, A new class for Hypertension Management, Manama Bahrain.
March 21, 1998.
52. Neurological Sciences Course. Hamad Medical Corporation, Doha
Qatar. March 1 3, 1998 (Speaker).
19
53. First Qatar International Pediatric Conference. Hamad Medical

Corporation, Doha Qatar. December 15 17, 1997.
54. Diabetes Education For A Better Life. Hamad Medical Corporation, Doha
Qatar. December 13, 1997 (Speaker).
55. Endocrinology, Diagnosis and Treatment. National Institute of Health,
October 15 19, 1997, Bethesda MD, USA.
56. Hypertension Risk And Therapy: Strategies For Prevention of Target
Organ Damage. Middle East Africa University Program. May 8 9,
1997, Dubai, UAE.
57. Recent Advances in Laboratory Medicine and Pathology. Hamad Medical
Corporation, Doha Qatar. April 5 7, 1997.
58. International Symposium on Emergency Trauma Care. Hamad Medical
Corporation. February 18 20, 1997, Doha Qatar.
59. Peripheral Vascular Disease and Diabetic Foot. Hamad Medical
Corporation. November 14, 1996, Doha Qatar (Speaker).
60. Minimized Insulin Pump therapy Symposium, St. Louis, Missouri, April
20, 1996.
61. Current Concepts in Thyroid Disease. Hamad Medical Corporation, April
6 8, 1996. Doha Qatar (Speaker).
62. Diabetes Update 1995. Diabetes Research and Training Center, Indiana
University School of Medicine and The Regenstrief Institute. November 6
8, 1995. Marshal, Indiana.
63. Clinical Endocrinology Update 1995 Syllabus. The Endocrine Society,
October 22 25, 1995, San Diego, California.
64. American College of Physicians, Missouri Affiliate Regional Meeting.
September 29 30, 1995, Lake Ozark, MO.
65. Diabetes and Endocrinology In The New Medical Environment. Fifth
Annual Endocrine Fellows Foundation Scientific Forum. June 8 9,
1995, Atlanta Georgia.
66. American College of Physicians, Missouri Regional Meeting. October 14,
1994, Lake Ozark, Missouri.
20
67. New Concepts and Directions in Thyroidology. September 27, 1994,

Chicago, Illinois (University of Colorado, School of Medicine).
68. American College of Physicians, 40th annual Michigan Scientific Meeting.
Septembre 22 25, 1994, Grand Traverse Village, Michigan.
69. American College of Physicians 16th Annual Associates Meeting. May 6,
1994, Flint, Michigan.
70. Advance in Internal Medicine. April 25 29, 1994, University of
Michigan, Ann Arbor, Michigan.
71. Clinical Endocrinology. April 11 15, 1994, Harvard Medical School,
Boston, Massachusetts.
72. The First Gulf Conference on Intensive Care Medicine. November 26
28, 1991, Hamad Medical Corporation, Doha Qatar.
73. Hypertension Associated with Diabetes Mellitus. November 21 23, 1991,
Harvard Medical School, Boston, Massachusetts.
74. Diabetes Mellitus. February 16 18, 1990, Hamad Medical Corporation,
Doha Qatar (Speaker).
75. First Arab Symposium on Hyperlipidemia and Atherosclerosis.
76. May 10, 1989, Kuwait City, Kuwait.
21
Secretary / Treasurer
Candidates
1. Wiam Ibrahim Hussein, MD FACE FACP; Bahrain
2. Khalid Faiq Mohammed Salih, MD FACE; UAE


1st Annual Meeting

October 12, 2012
1
Name: Wiam Ibrahim Hussein
Address: Gulf Diabetes and Endocrinology Center
City: Manama
Country: Bahrain
Email:drwiam@hotmail.com
2
purposes of Chapter business? __X_ yes ___ no
3
___ President
___ Vice President
_X__ Secretary
__X_ Treasurer
_X__ CV or bio-sketch included
CURRICULUM VITAE
NAME:
Wiam Ibrahim Hussein, MBBS, FACP, FACE
ADDRESS:
P.O.Box 16165
Adliya, Manama
Kingdom of Bahrain
CONTACT NUMBERS: Telephone:
(00973) 39726000
(Mobile)
(00973) 17239200
drwiam@hotmail.com
Fax:
E-mail:
PRESENT POSITION
10/2007-present
Consultant Endocrinologist & Medical Director, (Joslin Diabetes

Center up to 2008) at Gulf Diabetes Specialist Center, Bahrain.
August 1998 8/2007:
Consultant & Section Head, Endocrinology, Diabetes &

Metabolism (Medical Director of Outpatient Clinic)
Saad Specialist Hospital, Al Khobar, Kingdom of Saudi Arabia
EDUCATION AND TRAINING

July 1997 June 1998
Advanced Endocrinology and Clinical Research Fellowship.

The Cleveland Clinic Foundation, Ohio, USA
July 1995 June 1997
Endocrinology, Diabetes and Metabolism Fellowship

The Cleveland Clinic Foundation, Ohio, USA
I am the Chair, Steering members of the AACE Gulf Chapter and had worked for the last year with
USA- AACE to get their approval for this Gulf Chapter hoping to continue as Secretary/Treasurer
in the Gulf Chapter.


1st Annual Meeting

October 12, 2012
1
Name: KHALID FAEQ MOHAMMED SALIH KASHEF AL-GHETAA
Address:NATIONAL HOSPITAL/PO BOX 30666
City:ABU DHABI
Country:UAE
Email:
khalid_gittaa@yahoo.com
2
purposes of Chapter business? _yes__ yes ___ no
3
___ President
___ Vice President
___ Secretary
yes___ Treasurer
Curriculum Vitae
Name:Khalid Faiq Mohammad Salih.
Family name: KASHIF AL-GITTAA
Date of Birth: July, 29/1963.
Nationality: Iraqi
Passport No:G1510929
Postal address: United Arab Emirates.Abu
Dhabi,P.OBox:30666
E-Mail Address: khalid_gittaa@yahoo.com
Telephone : mobile
:00971555504255,ground:0097126396002,
Fax: 0097126720900
Qualifications
1.HIGH DIPLOMA IN LAPAROSCOPY/STRASBOURGE

UNIVERSTY /FRANCE MARCH 2012
2. Fellow of American College of Surgeons (USA) F.A.C.S
, 2011
3. Fellow of American College of Endocrinology/USA
(F.A.C.E) 2011.
4. Fellow of Iraqi commission for medical specializations
(Iraqi Board) /Baghdad/Iraq/ November 1994(19901994)
FICMS.
5. Higher Diploma degree in General Surgery / Baghdad
college of Medicine /University of Baghdad/ September 1994
6. PrimaryMedical Degree: M.B.Ch.B /Kufa college of
Medicine / Kufa University, Iraq/1987
7. Specialist surgeon A/United Arab Emirates/Ministry of

Health/in2.10.2005
8. Abu Dhabi Health Authority council License, number:
5799(GAHS), since 2006 and till now.
9. Oncoplastic Breast and Aesthetic Surgery, San Diego
/USA, 2009, one day full workshop.
10. IEO,European Institute of Oncology,Milano/italy
Breast Cancer: Oncologic and Reconstructive Surgery.
Interactive course with Live surgery,1517 June 2009
11. World Health Leader in Medicine and Surgery, 2012,
CAMBRIDGE/GREAT BRITAIN
WORK EXPERIENCE:
1. National Hospital /NMC,
22.7.2006 till present
Member of NMC hospital in Abu Dhabi on 22.7.2006,as a
consultant general surgeon dealing with all emergency and
elective surgical procedures, Thyroid surgeon, Breast cosmetic
surgery and continued with his work since that time.
2. Dijla Private hospital, 1999 to 25.6.2006
20 beds private, Breast and thyroid center / experienced
thyroid And Breast surgeon/Baghdad/Iraq/ consultant thyroid
and neck surgery referral.
3. AL-YARMOOK TEACHING HOSPITAL FULL SPECIALIST
GENERAL SURGEON FROM SEP/2005 TILL JAN 2006
4. Al-Karama teaching hospital Nov 1998 to Sept 2004
fully dependant consultant in general surgery in 400 beds
teaching hospital /Baghdad/Iraq/ , dealing with all emergency
and elective surgical problems, namely Trauma cases and neck
and thyroid and Breast diseases. One Year vacation ends on
27.9.2005, returned back to Al Yarmook hospital.
5. Al-yarmook teaching hospital, Oct.1997 to Nov.1998
600 beds. As a full responsible specialist in General
Surgery, Dealing with all elective and trauma surgical cases.
6. Al-Najaf Teaching
Jan. 1995 to Oct.1997,
Hospital with 600 beds main hospital in Najaf, full

responsibility specialist in general surgery , dealing with all
elective and trauma cases in addition to Forensic medicine.
7.Enrolled in a four years training program at the Medical
city teaching hospital /Baghdad/ working as a registrar , full
time resident, to get the fellowship of Iraqi commission for
medical specializations./from Oct.1990 to Nov.1994.
8. Full time resident in Al-Najaf teaching Hospital from
March 1990 to Oct 1990/department of surgery.
9. General practioner in a primary health center in AlHira&Souk Shaalan destricts in Najaf from Feb.1989 to
March.1990.
10.Rotational training in the Medical City Teaching
hospital /Baghdad/Iraq/From Aug.1987 to Dec.1988 as full
time S.H.O, in Obestetrics&Gynecology(2months),CCU (1
month),Internal medicine(3 months),Cardiovascular surgery
unit(3 months),General Surgery (3 months), Pediatric Unit (3
months).
11.October 1997: Join the teaching staff of Department of
Surgery ,as Lecturer in General Surgery, college of Medicine ,
Al-Mustansirya University, Baghdad , and still at present(
Vacation from the college for one year) , Candidate for
Assistant prof. applied 4 papers for this purpose.
12. December 1994: Lecturer in General Surgery, Join
the teaching staff of the Department of surgery, college of
Medicine, Kufa university.
13. About to Award assistant professor from Almustansirya university in 2006.
14. Award membership of American Associations for
Endocrinologist in 2007.(AAC).
15. Award membership of BAETS (British Association Of
Endocrine and Thyroid Surgeons), 2008.
16. Participating in BAETS annual meeting 9-10 October

in Marseille France were two papers presented and accepted as poster
presentation
17. Accepted and presenting Oral paper 3th International Congress of
Endocrinology - ICE 2008 (November 8-12, 2008 - Rio de Janeiro, Brazil).
18. Newly published Recurrent Laryngeal nerve is no more injury..
in MEDIMOND srl 2008
19.Oncoplastic Breast surgery Workshop, USA San Diego, April 23
2009.
20.Attend
and
participating
in
Milano Workshop for Breast

reconstructive surgery 1517 june 2009
21. Passed the BLS course on July 2009
WORK SCOPE:
1. I have worked with all types of surgical cases including
Trauma cases sharing in two programs during Iraqi/Iranian
War in Al-Imara Hospital in 1998 as a resident with a team
taken from Medical city Teaching hospital for 3 weeks and
during first gulf war in Al-Imara also for 3 weeks also, dealing
with all kinds of trauma cases.
2. Dealing with all elective surgical cases during 11years
post graduate experiences, notably Gastric surgery especially
Highly selective Vagotomy and I have 4 years Experiences in
Biliary surgery dealing with wipples procedures and
sophisticated biliary procedures like segment 3 biliary
explorations and others.
3. more than 100 cases experiences in large multiple
recurrent incisional Abdominal hernias using the way of
Darning , success in about 100%.
4. Neck Surgery, referral Consultant Surgeon from all
over Iraq, Dealing with Neck tumor Surgery and Block
Dissection of Neck including central compartment and lateral
compartment dissections.
5.Thyroid Surgeon referral , More than 3000
thyroidectomy in the last 10 years , all well documented and
pictured most of it,for different thyroid diseases, more than
300 thyroid tumors, about 800 toxic thyroids more than 1000
nontoxic, etc.Head of Department of thyroid and Neck surgery

in Dijla private hospital.
6. Doing all kinds of Breast surgical diseases including
Mastectomies, lumpectomies, Quadrentectomies etc more than
500 cases over past 15 years.
6. Performed more than 40 thyroidectomies in Abu Dhabi,
National hospital, in the last 12 months.
RESEARCH PROJECTS:
1. PRIMARY SUBSTERNAL ABERRANT THYROIDS IN IRAQ.
2006
2... Recurrent Laryngeal Nerve Injury is no more a Major
complication in thyroid surgery by using Intracapsular and
Infracapsular resections.2003..
3. The effect of Response of cAMP to TSH stimulation in
Benign and Malignant thyroid gland tumors the activity of
Adenylate cyclase in these tumors. 2001. Published recently.
4.Unusual presentations of Hashimotos thyroiditis in Iraq
.1999.published
5. Stab wounds accidents in Al-Najaf, Morbidity and
Mortality. 1996. published.
6.Lower Urinary tract injury associated with Pelvic
fractures , a prospective study.1997.published.
LOCAL COURSES AND MEETINGS:
1`.Participate in the second national meeting of
Surgery in Iraq from 11-12/12/2002
2. Participate in first national meeting of Surgery from 1416/9/2000.
3. Participate in fourteenth meeting of Cancer in Iraq
from 7-9/3/2000
4. Participate in first meeting of Iraqi society of Surgeon
from 13-14/10/1999.
5. Passes successfully the program of the ways of
teaching in Al-mustansirya university from 1.8.1998 to
26.8.1998.
Laparoscopic Surgery course in Medical City Teaching

Hospital, for 2 weeks, 2000.
6. Upper and Lower GIT endoscopy , 4 years training
, more than 2000 endoscopies, from 1990 to 1994.
7. Conduct CME meeting on 24.12.2006, in NMC hospital

in Abu Dhabi, presenting; Primary substernal thyroids in Iraq,
and Recurrent laryngeal nerve injury is no more complication
in thyroid surgery.
8 attending most of meetings and CME held here in Abu
Dhabi in the last 6 months.
INTERNATIONAL COURSES:
1. Participate in the 29 annual meeting of the Egyptian
Society of Surgeons from 13-15/2/2002, presenting two
papers.
th
2. Participate in 4 meeting of Jordan association of
Urological Surgeons from 3-5/12/2003.
3. Awarded training certificate for Laparoscopic Surgery
from Al-Mansura GIT center in Egypt .2001, 3 weeks course.
4.Oncoplastic Breast and Aesthetic Surgery, San Diego
/USA,2009 ,one day full workshop
5.IEO,European Institute of Oncology,Milano/italy Breast
Cancer: Oncologic and Reconstructive Surgery. Interactive
course with Live surgery,1517 June 2009
th
TEACHING EXPERIENCES:
1.Lecturer in General Surgery in Al-Mustansirya college of
Medicine/Baghdad/Iraq. From Oct.1997 till now teaching from
third year up to sixth year medical students, in clinical bases
and in theory, in addition in putting questions and in
examinations, candidate to assistant prof. in the department of
Surgery.
2. Lecturer in General; Surgery in Kufa college of
Medicine, in Najaf, from Dec.1994 to Oct.1997.
I am a member of Latin American Thyroid Society in

2005.
I am a member Of Iraqi Association since 1987
3.Member of AACE since 2007
4.member of BAETS SINCE 2007
REFEREES:
1. Dr.Raysan Al-Fayad . FRCS, prof. in General Surgery,

Al-Musansirya, college of Medicine. Tel. 00964790189190
2. Dr.Najeeb Slaiwa, FRCS, Director of Department of

Surgery
in
Al-mustansirya
college
of
Medicine.Baghdad.Tel.009647901617548
3 Dr.Shawqi y Fawzi , Consultant Surgeon, Al-Qasimya
hospital, Al-SHRJA/UAE, Tel. mobile: 0508974581.
4. Proff.Abdul Baqi Al-Khatib, plastic consultant surgeon,

chief of plastic department, Zayed Military hospital,MCA.
Vice President
Candidates
1. Ali Saeed Alzahrani, MD FACE; KSA
2. Ali Barnard Khalil MD, FACE; UAE


1st Annual Meeting

October 12, 2012
1
Name:
Ali S. Alzahrani
Address:
MBC-46, P.O. Box 3354
City:
Riyadh, 11211
Country:
Saudi Arabia
Email:
aliz@kfshrc.edu.sa az.kfsh@gmail.com
2
purposes of Chapter business? _X yes ___ no
3
___ President
__X_ Vice President
___ Secretary
___ Treasurer
__X_ CV or bio-sketch included
_X__ Candidate statement included
Nomination Statement- Ali Alzahrani, MD

I have been a member of the AACE since 1995 and I believe I understand its Nobel
mission. I have also served as a member of the International Committee of AACE
and that gave me a chance to appreciate the important role AACE is playing in
spreading knowledge, establishing networking and fostering the field of
Endocrinology and Metabolism within USA and around the globe. I have been an
active clinician and a researcher and I understand the difficulties and opportunities
that similar colleagues face in our region. Recently, I spent a year and half at the
Johns Hopkins University School of Medicine and that gave me a chance to also
witness and understand similar issues that face clinicians/researchers in the USA. I
am a member of a number of local societies including the Saudi Hypertension
Management Group and the Saudi Society of Endocrinology and Metabolism and I
have been actively involved in developing programs, organizing courses and
working with colleagues to improve the health care in our region. With these
experiences, I would like to nominate myself for the position of the vice president of
the Gulf Chapter. My objectives are to work with my colleagues, the Board Members
to:
1. Carry out the principle mission/values of AACE in our region
2. To enhance education for physicians by organizing workshops, local
endocrine clubs and major regional conferences.
3. I strongly believe that one major objective for us in the Gulf Chapter is to
initiate and enhance research in our region. We lack some of the most
important data on major endocrine diseases, such as diabetes and metabolic
disorders, thyroid diseases and metabolic bone diseases. Through the Gulf
1
Nomination Statement- Ali Alzahrani, MD

Chapter, I am hoping that we can start some research projects on these
subjects and others. Our role also is to help and collaborate with other
colleagues pursuing research pertinent to the health issues in our region
4. As a scientific body, the Gulf Chapter of AACE can communicate, network and
involve other scientific forums/groups in the region to influence decisions by
the health authorities in the Gulf regions for the sake of better health car. We
hope that the Gulf Chapter will be an important voice to be listened to and
sought out for opinion on important issues pertaining to Endocrinology and
Metabolism
5. Lastly, for any organization to be strong and thriving, financial strength is
very important. I hope that we will be able to generate funds that will
support our activities. This will come through fees for the educational
activities, support from industry and donations. I hope also that we can also
help AACE increases their membership. Our activities and visibility will
surely increase the number of people joining our Gulf Chapter and the
mother organization, AACE.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 1 of 25
Curriculum Vitae
ALI SAEED ALZAHRANI, MD, FACE
Updated: 01 August 2012
I.
Current Position and Address

Consultant Endocrinologist,
Associate Professor,
Alfaisal University
Scientist and Head,
Molecular Endocrine Unit/Department of Molecular Oncology
King Faisal Specialist Hospital and Research Centre
P.O. Box 3345, Riyadh 11211
Kingdom of Saudi Arabia
Tel No. 4472490
E-mail: aliz@kfshrc.edu.sa or azahrani66@hotmail.com
Recent appointment (March 2010-September 2011):
Visiting Scientist
Division of Endocrinology and Metabolism
Johns Hopkins School of Medicine
Baltimore, MD
USA
II.
Personal Information
Nationality
Saudi
Marital Status
Married with four children
III. Graduate and Postgraduate Education Degrees

1989
MBBS, College of Medicine, King Saud University, Riyadh, KSA

Grade: Very Good, GPA 4.24/5.00
Postgraduate Training
1989 1990
Rotating Intern in Pediatrics, Ob/Gyn, Surgery, and Internal Medicine (three

months each), King Khalid University Hospital, Riyadh, KSA
Grade: Excellent
Jan Dec 1993
Chief Resident, Department of Medicine, King Faisal Specialist Hospital &

Research Centre, Riyadh, KSA
1990 1995
Resident, Department of Medicine, King Faisal Specialist Hospital & Research

Centre, Riyadh, KSA
April 1995 - June 1997
Clinical and Research Fellow in Endocrinology & Metabolism,

The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Ali Saeed Alzahrani

CV, 01 August 2012
Page 2 of 25
IV.
CERTIFICATIONS
March 1994
MRCP UK, Royal College of Physicians of the United Kingdom
April 1994
ABIM (Arab Board of Internal Medicine)
1996
June 1997
V.
VI.
United States Medical Licensing Exam (USMLE)

Fellowship in Endocrinology and Metabolism, The Johns Hopkins University
School of Medicine, Baltimore, Maryland, USA
Professional Experience
1998-2000
Associate Consultant Endocrinologist

Riyadh, KSA
2000-Present
Riyadh, KSA
2001-2002
Acting Chairman
Department of Medicine,
King Faisal Specialist Hospital &Research Centre
Jeddah, KSA
2003-2006
Deputy Chairmen
Riyadh, KSA
2007 Jan 2010
Section Head, Endocrinology

Riyadh, KSA
Memberships and Fellowships
2003
Fellow, Royal Colleges of the United Kingdom (London) FRCP
1995-1997
Former member of The Medical and Surgical Association of the Johns Hopkins
University
1996-present
Member, the Endocrine Society of North America (USA)
Ali Saeed Alzahrani

CV, 01 August 2012
Page 3 of 25
2000-present
Member, The American Association of Clinical Endocrinologists (USA)
2000
Fellow, The American College of Physicians- FACP
2000
Fellow, The American College of Endocrinology -FACE
2003
Fellow, Royal Colleges of the United Kingdom (Edinburgh) FRCP (Edin)
VII.
Awards and Honors
May 2002
First Research Distinction Award, Department of Medicine, KFSH&RC,

Riyadh
May 2003
First & Second, Research Distinction Award, Department of Medicine,

KFSH&RC
May 2004
Second, Research Distinction Award, Department of Medicine, KFSH&RC
May 2006
Second & Fourth, Research Distinction Award, Department of Medicine,

KFSH&RC
VIII.
Committees and Administration
1999-2001
Deputy Director, Internal Medicine Residency Training Program, Department

of Medicine, KFSH&RC, Riyadh, KSA
1999- 2001
Coordinator, Medical Grand Rounds, Department of Medicine, KFSH&RC,

Riyadh, KSA
2000-Present
Member, Radiation Safety Committee, KFSH&RC, Riyadh, KSA
1998-2001
Member, Resident Education Committee, KFSH&RC, Riyadh, KSA
2001-2002
Member, Clinical Pathways Committee, KFSH&RC, Jeddah, KSA
2001-2002
Chairman, Business Working Group Committee, KFSH&RC, Jeddah, KSA
2001-2002
Co-Chairman, Business Council Committee, KFSH&RC, Jeddah, KSA
2001-2002
Member, Regional Council Committee, KFSH&RC, Jeddah, KSA
2001-2002
Member, Executive Advisory Group, KFSH&RC, Jeddah, KSA
Ali Saeed Alzahrani

CV, 01 August 2012
Page 4 of 25
2001-2002
Member, Charity Council Committee, KFSH&RC, Jeddah, KSA
2001-2002
Member, Evidence-Based Medicine, KFSH&RC, Jeddah, KSA
2001-2002
Member, Makkah Region Health Council, KFSH&RC, Jeddah, KSA
2001-2002
Member, Strategic e-Health Committee, KFSH&RC, Jeddah, KSA
2001-2002
Associate Executive Director, Health Outreach & Business Affairs,

KFSH&RC, KSA
2001- 2005
Adjunct Scientist, Research Center, KFSH & RC, KSA
2002-15 Feb 2010
Director, Endocrine Fellowship Training Program, Department of Medicine,

KFSH&RC, Riyadh, KSA
2002- Present
Member, Fellowship Committee, Department of Medicine
2000-Present
Member, Saudi Arabian Hypertension Management Group, Riyadh, KSA
2002-2004
Coordinator, Case presentation weekly meeting, KFSH&RC, KSA
2002-Present
Member, Radiation Safety Committee, KFSH&RC, KSA
2002-2004
Member, Credential Committee, KFSH& RC, KSA
2002-Present
Member, Research Promotion Group, Department of Medicine, KFSH&RC,

Riyadh KSA
2002-Present
Member, Evidence-Based Medicine working Group, Department of Medicine,

KFSH&RC, KSA
2003-2005
Member, Editorial Board, Annals of Saudi Medicine, KFSH&RC, Riyadh,

KSA
2004-Present
Member, Ambulatory Care Committee, King Faisal Specialist Hospital &

Research Centre, Riyadh, KSA
2004-Present
Patient Eligibility Review Committee, King Faisal Specialist Hospital &

Research Centre, Riyadh
2002-2004
Coordinator, Morbidity & Mortality Committee, KFSH&RC, KSA
2004-Present
Ambulatory Care Task Force
March 2006-present
Ambulatory Care Committee
- Present
Chairman, Clinical Utilization Management Committee, CFO#723 (Rev.2)
- Present
Chairman, Hospital Internet Website Content Review Committee, CFO#870
Ali Saeed Alzahrani

CV, 01 August 2012
Page 5 of 25
Feb 2007-2007
Co-Editor-in-Chief, Annals of Saudi Medicine
Oct 2007 - Present
Member, Research Unit, Department of Medicine
01 Dec 07-10 Jan 2010 Editor-in-chief, Annals of Saudi Medicine

01 Jan 08-10 Jan 2010 Associate Executive Director, Health Sciences Library
08 July 2009 30 March 2010
Member, KFSH&RC Diabetes Research Program, (CED 1369-30 dated 08 July

2009)
03 April - present
International Committee, American Association of Clinical Endocrinologists

(AACE)
Courses and Meetings

June 1990
Advanced Cardiac Life Support (ACLS), King Faisal Specialist Hospital & Research
Centre (KFSH&RC), Riyadh, KSA
November 1990
Workshop on Chemical Warfare Decontamination & Detoxification of Casualties,

KFSH&RC, Riyadh, KSA
May 1991
Design & Analysis in Clinical Research Course, KFSH&RC, Riyadh, KSA
December 1992
International Symposium on Acute Ischemic Syndromes, KFSH&RC, Riyadh, KSA
December 1993
International Symposium on Rheumatic Valvular Heart Diseases, KFSH&RC, Riyadh,

KSA
November 1994
The 2nd International Conference on AIDS, KFSH&RC, Riyadh, KSA
June 1995
The Endocrine Society Meeting, Washington, DC, USA
September 1995
International Thyroid Congress, Toronto, Ontario Canada
June 1995
The International Congress of Endocrinology, San Francisco, California, USA
November 1996
The Endocrine Fellows Meeting, San Diego, California, USA
November 1996
American Thyroid Association Annual Meeting, San Diego, California, USA
April 1997
The Annual Meeting of the American Association of Clinical Endocrinologists,

Philadelphia, Pennsylvania, USA
June 1997
The Endocrine Society Meeting, Minneapolis, Minnesota, USA
June 1998
The Endocrine Society Meeting, New Orleans, Louisiana, USA
Ali Saeed Alzahrani

CV, 01 August 2012
Page 6 of 25
April 1999
The Annual Meeting of the American Association of Clinical Endocrinologists, San

Diego, California, USA
October 1999
New Horizons in the Management of Diabetes Mellitus Symposium, King Fahad

Military Medical Complex, Dhahran, KSA
November 1999
the First National Thyroid Cancer Program Symposium, KFSH&RC, Riyadh, KSA
February 2000
Intensive Review Clinical Course in Medicine, Buraidah, Al-Qassim, KSA
May 2000
The Annual Meeting of the American Association of Clinical Endocrinologists
June 2000
The Endocrine Societys 82nd Annual Meeting, Toronto, Ontario, Canada
October 2001
Saudi Preparatory Course Part II for Internal Medicine, King Fahad National Guard
Hospital, Riyadh, KSA
January 2002
Principals of Medical Management, online Course as part of ongoing accreditation for

The American College of Physician Executives.
February 2002
Implementing Information Systems Interact Session, online course as part of ongoing

accreditation for The American College of Physician Executives.
March 2002
Organizational Politics for PE, online course, as part of ongoing accreditation for The
American College of Physician Executives.
April, 2002
Clinical Endocrinology 2002, Harvard Medical School, Boston, MA, USA
April 2002
Physician in Management seminar, San Diego, CA, USA as part of ongoing

accreditation for The American College of Physician Executives.
May 2002
Introduction to Informatics Interact Session, online course, as part of ongoing

accreditation for The American College of Physician Executive.
July 2002
Oxford Teaching Evidence Based Medicine Course 2002, Oxford, United Kingdom
March 2004
Fifth Pan Arab Congress on Endocrinology and Diabetes, Riyadh, Saudi Arabia.
June 2004
American Diabetes Association, Orlando, FA, USA
June 2004
Endocrine Society Meeting, New Orleans, USA
June 2004
AACE Thyroid Ultrasound & FNA Biopsy Accreditation Course, Atlanta, GA
Feb 2005
Symposium on Cardiovascular Risk Factors, Royal College of Physicians (London)
March 2005
Endocrine Panarab Conference, Alexandria
April 2005
Frontiers in Thyroid Cancer, American Thyroid Association, Baltimore, MD, USA
June 2005
The Endocrine Societys 87th Annual Meeting, San Diego
Ali Saeed Alzahrani

CV, 01 August 2012
Page 7 of 25
Oct 2005
Annual Congress of the European Association of Nuclear Medicine, Istanbul, Turkey
June 2006
Endocrine Societys 88th Annual Meeting, Boston, USA
Sept 2007
32nd Annual Meeting of the European Thyroid Association, Leipzig
June 2008
Endocrine Societys 90th Annual Meeting. San Francisco, USA
March 2009
The 6th Annual ENETS (European Neuroendocrine Tumor Society) Conference,

Granada, Spain
June 2009
The Endocrine Societys 91st Annual Meeting, Washington, DC, USA
Reviewer of major projects/journals:

KACST
SMJ
JCEM
KWAIT
RAC
International Journal of Cancer: Reviewed manuscript #IJC-08-1766 entitled Genetic and plasma
variation of insulin-like growth factor binding proteins in relation to
prostate cancer incidence and survival
Editorial Board Membership
Annals and British Journal of Diabetes & Vascular Disease
1. Bibliography
1.1 Invited Lectures
1.1.1
Ali S. Alzahrani. Medullary Thyroid Cancer; Screening, Diagnosis, and Follow Up. The First
National Thyroid Cancer Program Symposium, 21-23 November 1999, King Faisal Specialist
Hospital & Research Centre, Riyadh, Kingdom of Saudi Arabia.
1.1.2
Ali S. Alzahrani. Tutor, Intensive Review Course in Internal Medicine, King Fahad Specialist
Hospital, 03 February 2000, Buraidah, Qassim.
1.1.3
Ali S. Alzahrani. Management of Hyperthyroidism. Medical Outreach Program, King Fahad

Hospital, 27 May 2000, Jeddah, Saudi Arabia.
1.1.4
Ali S. Alzahrani. Tutor; Intensive Course in Internal Medicine, King Fahad National Guard
Hospital, 23 August 2000, Riyadh, Saudi Arabia.
1.1.5
Ali S. Alzahrani. Thyroid Cancer. Medical Grand Rounds, King Faisal Specialist Hospital,
Jeddah, 6 September 2000, Jeddah, Saudi Arabia.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 8 of 25
1.1.6
Ali S. Alzahrani. Management of Thyroid Cancer and Thyroid Nodules, Thyroid Disorders
(symposium) Bisha, September 28th, 2000.
1.1.7
Ali S. Alzahrani. Hypertension: Difficult Cases. DM, Dyslipidemia, HTN (symposium). October
2000, Dubai, UAE.
1.1.8
Ali S. Alzahrani. Endocrine Hypertension. DM, Dyslipidemia, HTN (symposium). October 2000,
Dubai, UAE.
1.1.9
Ali S. Alzahrani. Management of Thyroid Cancer. 2nd National Thyroid Cancer Program
Symposium, Ajiad General Hospital, 5-6 November 2000, Makkah.
1.1.10 Ali S. Alzahrani. Management of Thyroid Nodules. 2nd National Thyroid Cancer Program
Symposium, Ajiad General Hospital, 5-6 November 2000, Makkah.
1.1.11 Ali S. Alzahrani. Tutor, Intensive Review Course in Internal Medicine, King Fahad Specialist
Hospital, 3 February 2001, Buraidah, Qassim.
1.1.12 Ali S. Alzahrani. Advances in Thyroid Cancer (state of the art lecture).
Conference, 25-28 October 2001, Damascus, Syria.
Third Pan Arab
1.1.13 Ali S. Alzahrani. How to Approach a Patient with Goiter. Thyroid Diseases Workshop for
General Surgery Residents. King Faisal Specialist Hospital & Research Centre, Jeddah, 10 January
2002.
1.1.14 Speaker- Osteoporosis Workshop, King Fahad National Guard Hospital, Jeddah, 10 Oct 2003
1.1.15 Residents Lecture: Thyroid, Men & Adrenal, King Faisal Specialist Hospital & Research Centre.
17 October 2002.
1.1.16 Examiner, Intensive Internal Medicine Review Course, King Khalid National Guard Hospital
(KKNGH), Jeddah, 12-26 Oct 2002.
1.1.17 Speaker, Non-Communicable Diseases Symposium, Management of HTN in Diabetes & Medical
Management of Obesity, Makkah, 21 Oct 2002.
1.1.18 Speaker, 1st Osteoporosis Scientific Day, National Guard Health Affairs, Riyadh, 24 Oct 2002.
1.1.19 A Speaker & Chairman, One day symposium on Diseases of World Economy, Diabetes, Obesity,
And Hypertension, Arab Health Conference, Dubai, January 2003.
1.1.20 Invited speaker, Management of Hypertension in Diabetes Mellitus, King Abdulaziz University
Hospital, 06 Jan 2003.
1.1.21 Examiner, Intensive Review Course in Internal Medicine, King Fahad Specialist Hospital,
Buraidah, Al Gassim, KSA, 15 Jan 2003.
1.1.22 Speaker, Medical Grand Rounds, Department of Medicine, Stem Cell and Therapeutic Cloning.
The Future of Medicine, 17 Feb 2003.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 9 of 25
1.1.23 Speaker, Meet the Expert: Diabetic Nephropathy, 1st Saudi Diabetes Congress SDC, King
Abdulaziz University Hospital, 09 April 2003.
1.1.24 Speaker, 6th Gulf Group for the Study of Diabetes GSSD, Jeddah Kingdom of Saudi Arabia, 2122 May 2003.
1.1.25 Examiner, Clinical and oral exam for Fellowship Program, King Khaled University Hospital,
Riyadh, 04 June 2003.
1.1.26 Speaker, Evaluation and Management of Infertile Male, The Endocrinologist approach, Urology
Department, KFSH&RC, Riyadh, 25 June 2003.
1.1.27 Presenter, Simply unexpected, Medicine Case Presentation, KFSH&RC, 24 Sept 2003.
1.1.28 Presenter, Following a Standard approach: it pays off, Medicine Case Presentation, Department
of Medicine, KFSH&RC, 24 Sept 2003.
1.1.29 Lecturer, 10-Day Subspecialty Review Course, Department of Medicine, KFSH&RC, 10-19 Sept
2003
1.1.30 Examiner, Intensive Internal Medicine Review Course, King Abdulaziz Medical City, Jeddah, 04
October 2003.
1.1.31 Speaker, Combined Adult/Peds Endocrine Rounds, Department of Medicine, KFSH&RC,
Wednesday, 08 October 2004
1.1.32 Examiner, Saudi Board Clinical Course in Internal Medicine, Riyadh Armed Forces Hospital, 15
Dec 2003.
1.1.33 Lecturer, 9th Review Course in Internal Medicine, 17 December 2003, Buraidah, Qassim.
1.1.34 Examiner, Final Saudi Board Clinical Examination, December 2003, Riyadh.
1.1.35 Speaker and Temporary adviser- the Regional Consultation on Hypertension Prevention and
control, World Health Organization, Abu-Dhabi, UAE, 20-22 December 2003
1.1.36 Speaker, Management of Hypertension in DM, World Health Organization, Abu Dhabi, UAE,
February 2004.
1.1.37 Speaker, Issues in the follow-up to Thyroid Cancer, Fifth Pan Arab Congress on Endocrinology
and Diabetes, Riyadh, Saudi Arabia, 28 February 2 March 2004.
1.1.38 Speaker, Hypertension in Diabetes, Fifth Pan Arab Congress on Endocrinology and Diabetes,
Riyadh, Saudi Arabia, 28 February 2004.
1.1.39 Speaker, Primary Hypeparathyroidism: Medical VS Surgical Management, The International
Conference on Advances in Internal Medicine, King Abdulaziz National Guard Medical City,
Jeddah, 16-17 March 2004.
1.1.40 Speaker, Management of Osteoporosis, The International Conference on Advances in Internal
Medicine, King Abdulaziz National Guard Medical City, Jeddah, 16-17 March 2004.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 10 of 25
1.1.41 Speaker, Islet Cell Transplantation & Stem Cell Research in Diabetes, Recent Advances in
Diabetes Symposium, Jeddah, 22 March 2004.
1.1.42 Speaker and temporary adviser, Management of Male Osteoporosis: Practical considerations,
World Health Organization, Beirut, Lebanon, 06-08 May 2004.
1.1.43 Presenter, F-18 Fluorodeoxyglucose Positron Emission Tomography (PET) in the Follow-up of
Differentiated Thyroid Cancer (DTC), 6th RPG Day, 24 May 2004, KFSH&RC
1.1.44 Speaker, A Lecturer, 6-Day Subspecialty Review Course, Department of Medicine, King Faisal
Specialist Hospital & Research Centre. 14 September 2004.
1.1.45 Lecturer, Review of Endocrinology, Intensive Internal Medicine Review Course, King Khaled
National Guard Hospital, Jeddah, 15 September 2004.
1.1.46 Speaker, How to manage the bad couples diabetes and obesity, 9th World Diabetes DayProfessional Program, Four Seasons Hotel by King Abdulaziz University Hospital, Riyadh, 25
November 2004.
1.1.47 Speaker, Long-Term Follow-up of Thyroid Ca, Thyroid Seminar, King Abdulaziz University
Hospital, Riyadh, 04 January 2005.
1.1.48 Speaker, Medical Grand Rounds: Thyroid Cancer: A Local and International Perspective,
Department of Medicine, KFSH&RC, 21 February 2005.
1.1.49 Speaker, Saudi Guidelines for Management of Hypertension, 2nd London Symposium on
Vascular Biology of Atherosclerosis and its Impact in Clinical Practice. London, United Kingdom,
27 February 2005
1.1.50 Speaker, Update on Thyroid Cancer, Department of Medicine, Riyadh Military Hospital, 30
March 2005.
1.1.51 Grand Round, Thyroid Cancer: A Perspective from another continent John Hopkins Hospital,
Baltimore, Maryland, 13 April 2005.
1.1.52 Speaker, Thyroid Cancer in Saudi Arabia, King Fahad National Guard Hospital, Riyadh, 21 April
2005.
1.1.53 Speaker, Department of Medicine Case Presentation: Common and Rare, King Faisal Specialist
Hospital & Research Centre, 15 June 2005.
1.1.54 Invited Speaker, Designing the Research, Summarization of Data and the Testing Differences
Between Two Groups, King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia,
14-15 September 2005.
1.1.55 Invited Speaker, 8th Saudi/Arab Board Preparatory Course for Internal Medicine Part II, King
Abdulaziz Medical City, Postgraduate Training Centre, Riyadh, Saudi Arabia, 17-21 Sept 2005.
1.1.56 Invited Speaker, Insulin Therapy in Type 2 Diabetes, International Diabetes Day, King
Abdulaziz Medical City, Riyadh, 23-24 November 2005.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 11 of 25
1.1.57 Invited Speaker, Risk Factors for Cardiovascular Disease in Saudi Arabia, 2 nd Partners
International Symposium on Cardiovascular Disease, Dubai, 7-8 December 2005.
1.1.58 Invited Speaker, An update in the management of Thyroid Cancer, 3rd Diabetes Educator
Course, King Faisal Specialist Hospital & Research Centre, Jeddah, 18 April 2006.
1.1.59 Case Presentation, the Mid-Liner and Revisiting a given Diagnosis: A Rewarding Outcome,
Department of Medicine, King Faisal Specialist Hospital & Research Centre, 26 April 2006.
1.1.60 Invited Speaker, Management of Hypertension in Diabetes Mellitus. The National Hypertension
Symposium, Jubail, Saudi Arabia. 30 May 2006.
1.1.61 Invited Speaker, Hypertension Co-morbidities, The National Hypertension Symposium, Jubail,
Saudi Arabia. 31 May 2006.
1.1.62 Invited Speaker, Management of Hyperthyroidism. Health Outreach Locum Program, King Fahad
Hospital, Al Baha. 08-28 July 2006.
1.1.63 Invited Speaker, Endocrine Case, Health Outreach Locum Program, King Fahad Hospital, Al
Baha. 08-28 July 2006
1.1.64 Invited Speaker, Management of hypertension in diabetes.
King Fahad Hospital, Al Baha. 08-28 July 2006
Health Outreach Locum Program,
1.1.65 Speaker, General Endocrinology MCQs, 6-Day Subspecialty Review Course, Department of
Medicine, King Faisal Specialist Hospital & Research Centre.
1.1.66 Invited Speaker, Endocrinology Review, 9th Saudi/Arab Board Preparatory Course for Internal
Medicine Part II. National Guard Health Affairs, King Abdulaziz Medical City. 19 September
2006.
1.1.67 Invited speaker, Insulin Therapy in Type 2 DM, Intensive Diabetes Course for Physicians.
National Guard Health Affairs, King Abdulaziz Medical City. 24 January 2007.
1.1.68 Speaker, Pheochromocytoma: Local experience & A Man with abdominal and brain Tumors.
Medical & Surgical Aspects of Neuroendocrine Disorders Symposium. King Faisal Specialist
Hospital & Research Centre, Riyadh, Saudi Arabia, 03-04 April 2007.
1.1.69 Invited speaker, Differentiated thyroid cancer; a Middle East perspective. First Joint JSEDAACE Congress Amman, Jordan. 17 May 2007.
1.1.70 Invited speaker, Co-morbidities: DM and Dyslipidemia, The First training course on the
implementation of the Saudi Hypertension Management Guidelines, Mecca Almudarama, Mecca,
30 May 2007.
1.1.71 Invited speaker, Diagnosis beyond doubt in endocrinology: role of molecular biology. 8th Pan
Arab congress on Endocrinology and Diabetes (PACED 8), Kuwait, 07-12 Nov 2007.
1.1.72 Invited Speaker, Management of Hypercalcemia, 8th Acute Medicine Symposium, Riyadh
Military Hospital, Riyadh, Saudi Arabia. 27 November 2007.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 12 of 25
1.1.73 Invited speaker, Epidemiology of Diabetes in Saudi Arabia, 7th IEA-EMPO Scientific Meeting "
Epidemiology": Translating Research to Health Care", Epidemiology Workshop, Research Centre,
King Faisal Specialist Hospital & Research Centre, Riyadh. 27 Nov 2007.
1.1.74 Invited speaker, Management Approach (How to switch from oral hypogyny to insulin therapy,
Part I). 1st course of prevention & management of heart disease and its risk factor in Family
Medicine setting. King Abdulaziz Medical City, Riyadh, Saudi Arabia, 28 November 2007.
1.1.75 Invited speaker, Management Approach (How to switch from oral hypogyny to insulin therapy,
Part II). 1st course of prevention & management of heart disease and its risk factor in Family
Medicine setting. King Abdulaziz Medical City, Riyadh, Saudi Arabia, 29 November 2007.
1.1.76 Invited speaker, Endocrinopathies associated with HIV/AIDS, Fourth Annual HIV/AIDS
Workshop. Department of Medicine, King Faisal Specialist Hospital & Research Centre. 01
December 2007.
1.1.77 Lecturer: A Glance at the Nucleus, Wednesday Case Presentation: Department of Medicine,
KFSH&RC. 09 January 2008.
1.1.78 Invited speaker: Disorders of Vit D Deficiency-beyond the bone Second Annual Endocrine
disorders Conference, King Fahad Medical City. 27 Feb 2008.
1.1.79 Invited speaker: Thyroid Cancer, Internal medicine Update 2008. King Saud University,
Riyadh, Saudi Arabia. 05 March 2008.
1.1.80 Invited speaker: Management of thyroid nodules, Update in Diabetes & Endocrinology
Symposium, Madinah, KSA. 22-23 March 2008.
1.1.81 Invited speaker: Update in Thyroid Cancer Management, Update in Diabetes & Endocrinology
Symposium Medina, KSA.22-23 March 2008.
1.1.82 Invited speaker: Non-Surgical Treatment for Obesity, Update in Diabetes & Endocrinology
Symposium, Medina, KSA.22-23 March 2008.
1.1.83 Invited speaker: Insulin therapy in Type 2 DM, 5th Diabetes Educators Course, Postgraduate
Training Center, National Guard Hospital. 05 April 2008.
1.1.84 Invited speaker: 2nd Diabetes & Endocrinology Symposium. King Abdulaziz hospital & Oncology
Center, Jeddah, KSA, 26-27 August 2008.
1.1.85 Speaker: Pheochromocytoma: An Ever Fascinating Tumor, Medical Grand Rounds, Department
of Medicine, KFSH&RC, 20 Oct 2008.
1.1.86 Invited speaker: Pheochomocytoma, Family Medicine Educational Meeting, KFSH&RC,
Riyadh, 11 November 2008.
1.1.87 Speaker Endocrine Case Discussion, Dammam Central Hospital, Health Outreach Services, 13
May 2009.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 13 of 25
1.1.88 Speaker Mathematics in Medicine: X + Y = X + X, Case Presentation, Department of Medicine,

KFSH&RC, 27 May 2009.
1.1.89 Speaker, Insulin therapy in Type II Diabetes, 13th Medicine Update Symposium, Al Madinah,
Saudi Arabia, 19-20 May 2009.
1.1.90 Speaker, Recent Update in the Management of Thyroid Cancer, 9th Update in Internal Medicine
on endocrinology & Metabolic Disorders. King Faisal University College of Medicine, Riyadh,
Saudi Arabia. 09-10 December 2010.
1.1.91 Speaker, Initiation and adjustment of Insulin Therapy in Type 2 DM: Case-Based Approach, 3rd
International Gulf Group for the Study of Diabetes (GGSD) Conference, Jeddah Saudi Arabia. 0911 February 2010.
1.2 Meeting Abstracts

1.2.1
Muhammad M. Hammami, Ali S. Alzahrani, Abdul I. Butt, M. Phil, Leticia J. Vencer, Syed S.
Hussain. Primary Hyperparathyroidism and Polyostotic Fibrous Dysplasia: A mild Variant of the
McCune Albright Syndrome (poster). The Endocrine Society Meeting, Washington, DC, 1995.
1.2.2
Zainab Muttair, Ali S. Alzahrani. Thyroid Lymphoma: Clinical, Pathological and Therapeutic
Data of a Large Series (poster). The annual meeting of the American Association of Clinical
Endocrinologists, San Diego, California, USA, 1999.
1.2.3
Majid Al Mandil, Ali S. Alzahrani, Mohammed Ahmed. The frequency and predictive factors of
malignancy in the residual thyroid tissue after partial thyroid surgery in patients with differentiated
thyroid cancer (poster). The Endocrine Society Meeting, Toronto, Ontario, Canada.
1.2.4
Ali S. Alzahrani, Majid Al Mandil, Seima Bakheet, Abdalraof Almahfouz. A High Concordance
Between Pretreatment Diagnostic Whole Body Scan (DXWBS) Using Iodine 123Isotope and Post
Therapy Iodine 131 Whole Body Scan (TXWBS) in Differentiated Thyroid Cancer (poster). The
Endocrine Society Meeting, Toronto, Ontario, Canada.
1.2.5
Alya Al-Hajjaj, Mohammed Ahmed, Ali S. Alzahrani, The Molecular Genetics, Clinical &
Histopathological Findings in Medullary Thyroid Cancer Patients: King Faisal Specialist Hospital
& Research Centre Experience (poster). The Endocrine Society Meeting, Toronto, Ontario, Canada,
2000.
1.2.6
Ali S. Alzahrani, Hussein Raef, Ali Sultan, Saif Al Sobhi, Stig Ingemansson, Mohammed Ahmed,
Abdulraof Almahfouz. Impact of Second Surgery on the Serum Thyroglobulin (TG) and the Course
of the Disease in Patients (pts) with Papillary Thyroid Cancer (PTC) Who Have Elevated TG
Levels, Negative Diagnostic Radioactive Iodine Whole Body Scan (DXWBS) and
Recurrent/Persistent Disease Limited to the Neck (oral presentation). The Endocrine Society
Meeting, Toronto, Ontario, Canada, June 2000.
1.2.7
Ali S. Alzahrani, A case of Hashitoxicosis developing severe hyperthyroidism after radioactive

Iodine therapy and Hepatotoxicity secondary to Methimazole Treatment (poster). The Endocrine
Society Meeting, Toronto, Ontario, Canada, June 2000.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 14 of 25
1.2.8
Ali S. Alzahrani, Alya al-Hajjaj. Severe Hypertension Secondary to Renal Artery Stenosis and
Cushings Syndrome in a Single Patient (poster). The Endocrine Society Meeting, Toronto,
Ontario, Canada, June 2000.
1.2.9
Ali S. Alzahrani, Siema Bakheet, Majid Al Mandil, Alya Al-Hajjaj, Abdulraof AlMahfouz,
Abdallah al Haj. 123I Isotope as a diagnostic agent in the follow up of patients with differentiated
thyroid cancer:
Comparison with post therapy 131I Whole Body Scanning (speaker).
Medical/Surgical Treatment of Thyroid Disorders in the Kingdom of Saudi Arabia (symposium),
King Faisal Specialist Hospital & Research Centre, 12-14 February 2001.
1.2.10 S. Bakheet (speaker), Ali S. Alzahrani. Role of FDG-PET scanning in the Management of Thyroid
Cancer: KFSH&RC Experience. Medical/Surgical Treatment of Thyroid Disorders in the Kingdom
of Saudi Arabia, King Faisal Specialist Hospital & Research Centre (symposium), 12-14 February
2001.
1.2.11 Ali S. Alzahrani, Majid Al Mandil, Mohammed Ahmed, Gamal Eldin H. Mohammed. The
Frequency and Predictive Factors of Malignancy in Residual Thyroid Tissue After Partial Thyroid
Surgery in Patients with Differentiated Thyroid Cancer (speaker). Medical/Surgical Treatment of
Thyroid Disorders in the Kingdom of Saudi Arabia, King Faisal Specialist Hospital & Research
Centre, 12-14 February 2001.
1.2.12 Ali S. Alzahrani. Medullary Thyroid Carcinoma (speaker). Medical/Surgical Treatment of
Thyroid Disorders in the Kingdom of Saudi Arabia, King Faisal Specialist Hospital & Research
Centre, 12-14 February 2001.
1.2.13 Ali S. Alzahrani, Hussein Raef, Ali Sultan, Saif Al Sobhi, Stig Ingemansson, Mohammed Ahmed,
Abdulraof Almahfouz. Impact of second surgery on the serum thyroglobulin (TG) and the course of
the disease in patients with papillary thyroid cancer (PTC) who have elevated TG level, negative
diagnostic radioactive iodine whole body scan (DXWBS) and recurrent/persistent disease limited to
the neck (speaker). Medical/Surgical Treatment of Thyroid Disorders in the Kingdom of Saudi
Arabia, King Faisal Specialist Hospital & Research Centre, 12-14 February 2001.
1.2.14 M. Ahmed, Al. Alarifi, A. Almahfouz, Ali S. Alzahrani, A. Al Sugair, and S. Al Sobhi. PET
Scanning in adrenal cortical carcinoma (ACC). Presented at the Endocrine Society 83 rd Annual
Meeting, Denver, Colorado, 20-23 June 2001.
1.2.15 M. Ahmed, A. Alarifi, A. Al Hajjaj, A. Almahfouz, and Ali S. Alzahrani. Hemosiderin
endocrinopathies (HE) in patients with -Thalassemia major (TM). Submitted to the Endocrine
Society 83rd Annual Meeting to be held in Denver, Colorado, USA 20-23 June 2001.
1.2.16 Ali S. Alzahrani. Stem Cells Technology (speaker). Stem Cell Symposium. King Faisal Specialist
Hospital & Research Centre, Jeddah, Kingdom of Saudi Arabia, 6 August 2001.
1.2.17 Ali S. Alzahrani. Frequency of Malignancy in the Contralateral Lobe After Partial Thyroidectomy
(poster). Third Pan Arab Conference, Damascus, Syria, 25-28 October 2001.
1.2.18 Ali S. Alzahrani, Saif Al Sobhi, Hamad Al Suhaibani. Preoperative Ultrasound-Guided Surgical
Approach for Residual/Recurrent Differentiated Thyroid Cancer. Annual Endocrine Society
Meeting, San Francisco, USA June 2002.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 15 of 25
1.2.19 Ali S. Alzahrani, Afaf Al Shammary, Bakir Bin Saddiq. Predictive Factors of Elevated
Thyroglobulin (Tg) and Negative Diagnostic Radioiodine Whole Body Scan in Differentiated
Thyroid Cancer (DTC). Annual Endocrine Society Meeting, San Francisco, USA June 2002.
1.2.20 Ali S. Alzahrani, Hassan Al Eid, Hussain Raef, Fouad Al Dayel. Pheochromocytoma: TwentyYear Experience. Annual Endocrine Society Meeting, San Francisco, USA June 2002.
1.2.21 Ali S. Alzahrani, Salwa B Alaidarous. Operating on Empty Sella for Cushings Disease: The
Value of Inferior Petrosal Sinus Sampling. Annual Endocrine Society Meeting, San Francisco,
USA June 2002.
1.2.22 Ali S. Alzahrani. Kallmanns Syndrome Presenting with Ambigious Genitalia. Annual Endocrine
Society Meeting, San Francisco, USA June 2002.
1.2.23 Ali S Alzahrani. Serum thyroglobulin at the first follow-up visit after radioactive iodine ablation
predicts the long-term course of differentiated thyroid cancer: Do we need repeated scanning? , 5th
Annual Research Promotion Day, Department of Medicine, KFSH&RC, Riyadh 27 May 2003.
1.2.24 Ali S Alzahrani. Pre-operative Neck Ultrasound Mapping for persistent/recurrent papillary thyroid
cancer. 5th Annual Research Promotion Day, Department of Medicine, KFSH&RC, Riyadh 27 May
2003.
1.2.25 Ali S Alzahrani. Sensitive assay for the determination of fluvastatin in Plasma utilizing highperformance liquid chromatography with fluorescence detection. 5th Annual Research Promotion
Day, Department of Medicine, KFSH&RC, Riyadh 27 May 2003.
1.2.26 Ali S Alzahrani. The value of high resolution ultrasonography in diagnosing recurrent persistent
differentiated thyroid carcinoma. 5th Annual Research Promotion Day, Department of Medicine,
KFSH&RC, Riyadh 27 May 2003.
1.2.27 Ali S Alzahrani. Generating an answerable questions. Evidence-Based Medicine Workshop. 2829 May 2003. King Faisal Specialist Hospital & Research Centre, Riyadh, KSA.
1.2.28 Ali S Alzahrani. Evidence-Based Medicine; Diagnosis. Evidence-Based Medicine Workshop. 2829 May 2003. King Faisal Specialist Hospital & Research Centre, Riyadh, KSA.
1.2.29 Ali S Alzahrani. How to search for Evidence. Evidence-Based Medicine Workshop. 28-29 May
2003. King Faisal Specialist Hospital & Research Centre, Riyadh, KSA.
1.2.30 Yufei Shi, Ali Alzahrani, Ranjit S Parhar, Minjing Zou. Gene Therapy for Anaplastic Thyroid
Carcinoma with a single Chain Interleukin 12 Fusion Protein. Presented at the 6 th Annual Research
Celebration Day, 24 May 2004. King Faisal Specialist Hospital & Research Centre. WinnerSecond Best score.
1.2.31 A Almahfouz, E Alfadhli, M Ahmed, H Raef, and A Alzahrani. Factors Predictive of Clinical
Responses to Pioglitazone in Uncontrolled Diabetic Patients. Presented at the 6th Annual Research
Celebration Day, 24 May 2004, King Faisal Specialist Hospital & Research Centre.
1.2.32 H Raef, H Al Suhaibani, A Alzahrani and M Ahmed. The Value of Ethanol Injeciton of local
Metastasis in the Treatment of Differentiated Thyroid carcinoma. Presented at the 6th Annual
Research Celebration Day, 24 May 2004, King Faisal Specialist Hospital & Research Centre.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 16 of 25
1.2.33 M Mehthel, M Ahmed, A Alzahrani, A Almahfouz, A Alarifi, and H Raef. Metabolic Bone
Disease as a Clue to the Dx of Celiac Disease. Presented at the 6th Annual Research Celebration
Day, 24 May 2004, King Faisal Specialist Hospital & Research Centre.
1.2.34 Yufei Shi, Ranjit S Parhar, Minjing Zou, Essa Baitei, Ali Alzahrani, Futwan Al Mohana, Nadir R
Farid. Gene Therapy of Anaplastic Thyroid Carcinoma with a Single Chain Interleukin-12 Fusion
Protein. Presented at the Endocrine Society 85th Annual Meeting of the Endocrine Society, held in
Philadelphia, June 2003.
1.2.35 A Alzahrani, E Ba Essa, and N Al Juhani. Comparison of Familial and Sporadic Types of
Papillary Thyroid Cancer. Presented at The Endocrine Societys 86th Annual Meeting, New Orleans,
Louisiana, USA, 16-19 June 2004.
1.2.36 S Abdel Salam, M Mehthel, and A Alzahrani. Persistent Hypertension Following Complete
Resection of Extra Adrenal Pheochromocytoma (Paraganglioma). Presented at The Endocrine
Societys 86th Annual Meeting, New Orleans, Louisiana, USA, 16-19 June 2004.
1.2.37 A Alzahrani, S Abdel Salam, S Bakheet, G Mohammed, B Al Matouq and H Raef. Comparison F18-Fluorodeoxyglucose Positron Emission Tomography with Post I131 Therapy whole Body Scan
in Thyroglobulin-Positive, Scan-Negative Differentiated Thyroid Cancer. Presented at The
Endocrine Societys 86th Annual Meeting, New Orleans, Louisiana, USA, 16-19 June 2004.
1.2.38 A Alzahrani, M Al Mehthel, S Abdel Salam, A Almahfouz, and H Raef. A rare cause of
undetectable serum thyroglobulin in scan-positive widespread metastatic follicular thyroid cancer.
Presented at The Endocrine Societys 86th Annual Meeting, New Orleans, Louisiana, USA, 16-19
June 2004.
1.2.39 M Al Mehthel, S Abdel Salam, and A Alzahrani. Four months of inhospital management of severe
refractory hypocalcemia following parathyroidectomy of a single parathyroid adenoma. Presented
at The Endocrine Societys 86th Annual Meeting, New Orleans, Louisiana, USA, 16-19 June 2004.
1.2.40 A Alzahrani, G Mohamed, S Abdel Salam, S Bakheet, H Raef, and S Al Sobhi. F-1Fluorodeoxyglucose positron Emission Tomography (PET) in the follow-up of differentiated
thyroid cancer (DTC). Presented at The Endocrine Societys 86th Annual Meeting, New Orleans,
Louisiana, USA, 16-19 June 2004.
1.2.41 A Alzahrani, H Al Suhaibani, S Al Sobhi, S Al Sifri, G Mohamed, and M Akhtar. Accuracy of
Neck Ultrasonography in Predicting the presence of persisten/recurrent (P/R) differentiated thyroid
cancer. Presented at The Endocrine Societys 86th Annual Meeting, New Orleans, Louisiana, USA,
16-19 June 2004.
1.2.42 H Bin Yousef, A Alzahrani, S Al-Sobhi, H Al suhaibani, M Chaudhari and H Raef. Pre-operative
Neck Ultrasound Mapping for Persistent/Recurrent Papillary Thyroid Cancer. Presented at the
Annual Meeting of Endocrine surgeons Uppsala, Sweden, June 2004
1.2.43 Alzahrani A, Abdel Salam S, Mohammed G, Bakheet S and Raef H. The role of 18FFlourodeoxyglucose Positron Emission Tomography (PET) in the Initial Evaluation of
Differentiated Thyroid Cancer. International Congress of Endocrinology, Lisbon, Portugal, 31 Aug
04 Sept 2004.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 17 of 25
1.2.44 Ali Alzahrani, Suzan Abdel Salam, Gamal Mohammed, Ayman Rifai, Othman Solaiman and
Abdulaziz Al Sugair. F-18-Fluorodeoxyglucose Positron Emission Tomography (PET) in the initial
evaluation of Differentiated thyroid Cancer (DTC): Comparison with Diagnostic Radioiodine
Whole Body Scan (DxWBS). Submitted to The Endocrine Societys 87th Annual Meeting, San
Diego, 04-07 June 2005.
1.2.45 Ali Alzahrani, Othman Solaiman, Suzan Abdel Salam, and Gamal Mohammed. Serum
Thyroglobulin at the First Follow-Up Visit after Radioiodine (RAI) Remnant Ablation Predicts the
long-term Course of Differentiated Thyroid Cancer (DTC). Presented at the Endocrine Societys
87th Annual Meeting, San Diego, 04-07 June 2005.
1.2.46 Ali Alzahtrani, Abdulrahman Kabbani, Suzan Abdel Salam and Ayman Rifai. Recombinant TSHstimulated I131 Therapy of Highly Functioning Skeletal Metastases of Follicular Thyroid Cancer:
Acute Thyroid Hormone Changes and Risk of Hyperthyroidism. Presented at the Endocrine
Societys 87th Annual Meeting, San Diego, 04-07 June 2005.
1.2.47 Othman Solaiman, Ali Alzahrani, Ayman Rifai and Suzan Abdel Salam. F-18-Flourodeoxyglucose
Positron Emission Tomography (PET) is more sensitive than post I131 therapy whole body scan in
Tg-positive, Scan negative Papillary Thyroid Cancer (PTC). Presented at the Endocrine Societys
87th Annual Meeting, San Diego, 04-07 June 2005.
1.2.48
Ali Alzahrani, Suzan Salam, Gamal Mohammed, Ayman Rifai, Othman Solaiman, Maha Al
Fehaily, And Saif Al Sobhi. F-18 Flourodeoxyglucose Positron Emission tomography (PET) in the
initial Evaluation of differentiated Thyroid Ca (DTC): Comparison with Histopathological
Examination of Subsequent Surgery. Presented at the Endocrine Societys 87 th Annual Meeting,
San Diego, 04-07 June 2005.
1.2.49 Almahfouz A, Alfadhli E, Ahmed M, Alzahrani A, and Raef H. Factors Predictive of Clinical
Responses to Pioglitazone in Uncontrolled Diabetic Patients. Presented at the Endocrine Societys 87th
Annual Meeting, 4-7 June 2005.
1.2.50 O Demirkaya, A Rifai, and A Alzahrani. Quantification of Tumor Lesions in Whole Body Positron
Emission Tomography Images. Presented as Oral Presentation- Annual Congress of the European
Association of Nuclear Medicine, Istanbul, Turkey. 18 October 2005.
1.2.51 Ali S Alzahrani, Essa Biatie, Yufei Shi and Minging Zou. Thiamine Transporter Gene Mutations:
an example of Monogenic Diabetes Mellitus. Presented to Endocrine Societys 88th Annual
Meeting, Boston, USA, 24-27 June 2006.
1.2.52 Ali S. Alzahrani, Hamad Al-Suhaibani, Gamal Mohammed, Saif Al Sobhi and Suzan Abdel Salam.
How Accurate is the radiologists impression of the nature of ultrasonographic findings detected during
the follow-up of differentiated thyroid cancer. Presented to Endocrine Societys 88th Annual Meeting,
Boston, USA, 24-27 June 2006.
1.2.53 Ali Alzahrani, Khalid Abu-Amero, Minjing Zou and Yufei Shi. Germline Mitochondrial DNA
Mutations in Multiple Endocrine Neoplasia Type 2a. Presented to Endocrine Societys 88th Annual
Meeting, Boston, USA, 24-27 June 2006.
1.2.54 Mohammed Sheef and Ali Alzahrani. Severe Primary Hyperparathyroidism masked by
Asymptomatic Celiac Disease. Presented to Endocrine Societys 88th Annual Meeting, Boston,
USA, 24-27 June 2006.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 18 of 25
1.2.55 Summaya Eskandarani, Abdulraof AlMahfouz, Ali Alzahrani. An Unusual Cause of Ectopic
Adrenocorticotrophic Hormone (ACTH) Secretion: Cushings Syndrome Secondary to Prostate
Cancer. Presented at the 9th Annual Research Celebration Day, Department of Medicine, King
Faisal Specialist Hospital & Research Centre. 29 May 2007.
1.2.56 Nojoud Al Khaldi, Saleh Al-Ahmad, Ali Alzahrani. Diagnosis by Serendipity: Cushing's syndrome
Secondary to Cortisol-producing Adrenal Adenoma as the Presenting Feature of Multiple Endocrine
Neoplasia Type 1 (MEN 1). Presented at the 9th Annual Research Celebration Day, Department of
Medicine, King Faisal Specialist Hospital & Research Centre. 29 May 2007.
1.2.57 Ali Alzahrani1, Minjing Zou2, Essa Baitei2, Brian Meyer2, and Yufei Shi2. Frequent BRAF V600E
Mutation and its Association with Aggressive Behavior of Papillary Thyroid Carcinoma. Presented at
the 9th Annual Research Celebration Day, Department of Medicine, King Faisal Specialist Hospital
& Research Centre. 29 May 2007.
1.2.58 Omalkhair AlShaikh, MD, Ali Alzahrani. Multiple Paraganglioma Syndrome: a Skull Base
Paraganglioma Masquerading as Nasopharyngeal Cancer. Presented at the 9th Annual Research
Celebration Day, Department of Medicine, King Faisal Specialist Hospital & Research Centre. 29
May 2007.
1.2.59 Ali S. Alzahrani, Mohei-eldin M. Abouzeid, Suzan Abdel Salam, Gamal Mohamed, Ayman Rifai,
Abdulaziz Al Sugair, MD, Tarik Amin. The Role of F-18-Fluorodeoxyglucose Positron Emission
Tomography in the Initial Evaluation of Differentiated Thyroid Cancer. Presented at the 9th Annual
Research Celebration Day, Department of Medicine, King Faisal Specialist Hospital & Research
Centre. 29 May 2007.
1.2.60 Mohamed Al Harthi, Saud Al Harthi, Ali Alzahrani. Pheochromocytoma/Paragangliomas: A Study
of Cases Seen At KFSHRC over the Last Decade. Presented at the 9th Annual Research Celebration
Day, Department of Medicine, King Faisal Specialist Hospital & Research Centre. 29 May 2007.
1.2.61 Omar Al-Nozha, MD, Talal Dahan, MD, Ahmed Nazmi, MD, Ali Alzahrani. The Clinical,
Pathological and Outcome Profile of Thyroid Cancer in Saudi Arabia. Presented at the 9th Annual
1.2.62 Ali S. Alzahrani and Mohei-eldin M. Abouzeid. The Potential Role of F-18-Flourodeoxyglucose
Positron Emission Tomography in the Work up of Adrenal Nodules. Presented at the 9th Annual
1.2.63 Ali S Alzahrani. The Potential Diagnostic and Prognostic Role of F-18-Fluorodeoxyglucose
Positron Emission Tomography in the Initial Evaluation of Differentiated Thyroid Cancer. 32nd
Annual Meeting of the European Thyroid Association. Leipzig. 01-05 Sept 2007.
1.2.64 Ali Alzahrani, Muhammad Faiyaz-Ul Haque, Mohammed Tulaimat and Fouad Al Dayel. Multiple
paraganglioma Syndrome secondary to mutation in succinate dehydrogenase Type D. Presented at
the 10th Annual Research Celebration Day, Department of Medicine, King Faisal Specialist Hospital
& Research Centre. 06 May 2008. (Podium presentation)
1.2.65 Ibrahim Madhkali, Rafif Farhat, Jalaluddin Bhuiyan, Kim Nicholson, Shaikhah Al-Moussa and Ali
Alzahrani. A new approach to the diagnosis of thyrotoxicosis facticia: Measurement of stool
Ali Saeed Alzahrani

CV, 01 August 2012
Page 19 of 25
thyroxine level. Presented at the 10th Annual Research Celebration Day, Department of Medicine,
King Faisal Specialist Hospital & Research Centre. 06 May 2008.
1.2.66 Ali Alzahrani, Mohei-eldin Abouzeid, Suzan Salam, Gamal Mohammed, Ayman Rifai, Abdulaziz
Al sugair and Tarek Amin. Accuracy of F-18-Fluorodeoxyglucose Positron Emission Tomography
in Predicting Residual Cancer after Incomplete Thyroidectomy for Differentiated Thyroid Cancer.
Presented at the 10th Annual Research Celebration Day, Department of Medicine, King Faisal
Specialist Hospital & Research Centre. 06 May 2008.
1.2.67 Mashaal Al Mowanya, and Ali Alzahrani. An Unusual multiplicity and aggressiveness of tumors
in mulitple endocrine neoplasia type 1. Presented at the 10th Annual Research Celebration Day,
Department of Medicine, King Faisal Specialist Hospital & Research Centre. 06 May 2008.
1.2.68 Rafif Farhat, Fatma Al Zidjali and Ali Alzahrani. Outcome of treatment of male infertility due to
hypogonadotrophic hypogonadism with gonadotrophins. Presented at the 10th Annual Research
Celebration Day, Department of Medicine, King Faisal Specialist Hospital & Research Centre. 06
May 2008.
1.2.69 Ali Alzahrani, Mohei-eldin Abouzeid, Suzan Salam, Gamal Mohammed, AymanRifai, Abdulaziz
Al-Sugair and Tarek Amin. Accuracy of F-18-Fluorodeoxyglucose Positron Emission tomography
in predicting residual cancer after incomplete thyroidectomy for differentiated thyroid cancer:
radiopathological correlation study. Accepted for presentation at the Endocrine Societys 90th
Annual Meeting. San Francisco, USA, 15-18 June 2008.
1.2.70 Mohammed Al-Harthy, Saud Al Harthy and Ali Alzahrani. Comparison of head and neck
paragangliomas with below neck paraganglioma/pheochromocytomas. Accepted for presentation at
the Endocrine Societys 90th Annual Meeting. San Francisco, USA, 15-18 June 2008.
1.2.71 Rafif Farhat, Fatma Al Zidjali and Ali Alzahrani. Outcome of treatment of male infertility due to
hypogonadotrophic hypogonadism with gonadotrophins. Accepted for presentation at the
Endocrine Societys 90th Annual Meeting. San Francisco, USA, 15-18 June 2008.
1.2.72 Ali Alzahrani, Hindi Al-Hindi, Mohammed Amed, Hussein Raef, Tarek Amin, Nora Alkahtani,
Mohammed Tuli and Abdulraof Almahfouz. Response of liver metastases from duodenal
neuroendocrine tumor to indium-111 octreotide therapy and chemoembolization. The 6th Annual
ENETS (European Neuroendocrine Tumor Society) Conference, Granada, Spain, 5-7 March 2009.
1.2.73 Ali Alzahrani, Omalkhaire Al Shaikh, Summaya Eskandrani, Abdulraof Almahfouz and Hindi AlHindi. An unusual site and manifestation of a neuroendocrine tumor: Cushings syndrome
secondary to malignant neuroendocrine tumor of the prostate. The 6th Annual ENETS (European
Neuroendocrine Tumor Society) Conference, Granada, Spain, 5-7 March 2009.
1.2.74 Ali Alzahrani, Roua A Al Rijjal, Minjing Zou, Essa Baitei and Yufei Shi. A Novel Gene Mutation
of CYP27B1 in a large family with Pseudovitamin D Deficiency Rickets. 11th Annual Research
Celebration Day, Department of Medicine, 12 May 2009. (Oral presentation)
1.2.75 Ali Alzahrani, Rafif Farhat, Saud Al Harthi, Mohammed Al Harthi, Talal Dahhan, Omar Al Nozha
and Ahmed Nazmi. Impact of Therapeutic Interventions on the long-Term Outcome of Persistent
Differentiated Thyroid Cancer. The Endocrine Societys 91st Annual Meeting, Washington, DC,
USA, 10-13 June 2009.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 20 of 25
1.2.76 Rafif Farhat, Abdullah Alarifi, Nora Al Kahtani, Imaddudin Kanaan, Mohei-eldin abouzeid and Ali
Alzahrani. The diagnostic Vaue of Fused Postiron Emission Tomography/computed Tomography
in the localization of Adrenocorticotropin-Secreting Pituitary Adenoma in cushings Disease. The
Endocrine Societys 91st Annual Meeting, Washington, DC, USA, 10-13 June 2009.
1.2.77 Omalkhaire Al Shaikh, Hala Aba Alkhail, Muhammad Faiyaz Ul-Hague, Mohammed Ahmed,
Mohammed Tualimat, Fouad Al Dayel, and Ali Alzahrani. RET Oncogene Mutation Screening
and Genotype Phenotype Correlation in Familial Medullary Thyroid Cancer and MEN 2 Syndrome:
Data from the Middle East. The Endocrine Societys 91st Annual Meeting, Washington, DC, USA,
10-13 June 2009.
1.2.78 Ali S Alzahrani, Reem Alamawi, Rafif Farhat, and Mohammed Tuli. Iodine-123 Isotope for
Recombinant Human Thyrotropin-Stimulated Diagnostic Whole Body Scanning in the follow-up of
Differentiated thyroid cancer. The Endocrine Societys 91st Annual Meeting, Washington, DC,
USA, 10-13 June 2009.
1.2.79 Ali S Alzahrani, Roua A Al Rijjal, Minjing Zou, Essa Baitei and Yufei Shi. A Novel Gene
Mutation of CYP27B1 in a large family with Pseudovitamin D Deficiency Rickets. The Endocrine
Societys 91st Annual Meeting, Washington, DC, USA, 10-13 June 2009.
1.2.80 Ali S. Alzahrani, Rafif Farhat, Omalkhaire Al-Shaikh, Sameerah Al-Shehri, Mohammed AlHarthy, Saud Al-Harthy, Ahmed Nazmi, Omar Al-Nozha, MD, and Talal Dahhan. Long-term
Outcome of Patients with Persistent Differentiated Thyroid Cancer Following the Initial
Management. The Endocrine Societys 92nd Annual Meeting, San Diego, California, USA. 19-22
June 2010.
1.2.81 Ali S. Alzahrani, Minjing Zou, Nora Al-Kahtani, John KAmartey, Essa Y Baitei, Hussein Raef,
Roua Al-Rijjal, Abdulraof Almahfouz, Ranjit S Parhar, Futwan A Al-Mohanna, Brian Meyer, and
Yufei Shi, MD. A Novel Biallelic Mutation in the Insulin Binding Domain of the Insulin Receptor
Causing Severe Insulin Resistance Syndrome in Five Unrelated Saudi Families; A Possible Founder
Mutation. The Endocrine Societys 92nd Annual Meeting, San Diego, California, USA. 19-22 June
2010.
1.2.82 Ali S. Alzahrani, MD, Omalkhaire Alshaikh, MD, Sameerah Al-Shehri, and Rafif Farhat.
Radioactive Iodine (I-131) Therapy for Thyroglobulin Positive, Scan Negative Differentiated
Thyroid Cancer. The Endocrine Societys 92nd Annual Meeting, San Diego, California, USA. 19-22
June 2010.
1.2.83 Ali S. Alzahrani, Minjing Zou, Essa Baitei, Roua Al-Rijjal, MD, Omalkhaire Al-Shaikh, and Yufei
Shi. A Novel Biallelic R94G Mutation of the Steroid 5-Reductase-2 (SRD5A2) Gene in Two
Unrelated Cases of 46XY Male Pseudohermaphordite. The Endocrine Societys 92nd Annual
Meeting, San Diego, California, USA. 19-22 June 2010.
1.3 Peer-Reviewed Publication

1.3.1
Ali S. Alzahrani and Saeed Bohlega. Chorea and high antiphospholipid antibodies: probable
primary antiphospholipid syndrome. Eru J Neurol 1995; 2:363-367.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 21 of 25
1.3.2
Ali S. Alzahrani, Michael A. Levine. Primary Hyperparathyroidism (review). The Lancet 1997;
340:1233-1238.
1.3.3
Ali S. Alzahrani, Michael Levine, William Schwindinger. Parathyroid Hormone Resistance

Syndromes. Chapter in a book (Hormone Resistance), Larry Jameson (Ed), 1999.
1.3.4
Muhammad M. Hammami, Ali S. Alzahrani, Abdul I. Butt, M. Phil, Leticia J. Vencer, Syed S.
Hussain. Primary Hyperparathyroidism-Associated Polyostotic Fibrous Dysplasia: Absence of
McCune Albright Syndrome Mutations. J. Endocrinol Invest 1997; 20:552-558.
1.3.5
Jehad Al-Watban, Ali S. Alzahrani, Zoltan Patay, and Maher Hassounah. Pits, Patches, and
Protuberances. Int J. Neurorad 1999; 5:133-135.
1.3.6
Ali S. Alzahrani. Insulin Resistance, Metabolic Diseases and Diabetic Complications (book
review), Gaetano Crepaldi, Antonio Tiengo, and Stefano Del Prato (editors) 1999. Annals of Saudi
Medicine, 2000.
1.3.7
Ali S. Alzahrani (Corresponding Author), Siema Bakheet, Majid Al Mandil, Alya Al-Hajjaj,
Abdulraouf Almahfouz, and Abdallah Al Haj. I Isotope as a Diagnostic Agent in the Follow Up of
Patients with Differentiated Thyroid Cancer: Comparison with Post 131I Therapy Whole Body
Scanning. J Clin Endocrinol Metab, Nov 2001.
1.3.8
Ali S. Alzahrani (Corresponding Author), Hussein Raef, Ali Sultan, Saif Al Sobhi, Stig
Ingemansson, Mohammed Ahmed, Abdulraof Almahfouz. Impact of Second Surgery on the Serum
Thyroglobulin (TG) and the Course of the Disease in Patients with Papillary Thyroid Cancer who
have Elevated TG Level, Negative Diagnostic Radioactive Iodine Whole Body Scan (DXWBS) and
Recurrent/Persistent Disease Limited to the Neck. J. Endocrinol Invest, May 2002.
1.3.9
Ali S. Alzahrani (Corresponding Author), Majid Al Mandil, Mohammed Ahmed, and Gamal
Eldin Mohammed. Frequency and Predictive Factors of Malignancy in Residual thyroid tissue and
cervical lymph nodes after Partial Thyroidectomy for Differentiated Thyroid Cancer. Surgery,
April 2002.
1.3.10 Al-Rawithi S, Hussein RF, Alzahrani A. Sensitive Assay for the Determination of Fluvastatin in
Plasma Utilizing High-Performance Liquid Chromatography With Fluorescence Detection. .Ther
Drug Monit. 2003 Feb;25(1):88-92.
1.3.11 Hussam Bin Yousef, Ali S Alzahrani, Mohammed Ahmed, Abdullah Alarifi, Abdulraof
Almahfouz, Hussein Raef and Saif Al Sobhi. Laparoscopic VS Open Adrenalectomy: Experience
at King Faisal Specialist Hospital & Research Centre, Riyadh. Annals of Saudi Medicine, Vol 23,
Nov 1-2, 2003
1.3.12
Ali S. Alzahrani (Corresponding Author), Management of Hypertension in Diabetic Patients

(Chapter for the Saudi Hypertension Management Group)
1.3.13 Yufei Shi, Ranjit S Parhar, Minjing Zou, Essa Baitei, George Kessie, Nadir R Farid, Ali Alzahrani
and Futwan Al-Mohanna. Gene Therapy of Anaplastic Thyroid Carcinoma with a Single Chain
Interleukin-12 Fusion Protein.
Human Gene Therapy. 2003 Dec 10;14 (18) 1741-51.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 22 of 25
1.3.14 Hussam Bin Yousef, Ali Alzahrani (Corresponding Author), Saif Al Sobhi, Hamad Al Suhaibani,
Mohammed Chaudhari, and Hussein Raef. Preoperative Neck Ultrasonographic Mapping for
Persistent/Recurrent Papillary Thyroid Cancer. World J Surg 2004 Nov;28(11):1110-4.
1.3.15 Saleh Aldasouqi and Ali S Alzahrani (corresponding author), Terminology in Diabetes Mellitus, an
example of resistance to change. Saudi Medical Journal 2004; Vol 25(9): 1289-1291.
1.3.16 Saleh Al Dasouqi, David Nkansa-Dwamena, Samia Bokhari, Ali Alzahrani, Muthaza Khan, Amal
Reffi, and Amal Merdad. Is Subclinical Hypothyroidism Associated with Hyperhomocysteinemia.
Endocrine Practice Vol 10, No.5, September/October 2004, 399-403.
1.3.17 Abu-Amero KK, Alzahrani AS, Zou M and Shi Y. High frequency of somatic mitochondrial DNA
mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.
Oncogene, 2005 Feb 17; 24 (8) 1455-1460.
1.3.18 Ali Alzahrani (Corresponding Author), Alya Al Hajjaj, Jehad Al Watban and Imaddudin
Kanaan. Severe Hypertension Secondary to renal artery stenosis and Cushings syndrome. Saudi
Med J 2005 Apr; 26 (4).668-73.
1.3.19 Ali S Alzahrani (Corresponding Author), Hamad Al Suhaibani, Suzan Abdel Salam, Saud Al
Sifri, Gamal Mohammed, Saif Al Sobhi, Othman Al Solaiman, and Mohammed Akhtar. Diagnostic
Accuracy of High Resolution Neck Ultrasonography in the follow-up of differentiated Thyroid
Cancer: A Prospective study. Endocr Pract. 2005 May-June; 11 (3): 165-71.
1.3.20 Alzahrani AS (Corresponding Author), Al Dasouqi S, Salam SA, Sultan A. Autoimmune
Thyroid Disease with Fluctuating Thyroid Function. Public Library of Science, Medicine (PLOS
Med) 2005 May;2 (5);e89.
1.3.21 Ali Alzahrani (Corresponding Author), Mohammed G, Al Shammary A, AlDasouqi S,
AbdelSalam S, Shoukri. Long Term Course and Predictive Factors of Elevated Serum
Thyroglobulin and Negative Diagnostic Radioiodine whole Body scan in differentiated thyroid
cancer. J Endocrinol Invest. 2005 Jun; 28 (6) 540-546.
1.3.22 Alarifi A, Alzahrani A (Corresponding Author), Salam SA, Ahmed M. Repeated Remissions of
Cushings Disease Due to Recurrent Infarctions of an ACTH-Producing Pituitary Macroadenoma.
Pituitary. 2005;8(2):81-7.
1.3.23 Alzahrani, AS (Corresponding Author). Resistin: Can we resist its role in insulin resistance?
Ann Saudi Med. 2005 Jul-Aug;25(4):281-2
1.3.24 Abu-Amero KK, Alzahrani AS, Zou M, Shi Y. Association of mitochondrial DNA transversion
mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome.
Oncogene.2006 Feb 2;25 (5):677-84.
1.3.25 Ali S. Alzahrani (Corresponding Author), Gamal E. Mohamed, Ayman Rifai, Abdalaziz S. AlSugair, Suzan A. Abdel Salam, Othman M. Sulaiman, , and Omer Demirkaya. The Role of F-18Fluorodeoxyglucose Positron Emission Tomography in the Follow-up of Differentiated Thyroid
Cancer. Endocrine Practice, 2006 Mar-Apr;12 (2):152-8.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 23 of 25
1.3.26 Ali Alzahrani, Essa Y Baitei, Minjing Zou, and Yufei Shi. Clinical Case Seminar: Metastatic
Thyroid Follicular Carcinoma arising from congenital goiter due to a novel splice donor site
mutation in the thyroglobulin Gene. J Clin Endocrin Metab 2006 Mar;91 (3):740-6.
1.3.27 Mohammed Ahmed, Haroon Faraz, Abdulraof Almahfouz, Abdullah Alarifi, Hussein Raef, Fouad
Al Dayel, Abdulaziz Al Sugair and Ali Alzahrani. A case of vitamin D deficiency masquerading
as occult malignancy. Ann Saudi Med 2006;26 (3): 231-236.
1.3.28 Alzahrani AS, Baitei E, Zou M, Shi Y. Thiamine Transporter Mutations: an example of
Monogenic Diabetes Mellitus. Eur J Endocrinol. 2006 Dec;155(6):787-92.
1.3.29 Ali S Alzahrani (Corresponding Author). (Invited Review Article) Management of hypertension
in diabetes mellitus. Experts Rev. Endocrinol. Metab 2 (3), 2007.
1.3.30 Bouchama A, Kwaasi A, Dehbi M. Al Mohanna F, Eldali A, El-Sayed R, Tbakhi A, Alzahrani AS,
Roberts AG. Glucocorticoids do not protect against the lethal effects of experimental heatstroke in
baboons. Shock. 2007 May;27(5):578-83.
1.3.31 Elhadd TA, Al-Amoudi AA, Alzahrani AS. Epidemiology, clinical and complications profile of
diabetes in Saudi Arabia: a review. Ann Saudi Med, 2007 Jul-Aug;27 (4):241-50.
1.3.32 Siraj A, Bavi P, Abubaker J, Jehan Z, Sultana M, Al-Dayel F, Al-Nuaim A, Alzahrani A, Ahmed
M, Al-Sanea-O, Uddin S, Al-Kuraya K. Genome-wide expression analysis of Middle Eastern
papillary thyroid cancer reveals-Met as a novel target for cancer therapy. J Pathol.2007.
Oct;213(2):190-9.
1.3.33 Ahmed M, H Bin Yousef, W. Creer, HA Faraz, S. Al Sobhi, A Alzahrani, H Raef, A Al Ghamdi,
Y. Al Kadhi and F Al Dayel. Hurthle Cell Neoplasm of Thyroid Gland: Australia New Zealand
Journal of Surgery. 2008:78;139-143.
1.3.34 Alzahrani AS (Corresponding Author). Predictors of obstructive sleep apnea in snorers:
statistical errorsComment from the Annals. Ann Saudi Med. 2008 Jan-Feb;28(1):60-1.
1.3.35 Shi Y, Zou M, Baitei EY, Alzahrani AS, Parhar RS, Al-Makhalafi Z, Al-Mohanna FA.
Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment
of anaplastic thyroid carcinoma. Cancer Gene Ther. 2008 Feb;15 (2):101-7.
1.3.36 Ali Alzahrani (Corresponding Author) and Mohammed Al Sheef. Severe Primary
Hyperparathyroidism Masked by Asymptomatic Celiac Disease. Endocr Pract. 2008
Apr;14(3):347-50.
1.3.37 Alzahrani A (Corresponding Author), Abouzeid M, Abdel-Salam S, Gamal M, Rifai A, AlSugair A, Amin T. The role of F-18 Fluorodeoxyglucose Positron Emission Tomography
in the Postoperative evaluation of differentiated thyroid cancer. Eur. J. Endocrinol., May
2008;158:683-689.
1.3.38 Alzahrani AS (Corresponding Author), Goiter (Invited chapter). In: Ebell MH, ed.
Evidence at Hand. 1st ed. Hoboken, NJ: John Wiley and Sons.
Ali Saeed Alzahrani

CV, 01 August 2012
Page 24 of 25
1.3.39 Alzahrani AS (Corresponding Author), Multiple Endocrine Neoplasia type 1 (Invited

chapter). In: Ebell MH, ed. Evidence at Hand. 1st ed. Hoboken, NJ: John Wiley and Sons.
1.3.40 Alzahrani AS (Corresponding Author), Al-Harthy S. Multiple Endocrine Neoplasia type 2
(Invited Chapter) In: Ebell MH, ed. Evidence at Hand. 1st ed. Hoboken, NJ: John Wiley
and Sons.
1.3.41 Ali Alzahrani (Corresponding Author), Nojoud Al Khaldi, Yufei Shi, Roua Al AlRijjal,
Minjing Zou, Essa Y Baitei and Tarek Amin. Diagnosis by Serendipity: Cushings
syndrome attributable to cortisol-producing adrenal adenoma as the initial manifestation of
multiple endocrine neoplasia type 1 due to a rare splicing site MEN1 Mutation. Endocr
Pract. 2008 Jul-Aug:14 (5):595-602.
1.3.42 Zou M, Baitei EY, Alzahrani AS, Al-Mohanna F, Farid NR, Meyer B, Shi Y. Oncogenic
activation of MAP kinase by BRAF pseudogene in thyroid tumors. Neoplasia. 2009 Jan;
11(1):57-65.
1.3.43 Baitei EY, Zou M, Al-Mohanna F, Collison K, Alzahrani AS, Farid NR, Meyer B, Shi Y.
Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in
thyroid carcinoma. J pathol. 2009 Apr; 217: 707-715.
1.3.44 Alzahrani AS (Corresponding Author), Farhat R, Alarifi A, AlKahtani N, Kanaan I,
Abouzeid M. The diagnostic value of fused positron Emission tomography/computed
tomography in the localization of adrenocorticotropin-secreting pituitary adenoma in
cushings disease. Pituitary. 2009: 12 (4) 309-14.
1.3.45 Al-Harthy M, Al-Harthy S, Al-Otieschan A, Velagapudi S, Alzahrani AS (corresponding
author). Comparison of pheochromocytomas and abdominal and pelvic paragangliomas
with head and neck paragangliomas. Endocr Pract. 2009 May-June: 15 (3):194-202.
1.3.46 Farhat R, Zidjali F, Alzahrani AS (Corresponding Author). Outcome of gonadotropin
therapy for male infertility due to hypogonadotrophic hypogonadism. Pituitary. 2010 Jun:
13(2):105-10.
1.3.47 Alshaikh O, Al-Mahfouz A, Al-Hindi H, Mahfouz AB, Alzahrani AS (Corresponding
Author). An unusual cause of ectopic secretion of adrenocorticotropic hormone: Cushing's
syndrome attributable to small cell prostate cancer. Endocr Pract. 2010 Mar-Apr;16(2):24954.
1.3.48 Alzahrani AS (Corresponding Author), Alshaikh O, Faiyaz-Ul-Haque M, Abalkhail H, AlDayel F, Al Hindi HA. Multiple Paraganglioma Syndrome type 4 due to Succinate
Dehydrogenase B Mutation: Diagnostic and Therapeutic Challenges of a Skull Base
Paraganglioma Masquerading as Nasopharyngeal Cancer. Endocr Pract. 2010 MayJun:16(3):452-8.
1.3.49 Uddin S, Bavi P, Siraj AK, Ahmed M, Al-Rasheed M, Hussain AR, Ahmed M, Amin T,
Alzahrani A, Al-Dayel F, Abubaker J, Bu R, Al-Kuraya KS. Leptin-R and its association
Ali Saeed Alzahrani

CV, 01 August 2012
Page 25 of 25
with PI3K/AKT signaling pathway in papillary thyroid carcinoma. Endocr Relat Cancer.
2010 Feb 18;17 (1):191-202. Print 2010 Mar.
1.3.50 Alzahrani AS, Zou M, Baitei EY, Alshaikh OM, Al-Rijjal RA, Meyer BF, Shi Y. A novel
G102E mutation of CYP27B1 in a large family with vitamin D-dependent rickets type 1. J
Clin Endocrinol Metab. 2010 Sep;95(9):4176-83.
1.3.51 Alshaikh OM, Almanea H, Alzahrani AS (Corresponding Author). Paget disease of the
bone: Does it exist in Saudi Arabia? Ann Saudi Med. 2011 May-June: 31(3):305-10.
1.3.52 Zou M, Baitei EY, Alzahrani AS, Parhar RS, Al-Mohanna FA, Meyer BF, Shi Y. Mutation
prediction by PolyPhen of functional assay, a detailed comparison of CYP27B1 missense
mutations. Endocrine. 2011 August: 40(1).
1.3.53 Alzahrani AS, Zou M, Baitei EY, Parhar RS, Al-Kahtani N, Raef H, Almahrouz A,
Amartey JK, Al-Rijjal R, Hammami R, Meyer BF, Al-Mohanna FA, Shi Y. Molecular
Characterization of a Novel p.R118C Mutation in the Insulin Receptor Gene from Patients
with Severe Insulin Resistance. Clin Endocrinol (Oxf). 2012 Apr;76(4):540-7
1.3.54 Ali Alzahrani, Graziano Ceresini, Saleh Al Aldasouqi, Ultrasound in Thyrotoxicosis: A
non-invasive, cost-3ffective, and widely available but under-utilized diagnostic tool.
Endocr Pract. 2012 Feb 20:1-35
1.3.55 Alzahrani Ali (Corresponding Author) Al Qarawi Abdullah, Al Suhaibani Fahad, Al Mana
Hadeel, Abalkhail Halah. Pancreatic metastasis arising from BRAF-positive papillary
thyroid cancer: the role of endoscopic ultrasound - guided biopsy and response to sorafenib
therapy. Thyroid. 2012 Mar 21. [Epub ahead of print]
1.3.56 Ali Alzahrani (Corresponding Author), Omalkhaire Al Shaikh, Mahmoud Tuli, Abdulaziz
Al Sugair, Reem Alamawi, Maha Al Rasheed. Diagnostis value of recombinant human
thyrotropin stimulated iodine 123 whole body scintigraphy in the follow up of patients with
differentiated thyroid cancer. Clin Nucl Med. 2012 Mar;37(3):229-34.

245 Riverside Avenue
Suite 200 Jacksonville, Florida 32202 Phone: (904) 353-7878 Fax: (904) 353-8185 http://www.aace.com

1st Annual Meeting

October 12, 2012
Name:
Aly Bernard Khalil
Address: Sheikh Khalifa medical city

City:
Abu Dhabi
Country: UAE
Email: akhalil771@gmail.com
___ President
_X__ Vice President
___ Secretary
___ Treasurer
_X__ CV or bio-sketch included
_X__ Candidate statement included
Dear Colleagues,
I would like you to join me in suppor ng the ins tu on of the rst chapter of the American Associa on
of Clinical Endocrinologists in the Gulf area as well my candidacy for the posi on of Vice -President for
the Gulf chapter Board of directors.
As stated in my brief bibliography, I have been one of the founders and ac ve par cipants of the United
Arab Emirates endocrine Club. My mission was and s ll is to contribute to the enhancement of the level
of the knowledge needed for the prac ce of clinical endocrinology.
With your support, I would like to be given the chance to serve ocially as one of your representa ve in
the rst AACE chapter in the Gulf area.
Ali Khalil
Dr. Ali B KHALIL, MD, FRCPC, FAACE

Consultant Endocrinologist, Department of Medicine,
Sheikh Khalifa Medical City (SKMC), Abu Dhabi UAE
Consultant at SKMC, Abu Dhabi, since 2003
Certified by the American board of Internal medicine since 1988 and the American board of
Endocrinology and Metabolism since 1995 (recertified 2005).
Ex- fellow of the American Endocrine Society
Fellow of the American Association Clinical Endocrinologists FACE since 2005
Founding member of the endocrine group for the United Arab Emirates
During my professional career, I have assumed different clinical and administrative positions
the most relevant are highlighted below:
1- Head of the division of Endocrinology at the Queensway Hospital /Trillium Health
Center between 1989-1998
2- President of the medical staff and member of the board of Governors at Queensway
Hospital /Trillium Health Center between 1989-1998
3- Chairman of the medical surgical Intensive care Queensway Hospital /Trillium Health
Center between 1998- 2000
4- President of the Ontario Diabetes Association Canada 1999-2000
5- Vice President of the Committee for Pensions and Civil Retirement for the government of
Abu Dhabi from 2006 to present
6- Deputy Chair of the Intensive care at Sheikh Khalifa medical city /Abu Dhabi 2000-2002
7- Chairperson of the Institutional review board for Research at SKMC: 2007-2011
8- Program Manager of the multidisciplinary Thyroid cancer program 2008 to -present
.
President Candidates
1. Fatma AlMarashi, MD FACE; UAE
2. Kamal A S Al-Shoumer, BSC, MB, DIC, PhD,
FRCP, FACE; Kuwait
3. Mahmoud Mohamed A Fikri, MBBCh, PhD;
UAE
4. Ahmed A K Hassoun, MD FACE; UAE


1st Annual Meeting

October 12, 2012
1
Name: FATMA H. ALMARASHI
Address: P. O. BOX 7013
City:
DUBAI
Country:
U.A.E.
Email: dralmarashi@gmail.com
2
3
__X_ President
___ Vice President
___ Secretary
___ Treasurer
Dr. Fatma AlMarashi
Dr. Al Marashi recently served as the Medical Director at University Hospital, part of the Mohammed Bin
Rashid Academic Medical Center in Affiliation with Harvard Medical school Dubai Center in Dubai
Healthcare City, where she developed strategy for the Medical and Physicians Affairs Department. She has
been featured in many national TV programs for Diabetes and other Endocrinological Problems. She was a
contributing writer for the Healthcare Middle-East Journal providing physician and patient education material
on the topic of Endocrinology and Diabetes. She has organized many community activities in her field for
education of the community at large besides the courses for Education of the physicians to improve the
standards of care for patients with Endocrinological problems.
Dr. Fatma AlMarashi is the first UAE physician to earn American double board certification. She is the only
UAE physician with double American Board Degrees in Endocrinology, Diabetes and Metabolism. She is
American Board certified in Endocrinology and Internal Medicine. Dr. Al Marashi earned her medical degree
from Shiraz Medical School. She focused on Internal Medicine as her first specialty as a resident at St.
Vincent Hospital, a University of Massachusetts affiliate, in Worcester, MA,U.S.A. She furthered her
specialization by completing a fellowship in Endocrinology, Diabetes and Metabolism, at the University of
Texas Medical School in Houston, TX, U.S.A.She received her training from MD- Anderson and Herman
Hospital, Houston, USA. Dr AlMarashi has active Medical licenses in USA Massachusetts, Texas and
California, besides having a CPQ license and DOHMS License, UAE.
After coming back to UAE in 1998, she was constantly trying to get the Health care Standards improved in
UAE; she founded the Department of Endocrinology, Diabetes and Metabolism at Al Baraha Hospital
/MOH , and served as the Chair for five years. In her dedicated efforts to improve the healthcare status in
the U.A.E., Dr. Al Marashi was appointed as a U.A.E. representative in the Gulf Cooperation Council for the
Diabetes Control Committee in striving to control the rising number of diabetes cases in the area. In 1999,
she founded and served as Chairperson of the U.A.E. National Diabetes Control committee ( UAE- NDCC),
in the Ministry of Health and also founded and designed the first and only stand alone Diabetes and
Endocrine Center called Alsalam Diabetes and Endocrine center. She trained the staff for the center and
headed the project She also voluntarily helped and to develop Diabetes Center in Ajman Medical district. As a
Chair of UAE- NDCC. She developed Diabetes registry plat form for MOH and Developed Diabetes
standard of care for primary care for UAE.
She has participated in several courses, lectures and symposium to Educate Physicians as well as the
community, and the policy makers.
As a member of the Drug Formulary Committee in Ministry of Health from 2001-2003 she tried to put the
policies and procedures to develop and improve the drug approval processes. Afterwards she moved on to fill
the position as Chief of the Division of Endocrinology, Diabetes and Metabolism at Welcare Hospital before
joining Dubai Healthcare City. Dr. Al Marashi has consulted at multiple healthcare facilities in the U.A.E.
including Welcare, Al Baraha, Al Kuwaiti, Neurospinal and American Hospitals
Dr AlMarashi is a member of several International and National Scientific Associations. She is member of
International committee for American Association of Clinical Endocrinologist (AACE), and recently
appointed as a member of Primary Care Physician Education Initiative Committee of AACE USA.
She was a board member of Emirates Medical Association (EMA) and chair person of EMA Scientific
committee.
Gulf Chapter, AACE Priorities & experience

President candidate: Dr. Kamal Al-Shoumer MD, DIC, PhD, FRCP, FACE
DR. AL-SHOUMER IS AN ASSOCIATE PROFESSOR OF MEDICINE AND CLINICAL ENDOCRINOLOGY AT THE DEPARTMENT OF
MEDICINE, FACULTY OF MEDICINE, AT KUWAIT UNIVERSITY. HE IS SENIOR CONSULTANT & HEAD OF THE DIVISION OF
ENDOCRINOLOGY & METABOLIC MEDICINE AT MUBARAK AL-KABEER TEACHING HOSPITAL IN KUWAIT. HE WAS THE VICE-DEAN
TH
TH
OF THE FACULTY OF MEDICINE AT KUWAIT UNIVERSITY (APRIL 12 2004 - APRIL 11 2008). DR. AL-SHOUMER HAD HIS POSTGRADUATE EXPERIENCE IN THE UK AT ST MARY'S HOSPITAL IN LONDON WHERE HE RECEIVED HIS MRCP/FRCP. HIS FELLOWSHIP
RESULTED IN A PHD IN ENDOCRINOLOGY & METABOLIC MEDICINE FROM UNIVERSITY OF LONDON, IMPERIAL COLLEGE, WHEN HE
PERFORMED RESEARCH ON ADULT HYPOPITUITARISM AND ADULT GROWTH HORMONE THERAPY. HE HAS OVER 100 PUBLICATIONS
INCLUDING PEER REVIEWED ARTICLES IN INTERNATIONAL JOURNALS, HE WROTE SEVERAL CHAPTERS IN TEXTBOOKS, PRESENTED
SEVERAL RESEARCH PAPERS AND TOPICS AS INVITED SPEAKER IN LOCAL AND INTERNATIONAL MEETINGS, AND HE IS AN EDITORIAL
BOARD MEMBER OF SEVERAL JOURNALS. HE IS AN EXTERNAL EXAMINER CERTIFIED BY THE ROYAL COLLEGE OF PHYSICIANS OF
LONDON FOR THE MRCP-PACES . DURING HIS TERM OF ALL OFFICES, SEVERAL ADMINISTRATIVE, CLINICAL, AND ACADEMIC
ACHEIVEMENTS WERE OBTAINED THAT RESULTED IN ACREDITATION/INCREASED RECOGNITION OF THE INSTITUTES HE WORKED AT.
Mission:
- To establish an administrative Gulf body that works to enhance the development of activities of all AACE
Chapters
- To assist endocrinologists to provide the highest quality of patient care
-To work as an advocate for patient care issues in endocrinology, diabetes, metabolism and nutrition
Channels:
- To coordinate the work of Gulf body as the official representative of AACE in the Gulf:
a. In consistence with the views, policy and guidelines established by AACE, to serve as a communication link
between members at Gulf region level.
b. To facilitate AACE policies and programs at the Gulf region.
- To develop committees where appropriate to carry out the work of chapter. Preliminary committees include: Scientific &
program committee, Membership committee, Nomination committee, and External relations committee.
- To coordinate and help all committees in the plan and assist them in implementation of their functions.
Basics needed to fulfil function:

- To prepare the infrastructure needed (office, technical needs, IT matters) for the Chapter
- To plan to assure adequate Gulf Chapter financial resources (along with the chapters treasurer)
- To ensure committee will tackle the related necessary roles in:
a. Recruitment of new members as qualified by AACE.
b. Establish necessary link among members (Website, email, periodic newsletter)
c. Disseminate AACE clinical practice guidelines and endocrine educational tools that will enhance the delivery of
health care in the Gulf chapter.
d. Foster mutually supportive professional relationships between AACE and endocrine organizations in the Gulf region.
Endocrinologists continued education

To increase creativity and new skills developments for endocrinologists in Gulf Chapter by their involvement in
workshops, symposia, or events organized by Gulf Chapter, or linked to or co-organized with other AACE
chapters in a CME accredited manner by AACE
Personal administrative experience of Dr. Kamal Al-Shoumer:

A. At the student level:
1.President, Kuwait Medical Students Association at Faculty of Medicine, Kuwait University and President of Standing
Committee for International Federation of Medical Students Associations (Oct.1984- Oct.1985)
B. At the Post-Graduate level:
1.President, National Union of Kuwaiti students UK and Ireland branch, the official association representing scholar Kuwaiti
under- and post-graduate students in the UK and Ireland. (Sept. 1993-Sept.1994)
C. At the department of Medicine level, Faculty of Medicine level:
1.Head of Division of Endocrinology & Metabolic Medicine (1997-to date).
2.Team Leader and Chief Coordinator of Endocrine system block at the new curriculum of Phase II program (Nov. 2005 to date)
D. At the Faculty of Medicine and University of Kuwait levels:
1. President of Conference, Ninth Annual Health Sciences Poster Conference, Faculty of Medicine, HSC (2004).
2. Vice-Dean (Administration & Finance), Faculty of Medicine (April 2004 to April 2008)
E. At the Regional Arab level:
1. President, Pan-Arab Society of Endocrinology and Diabetes (Nov. 2007-to May 2010)
CURRICULUM VITAE
KAMAL A. S. AL-SHOUMER
B.Sc., M.B.B.Ch., D.I.C.(UK), Ph.D.(UK),
M.R.C.P.(UK), F.R.C.P. (UK), F.A.C.E.(USA)
ASSOCIATE PROFESSOR OF CLINICAL
ENDOCRINOLOGY AND MEDICINE
DEPARTMENT OF MEDICINE
FACULTY OF MEDICINE/KUWAIT UNIVERSITY
HEAD, DIVISION OF ENDOCRINOLOGY &
METABOLIC MEDICINE / FACULTY OF MEDICINE
& MUBARAK AL-KABEER UNIVERSITY
TEACHING HOSPITAL
EX-(PAST) VICE-DEAN, FACULTY OF MEDICINE,
KUWAIT UNIVERSITY
PRESIDENT OF PAN-ARAB SOCIETY OF
ENDOCRINOLOGY AND DIABETES
(NOV.2007 TO MAY 2010)
PERSONAL DETAILS
Name :
Date of birth :
Place of birth :
Nationality :
Address:
Fax:
Mobile:
E-mail
Kamal Abdul Aziz Sulaiman Al-Shoumer

3rd Oct. 1961
Kuwait
Kuwaiti
P.O.Box 1086 Surra
45711 Kuwait
+965 25340549
+965 99707539
kshoumer@hsc.edu.kw or kshoumer@gmail.com
QUALIFICATIONS
B.Sc.
1983, Faculty of Medicine, Kuwait University (Kuwait).
M.B.B.Ch
1986, Faculty of Medicine, Kuwait University (Kuwait).
M.R.C.P. (Medicine)
1993, Membership, Royal College of Physicians (UK).
Ph. D. (Clinical Endocrinology)
1996, University of London (UK).
D.I.C. (Clinical Endocrinology)
1997, Imperial College of Science, Technology and

Medicine, London (UK).
F.R.C.P (UK)
2002, Fellowship, Royal College of Physicians (UK)
F.A.C.E (USA)
2003, Fellowship, American College of Endocrinology
SUMMARY OF POSTS
Trainee
Assistant Registrar - General Medicine
Registrar - General Medicine
Honorary Registrar - Endocrinology
Clinical Research Fellow - Endocrinology
& Senior Registrar (Kuwait)
Consultant & Head of Division of Endocrinology
& Metabolic Medicine - Dept. of Medicine Assistant Professor of Medicine - Faculty of
Medicine
Associate Professor of Medicine - Faculty of
Medicine
Vice-Dean, Faculty of Medicine
Current Post: Consultant/Head of division
Of Endocrinology & Metabolic Medicine at
Faculty of Medicine & Mubarak Al-Kabeer
Teaching hospital
2
July 1986 - July 1987

Aug. 1987 - April 1990
May 1990 - Feb. 1992
March 1992 - March 1993
April 1993- Dec 1996
March 1997 to date
(I.D 9703152) Sept 1997 to 20th June 2001
20th June 2001 to date
12 April 2004 to 11April 2008
Since March 1997 to date
PROFESSIONAL HISTORY:
Transitional Internship: This included rotations in the 4 major branches of medicine
1. General Surgery
July 1986 - End Oct. 1986
Farwaniya Hospital - Kuwait
Consultant:
Dr. Parkash FRCS
2. Obstetrics & Gynaecology
Nov.1986 - End Dec. 1986
Al-Adan Hospital - Kuwait
Consultant: Dr. S. Kamil MRCOG
3. General Medicine
Jan.1987 - End April 1987
Consultant: Dr. J. Cherian FRCP
4. Paediatrics
May 1987 - End June 1987
Consultant: Dr. Sharda MRCPaed.
Postgraduate Training Programme (PGTP) in Medicine in Kuwait:
This included rotations in all subspecialities of Medicine including general medical rotations:
As Assistant Registrar
1. General Medicine
July 1987 - End June 1988
Amiri Hospital- Kuwait
Consultants: Dr. H.K.Walia FRCP & Dr. Menon FRCP
2. General Medicine
July 1988 - End Dec. 1988
Mubarak Hospital - Kuwait
Consultants: Prof.A.Razzaq FRCP & Prof.M.Barakat MD
3. Endocrinology subspeciality
1st-End Jan 1989
Consultant: Dr. Berg MD
4. Rheumatology rotation
1st-End Feb. 1989
Consultant: Dr.M.Sattar FRCP
5. Hematology rotation
1st-End March 1989
Amiri Hospital - Kuwait
Consultant: Dr. H.Habboush MRCP MRCPath
6. Coronary Care Unit
1st- End April 1989
Consultant: Dr. M.Khafaji MRCP
7. Intensive Care Unit
1st-End May 1989
Consultant: Dr.Farouq
8. Oncology rotation
1st - End June 1989
Kuwait Cancer Centre
Consultant: Dr.S.Mutawe FRCS
9. Cardiology rotation
1st July - End Sep. 89
Chest Disease Hospital - Kuwait
Consultants: Prof. G.Cherian MD, Dr. Nazir

10. Dermatology rotation
1st Oct.- 15 Nov. 1989
Shuwaikh Skin Centre- Kuwait
Consultant: Prof. M Al-Din MD
11. Psychiatry rotation
16 Nov.- End Dec. 1989
Psychiatric Diseases Hospital-Kuwait
Consultant: Prof.M.F.Islam MRCPsy
12. Neurology rotation
1st Jan-End March 1990
Ibn Sina Hospital-Kuwait
Consultant: Dr.R.Shakir MRCP
13. Respiratory diseases rotation
1st-End April 1990
Mubarak Hospital Respiratory Unit-Kuwait
Consultant: Dr. Karnick MD
As Registrar
14.Radiology rotation
1st-End May 1990
Amiri Hosp. Radiology Dep.-Kuwait
Consultant: Dr. Mohy MD
15.Emergency medicine
1st-End June 1990
A.&E. Amiri Hospital - Kuwait
Consultant: Prof. B. Al-Naqib FACP FRCP
16.General Medicine
1st June-End Feb. 1992
Amiri Hospital -Kuwait
Consultant: Dr. H.K.Walia FRCP
As Honorary Registrar (In UK)
In the Unit of Metabolic Medicine
2nd March 1992- March 1993
& Clinical Endocrinology at
St. Marys Hospital-London W2
Consultant: Professor D.G.Johnston PhD FRCP
Dr.R. S. Elkeles MD FRCP
As Clinical Research Fellow (Senior Registrar)
In the Unit of Metabolic Medicine
April 1993 - Dec. 1996
St. Marys Hospital-London W2
Consultant: Professor D.G.Johnston PhD FRCP
Dr.R. S. Elkeles MD FRCP
During this period, I was involved in the academic activities of the Unit of Metabolic Medicine.
This included teaching at the Imperial College School of Medicine at St. Marys for medical
students in the course of Endocrinology. In addition to this, regular weekly clinics on general
endocrinology, diabetes and lipids at St Marys and St Charless Hospitals were part of my
clinical activities.
After 1996 to date:
1. Consultant & Head of Division of Endocrinology & Metabolic Medicine (1997-to date)
This post includes a full responsibility of patients as a head of division of Endocrinology &
Metabolic Medicine in the Medical Department at Mubarak Al-Kabeer Hospital. It covers
services in the subspeciality of Endocrinology and Metabolism. It includes inpatient care,
outpatient care, duties, arrangement of bone densitometry and metabolic day assessments. In
addition to regular in bedside teaching for medical students and postgraduates.
2. Assistant Professor of Medicine- Department of Medicine (1997-19th June 2001)
This includes full engagement in teaching activities in the Faculty of Medicine for undergraduates
and postgraduates. Organization of the 5th year Endocrine & Diabetes system course,
presentation of lectures to postgraduate candidates in the MRCP part I and II course, presentation
of lectures to students, and supervising the activities in the departmental endocrine laboratory
(with a backdated appointment since Sept. 1993).
3. Associate Professor, Department of Medicine, Faculty of Medicine (20th June 2001-to
date)
This post was achieved based on the distinguished research, community services and clinical
teaching for students and post-graduates in the Faculty of Medicine at Kuwait University and at
the Faculty of Internal Medicine at the Post-graduate Training Program.
4. Vice-Dean (Administration & Finance), Faculty of Medicine (12 April 2004 to 11 April
2008)
ADMINISTRATIVE EXPERIENCE:
A. At the student level:
1. Director of student affairs committee, Kuwait Medical Student Association (KuMSA), the
official association representing medical students at Faculty of medicine, Kuwait
University (Oct.1981-Oct.1982)
2. Vice-President of KuMSA and Director of students affairs committee in KuMSA
(Oct.1982- Oct.1983)
3. Director of the Standing Committee of Refugees (SCOR) at the International Federation
of Medical Students Association (IFMSA) (1983-1985)
4. Vice-president of the General Assembly of the IFMSA 1984 meeting held at Solbaka,
Sweden
5. President, KuMSA at Faculty of Medicine, Kuwait University and President of Standing
Committee for IFMSA (Oct.1984- Oct.1985)
B. At the Post-Graduate level:
1. President, National Union of Kuwaiti students UK and Ireland branch, the official
association representing scholar Kuwaiti under- and post-graduate students at UK and
Ireland. (Sept. 1993-Sept.1994)
C. At the Faculty of Medicine level:
Department of Medicine:
1. Head of Division of Endocrinology & Metabolic Medicine (1997-to date).
2. Member, of the departmental Research Committee (1997-1999).
3. Chief Coordinator, of departmental Research Committee (1999-2002)
4. Member, of departmental Postgraduate Committee (1999 to date).

5. Chief Coordinator, department Examination Committee (2002-2004)
Under and Post-graduate teaching levels and program:
1. Coordinator at Kuwait Institute for Medical Specialization (KIMS), Postgraduate training
program in Medicine - Mubarak Al-Kabeer Hospital (2000-2004)
2. Chief Coordinator of the Endocrinology system course to the 5th year students in the
Faculty of Medicine (1998 to date)
3. Team Leader and Chief Coordinator of Endocrine system block at the new curriculum of
Phase II program (Nov. 2005 to date)
4. Chief Coordinator of Updates on Endocrinology & Metabolism (UEM) (1999-2006)
5. Co-ordinator, Joint Mayo clinic and Kuwait National program to fight hypertension, Fight
hypertension congress 15-17th Jan. 2007
Faculty of Medicine level
1. Executive Member, the organizing committee for the annual poster day at
Faculty of Medicine, Health Sciences Center (1997 to 2004).
2. Member, the executive board of Medical Research Council (MRC) of the
Faculty (1998-2001).
3. Member of the Faculty of Medicine Scientific Affairs Advisory Committee (1999)
4. Chairman, Faculty Committee for staff salary cadre recommendations (2005-6)
5. Chairman, Faculty Committee for space allocation in faculty of medicine (2005-6)
6. Chairman, Faculty Recruitment Committee for support academic staff at Faculty of
Medicine (2006-)
7. Chairman of Committee, Ninth Annual Health Sciences Poster Conference
2004.
8. Director, Faculty of Medicine Consultation Office (2006 to date)
9. Member, Interview Committee of new applicants to Faculty of Medicine (20057)
D. At Deanship level of Faculty of Medicine:
1. Vice-Dean (Administration & Finance), Faculty of Medicine (12 April 2004 to April
2008)
2. Acting Dean, Faculty of Medicine at the following periods;
- 17 July 2004 to 1st August 2004
- 25 Sept. 2004 to 29 Sept. 2004
- 16th November 2004
- 27 Nov. 2004 to 29 Nov. 2004
- 25 Dec. 2004 to 28 Dec. 2004
- 8th Jan 2005 to 10th Jan 2005
- 2nd July 2005 to 29th July 2005
- 8th Oct. 2005 to 12th Oct. 2005
- 18th Feb. 2006 to 20th Feb. 2006
- 15th July 2006 to 2nd August 2006
- 10th Sept. 2006 to 14th Sept. 2006
- 24th March 2007 to 29th March 2007
3. Dean Representative of Faculty of Medicine of Kuwait on the third Conference

of Arab Society of Medical Faculties, held on 12-13 April 2006, Irbid, Jordan
E. At the University level:
1. Council member, University Recruitment committee for support academic staff (20042005-2006-2007)
2. Member, University Committee for the study of merging colleges (2004-5)
3. Member, University Committee to study the cadre for support academic staff, teaching
assistants and English language tutors (Jan-May 2006)
4. Member, University Committee for the evaluation of certificates for academic staff
(2007- )
F. At the regional Arab level:
1. President, Pan Arab Society for Endocrinology and Diabetes (Nov. 2007- May 2010)
ACADEMIC ACTIVITIES :
PublishedResearch papers in refereed cited journals:
1. Al-Shoumer KAS, Beshyah SA & Johnston DG. (1994) Growth hormone and malignancy.
Endocrine-Related Cancer; 1 : 19-26
2. Al-Shoumer KAS, Beshyah SA, Niththyanathan R & Johnston DG. (1995) Effect of
glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in
hypopituitary adults. Clinical Endocrinology; 42: 85-90
3. Al-Shoumer KAS, Ali K, Anyaoku V, Niththyananthan R & Johnston DG. (1996) Overnight
metabolic fuel deficiency in patients treated conventionally for hypopituitarism. Clinical
Endocrinology; 45, 171-178.
4. Al-Shoumer KAS, Page B, Thomas E, Murphy M, Beshyah SA & Johnston DG. (1996)
Effects of four years treatment with biosynthetic human growth hormone (GH) on body
composition in GH-deficient hypopituitary adults. European Journal of Endocrinology ; 135:
559-567.
5. Al-Shoumer KAS, Cox K, Hughes C, Richmond W & Johnston DG. (1997) Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
Journal of Clinical Endocrinology and Metabolism ; 82: 2653-2659.
6. Al-Shoumer KAS, Anyaoku V, Ali K & Johnston DG. (1997) Metabolic effects of short-term
reproduction of the normal diurnal cortisol rhythm in hypopituitary adults. Endocrinology &
Metabolism ; 4: 207-214.
7. Al-Shoumer KAS, Anyaoku V, Richmond W & Johnston DG.(1997) Elevated leptin
concentrations in growth hormone-deficient hypopituitary adults. Clinical Endocrinology; 47:
153-159.
8. Al-Shoumer KAS, Gray R, Anyaoku V, Hughes C, Beshyah SA, Richmond W & Johnston
DG. (1998) Effects of four years treatment with biosynthetic human growth hormone (GH) on
glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clinical
Endocrinology, 48, 795-802.
9. Kousta E, Chrisoulidou A, Lawrence N J, Al-Shoumer KAS, Parker KH, McCarthy MI &
Johnston DG. (1998) The circadian rhythm of leptin is preserved in growth hormone deficient
hypopituitary adults.Clinical Endocrinology; 48, 685-690.
7
10. Johnston DG, Al-Shoumer KAS, Chrisoulidou A, Kousta E, Beshyah S and Robinson S.
(1999). Long-term effects of GH therapy on intermediary metabolism and insulin sensitivity in
hypopituitary adults. Journal of Endocrinological Investigation , 22, 37-40.
11. Kousta E, Chrisoulidou A, Lowrence NJ, Anyaoku V, Al-Shoumer KAS & Johnston DG.
(2000) The effects of growth hormone replacement therapy on overnight metabolic fuels in
hypopituitary patients.Clinical Endocrinology 52, 17-24
12. Al-Shoumer KAS, Vasanthy BK, Makhlouf HA & Al-Zaid MM. (2000) Leptin levels in
Arabs with primary hyperthyroidism. Annals of Saudi Medicine, 20, 113-118.
13. Doi SAR, Loutfi I & Al-Shoumer KAS. (2001) A mathematical model of optimized
radioiodine-131 treatment of Graves hyperthyroidism. BMC Nuclear Medicine 1:1
14. Parappil A, Doi SAR & Al-Shoumer KAS. (2002) Diagnostic criteria for diabetes revisited:
making use of combined criteria. BMC Endocrine Disorders 2:1
15. Al-Gharabally A, Doi SAR, Al-Shoumer KAS (2002) Spironolactone for the treatment of
hypercalcuric hypocalcemia. Journal of Bone and Mineral Metabloism 20, 243-247
16. Abalkhail S, Doi SAR, Al-Shoumer KAS. (2003) The use of corticosteroids versus other
treatments for Graves ophthalmopathy: a quantitative evaluation. Medical Sciences Monitor
9(11), CR477-483.
17. Mehraj S, Doi SAR, Al-Shoumer KAS.(2004) Technical observations on the assessment of
thyroid volume by palpation and ultrasonography. Journal of Ultrasound in Medicine 23(2), 261266.
18. Doi SA, Al-Zaid M, Towers PA, Scott CJ, Al-Shoumer KAS. Irregular cycles and steroid
hormones in polycystic ovary syndrome. Hum Reprod. 2005 Sep;20(9):2402-8.
19. Lasheen I, Doi SA, Al-Shoumer KAS. Glucocorticoid replacement in panhypopituitarism
complicated by myelinolysis. Med Princ Pract. 2005 Mar-Apr;14(2):115-7.
20. Doi SA, Al-Zaid M, Towers PA, Scott CJ, Al-Shoumer KAS. Ovarian steroids modulate
neuroendocrine dysfunction in polycystic ovary syndrome. J Endocrinol Invest. 2005 Nov
28(10):882-92.
21. Al-Shoumer KAS, Vasanthy BA, Al-Zaid MM. Effects of treatment of hyperthyroidism on
glucose homeostasis, insulin secretion and markers of bone turnover. Endocrine Practice 2006,
12 (2): 121-130.
22. Doi SA, Lasheen I, Al-Humood K, Al-Shoumer KAS. Relationship between cortisol
increment and basal cortisol: implications for the low dose short adrenocorticotrophic hormone
stimulation test. Clin Chem. 2006 Apr; 52(4):746-9.
23. Doi SA, Al-Zaid M, Towers PA, Scott CJ, Al-Shoumer KAS. Steroidogenic alterations and
adrenal androgen excess in PCOS. Steroids. 2006, 71: 751-759.
24. S. A.R. Doi, D. Issac, S. Abalkhail, M. M. Al-Qudhaiby, M. F. Hafez, and KAS Al-Shoumer.
TRH Stimulation When Basal TSH is Within the Normal Range: Is There "Sub-Biochemical"
Hypothyroidism? Clin. Med. Res., October 1, 2007; 5(3): 145 - 148.
25. Sheikh, M; Abalkhail, S; Doi, SAR; Al-Shoumer, KAS. Normal measurement of orbital
structures: Implications for the assessment of Graves' ophthalmopathy. Australasian Radiology.
51(3):253-256, June 2007.
26. Kamal Al-Shoumer, Hafez Mohamad, Suhail Doi. A case of hypocortisolemic clinical
Cushings syndrome. Annals of Saudi Medicine (2008): 28(2):124-127.
27. Kamal Al-Shoumer, Adnan Al-Asoosi, Suhail Doi, Bagavathy Vasanthy. Serum leptin and
metabolic variables in Arabs with type 2 diabetes. Annals of Saudi Medicine (2008): 28(5): 267370.
28. Kamal Al-Shoumer & Bagavathy Vasanthy. Serum chromogranin A concentration in
hyperthyroidism before and After medical treatment. Journal of Clinical Endocrinology &
Metabolism (2009): 94: 23212324. Published online on April 14, 2009 as doi:10.1210/jc.20082231
29. Moussa Alkhalaf and Kamal Al-Shoumer. Cytogenetic abnormalities and azoospermia
factor (AZF) microdeletions in infertile men from Kuwait. J Mol Genet Med (2010), 4(1), 232234
30. Kamal Al-Shoumer & Vasanthy Nair. Prevalence of low bone mass in post-menopausal
Kuwaiti women resident in the largest province at Kuwait. Archives of osteoporosis (2012 In
press)
Published Reviews, Book Chapters:
31. Al-Shoumer KAS, Kousta E, Beshyah S & Johnston DG. Growth hormone (GH) deficiency Does it cause atherosclerosis ? In Proceedings of 3rd International hGH Symposium on GHD in
adults (1996) (ed. JS Christiansen, JOL Jrgensen, AVZ Mhlen & W Waldhusl), pp. 20-25,
Medical Forum International, The Netherlands.
32. Johnston DG, Al-Shoumer KAS, Beshyah SA, Chrisoulidou A, Kousta E & Anyaoku V.
Interactions of cortisol and growth hormone replacement: intermediary metabolism. In The
diagnosis and treatment of pituitary insufficiency (1997) (ed.SWJ Lamberts), pp. 63-77.
BioScientifica Ltd, Bristol.
Growth hormone replacement in young adults: if and when to continue?. In Adolescent
Endocrinology (1998) (ed.R Stanhope), pp. 17-23. BioScientifica Ltd, Bristol.
34. Doi SA, Towers PA, Scott CJ, Al-Shoumer KAS. PCOS: an ovarian disorder that leads to
dysregulation in the hypothalamic-pituitary-adrenal axis? Eur J Obstet Gynecol Reprod Biol.
2005 Jan 10;118(1):4-16
35. Perros P & Al-Shoumer KAS. Endocrinology alarm bells. Textbook: Alarm Bells in
Medicine 2005, BMJ Books, Blackwell Publ, 25-29.
36. Doi SA, Abalkhail S, Al-Qudhaiby MM, Al-Humood K, Hafez MF, Al-Shoumer KAS.
Optimal use and interpretation of the aldosterone rennin ratio to detect aldosterone excess in
hypertension. J Human Hypertens. 2006 Jul 20 (7):482-9.
37. Al-Shoumer KAS. Vitamin D: A Methodological Update. United Updates 2011, Jan. Issue 4:
12-17.
38. Al-Shoumer KAS & Gharib Hossein. Hyperthyroidism: Toxic Nodular Goiter and Graves
Disease. Surgery of the Thyroid and Parathyroid Gland, Second Edition. Edited by Gregory W.
Randolph, M.D., F.A.C.S (in press 2012)
Editor of a book:
39. Al-Shoumer KAS. Reflections of Health Sciences Center Poster Days 1996-2001, April
2001, Kuwait.
40. Diabetes: The hidden pandemic and its impact on the middle east and northern Africa.
Published and distributed on MENA Diabetes Leadership forum 2010 Dubai, 1-38. (12-13 Dec.
2010)
Published abstracts in refereed journals & presented (Posters) in meetings
41. Al-Shoumer KAS, Beshyah SA, Niththynanathan R & Johnston DG. (1993) Glucocorticoid
replacement regimen and glucose tolerance in hypopituitary adults. Journal of Endocrinology;
139 (Suppl.): P126.
42. Al-Shoumer KAS, Beshyah SA, Niththynanathan R & Johnston DG. (1994) Day to day
variation in glucose tolerance and intermediary metabolites caused by glucocorticoid replacement
therapy in hypopituitary adults. Clinical Science; 86 (Suppl.30): 22P.
43. Al-Shoumer KAS, Andres C, Beshyah SA, Gray IP & Johnston DG. (1994) Day to day
variation in pancreatic beta cell products caused by glucocorticoid replacement therapy in
hypopituitary adults. Journal of Endocrinology; 140 (Suppl.): P164.
44. Al-Shoumer KAS, Ali K, Niththyanathan R & Johnston DG. (1994) 24 Hour glucose and
insulin profiles in hypopituitary adults on conventional replacement therapy.Diabetic Medicine;
11(Suppl.2): P54.
45. Al-Shoumer KAS, Anyaoku V & Johnston DG. (1995) Total plasma cortisol profiles in
hypopituitary adults with growth hormone deficiency on conventional replacement therapy.
Endocrinology and Metabolism ; 2 (Suppl.B): page 143.
46. Al-Shoumer KAS, Hughes C, Ali K, Richmond W & Johnston DG. (1995) Abnormalities of
lipid metabolism in ACTH-deficient hypopituitary adults on conventional replacement therapy.
Journal of Endocrinology; 144 (Suppl.): P107.
47. Al-Shoumer KAS, Anyaoku V, Ali K & Johnston DG. Plasma free cortisol profiles in
conventionally treated hypopituitary adults. 77th Annual Meeting of the American Endocrine
Society: Washington DC, held on 14-17 June (1995). Conference Programme and Abstract Book
(Poster P3-75, page 487).
48. Al-Shoumer KAS, Gedroyc W, Beshyah SA, Anyaoku V & Johnston DG. Does growth
hormone (GH) treatment cause reactivation or recurrence of pituitary tumours in hypopituitary
patients (HP). Fifth International Congress on Hormones and Cancer: Quebec City, held on 16-20
September (1995). Conference Programme and abstract Book (Poster 94, page 118).
49. Al-Shoumer KAS, Cox K, Richmond W & Johnston DG. (1995) Plasma lipid profiles over
24 hours in hypopituitary adults (HPA) on conventional replacement therapy.Journal of
Endocrinology; 147 (Suppl.): P67.
50. Al-Shoumer KAS, Anyaoku V, Niththyanathan R & Johnston DG. (1996) Abnormalities of
intermediary metabolites in hypopituitary adults with growth hormone (GH) deficiency on
conventional replacement. Endocrinology and Metabolism ; 3 (Suppl A), 122.
51. Al-Shoumer KAS, Anyaoku V, Gray R & Johnston DG. (1996) Effects on glucose and
insulin of short- term reproduction of the normal diurnal cortisol rhythm in ACTH-deficient
hypopituitary adults.Journal of Endocrinology ; 148 (Suppl.): P141.
52. Al-Shoumer KAS, Page B, Anyaoku V, Beshyah S & Johnston DG. (1996) Body
composition in hypopituitary adults (HPA): results after four years of growth hormone (GH)
replacement therapy. Journal of Endocrinology ; 148 (Suppl.): P142.
10
53. Al-Shoumer KAS, Gray R, Barr J, Anyaoku V, Ali K & Johnston DG. (1996) Plasma
glucose and insulin in hypopituitary adults: results after 4 years of growth hormone (GH)
replacement. Diabetic Medicine ; 13 (Suppl.3): P50: S27-28.
54. Al-Shoumer KAS, Gray R, Barr J, Anyaoku V, Hughes C, Richmond W & Johnston DG.
Carbohydrate tolerance and lipid metabolism in hypopituitary adults after long-term growth
hormone (GH) replacement. 10th International Congress of Endocrinology: San Francisco, held
on 12-15 June (1996). Conference Programme and Abstract Book (Poster P2-464, page 520).
55. Al-Shoumer KAS, Kyd P, Murphy M, Thomas E & Johnston DG. (1996) Preserved increase
in bone turnover and maintained level of bone mass in growth hormone (GH) deficient
hypopituitary adults treated with human biosynthetic GH for four years.Journal of
Endocrinology;151(Suppl.): P66.
56. Al-Shoumer KAS, Anyaoku V, Gray R, Hughes C, Richmond W & Johnston DG.(1997)
Anthropometric and metabolic effects of four years treatment with biosynthetic human growth
hormone (GH) in hypopituitary adults (HPA). Endocrinology and Metabolism ; 4 (Suppl. A),
P047, page 53.
57. Al-Shoumer KAS, Kousta E, Richmond W & Johnston DG. (1997) Increased prevalence of
abnormal fasting lipids and lipoproteins in growth hormone (GH) deficient hypopituitary adults.
Endocrinology and Metabolism ; 4 (Suppl. B), Poster A3, page 157.
58. Kousta E, Chrisoulidou A, Lawrence N, Al-Shoumer KAS, Markou A & Johnston DG. The
circadian rhythm of leptin is preserved in hypopituitary patients. 24th International Symposium
on Growth Hormone and Growth factors in Endocrinology and Metabolism, Antwerp, held on 34 October (1997). Conference Programme and abstract Book (Poster A7, page 54).
59. Al-Shoumer KAS, Ali K, Anyaoku V & Johnston DG. (1997) Intravenous versus oral
hydrocortisone replacement therapy in ACTH-deficient hypopituitary adults: effects on metabolic
fuels. Journal of Endocrinology; 155 (Suppl. 2): P47.
60. Chrisoulidou A, Anyaoku V, Beshyah SA, Al-Shoumer KAS, Robinson S & Johnston DG.
(1998) Effects of GH treatment for 7 years versus no treatment on anthropometry and vascular
risk factors in adult hypopituitarism. Journal of Endocrinology , 156 (Supp.), P151.
61. Al-Shoumer KAS, Makhlouf HA, Al-Zaid MM, Qurtum M & Hussein AAA. Effects of
treatment of thyrotoxicosis on carbohydrate metabolism in hyperthyroid adults. Third Health
Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait, April 20, 1998,
Conference Programme and abstract Book (page 40).
62. Al-Shoumer KAS, Vasanthy BK, Makhlouf HA & Al-Zaid MM. Increased bone turnover in
untreated thyrotoxicosis. Third Health Sciences Poster day, Faculty of Medicine, Kuwait
University, Kuwait, April 20, 1998, Conference Programme and abstract Book (page 41).
63. Al-Shoumer KAS, Kyd P, Murphy M, Thomas E, Beshyah SA & Johnston DG. Effects of
longterm growth hormone (GH) therapy on bone metabolism in GH-deficient adults. 80th Annual
Meeting of the American Endocrine Society: New Orleans, Louisiana, held on 24-27 June 1998.
Conference Programme and Abstract Book (P1-213, page 165).
64. Al-Shoumer KAS, Vasanthy BK & Makhlouf HA. (1998) Leptin concentration in thyrotoxic
patients. Journal of Endocrinology ; 159 (Supp): P87.
65. Al-Shoumer KAS, Vasanthy BK & Makhlouf HA. Effects of treatment of hyperthyroidism
on leptin concentrations. 2nd Meeting of the British Thyroid Association. St. Thomas Hospital,
London, held on 25 November 1998. Programme and Abstract Book ( P11, page 17).
11
The effects of GH therapy on overnight metabolic fuels in hypopituitary patients. 26th
International Symposium on GH and Growth Factors in Endocrinology and Metabolism. Palma
de Mallorca, held on 23-24 October, 1998. Programme and Abstract Book (B3, page 68).
67. Al-Shoumer KAS, Al-Zaid MM & Vasanthy BK. Leptin concentration in women with
hirsutism. Forth Health Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait,
April 25, 1999, Conference Programme and abstract Book (page 56).
68. Al-Shoumer KAS, AlBony A, El-Gazzar A & Vasanthy BK. Outcome of radionuclide
technetium thyroid scan (TC-99M pertechnetate) over twelve months in Mubarak Al-Kabeer
Hospital. Fourth Health Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait,
69. Al-Juwaiser A, Abdulla MA & Al-Shoumer KAS. Fine needle aspiration biopsy of the
thyroid gland in Mubarak Al-Kabeer Hospital. Fourth Health Sciences Poster day, Faculty of
Medicine, Kuwait University, Kuwait, April 25, 1999, Conference Programme and abstract Book
(page 135).
70. Al-Shoumer KAS & Vasanthy BK. Reduced leptin concentration in women with hirsutism.
81st Annual Meeting of the American Endocrine Society: San Diego, California, held on 12-15
June 1999. Conference Programme and Abstract Book (P1-449, page 230).
71. Al-Shoumer KAS, Al-Zaid MM & Vasanthy BK.(1999) Leptin levels in Arab women with
hirsutism and its metabolic correlations. Journal of Endocrinology ; 163 (Suppl): P67.
72. Al-Shoumer KAS, Vasanthy BK & Al-Zaid MM. Effects of antithyroid therapy on
biochemical markers of bone turnover in primary hyperthyroidism. Fifth Health Sciences Poster
day, Faculty of Medicine, Kuwait University, Kuwait, April 24, 2000, Conference Programme
and abstract Book (page 63).
73. Al-Shoumer KAS, Vasanthy BK, Shalabi FM, Makhlouf HA & Al-Zaid MM.
Hyperproinsulin-aemia and insulin resistance in primary hyperthyroidism. Fifth Health Sciences
Poster day, Faculty of Medicine, Kuwait University, Kuwait, April 24, 2000, Conference
Programme and abstract Book (page 64).
74. Al-Shoumer KAS, Al-Assoussi A & Doi S. (2000) Variations in leptin concentrations in type
2 diabetes in Arabs. Diabetes, 49 (Suppl 1): 1424-PO, page A340.
75. Al-Shoumer KAS , Vasanthy BK & Al-Zaid MM. Effects of hyperthyroidism on glucose
homeostasis, insulin secretion and markers of bone turnover. 82nd Annual Meeting of the
American Endocrine Society: Toronto, Canada, held on 21-24 June 2000. Conference Programme
and Abstract Book (2429, page 587-8).
76. Al-Shoumer KAS, Vasanthy BK, Al-Assoussi A & Doi A (2000) Leptin level in Arabs with
type 2 diabetes (Second Pan-Arab Congress of Diabetes and Endocrinology and The 10th
International Clinical Genetics Seminar, October 20-24, 2000, OP-61, page 87).
77. Al-Shoumer KAS , Vasanthy BK & Al-Zaid MM. Glucose homeostasis and bone
metabolism in hyperthyroidism: Follow up after therapy. 11th International Congress of
Endocrinology. Australia, Sydney, held on 29 October-2 November 2000. Conference
Programme and Abstract Book (Abstract P764, page 285).
78. Al-Shoumer KAS, Doi SAR, Vasanthy BK & Al-Asoussi A. Bone metabolism in type 2
diabetes. Sixth Health Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait,
12
79. Al-Shoumer KAS, Vasanthy BA & Akanji A. Lipoprotein (a) in hyperthyroidism: effects of
medical therapy. Sixth Health Sciences Poster day, Faculty of Medicine, Kuwait University,
Kuwait, April 23, 2001, Conference Programme and abstract Book (page 71).
80. Ghanem H, El-Meliegy A, Mansi M, Younis N, Al-Shoumer K, Al-Rubaei S & Merhej S.
(2001) Hormone replacement therapy for PADAM: Outcome and safety (Middle East Multicenter
Trial), The Journal of Andrology, May/June Sup, P5/6-073, page 172.
81. Al-Shoumer KAS , Doi SA & Vasanthy BK. (2001) Markers of bone turnover and
longstanding type 2 diabetes in Kuwait. 83rd Annual Meeting of the American Endocrine
Society: Denver, USA, held on 20-23 June 2001. Conference Programme and Abstract Book (P376, page 465).
82. Al-Shoumer KAS, Vasanthy BK, Shalabi FM & Al-Zaid MM. Bone metabolism in hirsute
women. Seventh Health Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait,
83. Al-Shoumer KAS, Vasanthy BK & Al-Zaid MM. Sreum interleukin-6 (IL-6) and soluble
interleukin-6 Receptor (sIL-6) in hyperthyroidism due to Graves disease: effects of medical
therapy. Seventh Health Sciences Poster day, Faculty of Medicine, Kuwait University, Kuwait,
84. Al-Shoumer KAS, Vasanthy BK, Shalabi FM & Al-Zaid MM. (2002) Markers of bone
metabolism in hirsute women. 84th Annual Meeting of the American Endocrine Society: San
Francisco, USA, held on 19-22 June 2002. Conference Programme and Abstract Book (P2-630,
page 467-8).
85. Al-Shoumer KAS, Vasanthy BK, Al-Zaid MM. Human Chromogranin A (CgA) in patients
with hyperthyroidism, Eighth Annual Health Sciences Poster Day 2003, P. 71
86. Al-Shoumer KAS, Vasanthy BK. Leptin and metabolic variables in Arab patients with type 2
diabetes in a University teaching hospital in Kuwait. 2003 Syllabus AACE 14-18th May, San
Diego, Abs # 77, P. 318-319.
87. Johnston, DG, Kearney T, Robinson S, Venkatesan S, Chrisoulidou A, Bannister P,
Anayaoku V, Parker K, Beshyah S, Al-Shoumer KAS (2003) Hypopituitarism and
atherosclerosis. 85th Annual Meeting of the American Endocrine Society: Philadelphia, USA,
held on 19-22 June 2003. Conference Programme and Abstract Book (S29-1).
88. AL-Qudaiby MM, Doi SAR, Al-Shoumer KAS. Reversible renal dys function in immune
thrombocytopenic diabetic patient induced by Intravenous Immunoglobulin (IVIG). Ninth
Annual Health Sciences Poster Conference, Faculty of Medicine, Kuwait University, Kuwait,
April 19-21, 2004, Conference Programme and abstract Book (page 75).
89. Naddaf S , Anim H, Farghaly M, Behbehani AM, Al-Shoumer KAS, Collier D, Elgazzar A.
Ultrastructure Of Hyperfunctioning Parathyroid Glands: Does It Explain Various Patterns Of
Sestamibi Uptake? Ninth Annual Health Sciences Poster Conference, Faculty of Medicine,
Kuwait University, Kuwait, April 19-21, 2004, Conference Programme and abstract Book (page
61).
90. Girgis M.,Chadha G., Doi SAR, Al Shoumer KAS, Al Shammari S. Kearns Sayre Syndrome
in a young Kuwaiti male-A case report. Ninth Annual Health Sciences Poster Conference, Faculty
of Medicine, Kuwait University, Kuwait, April 19-21, 2004, Conference Programme and abstract
Book (page 82).
91. Doi SAR, Parappil A, Sheikha A, Al-Shoumer KAS. Redefining Optimal Glucose Cutoffs
In The Diagnosis Of Diabetes. Ninth Annual Health Sciences Poster Conference, Faculty of
13
Medicine, Kuwait University, Kuwait, April 19-21, 2004, Conference Programme and abstract
Book (page 79).
92. Lasheen I, Doi SAR, Al-Shoumer KAS, Al-Aqeel AAA. Glucocorticoid replacement in
panhypopituitarism complicated by myelinolysis: A Case Report. Ninth Annual Health Sciences
Poster Conference, Faculty of Medicine, Kuwait University, Kuwait, April 19-21, 2004,
93. Al-Shoumer K.A.S., Doi S.A.R., Abalkhail S, Nair V.S.Is osteoporosis common in Arab
women in Kuwait? Ninth Annual Health Sciences Poster Conference, Faculty of Medicine,
Kuwait University, Kuwait, April 19-21, 2004, Conference Programme and abstract Book (page
77).
94. Al-Shoumer KAS , Doi SAR & Vasanthy BK. (2004) Prevalence of low bone mass in Arab
women in the largest district area in Kuwait. 86th Annual Meeting of the American Endocrine
Society: New Orleans, USA, held on 16-19 June 2004. Conference Programme and Abstract
Book (P2-527).
95. Al-Shoumer K.A.S., Vasanthy BA, Al-Zaid M. New markers for disease activity in
hyperthyroidism. Tenth Annual Health Sciences Poster Conference, Faculty of Medicine, Kuwait
University, Kuwait, April 25-27, 2005, Conference Programme and abstract Book (page 95).
96. Doi SA, Al-Zaid M, Tower PA, Scott CJ, Al-Shoumer K.A.S. Pathophysiology of
neuroendocrine dysfunction in polycystic ovary syndrome. Tenth Annual Health Sciences Poster
Conference, Faculty of Medicine, Kuwait University, Kuwait, April 25-27, 2005, Conference
97. Al-Shoumer KAS , Vasanthy BA, Al-Zaid MM. (2005) New marker of disease activity in
hyperthyroidism: human chromogranin A (CgA). 87th Annual Meeting of the American
Endocrine Society: San Diego, USA, held on 4-7 June 2005. Conference Programme and
Abstract Book (P1-579).
98. Al-Shoumer K.A.S., Vasanthy BA, Doi SA, Abalkhail S, Al-Gudhaiby MM. Risk factors and
predictors of increased risk for type 2 diabetes in Arabs resident in Kuwait. Eleventh Annual
Health Sciences Poster Conference, Faculty of Medicine, Kuwait University, Kuwait, April 2426, 2006, Conference Programme and abstract Book (page 93).
99. Al-Shoumer K.A.S., Vasanthy BA, Doi SA. The relation between intact proinsulin and
adiponectin with insulin resistance. Eleventh Annual Health Sciences Poster Conference, Faculty
of Medicine, Kuwait University, Kuwait, April 24-26, 2006, Conference Programme and abstract
Book (page 96).
100. Al-Shoumer KAS , Vasanthy BA, Doi SA, Abalkhail S, Al-Gudhaiby MM (2006)
Cytokines and obesity-related hormones in Arabs with type 2 diabetes resident in Kuwait. 88th
Annual Meeting of the American Endocrine Society: Boston, USA, held on 24-27 June 2006.
Conference Programme and Abstract Book (P2-594).
101. Al-Shoumer K.A.S., Vasanthy BA, Doi SA. Abnormal cardiovascular risk profel in Arab
patients with polycystic ovary syndrome Twelvth Annual Health Sciences Poster Conference,
Faculty of Medicine, Kuwait University, Kuwait, April 24-26, 2007, Conference Programme and
abstract Book (page 96).
102. Al-Shoumer KAS , Vasanthy BA, Abalkhail S, Doi SA, Al-Gudhaiby MM (2007) Intact
proinsulin to adiponectin ratio is a strong predictor of insulin resistance in type 2 diabetes. 89th
Annual Meeting of the American Endocrine Society: Torronto, Canada, held on 24-27 June 2007.
14
103. Al-Shoumer K.A.S., Vasanthy BA, Doi SA, Abalkhail S, Hafez MF. Spectrum of bone
mineral density in Arab women resident in Kuwait. Thirteenth Annual Health Sciences Poster
Conference, Faculty of Medicine, Kuwait University, Kuwait, April 24-26, 2008, Conference
104. Al-Shoumer KAS , Vasanthy BA, Doi SA, Abalkhail S, Al-Gudhaiby MM, Hafez MF
(2008) Arab women with polycystic ovary syndrome: cardiovascular risk profile. 90th Annual
Meeting of the American Endocrine Society: San Francisco, USA, held on 15-18 June 2008.
105. Abalkhail S., Hilali N., Al-Kandari N., Doi SA, Al-Duaij S, Hafez MF, Nair VS, Ali AH,
Al-Shoumer K.A.S. Oscillations on osteocalcin levels in uremic patients Maintained on regular
hemodialysis. 14Th Annual Health Sciences Poster Conference, Faculty of Medicine, Kuwait
University, Kuwait, April 21-23, 2009, Conference Programme and abstract Book (page 72).
106. Al-Otaibi FK, Al-Bader MD, Al-Shoumer K.A.S, Al-Yatama FI. The effect of clothing and
cultural practice on bone mineral density (BMD) in Kuwaiti pre-menopausal women. 14Th
Annual Health Sciences Poster Conference, Faculty of Medicine, Kuwait University, Kuwait,
April 21-23, 2009, Conference Programme and abstract Book (page 183).
107. Al-Shoumer KAS & Vasanthy BA. (2009) Low bone mass is prevalent in young Arab
women resident at Kuwait. 91ST Annual Meeting of the American Endocrine Society:
Washington DC, USA, held on 10-13 June 2009. Conference Programme and Abstract Book (P2237).
108. Al-Shoumer K.A.S., Nair VS, Ali AH, Haider MZ. Genotyping of non-classical congenital
adrenal hyperplasia (NCCAH) in a subgroup of Kuwaiti females. 15th Annual Health Sciences
Poster Conference, Faculty of Medicine, Kuwait University, Kuwait, April 20-22, 2010,
109. Al-Shoumer K.A.S., Nair VS, Ali AH. Genetic Assessment of a Subgroup of Kuwaiti
Females with Non-Classical Congenital Adrenal Hyperplasia (NCCAH). Endocrine
Reviews, Supplement 1, June 2010, 31[3]: S733.
110. Al-Shoumer K.A.S., Nair VS, Ali AH. Vitamin D levels in Kuwaiti subjects with type 2
diabetes. 16th Annual Health Sciences Poster Conference, Faculty of Medicine, Kuwait
University, Kuwait, May 3-5, 2011, Conference Programme and abstract Book (page 68).
111. Al-Shoumer K.A.S., Nair VS, Abalkhail S. Changes in acid-labile subunit and insulinlike growth factor 1 in hyperthyroidism after medical treatment. 93rd Annual Meeting of the
American Endocrine Society: Boston, USA, held on 4-7 June 2011. Conference Programme and
Abstract Book (P3-593, P. 197)
112. Ali A.H., Nair V.S. and Al-Shoumer K.A.S. Effects of lifestyle and environmental factors
on bone mineral density in healthy Kuwaiti females. 17th Annual Health Sciences Poster
Conference, Faculty of Medicine, Kuwait University, Kuwait, May 8-10, 2012, Conference
113. Al-Shoumer K.A.S., Nair VS, Ali A.H. Does Insulin Resistant Type 2 Diabetes Alter
Vitamin D Status. 94th Annual Meeting of the American Endocrine Society: Houston, USA, held
on 23-26 June 2012. Conference Programme and Abstract Book (Mon-369. P. 166))
ORAL PRESENTATIONS:
I. INTERNATIONAL CONFERENCE & INVITED SPEAKER (Presented & published)
15
114. Al-Shoumer KAS, Niththyanathan R & Johnston DG. (1994) Profiles of intermediary
metabolites in hypopituitary adults on conventional replacement therapy. Journal of
Endocrinology; 143 (Suppl.): O31 (London, 23-25 November, 185th Meeting of the Society for
Endocrinology).
115. Al-Shoumer KAS, Hughes C, Richmond W, Beshyah S & Johnston DG. (1995) Beneficial
changes in plasma lipids, lipoproteins and apolipoproteins in hypopituitary adults (HPA) after 4
years of growth hormone (GH) replacement therapy. Journal of Endocrinology ; 147 (Suppl.):
O47 (London, 22-23 November, 186th Meeting of the Society for Endocrinology).
116. Al-Shoumer KAS, Anyaoku V & Johnston DG. (1996) Serum leptin and its anthropometric,
gender and metabolic relations in hypopituitary adults with growth hormone (GH) deficiency.
Journal of Endocrinology; 151 (Suppl.): O11 (London, 26-28 November, 187th Meeting of the
Society for Endocrinology).
117. Al-Shoumer KAS, Kousta E, Richmond W & Johnston DG. (1997) Increased prevalence of
abnormal fasting lipids and lipoproteins in growth hormone (GH) deficient hypopituitary adults.
Endocrinology and Metabolism ; 4 (Suppl. B), P. A3, page 157 (Berlin, Germany).
118. Al-Shoumer KAS, Al-Zaid MM & Vasanthy BK. (1999) Changes in leptin values in Arabs
with hirsutism: Mubarak Al-Kabeer University teaching hospital experience in Kuwait.(First PanArab Congress of Endocrinology and Metabolic Diseases, October 20-23, 1999, OPS 10).
119. Al-Shoumer KAS, Vasanthy BK, Al-Assoussi A & Doi A (2000) Leptin level in Arabs
with type 2 diabetes (Second Pan-Arab Congress of Diabetes and Endocrinology and The 10th
International Clinical Genetics Seminar, October 20-24, 2000, Amman, Jordan, OP-61, page 87).
120. Al-Shoumer KAS, Doi SAR & Al-Assousi A (2001). Markers of bone turnover and
metabolic abnormalities in type 2 diabetes in Kuwait. Conference of Diabetes in The Arab World,
24-26th March 2001, Bahrain, Oral presentation, Abstract book page 55.
121. Al-Shoumer KAS , Doi SA & Vasanthy BK. (2001) Bone metabolism in Arab with type 2
diabetes mellitus. Third Pan Arab Congress on Edocrinology and Diabetes 25-28 October 2001,
Damascus. OP. 83 page 103
II. AS AN INTERNATIONAL INVITED SPEAKER
122. Al-Shoumer KAS. (2001) Syndrome X : the clinical presentation of insulin resistance. 5Th
Pan Arab Conference On Diabetes, 27-30 March 2001, Cairo, Egypt, OPII 005.
123. Al-Shoumer KAS (2001) Dysleptinemia in endocrinology and Metabolism. Third Pan Arab
Congress on Edocrinology and Diabetes 25-28 October 2001, Damascus. Plennary talk, page 6
124. Al-Shoumer KAS (2002) The role of endocrine and metabolic disorders in the outcome of
pregnancy and fertility. International Symposium: Recent advances in the management of
infertility. March 9-11 2002, Kuwait Absract book page 34-35.
125. Al-Shoumer KAS (2002) Is diabetes mellitus associated with osteoporosis. 6Th Pan Arab
Conference on Diabetes. March 26-29, 2002, Cairo, Egypt.
126. Al-Shoumer KAS (2002) Subclinical thyroid diseases. Fourth Pan Arab Congress on
Endocrinology and Diabetes 23-26 October 2002, Tunisia. Plennary talk, Symposium on thyroid.
127. Al-Shoumer KAS (2004) Chronic complications of Diabetes mellitus (cardiovascular
disease). Fifth Pan Arab Congress on Endocrinology and Diabetes 28 Feb. to 2nd March 2004,
Riyadh. Main session talk.
16
128. Al-Shoumer KAS (2005) Adult hypopituitarism and growth hormone deficiency. The 1st
Jordanian Congress of Endocrinology, Diabetes & Metabolic Diseases, Amman 12-14 April, P.
21
129. Al-Shoumer KAS (2005) Leptinology and endocrinology. The 1st Jordanian Congress of
Endocrinology, Diabetes & Metabolic Diseases, Amman 12-14 April, P. 32.
130. Al-Shoumer KAS (2005) Overview of osteoporosis. The 1st Jordanian Congress of
Endocrinology, Diabetes & Metabolic Diseases, Amman 12-14 April, P. 26
131. Al-Shoumer KAS (2005) The Syndrome of adult GH deficiency: Clinical implications. The
2nd International conference of Endocrinology & Diabetes , Jeddah 11-12 April, P. 21
132. Al-Shoumer KAS (2005) Obesity and diabetes mellitus. The 14nd Annual scientific Meeting
of the Syrian Diabetes Association, Lattakia- Syria 10-12 November
133. Al-Shoumer KAS (2006) Adrenal incidentaloma. Seventh Pan Arab Congress on
Endocrinology and Diabetes 4-7 May 2006, Rabat- Morocco. Main session talk.
134. Al-Shoumer KAS (2008) Obesity, DM & ED. Second AACE/ESEO meeting in Alexandria,
23rd to 25th of April, 2008.
135. Al-Shoumer KAS (2009) Epidemiology of thyroid diseases. Merck Serono 's 1st
International Forum on Thyroid disorders in the Middle East. - Dubai, U.A.E. - 19-20 February
2009
136. Al-Shoumer KAS (2010) Initiation and adjustments of lanreotide autogel therapy in
acromegaly: case-based examples from Kuwait. In Symposium: Novel treatment in the
management of acromegaly. Ritz carlton, Istanbul-Turkey, March 18th 2010.
137. Al-Shoumer KAS (2011) Challenges in the management of acromegaly. In Symposium:
Therapeutic strategies in growth hormone secreting adenoma. Dubai UAE, 16-18th March
2011
II. LOCAL CONFERENCE LECTURES PRESENTATIONS (invited speaker):
1. Growth hormone in IDDM adolescents in Update in Diabetes, 17-19 November 1997,
Faculty of Medicine - KIMS.
2. Thyroid diseases in adult clinical practice in Workshop on Thyroid Diseases, 13-16 June
1998, Faculty of Laboratory Medicine - KIMS.
3. Secondary dyslipidaemia-Thyroid disease in Workshop on Disorders of Lipid Metabolism,
3-5 May 1999, Faculty of Laboratory Medicine - KIMS.
4. Leptin and endocrine disorders in Update in Endocrinology and Metabolism (UEM), 1-4
November 1999, Faculty of Medicine, Kuwait.
5. Fitness to work for Diabetes mellitus in Symposium of fitness to work in Kuwait, 22-26
April, 2000, Kuwait Medical Association, Kuwait.
6. Evaluation of a patient with a thyroid nodule in Update in Endocrinology and Metabolism, 78th April 2001, CME activity, Faculty of Medicine, Kuwait.
7. Primary amenorrhea in Training progromme For Obst & Gynecology, 7-11th April 2001,
Kuwait Medical Association, Kuwait.
8. Association between diabetes mellitus and osteoporosis Update in Endocrinology and
Metabolism, 1-2 April 2002, Faculty of Medicine, Kuwait
9. Subclinical thyroid disease. Update in Endocrinology and metabolism, 26-27th April 2003.
Faculty of Medicine, Kuwait
17
10. Controversial aspects of GH therapy in adults. Update on Growth Hormone therapy. 14-15
Feb. 2004, Kuwait Medical Association.
11. Solitary thyroid nodule: clinical approach in Workshop on Thyroid Diseases, 9th Feb 2005,
Faculty of Laboratory Medicine - KIMS.
12. DM, obesity and erectile dysfunction in 2nd Diabetic workshop of Sheikh Nasser Alsabah
Medicak health Center. 2-3rd April 2005.
13. Definition and diagnosis of osteoporosis. Update in Endocrinology and metabolism:
workshop on osteoporosis, 4th April 2005. Faculty of Medicine, Kuwait
14. New modalities of treatment for osteoporosis. Update in Endocrinology and metabolism:
workshop on osteoporosis, 5th April 2005. Faculty of Medicine, Kuwait
15. Andropause. The first Amiri Endocrinology Conference Obesity-Endocrine problems after
5th decade 18-19 April 2005
16. Osteoporosis. Workshop on women health, Ministry of Health, 2-4th May 2005, Kuwait.
17. Evaluation and preoperative assessment of adrenal masses. 1st Update in Urologic
laparoscopy. 14th 15th May 2005
18. Definition of insulin resistance. Update in Endocrinology and metabolism: Insulin resistance
syndrome: the endocrine perspective, 17th April 2006. Faculty of Medicine, Kuwait
19. Leo Pharma meeting. Falls and Fractures in Osteoporosis: Osteoporosis overview, Radisson
SAS Hotel, Kuwait 7 June 2006. Speaker and chairman of session.
20. Chairman of symposium Testosterone administration: new androgel preparations. Dec.
2008, Crown Plaza Hotel, Kuwait.
21. Chairman of workshop: Plain Vitamin D or its active analogue in osteoporosis, 12 Jan.
2009, Radissons SAS Kuwait.
22. Update on metabolic syndrome. Lecture: Adipocytokines. 29-30 April 2009, Faculty of
Medicine, Kuwait.
23. Update in Mens Health. Lecture: Male Menopause. 23-24 April 2011, Movenpick Hotel %
Resort Al-Bida, Kuwait
III. EDUCATIONAL LECTURES TO MEDICAL SUBSPECIALITIES:
1. Endocrine emergencies in the programmed schedule to emergency medicine in Mubarak AlKabeer Hospital, 26th April 1997, Mubarak Al-Kabeer Hospital, Kuwait.
2. Management of diabetic Ketoacidosis and hyperosmolar coma in the programmed schedule
to emergency medicine in Mubarak Al-Kabeer Hospital, 15th Dec. 1997, Mubarak Al-Kabeer
Hospital, Kuwait.
3. Hirsutism and polycystic ovary syndrome in Programmed polyclinic activities, 26th May
1999, Salmiyah specialized centre, Hawalli area, Kuwait.
4. Presentation of monthly endocrine talks in department of medicine at Mubarak Al-Kabeer
Hospital to other subspecialities
5. Polycystic ovary syndrome in training programme for Salmiya speciality center, 27th May
2001, Kuwait.
6. Osteoporosis Symposium for Primary care physicians, Overview on osteoporosis and the
relations with diabetes. 12th April 2004. Kuwait Medical Association.
7. Diabetes mellitus, obesity and erectile dysfunction in 2nd Diabetic Workshop: diabetes and
ED, 2-3 April 2005, KMA
18
8. Update on the current Treatment of Vitamin D deficiency: Tuesday 16th March 2010, Hisham
Al-Obaidan meeting room, Mubarak Al-Kabeer Hospital, Kuwait
9. Update on osteoporosis to orthopaedic surgeons. Al-Razi Orthopedic Hospital, 27 Jan 2011,
Kuwait.
RESEARCH
1.Cardiovascular risk factors in hypopituitarism (1992-1995) at St. Marys Hospital, London
2. Research grant (MM041, Kuwait University 1999) Metabolic abnormalities in patients with
primary hyperthyroidisim Completed Sept. 2000, Kuwait
3. Hirsutism in Arab populations : intermediary metabolites and obesity related-factors
(completed 2002), Kuwait.
4. Pattern of behaviour of type 2 Diabetes Mellitus in Kuwait in relation to pathogenesis
(completed 2004), Kuwait.
5. Correlation between histopathological and clinical diagnosis in hyperparathyroidism (Kuwait
University granted, MN01/01)
6. Prevalence of low bone mass in Kuwait (ongoing)
7. Bone mineral density in patients with rheumatoid arthritis at various disease activity
8. Bone metabolism in patients with Multiple sclerosis
ATTENDED POSTGRADUATE COURSES & SYMPOSIA-CONFERENCES

1. Section of Measurements in Medicine Arterial wall changes using high resolution ultrasound
: A risk factor or screening test. The Royal Society of Medicine, London. 11 Oct. 1993.
2. Postgraduate Education Course in Endocrinology and Diabetes, St. Marys Hospital, London.
24 Feb. 1994.
3. Postgraduate training course in Endocrinology. Society for Endocrinology/ Royal Society of
Medicine Endocrine Section/ British Diabetic Association. St. Marys Hospital Medical School,
London W2 6th-7th July 1994.
4. Cardiovascular Disease Prevention II. Kensington Town Hall, London 19th - 22nd July 1994.
5. Forum on lipids in Clinical Medicine : Diabetes lipids and atherosclerosis . Royal society of
Medicine; London 27 Oct. 1994.
6. International Symposium : A new look at insulin resistance in type 1 diabetes. St.
Bartholomews Hospital Medical College, London 14th July 1995.
7. Update in Diabetes. Faculty of Medicine - Kuwait University. Kuwait, 17-19 November 1997.
8. Polycystic Ovary Syndrome: Metabolic challenges and New Treatment Options. New
Orleans, Louisiana, June 23rd, 1998.
9. Growth hormone deficiency across the lifespan. New Orleans, Louisiana, June 24rd, 1998.
10. Osteoporosis: A call for action. Jumeira Beach Hotel, Dubai; 26-27 February 1998.
11. 189Th Meeting of the British Society for Endocrinology, London 23-24 November 1998.
12. 2ND Meeting of the British Thyroid Association, St. Thomas Hospital, London 25
November 1998.
13. The first Gulf Osteoporosis Conference. Al-Bustan Palace Hotel, Muscat, Sultanate of Oman,
20-23 March 1999.
14. The first GCC Conference of Faculties of Medicine: Medical Education in GCC Countries.
Faculty of Medicine, Health Science Centre-Kuwait University, Kuwait, 26-28 April 1999.
19
15. Evista Global Medical conference & 21st Annual Meeting of the American Society for Bone
and Mineral Research. Indianapolis/St. Louis, Sept. 27 - October 4, 1999.
16. 81ST Annual Meeting of the American Endocrine Society, San Diego, California 12-15 June
1999.
17. The 2nd World Congress on The Aging Male, Geneva, Switzerland, February 9-13, 2000.
18. 82nd Annual Meeting of the American Endocrine Society, Toronto, Canada 21-24 June 2000
19. 11th International Congress of Endocrinology, Sydney, Australia 29th Oct -2nd Nov. 2000.
20. VIIth International Congress of Andrology, Montreal, Canada, 15-19th June 2001.
21. 83rd Annual Meeting of the American Endocrine Society, Denver, USA 20-23 June 2001
22. Symposium of Treating to target in type 2 diabetes mellitus, Prague, Czech Republic May 558th, 2002.
23. 84th Annual Meeting of the American Endocrine Society, San francisco, USA 19-22 June
2002
24. Thyroid Ultrasound Accreditation Course, Washington DC, USA 24-25 August 2002
25. Obesity Workshop: Reductil Medical Education Programme 23 July 2003, Cairo, Egypt
26. 18th International Diabetes Federation Congress, August 24-29, 2003, Paris, France.
27. Diabetes Regional Experts Avandia Meeting (DREAM). Athenes, September 20-21. 2003
28. Bone mineral density certification course. Amman Dec 18th 2003.
29. Osteoporosis and needs for action. Rome 15th march 2004.
30. Therapeutic Innovation in the osteoporosis field. El Gouna, Red Sea, Egypt, April 23-24,
2004.
31. 86th Annual Meeting of the American Endocrine Society, New Orleans, USA 16-19 June
2004.
32. 40Th Annual Meeting of the European Association for the Study of Diabetes, 5-9 September
2004, Munich, Germany
33. Intensive Pediatric Workshop on Insulin Pump Therapy & CGMS. Kuwait SAS, 24
September 2004.
34. The first International GGSD Conference. Dubai 13-15th Feb. 2005
35. Six Pan Arab Congress of Endocrinology & Diabetes, Alexandria 2-4 th March 2005
36. Advancing to new levels in osteoporosis management, Rome March 13th 2005
37. 87th Annual Meeting of the American Endocrine Society, San diego, USA 4-7 June 2005.
38. The 14th Annual scientific Meeting of the Syrian Diabetes Association, Lattakia- Syria 10-12
November 2005.
39. Conference:New approach for the treatment of postmenopausal osteoporosis, Cairo-Egypt 89 Dec. 2005
40. Sixth European Congress on Clinical and Economic Aspects of Osteoporosis and
Osteoarthritis. Vienna, Austria 15-18th March 2006.
41. Seventh Pan Arab Congress of Endocrinology & Diabetes, Rabat- Morroco 4-7th May 2006.
42. Leo Pharma meeting. Falls and Fractures in Osteoporosis, Radisson SAS Hotel, Kuwait 7
June 2006
43. 88th Annual Meeting of the American Endocrine Society, Boston, USA 24-27 June 2006.
44. 89th Annual Meeting of the American Endocrine Society, Toronto, Canada 24-27 June 2007.
45. 90th Annual Meeting of the American Endocrine Society, San Francisco USA 15-18th June
2008.
20
46. 91st Annual Meeting of the American Endocrine Society, Washington DC, USA 10-13th June
2009.
47. The 3rd International Conference of Gulf Group for the Study of Diabetes (GGSD), 9-11 Feb.
2010, Jeddah, KSA, Invited as Chairperson, session II first day.
48. 92nd Annual Meeting of the American Endocrine Society, San Diego, USA 19-22 June 2010.
49. 93rd Annual Meeting of the American Endocrine Society, Boston, USA 4-7 June 2011.
50. ASBMR 2011 Annual Meeting of the Society for Bone and Mineral Research. San Diego
USA, September 16 - 20, 2011
51. 93rd Annual Meeting of the American Endocrine Society, Houston, USA 23-26 June 2012.
52. 2012 Pituitary Masterclass meeting. Massachusetts General Hospital at Boston, USA. 28th
June to 1st July 2012.
SOME OF THE CITATIONS:

1. Al-Shoumer KAS, Ali K, Anyaoku V, Niththyananthan R & Johnston DG. (1996) Overnight
metabolic fuel deficiency in patients treated conventionally for hypopituitarism. Clinical
Endocrinology; 45, 171-178.
2. Al-Shoumer KAS, Page B, Thomas E, Murphy M, Beshyah SA & Johnston DG. (1996) Effects
of four years treatment with biosynthetic human growth hormone (GH) on body composition in
GH-deficient hypopituitary adults. European Journal of Endocrinology ; 135: 559-567.
3. Al-Shoumer KAS, Kousta E, Beshyah S & Johnston DG. Growth hormone (GH) deficiency Does it cause atherosclerosis ? In Proceedings of 3rd International hGH Symposium on GHD in
adults (1996) (ed. JS Christiansen, JOL Jrgensen, AVZ Mhlen & W Waldhusl), pp. 20-25,
Medical Forum International, The Netherlands.
4. Peacey SR, Guo C-Y, Robinson AM, Price A, Giles MA, Eastell R & Weetman (1997)
Glucocorticoid replacement therapy: are patients over treated and does it matter? Clinical
Endocrinology 46, 255-261.
5. Monson JP (1997) The assessment of glucocorticoid replacement therapy. Clinical
Endocrinolgy 46, 269-270.
6. Al-Shoumer KAS, Cox K, Hughes C, Richmond W & Johnston DG. (1997) Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
Journal of Clinical Endocrinology and Metabolism ; 82: 2653-2659.
7. Al-Shoumer KAS, Anyaoku V, Ali K & Johnston DG. (1997) Metabolic effects of short-term
reproduction of the normal diurnal cortisol rhythm in hypopituitary adults. Endocrinology &
Metabolism ; 4: 207-214.
8. Al-Shoumer KAS, Anyaoku V, Richmond W & Johnston DG.(1997) Elevated leptin
concentrations in growth hormone-deficient hypopituitary adults. Clinical Endocrinology; 47:
153-159.
Interactions of cortisol and growth hormone replacement: intermediary metabolism. In The
diagnosis and treatment of pituitary insufficiency (1997) (ed.SWJ Lamberts), pp. 63-77.
BioScientifica Ltd, Bristol.
10. Kousta E, Chrisoulidou A, Lawrence N J, Al-Shoumer KAS, Parker KH, McCarthy MI &
Johnston DG. (1998) The circadian rhythm of leptin is preserved in growth hormone deficient
hypopituitary adults.Clinical Endocrinology; 48, 685-690.
21
Growth hormone replacement in young adults: if and when to continue?. In Adolescent
Endocrinology (1998) (ed.R Stanhope), pp. 17-23. BioScientifica Ltd, Bristol.
12. Pancreatic & Salivary secretion in Current Awareness in Biomedicine (1998) Vol 20 (15), 18.
13. Evans LM, Davies JS, Goodfellow J, Rees JAE & Scanlon. (1999) Endocthelial dysfunction
in hypopituitary adults with growth hormone deficiency. Clinical Endocrinology 50, 457-464.
14. Al-Shoumer KAS, Gray R, Anyaoku V, Hughes C, Beshyah SA, Richmond W & Johnston
DG. (1998) Effects of four years treatment with biosynthetic human growth hormone (GH) on
glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clinical
Endocrinology, 48, 795-802.
15. Gill MS, Toogood AA, Jones J, Clayton PE & Shalet SM. (1999) Serum leptin response to
acute and chronic administration of growth hoemone (GH) to elderly subjects with GH
deficiency. Journal of Clinical Endocrinology and Metabolism 84, 1288-1295.
16. Rodriguez-Arnao J, Jabbar A, Fulchert K, Besser GM & Ross RJM. (1999) Effects of growth
hormone replacement on physical performance and body composition in GH deficient adults.
Clinical Endocrinology 51, 53-60.
17. Leonssson M, Oscarsson J, Bosaeus I, Lundgren BK, Johannsson G, Wiklund O & Bentgsson
B-A. (1999) Growth hormone (GH) therapy in GH-deficient adults influences the response to
dietary load of cholesterol and saturated fat in terms of cholesterol synthesis, but not serum low
density lipoprotein cholesterol levels. Journal of Clinical Endocrinology and Metabolism 84,
1296-1303.
18. Peacey SR, Guo CY, Eastell R & Weetman AP. (1999) Optimization of glucocorticoid
replacement therapy: the long-term effect on bone mineral density. Clinical Endocrinology 50,
815-819.
19. Abs R, Bentgtsson B-A, Hernberg-Stahl E et al (1999) GH replacement in 1034 growth
hormone deficient hypopituitwry adults: demographic and clinical characteristics, dosing and
safety. Clinical Endocrinology 50, 703-713.
20. Barretto ES, Gill MS, de Freitas MES et al (1999) Serum leptin and body composition in
children with familial GH deficiency (GHD) due to a mutation in the growth-hormone-releasing
hormone (GHRH) receptor. Clinical Endocrinology 51, 559-564.
21. Brennan BMD, Rahim A, Blum WF, Adams JA, Eden OB & Shalet SM (1999)
Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone
deficiency or leptin insensitivity. Clinical Endocrinology 50, 163-169.
22. Beshyah SA & Desmond Johnston (1999) Cardiovascular disease and risk factors in adults
with hypopituitarism. Clinical Endocrinology 50, 1-15.
23. Johnston DG, Al-Shoumer KAS, Chrisoulidou A, Kousta E, Beshyah S and Robinson S.
(1999). Long-term effects of GH therapy on intermediary metabolism and insulin sensitivity in
hypopituitary adults. Journal of Endocrinological Investigation , 22, 37-40.
24. ONeal DN, Hew FL, Best JD & Alford F. (1999) The effect of 24 months recombinant
human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in
hypopituitary adults previously treated with conventional replacement therapy. Growth Hormone
& IGF Research 9, 165-173.
22
(2000) The effects of growth hormone replacement therapy on overnight metabolic fuels in
hypopituitary patients.Clinical Endocrinology 52, 17-24
26. Damjanovic SS, Petakov MS, Raicevic S, Micic D, Marinkovic J, Diegues C, Casanueva FF
& Popovic V (2000) Serum leptin in patients with acromegaly before and after correction of
hypersomatotropism by transsphenidal surgery. Journal of Clinical Endocrinology and
Metabolism 85, 147-154.
27. Abdu TAM, Neary R, Elhadd TA, Akbaer M & Clayton RN (2001) Coronory risk in growth
hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile
abnormalities. Clinical Endocrinology 55, 209-216.
28. French human growth hormone recepients. (1999) American J Epidemiology 147, 597-604
29. Hawkins EP (1999) Nutrients in the news - human growth hormone. Natural Pharmacy
30. Kuhnel W (1997) Leptin - Neue Mglichkeiten in Diagnostik und Therapie. Med Research
Review 17 (3), 225-234.
31. Braught L. Liquid mineral fortified HGH: A tremendous advancement in anti-aging.
Published by Reality Health Research.
32. Jeffcoate W (1999) Assessment of corticosteroid replacement therapy in adults with adrenal
insufficiency. Ann Clin Biochem 36, 151-157.
33. Vance M L, Mauras N (1999) Growth hormone therapy in adults and children. The New
England Journal of Medicine 341 916), 1206-1216.
34. Pfeifer M (2001) Syndrome of growth hormone deficiency in adults: effects of growth
hormone replacement therapy. Zdrav Vestn 70, 296-299.
35. Sulaiman AM, Freaney R, Smith TP, McBrinn Y, Murray B, Mckenna TJ (2003) The impact
of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in
patients with adrenal insufficisncy. Clinical Endocrinology 59, 380-387.
TEACHING ACTIVITIES:
1. Undergraduate teaching:
A. Faculty of Medicine:
1. Full teaching load consisting of Formal lectures, seminars, case discussions, tutorials and
bedside teaching. This comes to approximately over 120 hours per year as follows:
- Participation in lecturing for the Endocrinology system course teaching for BSc
students at St. Marys Hospital (1994-1996, didactic 3 hours per course, # of
students=70 per yr)
- Teaching in the theory Endocrinology system course for the fifth year students
(1997-) (12 hrs didactic per course of 36 hours over 4 weeks every year, # of
students=72-94 per yr)
- Bedside clinical teaching for fifth year clinical students in Mubarak Hospital (1997-)
(2 hours per week over 36 weeks every year, # of students=72-93 per yr divided
into groups, each of 6 students)
- Bedside clinical teaching for seventh year clinical students in Mubarak Hospital (1997-)
(2 hours alternating with 3 hours per week over 36 weeks every year, # of
students=48 per yr, divided into groups, each of 4 students)
- Preparation and execution of examination for undergraduates (1997-)
B. Faculty of Pharmacy:
23
- Teaching the third year students in the Pathophysiology course No. 332 (1999-)
(2 hours per course every year, # of students=40 per yr)
C. Ministry of Health : To paramedics:
- Teaching of basic handling, investigation and treatment of endocrine disorders
- Legislation and formation of standard protocols for dynamic tests in endocrinology
2. Postgraduate Teaching:
- Member, Faculty of Medicine, Kuwait Institute for Medical Specializations (KIMS)
- KIMS, Postgraduate training program in Medicine - program (PGTP) coordinator for
Mubarak Al-Kabeer Hospital (2000-2004)
- Teaching of candidates to MRCP part I (November 1997)
- Clinical session teaching for PGTP and MRCPII candidates in Mubarak AlKabeer Hospital
- Journal Club Teaching to PGTP candidates in Mubarak Al-Kabeer Hospital (1997-)
- Teaching in the program for postgraduates in Immunology in Faculty of
Medicine (1998-9)
- Teaching Residants in the board program for postgraduates in Nuclear Medicine
in Faculty of Medicine (2000-)
- Arrangement of educational sessions to members of endocrinology division
every fortnight
- Attendance, participation and presentations at intra and interdepartmental medical
clinical meetings and grand rounds accounting for approximately 120 hours per year
COMMUNIY& UNIVERSITY SERVICES:

A. University:
1. Member of Faculty of Medicine Research Committee (1998-2001).
2. Interview Committee of new applicants to Faculty of Medicine.
3. Health Sciences Poster Day Committee (1997 to 2003).
4. Establishment of endocrine laboratory in Faculty of Medicine.
6. Council member, University Recruitment committee for support academic staff (20042005-2006)
7- Member, University Committee for the study of merging colleges (2004-5)
B. Ministry of Health:
1. Major contribution in:
a. Establishment of endocrine division in Mubarak Al-Kabeer Hospital
b. Foundation of Dynamic testing service to endocrine patients in
Mubarak Al-Kabeer Hospital
c. Establishment of a regular service of Bone Mineral Density
assessment using Dual Energy x-ray absorptiometry (DEXA) in
Mubarak Al-Kabeer Hospital (1997-2002)
2. Supervision of training in endocrinology for postgraduates (residents and fellows) in
Ministry of Health.
3. Member, Interview committee for endocrinology applicants in the Ministry
24
4. Member, Diabetes Team: Committee for prevention and control of Diabetes mellitus
(1998-2003)
C. Societies:
International:
1. Collegiate member, Royal College of Physicians of London.
2. Member, Medical & Scientific section, British Diabetic Association (BDA).
3. Member, British Society for Endocrinology (BES).
4. Member, Growth Hormone Research Society (GRS).
5. Member, British Medical Association (BMA).
6. Member, American Endocrine Society.
7. Member, American Diabetes Association (ADA).
8. Member, New York Academy for Science.
9. Member, American Association of Clinical Endocrinologists (AACE).
10. Member, International Diabetes Federation (IDF).
11. President, Pan-Arab Society of Endocrinology and Diabetes (2007-to 2010)
Faculty of Medicine committees:
Faculty:
1. Member, of the organizing committee for the annual poster day in the Health
Sciences Center (1997 to 2004).
2. Member, the executive board of Medical Research Council (MRC) of the
Faculty (1998-2001).
4. Chairman, Committee for staff salary cadre recommendations (2005-6)
5. Chairman, Committee for space allocation in faculty of medicine (2005-6)
6. Chairman, Recruitment Committee for support academic staff at Faculty of Medicine
(2006 -2008)
Department of Medicine:
1. Member, of the departmental Research Committee (1997-1999).
2. Chief Coordinator, of departmental Research Committee (1999-2002)
3. Member, of departmental Postgraduate Committee (1999 to date).
4. Chief Coordinator, department Examination Committee (2002-2004)
D. Journals:
1. Referee of papers submitted to Kuwait Medical Association Journal (1997-todate)
2. Referee papers submitted to Annals of Saudi Medicine Journal (2001 to date)
3. Referee of papers submitted to MPP , Faculty of Medicine Journal (2000 to date)
4. Referee to Journal of Woman Health (2008-)
5. Referee to JCEM (2010 to date)
5. Co-editor of the 4th Health Science Center Poster day programme & abstract book.
6. Local Editorial Board (member), Kuwait Medical Journal (2000- to date)
7. Advisory Board member, Diabetes Care, Mediteranian issues
E. Other Community services:
1. Provision of health services to patients with endocrinological disorders
2. Educational television and radio programmes (more than 30 appearances) and
newspaper articles (more than 30 short and long topics).
25
3. Head of University Faculty Association mission to Saudi Arabia for Mekka (2325th Feb 2000)
F. Other Professional Achievements:
1. Evaluator of grants for projects to the Faculty of Medicine.
2. Referee to grants submitted to the Kuwait Foundation for the Advancement of
Sciences.
3. Coordinator & founding member of the thyroid disease study group - established in July
1997.
4. Coordinator of the Endocrinology system course to the 5th year students in the
Faculty of Medicine (1998 to 2011).
5. Member of the organizing committee for the Diabetes Update 17-19th November 1997.
6. Holder of an active licence for use of radioactive materials (1997 to date).
7. Holder of Full registration in the General Medical Council in London (1993 to date).
8. Holder of a certificate from the American College of Endocrinology on thyroid
Ulrasound Accreditated course
9. Chief Coordinator of Update on Endocrinology & Metabolism (UEM) in 1-4
November 1999.
10. Chief Coordinator of Update in Endocrinology and Metabolism CME in 7-8th
April 2001.
11. Member of Expert Panell of Middle East on Hormone Replacement Therapy
12. Listed in WhosWho in the World, 19th Edition 2002
13. Listed in WhosWho in Medicine and Healthcare 2002-2003
14. Invited as Conference Chairman, New approach for the treatment of postmenopausal
osteoporosis Cairo-Egypt 8-9th Dec. 2005.
15. Coordinator and team leader on the endocrine block for the curriculum reforms phase
II in the faculty of Medicine (2005 to date)
16. Invited as Chairperson, session II first day of the 3rd International Conference of Gulf
Group for the Study of Diabetes (GGSD), 9-11 Feb. 2010, Jeddah, KSA
G. Honors:
Winner of best clinical abstract in the 8th Health Sciences Annual Poster Day (2003),
Faculty of Medicine. Abstract : Al-Shoumer KAS, Vasanthy BK, Al-Zaid MM. Human
Chromogranin A (CgA) in patients with hyperthyroidism, Annual Health Sciences Poster
Day 2003, P. 71
Listed in WhosWho in the World, 19th Edition 2002
Listed in WhosWho in Medicine and Healthcare 2002-2003
President, Ninth Annual Health Sciences Poster Conference 2004.
Chief Representative of Faculty of Medicine, Kuwait on the third Conference
of Arab Society of Medical faculties, held on 12-13 April 2006, Irbid, Jordan
H. Examiner ;
Faculty of Medicine, Undergraduate students (2001- to date)
MRCP (PACES) Postgraduate UK examination (October 2003-Oman Center, October
2004-Oman Center, 26-28th March 2006-Oman center, October 2006-Oman Center,
October 2007 Kuwait, 26th March 2009, Kuwait; 24TH March 2010, Kuwait,
November 2010, Kuwait; 24 March 2011, Kuwait, March 2012)
26
Saudi Medical Board post-graduate program, KSA, examiner 9-13 December 2006
Saudi Commission for Health specialities- Sub-speciality examination, Saudi Board of
Endocrinology and Metabolism in adults, 23 Jan. 2010.
Oman Medical College, Sohar Medical campus. Examiner on 2011.
Master thesis examiner:
1. Diabetic hand syndromes among with Type 2 Diabetes Mellitus: its related factors,
and its associations with microvascular complications (May 2008, in NCDEG,
Jordon).
2. Factors associated with poor glycemic control among patients with type 2 diabetes
attending NCDEG (May 2008, in NCDEG, Jordon).
3. The Effect of Clothing on Vitamin D Status, Bone Turnover Markers and Bone
Mineral Density in Young Unmarried Kuwaiti Females (Kuwait University, Faculty of
Medicine, Physiology Department, June 2010).
I. Certifications in techniques and investigations:

Thyroid Ultrasound by AACE (24-25th August 2002 post-course attendance and
passing the certification exam)
Bone Densitometry by IOF/ISCD (18-19th Dec. 2003 post-course attendance and
passing the certification exam)
27


1st Annual Meeting

October 12, 2012
1
Name: Dr. Mahmoud Fikri
Address: Ministry of Health, Muhaisnah 2 , Near Etisalat Academy P.O.Box 1853
City:
Dubai
Country:
Email:

dr.m.fikri@gmail.com
2
purposes of Chapter business? yes ___ no
3
___ President
___ Vice President
___ Secretary
___ Treasurer
Statement of why I would like to serve for the AACE Gulf Chapter Board of
members
From my current positions and status that I have in this country and in the Gulf
region, as I represent the Assistant undersecretary for Health policies and as I am
the Chairman of the National Committee for control of Diabetes and as a member
of the Gulf NCDs, I see working as a president for AACE Gulf chapter will represent
an opportunity to influence policies and decision making processes for Diabetes
control and for Capacity Building of manpower for Diabetes and strengthening
the alliances and cooperation with international, regional and local public or
private sectors and institutions working in the field of Diabetes and
endocrinology.
This is in addition to my long association with AACE and their activities in this
country. I have the honor of facilitating and strengthening the ties of AACE with
UAE MOH since 2009 when we have started our collaboration in training the
Medical doctors in Diabetes by conducting the First international AACE Diabetes
training in the country, later on in 2010 2011 we have managed to bring on
board participants of this course from the other Gulf Countries. In addition to our
participation in the first AACE Diabetes Conference held in Doha/Qatar.
For all of this reasons, I am definitely capable of performing the duties of the
president of the AACE Gulf Chapter.
Dr. Mahmoud Fikri
Assistant Undersecretary Health policies
Chairman National Committee for Control of Diabetes
CURRICULUM VITAE
A. PERSONAL INFORMATION:
Name
: MAHMOUD MOHAMED A. FIKREE
Date and Place of Birth : October 1st 1953, Kalba-Sharjah
Sex
: Male
Marital Status
: Married
Nationality
: United Arab Emirates (UAE)
Designation
: Assistant Undersecretary for Preventive Medicine
Address
: Resi: Sharjah, P O Box 32222, Tel: 971-65487333
Fax: 971-6-5487773
Off: Ministry of Health, Abu Dhabi, P O Box 848
UAE. Tel: 971-2-6323480, Fax: 971-2-632691
E-mail:
dr.m.fikri@gmail.com
Honorary positions:
a) Member of International Advisory Committee of World Congress on Vaccines
/ Infections Control World Organization.
b) Nominated for appointment as Assistance to the Director General of World
Health Organization, (Geneva, 2005)
c) Member of the Advisory Council of the Emirates of Sharjah and Chairman of
the Health Committee of the Council 2000
d) Member of the Board Directors for the WHO Center for Health Development
and Research in Japan (KOBE)
e) Member of the Board of Directors of the World Surveys Council-WHO
(COHERD)
f) Vice Chairman of the World Health Assembly-Geneva 2005
g) Member of Advisory Board of UK COCHRANE Center- Bahrain Branch
h) Member of Advisory Board of GCC Health Counsel (1996-2005)
B. EDUCATION
Qualification
School / University
MFPHM
Royal College of Physicians of the United
Membership
Kingdom, UK (faculty of Public Health)
FACP
American College of Physicians, USA
Ph. D. in
Dermatology
Membership of
ACP
University of Medicine and Pharmacy, Carol

Devila, Romania
American College of Physicians, USA
Year
2000
1999
1999
1997
Member of AACE
Americal Association of Clinical Endocrinologist
2011
Fellowship of
Community
Medicine
M Sc.
Dermatology and
Venereology
DTM and Hygiene
College of Physicians and Surgeons, Pakistan
1996
Faculty of Medicine, Cairo University, Egypt
1989
Liverpool School of Tropical Medicine and

Hygiene, UK
1984
Internship
Ain Shams University, Cairo, Egypt
1980
MBBCh.
Ain Shams University, Cairo, Egypt(with Honors)
1979
High School
Ministry of Education School, UAE
1973
C. CURRENT PROFESSIONAL LICENSE

Consultant public health medicine - MOH, UAE
D. CURRENT PROFESSIONAL POSITIONS AND APPOINTMENTS
International Level
1996-2001
Member of the Executive Board, World Health Organization,
Geneva
1995 to 2006
Member of Gulf Cooperative Council Executive Board Health
Council GCC Health Minister Council
1995
Chairman of World Bank Health Sector Study , UAE team
1995-1996
Chairman(Director) of UAE Family Health Study, part of the
GCC countries Family Health Study
Country Level
Period
1980-1984
1984-1986
1986-1988
1988-1997
1990-May 1996
May 1996-1997
Mar 1998 2006
Place of Employment and Designation

Director of Kalba Hospital - 90 bedded hospital in Sharjah,
Ministry of Health, UAE
Director of Sharjah Regional Hospitals 300-bedded hospitals in
Sharjah East Coast, Ministry of Health UAE
Deputy Director of Sharjah Medical District, Ministry of Health,
UAE
Director of Curative Medicine Department, Ministry of Health,
UAE
Director of Ras Al Khaimah Medical District administering the
health facilities of the district which included 3 General Hospitals,
18 Primary Health Centres and a staff of 1800 persons.
Director General of Hospital Administration, as part of the
Curative Medicine Department
Assistant Undersecretary for Preventive Medicine, directing the
Mother and Child health, School Health, Occupational Health,

Disease Prevention and Control and Health Education
departments and International Health Regulations as National
Focal Points.
2010
2009 to Date
2009 to Date
2009 to Date
2009 to Date
2006 to Date
2002 to Date
1991 to Date
April 2006-2009
Other posts
Chairman of the National Cancer Control Board

Assistant Undersecretary for Health Policies Affairs -In charge of
departments of: Primary Health Care, Special Health care, Health
Insurance, Health Promotional Education, Health Legislation,
Preventive Medicine, Disease Control Department and 6 National
Programs..
Chairman of the Higher National Scientific Board for H1N1
Control and Prevention.
Reporter (Member) of the Supreme National Board for H1N1
Control and Prevention
(Strategic level).
Chairman of the Higher National Board for the Control and
Prevention of Diabetes Mellitus.
Chairman of National AIDS Prevention and Control Committee.
Chairman of the National Scientific Board for Vaccination.
Manager of National Cancer Control Program.
CEO for Health Policies Affairs In charge of departments of:

Primary Health Care, Special Health care, Health Insurance,
Health Promotional Education, Health Legislation, Preventive
Medicine and Disease Control Department.
1986 to 2006
1996-2002
1992-2000
1996
Manager of National AIDS Prevention Program, UAE

Chairman of National Drug Formulary Committee
Manager of National Committee for Organ Transplantation, UAE
Vice Chairman of National Drug Registration Committee
Other special duties:

2007 to Date
2000 to Date
1996 to Date
1996 to Date
Chairman and Director for Polio Eradication Program.

Iodine Deficiency Elimination Program.
Chairman of National Malaria Control Program.
Chairman of National Board for Premarital Testing Program.
E. NATIONAL AND REGIONAL ACHIEVEMENTS

-
Responsible for Polio Eradication Program - achieved by 2002.

Responsible for Malaria-Free Certification - achieved by Oct. 2007.
Responsible for Iodine deficiency Disease Elimination - achieved by Oct. 2010.
Responsible for Measles Elimination - Under Process.
F. Summary of leadership and managerial experience:

In the last 26years of my work in the Ministry of Health in 1980, I have contributed in
different capacities to create effective and efficient health management systems.
During the initial years of my work, I participated in the development and
management of secondary and tertiary care hospitals in the various districts of UAE.
These include the Kalba General Hospital, Khorfakkan General Hospital, old Al
Qassimi Hospital-Sharjah and the extension of the Saqr Hospital in Ras Al Khaimah.
As Assistant Undersecretary for Curative Medicine, I was instrumental in developing
the National Strategy, Federal Laws and byelaws for Organ transplantation within the
country. In addition I also played a key role in the development of Radiation
Protection and Control Laws and hospital units in the Ministry of Health. Another of
my proud achievements in the Ministry has been the development of a National
Cancer Registry to help assess the burden of cancers in the UAE. Within the Ministry,
I have utilized my heath management skills to contribute to the restructuring of the
Ministry of Health and development of short and long-term strategies for the Ministry
of Health in 1985. On numerous occasions such as the Liberation of Kuwait (1991),
Haj Pilgrimage (1989) and Earthquake in Yemen (1984), I have had the honor of
leading country level medical relief teams to provide medical aid.
While leading the Preventive Medicine department, I was responsible for upgrading
and adapting the National Immunization Program of UAE in line with the EPI
program of World Health Organization. Older vaccines such as Measles vaccine
(monovalent) have been replaced with combined Measles Mumps and Rubella (MMR)
vaccine.and newer vaccines such as Hepatitis B, HiB(against H.Influenzae B) have
been introduced into the program. As Undersecretary of the Preventive Medicine, I
have played a pivotal role in directing efforts towards eradication/elimination of
infectious diseases by setting up the requirement for WHO accredited laboratories and
an efficient surveillance system particularly in the field of Poliomyelitis, Malaria and
Measles. Due to these efforts, the United Arab Emirates has achieved Polio and
Malaria-free status. Within the Ministry, I have been actively involved in undertaking
capacity development to face new threats from emerging and remerging diseases such
as SARS and Avian Flu and prevent their importation through collaboration with
global partners WHO as well as local and regional organizations. Under my
leadership the school health department strengthened its school health services and
provided free vaccination to not only government but also private schools. I was
instrumental in accepting the Abu Dhabi declaration of the International School
Health Conference to adopt the concept of Health Promoting Schools in UAE. I have
made extensive efforts to direct health education activities to promote positive
behavior change of populations especially in the Tobacco control program. Extensive
school health education programs such as IGROW (for adolescent girls) and
LIFESMIC (for encouraging healthy lifestyles) have been undertaken by the Ministry
of Health in conjunction with the Ministry of Education. During my tenure in the
Ministry of Health, I have also been involved in Global surveys for Family Health
and Child Health survey, World Bank situational analysis of the UAE to name a few.
1
2
3
4
5
G. PRIZES AND AWARDS

GCC Health Counsel Prize for UAE National Diabetes
Awareness Campaign.
GCC Health Counsel Prize for Health Promotion for AIDS
Control and Prevention.
GCC Health Counsel Prize for Health Promotion for UAE
National Campaign for Prevention of Obesity.
UAE Health Foundation Prize by World Health Organization
H. H. Sheikh Rashid Bin Saeed Al-Maktoum Honors Awards and
Certificates for Science
2011
2010
2009
2003
1990
G. TRAINING COURSES
Period
Place
Name and Place of the Course
1994
Saudi Arabia Course on Epidemiology of Diabetes Mellitus, King Saud
University,
1992
UAE
Course on Decision Making for Managers, UAE
1985
Bahrain
International Course on the Management and Control of
Diarrhoeal Diseases organized by the World Health
Organization, Eastern Mediterranean Region
1983
Oman
International Course on the Management and Control of
Diarrhoeal Diseases organized by the World Health
Organization, Eastern Mediterranean Region
1983
Bahrain
International Course on the Management of Expanded
Program of Immunization, organized by the World Health
Organization
1983
UAE
Course on Response to Oil Pollution, organized by the
United States Coast Guard, Abu Dhabi
1980
Bahrain
Course on the Expanded Program of Immunization,
organized by the World Health Organization
H. RESEARCH
Published Research
Title of article
Incidence and Prevalence of HBV among
health workers in UAE,
Role of Micro-Organisms in the
pathogenesis of Seborrhic Dermatitis,
Incidence and Prevalence of Smoking
among a certain age group-School
children
Global School Health Survey
Global School Health Survey
Journal and Year of Publishing

Emirates Medical Journal 1986
Egyptian Journal of Dermatology, 1995
MOH-WHO, 2004
MOH-WHO-CDC Atlanta, 2005

MOH-WHO-CDC Atlanta, 2010
I. TO BE PUBLISHED RESEARCH
-
Assessment of Community Awareness Towards Healthy Life Style 2011.

Assessment of Type 2 Diabetes Among Adults in UAE 2010.
Assessment of Iodine Deficiency Disease in UAE 2009.
J. ON GOING RESEARCH
Epidemiology and Diabetes Type 2: Associated Risk Factor Among Different Age
Groups (MOH, Baker Institute, University Of Sharjah and WHO) 2010-2012.
Assessment of Diabetes Mellitus among School Children (MOH and RCDR)
2010-2011.
National Nutritional Survey Among Different Public Age Groups (MOH, UAE
University and WHO) 2009-2011.
Other Research conducted:

1. Evaluation of oral Ketoconazole in the treatment of Tinea Versicolor, 1987
2. Role of immunity in the pathogenesis of Seborrheic Dermatitis, 1995 (Ph. D
thesis)
3. Project of Population- Human T-Lymphocytotropic Virus Type I (HTLV-I),
1994
4. Child Health Survey for GCC countries, 1985
5. Medical Herbs in the UAE, UAE University-Al Ain, 1993
6. Family Health Survey in the GCC countries, 1996
7. Incidence and Prevalence of Diabetes in the UAE, in collaboration with World
Health Organization and Centre for Disease Control, USA.
K. MANAGEMENT OF PROGRAMS AND TECHNICAL
COMITTEES
1989 to 2006
Manager of National AIDS Prevention Committee
1992 -2006
Manager of National Committee for Organ Transplantation, UAE
2000 to date
Chairman of the National Vaccination Committee
1991 2006
Member of Staff Recruitment Board at Ministry of Health, UAE
1991 1996
Member of Executive National Health Planning Board, UAE
1996 2006
Vice Chairman of the National Drug Registration Committee
1996 2006
Manager of National Cancer control Program
1994
Member of the Committee for the Organizational Structure of the
Ministry of Public Health and Civil service
1989 to 2004
Member of Technicians Private Licensing Division Board
1989-1991
Member of Doctors Licensing and Degree Evaluation Committee,
UAE
1989-1990
Chairman of Medical Mission to Kingdom of Saudi Arabia during
the Pilgrimage Season, (40 medical staff)
1991
Chairman of Medical Team during Liberation of Kuwait state
1984
Chairman of Medical Mission to Yemen, during earthquake
1998- 2001
Member of Tropical Disease Research (TDR) Board, World
Health Organization, Geneva.
S No.
1
2
3
4
5
6
7
8
9
1
2
3
4
L. PROFESSIONAL SOCIETIES MEMBERSHIP

Name of Organization/Society/Committee
Place
International Epidemiology Association
U.K
Royal College of Physicians of United Kingdom
U.K
American College of Physicians
USA
Regional member of Advisory Board of the Bahrain Bahrain
Branch of the UK Cochrane Center
Administrative Board of the Pan Arab Leagues of
Arab
Dermatology
Countries
Leagues of Dermatology for Gulf Countries
GCC
Board of Emirates Medical Association
Secretary General of Dermatology Division of the
Emirates Medical Association
Fathers Council of Sharjah City
UAE
UAE
UAE
Since
2008
2000
1999
2006
1989-1998
1989- to
date
1984-1988
1993
1996
1986-1988
M. CIVIC ACTIVITIES AND COMMUNITY INVOLVEMENT

1997
Secretary General for the 1st Gulf Organ Transplantation
Congress, Abu Dhabi
Chairman of Ras Al Khaimah Social District Committee for
1990-1996
Development of Old People Geriatric Home(48 beds)
Secretary General for 4th Asian Congress of Dermatology, Dubai 1995-1996
Chairman of Sharjah District Committee for Establishment of
1996-1998
Old People Home(40 beds)
N. ACHIEVEMENTS
In Public Health Legislation:

1- Development of National Tobacco Control Laws and Implementation
Regulation (2011).
2- The Development and the update of the National Organ Transplantation
Law (1994-2011).
3- Development of HIV/AIDS People Rights and Responsibilities Regulation
(2010).
4- Development of National Public Health Law (ongoing 2010).
5- Modification and Update of other Laws; Birth and Death Law,
Communicable Disease Law, Non communicable Disease Law and Mental
Health law.
6- Development of National Tobacco Control Law (2009).
7- Development of National Radiation Protection Law (2002).


(Bahrain, Kuwait, Oman, Qatar, Kingdom of Saudi Arabia, United Arab Emirates)
1st Annual Meeting

October 12, 2012
Name:
AHMED A.K. HASSOUN
Address:
PODIUM VILLA D-101, EXECUTIVE TOWERS, BUSINESS BAY
City:
DUBAI
Country:
UNITED ARAB EMIRATES
Email:
aakhass@yahoo.com
purposes of Chapter business? YES
President
___ Vice President
___ Secretary
___ Treasurer
CV or bio-sketch included
Candidate statement included
AHMED A.K. HASSOUN, MD, FACE, FACP

Consultant Endocrinologist & Chairman of Research and Medical Education
Dubai Diabetes Center - Dubai Health Authority
Dr. Hassoun completed his residency training in Internal Medicine at Brown
University - Rhode Island, USA. After 3 years of extensive clinical and research
fellowship in Endocrinology, Diabetes & Metabolism at the Mayo Clinic in
Rochester, Minnesota, he joined the Endocrinology staff at Mayo Clinic.
He is American board certified in both Internal Medicine & Endocrinology, Diabetes,
and Metabolism.
Dr. Hassoun is a fellow of the American College of Physicians and the American
College of Endocrinology. In addition, he is an active member of: American Diabetes
Association (ADA), American Endocrine Society (ES), and the American Association
of Clinical Endocrinologists (AACE). His previous appointments included: Chief of
Endocrinology, Emirates Diabetes Society Board member, Clinical Assistant
Professor at Wayne State University in Michigan and the Faculty of Medicine at the
UAE University.
He has been actively participating in: developing and updating the UAE Diabetes
guidelines, educating & training doctors & other healthcare providers, as well
as conducting research in the field of diabetes & endocrinology. Dr. Hassoun is a
founding member and active coordinator of the monthly UAE Endocrinology
meetings, which was established in the year 2000, to encourage up-to-date education
and dialogue amongst endocrinologists in UAE.
After great anticipation, I was delighted to hear the news of the initiation of the Gulf
Chapter of AACE. This is an exciting opportunity for Endocrinologists in the region
to collaborate with one another and progress (as a group) within the scientific field.
It would be a great honor and a stimulating challenge to be appointed as the
President of the Gulf Chapter.
With consultation and the support of the Chapter members, my efforts would be
focused primarily on: implementing regional endocrinology guidelines, increasing
scientific meetings in collaboration with AACE and its other Chapters, and educating
healthcare providers with the ultimate aim of empowering our patients to achieve
optimum endocrine health through our initiatives. In addition, I would like to
establish collaborative research efforts between the Gulf member countries. I believe
that I have the appropriate background, experience and rapport to assist the Gulf
Chapter in its commencement, growth, and development.
Having been an AACE member since 1995 and actively participating and presenting
in its annual meetings, I have a definite understanding of the organization and its
values. Also, the intensive clinical training I received at the Mayo Clinic provided me
with exceptional knowledge and clinical skills. Furthermore, I have considerable
experience in design, coordination and management of several scientific educational
programs.
If chosen to represent the Gulf Chapter, as President I will do my best to successfully
accomplish the organizations goals. I look forward to advocating the Gulf Chapter
of AACE and its members. Finally, I would like to thank all the individuals who have
been involved in initiating the AACE Gulf Chapter, and for giving us this wonderful
opportunity.

Gulf Chapter American Association of Clinical Endocrinologists

Hochgeladen von

Dokumentinformationen

Copyright

Verfügbare Formate

Dieses Dokument teilen

Dokument teilen oder einbetten

Freigabeoptionen

Stufen Sie dieses Dokument als nützlich ein?

Sind diese Inhalte unangemessen?

Copyright:

Verfügbare Formate

Gulf Chapter American Association of Clinical Endocrinologists

Hochgeladen von

Copyright:

Verfügbare Formate

Gulf Chapter

CHAPTER II: MEMBERSHIP

CHAPTER III: MEETINGS

CHAPTER IV: BOARD OF DIRECTORS

Section 3. Election and Term of Office. The

Board of Director Nominees

Thamer Alessa, MD; Kuwait

Salem Arifi Beshyah, MBBCh

Vice President Nominees

Thamer M. Alessa, M.D.

Fellowship in Endocrinology, Diabetes and Metabolism at the J. Maxwell

Nov 2005Nov 2008

Internal Medicine Residency Program at the University of Miami/Jackson

Kuwait University Faculty of Medicine

Kuwait University Faculty of Medicine

Endocrine Division - Mubarak Al-Kabeer Hospital State of Kuwait Senior

Nov 2008July 2009

Internal Medicine - Mubarak Al-Kabeer Hospital State of Kuwait Assistant

Aug 2004Nov 2005

Internal Medicine - Mubarak Al-Kabeer Hospital State of Kuwait Assistant

Aug 2003Aug 2004

Mubarak Al-Kabeer Hospital State of Kuwait Internship

Professional Exchange Clerkship, International Federation of Medical Students

RESEARCH & PUBLICATIONS

Poster Presentation at the Endocrine Society 93rd Annual Meeting in Boston,

Management of Diabetic Dyslipidemia: an update Review Article

Thamer M. Alessa, M.D.

Inhaled Insulin Research Study University of Miami Miller School of Medicine

HONORS & AWARDS

Chief Fellow, the J. Maxwell McKenzie Endocrinology, Diabetes and Metabolism

Kuwait Medical Students Association Outstanding Student Award

HRH the Emir of Kuwaits Graduation Ceremony

Kuwait Medical Students Association Outstanding Student Award

Kuwait Medical Students Association Outstanding Student Award

Educational Commission for Foreign Medical Graduates certification.

My name is Eman Alfadhli, Assistant professor of Medicine, consultant

Dr. Eman Mohammed Alfadhli

Eman Mohammed Al Fadhli, MD, MRCP, SBIM,

Al Madinah Al-Monawara, Saudi Arabia

Mobile: 0555305170, Home: 04- 8443195

King Saud University, 1994

King Saud University, 1994 - 1995

Riyadh Armed Forces Hospital

Senior Registrar, Endocrinology

Oct 2000 December 2003

:* Locum as a consultant endocrinologist at different

5. Medical Council of Canada Evaluating Exam (MCCEE), February 2003

1- Recent Advances in Diabetes Management, at Islet transplantation

9- Endocrine emergency, at Introduction to Emergency Nursing course at

22- Update in the management of Gestational Diabetes, at International

34-Management of hyperglycemia in hospitals at Annual Regional Hajj

Courses and Symposia

16- International Symposium on Osteoporosis, Security Forces Hospital,

29- Diabetes update symposium, Madinha, Saudi Arabia, Saudi Society of

56- Introductory Hands-On Thyroid Ultrasound Workshop, Washington, DC,

69- Islet Cell Transplantation, at Surgery Update Symposium, at Diabetes

Organization for Courses and Symposia:

Best resident of Internal Medicine, Riyadh Armed Forces Hospital, 1996

Riyadh Armed Forces Hospital Award for achievement, 2000

Riyadh Armed Forces Hospital Award for achievement, 2001

Board member of Saudi Society for Endocrinology & Metabolism

Member of Endocrine Society.

Peer- reviewer for:

The Annals of Saudi Medicine Journal.